<GENERIC_NAME> alendronic_acid </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <GENERIC_NAME> colecalciferol </GENERIC_NAME> <GENERIC_NAME> vitamin_d3 </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <DX_NAME> loss_of_bone </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> hip_fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> vitamin_d </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> vitamin_d_deficiency </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_weakness </DX_NAME> <DX_NAME> falls </DX_NAME> <DX_NAME> fractures </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> vitamin_d_insufficiency </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> hip_fractures </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> thinning </DX_NAME> <DX_NAME> weakening </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skeleton </SYSTEM_ORGAN_SITE> <DX_NAME> skeleton_healthy </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> hurt </DX_NAME> <DX_NAME> breaks </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> height_loss </DX_NAME> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> injury </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrist </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> stooped_posture </DX_NAME> <DX_NAME> loss_of_mobility </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> exercise_programme </TREATMENT_NAME> <TREATMENT_NAME> balanced_diet </TREATMENT_NAME> <TREATMENT_NAME> dietary_supplements </TREATMENT_NAME>
<BRAND_NAME> evotaz </BRAND_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <GENERIC_NAME> atazanavir </GENERIC_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> cobicistat </GENERIC_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <GENERIC_NAME> cobicistat </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <BRAND_NAME> evotaz </BRAND_NAME> <AGE> 18 </AGE> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> immunodeficiency_syndrome </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <BRAND_NAME> evotaz </BRAND_NAME>
<BRAND_NAME> vaniqa </BRAND_NAME> <GENERIC_NAME> eflornithine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> hair </SYSTEM_ORGAN_SITE> <BRAND_NAME> vaniqa </BRAND_NAME> <SYSTEM_ORGAN_SITE> hair </SYSTEM_ORGAN_SITE> <DX_NAME> hirsutism </DX_NAME> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> mylan </BRAND_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> taxoids </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <DX_NAME> head_and_neck_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_node </SYSTEM_ORGAN_SITE> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <GENERIC_NAME> prednisolone </GENERIC_NAME> <DX_NAME> gastric_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> neck_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME>
<GENERIC_NAME> alogliptin </GENERIC_NAME> <TREATMENT_NAME> dpp4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <TREATMENT_NAME> dipeptidyl_peptidase4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <TREATMENT_NAME> “oral_antidiabetics” </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> niddm </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TREATMENT_NAME> antidiabetic_medicines </TREATMENT_NAME> <DX_NAME> sulphonylureas </DX_NAME> <GENERIC_NAME> sulphonylureas </GENERIC_NAME> <GENERIC_NAME> glipizide </GENERIC_NAME> <GENERIC_NAME> tolbutamide </GENERIC_NAME> <GENERIC_NAME> glibenclamide </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> thiazolidinediones </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TREATMENT_NAME> oral_antidiabetic_medicines </TREATMENT_NAME> <TREATMENT_NAME> antidiabetic_medicine </TREATMENT_NAME>
<GENERIC_NAME> raloxifene </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> postmenopausal </DX_NAME> <GENERIC_NAME> raloxifene </GENERIC_NAME> <DX_NAME> vertebral_fractures </DX_NAME> <DX_NAME> postmenopausal_osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> hip_fractures </DX_NAME> <GENERIC_NAME> raloxifene </GENERIC_NAME> <GENERIC_NAME> raloxifene </GENERIC_NAME> <TREATMENT_NAME> nonhormonal_medicines </TREATMENT_NAME> <TREATMENT_NAME> selective_oestrogen_receptor_modulators </TREATMENT_NAME> <DX_NAME> menopause </DX_NAME> <GENERIC_NAME> raloxifene </GENERIC_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> thin </DX_NAME> <DX_NAME> fragile </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hips </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE> <DX_NAME> back_pain </DX_NAME> <DX_NAME> loss_of_height </DX_NAME>
<GENERIC_NAME> kogenate_bayer </GENERIC_NAME> <GENERIC_NAME> human_recombinant_coagulation_factor_viii </GENERIC_NAME> <GENERIC_NAME> octocog_alfa </GENERIC_NAME> <GENERIC_NAME> kogenate_bayer </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> congenital_factor_viii_deficiency </DX_NAME> <DX_NAME> von_willebrand_factor </DX_NAME> <DX_NAME> von_willebrand's_disease </DX_NAME>
<BRAND_NAME> zercepac </BRAND_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <TEST_NAME> monoclonal_antibodies </TEST_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <BRAND_NAME> zercepac </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> tumour </DX_NAME> <BRAND_NAME> zercepac </BRAND_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <TREATMENT_NAME> aromatase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> aromatase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> hormone_receptorpositive </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <DX_NAME> high_levels_of_her2 </DX_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> 5flououracil </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME>
<TREATMENT_NAME> oral_antidiabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TEST_NAME> glucose </TEST_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> weight_reduction </TREATMENT_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> lutropin_alfa </GENERIC_NAME> <TREATMENT_NAME> hormone_called_follicle_stimulating_hormone </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> ovary </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> release_of_an_egg_from_the_follicle_(ovulation) </PROCEDURE_NAME>
<GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessel_wall </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME>
<GENERIC_NAME> desloratadine </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> antihistamine </GENERIC_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> antiallergy_medicine </GENERIC_NAME> <DX_NAME> drowsy </DX_NAME> <DX_NAME> allergic_reaction </DX_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <DX_NAME> allergic_rhinitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> nasal_passages </SYSTEM_ORGAN_SITE> <DX_NAME> allergy </DX_NAME> <DX_NAME> hay_fever </DX_NAME> <DX_NAME> allergy </DX_NAME> <AGE> 12 </AGE> <DX_NAME> sneezing </DX_NAME> <DX_NAME> runny </DX_NAME> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> palate </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <DX_NAME> red </DX_NAME> <DX_NAME> watery_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <GENERIC_NAME> desloratadine </GENERIC_NAME> <DX_NAME> urticaria </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_condition </DX_NAME> <DX_NAME> allergy </DX_NAME> <DX_NAME> itching </DX_NAME> <DX_NAME> hives </DX_NAME>
<GENERIC_NAME> follitropin </GENERIC_NAME> <DX_NAME> infertility </DX_NAME> <PROCEDURE_NAME> vitro_fertilisation </PROCEDURE_NAME> <TREATMENT_NAME> ivf </TREATMENT_NAME> <TREATMENT_NAME> intracytoplasmic_sperm_injection </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> dimethyl_fumarate </GENERIC_NAME> <GENERIC_NAME> dimethyl_fumarate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> plaque_psoriasis </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> thickened </DX_NAME> <DX_NAME> inflamed </DX_NAME> <DX_NAME> red_areas </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> scales </DX_NAME> <GENERIC_NAME> dimethyl_fumarate </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> 24_months </TIME_TO_MEDICATION_NAME>
<DX_NAME> hereditary_transthyretin_amyloidosis </DX_NAME> <DX_NAME> hereditary_transthyretin_amyloidosis </DX_NAME> <DX_NAME> genetic_disease </DX_NAME> <DX_NAME> polyneuropathy </DX_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> nerve_damage </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> sevelamer </GENERIC_NAME> <SYSTEM_ORGAN_SITE> digestive_tract </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <TREATMENT_NAME> peritoneal_dialysis </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <PROCEDURE_NAME> peritoneal_dialysis </PROCEDURE_NAME> <DX_NAME> hyperphosphataemia </DX_NAME> <DX_NAME> hard_deposits </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> calcification </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> itchy_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> red_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <DX_NAME> fractures </DX_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <TREATMENT_NAME> vitamin_d_supplements </TREATMENT_NAME> <GENERIC_NAME> vitamin_d_supplements </GENERIC_NAME> <DX_NAME> renal_bone_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE>
<DX_NAME> wilson’s_disease </DX_NAME> <GENERIC_NAME> trientine </GENERIC_NAME> <DX_NAME> wilson’s_disease </DX_NAME> <DX_NAME> inherited_condition </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_damage </DX_NAME> <SYSTEM_ORGAN_SITE> nervous_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> penicillamine </GENERIC_NAME>
<GENERIC_NAME> ipilimumab </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> immune_cells </TREATMENT_NAME> <GENERIC_NAME> Ipilimumab </GENERIC_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <GENERIC_NAME> Ipilimumab </GENERIC_NAME> <GENERIC_NAME> nivolumab </GENERIC_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> renal_cell_carcinoma </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cancer </DX_NAME> <GENERIC_NAME> nivolumab </GENERIC_NAME> <GENERIC_NAME> nivolumab </GENERIC_NAME>
<GENERIC_NAME> darunavir_krka </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <NAME> krka </NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> darunavir_krka </GENERIC_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicines </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicines </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME>
<BRAND_NAME> epidyolex </BRAND_NAME> <GENERIC_NAME> cannabidiol </GENERIC_NAME> <GENERIC_NAME> cannabidiol </GENERIC_NAME> <GENERIC_NAME> sucralose </GENERIC_NAME> <GENERIC_NAME> strawberry_flavour </GENERIC_NAME> <GENERIC_NAME> benzyl_alcohol </GENERIC_NAME> <BRAND_NAME> epidyolex </BRAND_NAME> <ADDRESS> gw_pharma </ADDRESS> <DATE> databankweg_26,_3821al </DATE> <EMAIL> info@gwpharm.com </EMAIL> <DATE> databankweg_26,_3821al </DATE> <EMAIL> info@gwpharm.com </EMAIL> <ADDRESS> gw_pharma_limited,_kent_science_park,_sittingbourne,_kent </ADDRESS> <ADDRESS> me9_8ag,_united_kingdom </ADDRESS> <EMAIL> info@gwpharm.com </EMAIL> <ID> 337981015 </ID> <ADDRESS> lietuva_tel </ADDRESS> <ID> 337981015 </ID> <ID> 337981015 </ID> <ID> 337981015 </ID> <ID> 337981015 </ID> <ID> 337981015 </ID> <ID> 337981015 </ID> <ADDRESS> malta_tel </ADDRESS> <ID> 337981015 </ID> <ID> 3022957821 </ID> <ID> 337981015 </ID> <EMAIL> info@gwpharm.com </EMAIL> <EMAIL> info@gwpharm.com </EMAIL> <EMAIL> info@gwpharm.com </EMAIL> <ID> 337981015 </ID> <ID> 337981015 </ID> <ID> 337981015 </ID> <ID> 337981015 </ID> <ADDRESS> gw_pharma_spain,_s.l._tel </ADDRESS> <ID> 34914197379 </ID> <NAME> polska_tel </NAME> <ID> 337981015 </ID> <ID> 170755854 </ID> <ID> 337981015 </ID> <NAME> hrvatska_tel </NAME> <ID> 337981015 </ID> <ID> 337981015 </ID> <ADDRESS> ireland_tel </ADDRESS> <ID> 337981015 </ID> <NAME> slovenija </NAME> <ID> 337981015 </ID> <ID> 337981015 </ID> <ID> 337981015 </ID> <NAME> italia </NAME> <ADDRESS> gw_pharma_italy </ADDRESS> <ID> 687501801 </ID> <NAME> suomi </NAME> <ID> 337981015 </ID> <ID> 337981015 </ID> <ID> 337981015 </ID> <NAME> latvija_tel </NAME> <ID> 337981015 </ID> <ADDRESS> united_kingdom_tel </ADDRESS> <ID> 337981015 </ID>
<BRAND_NAME> kepivance </BRAND_NAME> <GENERIC_NAME> palifermin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> digestive_tract </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> palifermin </GENERIC_NAME> <BRAND_NAME> kepivance </BRAND_NAME> <DX_NAME> oral_mucositis </DX_NAME> <DX_NAME> soreness </DX_NAME> <DX_NAME> dryness </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> side_effect </DX_NAME> <DX_NAME> blood_cancer </DX_NAME> <DX_NAME> blood_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <TREATMENT_NAME> autologous_hematopoietic_stem_cell_transplantation </TREATMENT_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> side_effects </DX_NAME> <DX_NAME> oral_mucositis </DX_NAME> <BRAND_NAME> kepivance </BRAND_NAME> <DX_NAME> oral_mucositis </DX_NAME> <BRAND_NAME> kepivance </BRAND_NAME> <AGE> 18 </AGE>
<GENERIC_NAME> Pemetrexed </GENERIC_NAME> <BRAND_NAME> Sandoz </BRAND_NAME> <NAME> Sandoz </NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> Pemetrexed </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <DX_NAME> malignant_pleural_mesothelioma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lining_of_the_lung </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> Pemetrexed </GENERIC_NAME> <BRAND_NAME> Sandoz </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> Pemetrexed </GENERIC_NAME> <BRAND_NAME> Sandoz </BRAND_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> Pemetrexed </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<GENERIC_NAME> bimatoprost </GENERIC_NAME> <GENERIC_NAME> timolol </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <GENERIC_NAME> bimatoprost </GENERIC_NAME> <GENERIC_NAME> prostaglandin </GENERIC_NAME> <GENERIC_NAME> timolol </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> glaucoma </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> glaucoma </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> eye_drops </TREATMENT_NAME> <GENERIC_NAME> prostaglandin_analogues </GENERIC_NAME>
<GENERIC_NAME> tolvaptan </GENERIC_NAME> <GENERIC_NAME> vasopressin </GENERIC_NAME> <DX_NAME> cysts </DX_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <GENERIC_NAME> vasopressin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cysts </DX_NAME> <DX_NAME> polycystic_kidney_disease” </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> adpkd </DX_NAME> <DX_NAME> fluidfilled_cysts </DX_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_function </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <DX_NAME> adpkd </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> ckd </DX_NAME> <DX_NAME> progressing_disease </DX_NAME>
<GENERIC_NAME> ibandronic_acid </GENERIC_NAME> <GENERIC_NAME> ibandronic_acid </GENERIC_NAME> <GENERIC_NAME> sodium_monohydrate </GENERIC_NAME> <GENERIC_NAME> lactose_monohydrate </GENERIC_NAME> <GENERIC_NAME> povidone </GENERIC_NAME> <GENERIC_NAME> cellulose_microcrystalline </GENERIC_NAME> <GENERIC_NAME> crospovidone </GENERIC_NAME> <GENERIC_NAME> stearic_acid_purified </GENERIC_NAME> <GENERIC_NAME> silica_colloidal_anhydrous_tablet </GENERIC_NAME> <GENERIC_NAME> hypromellose </GENERIC_NAME> <GENERIC_NAME> titanium_dioxide </GENERIC_NAME> <DX_NAME> dic </DX_NAME> <ADDRESS> Falcon_Way_Shire_Park_Welwyn_Garden_City_AL7 </ADDRESS> <ADDRESS> 1TW_United_Kingdom </ADDRESS> <ADDRESS> Manufacturer_Roche_Pharma </ADDRESS> <NAME> Emil-Barell </NAME> <ADDRESS> Strasse </ADDRESS> <PHONE_OR_FAX> D-79639 </PHONE_OR_FAX> <ADDRESS> Grenzach-Wyhlen_Germany </ADDRESS> <ADDRESS> Belgique/Belgien_N.V._Roche </ADDRESS> <PHONE_OR_FAX> 359_2_818_44_44 </PHONE_OR_FAX> <ADDRESS> Magyarország_Roche </ADDRESS> <ADDRESS> Magyarország </ADDRESS> <ADDRESS> Kft </ADDRESS> <PHONE_OR_FAX> 36_-_23_446_800_Česká </PHONE_OR_FAX> <NAME> republika_Roche_s. </NAME> <NAME> r._o._Tel </NAME> <PHONE_OR_FAX> 420_-_2_20382111 </PHONE_OR_FAX> <ADDRESS> Malta </ADDRESS> <ADDRESS> United_Kingdom </ADDRESS> <NAME> Danmark_Roche </NAME> <TEST_NAME> Tlf </TEST_NAME> <NAME> Roche_Nederland </NAME> <TEST_NAME> B.V. </TEST_NAME> <PHONE_OR_FAX> 438050 </PHONE_OR_FAX> <ADDRESS> Deutschland_Roche_Pharma_AG_Tel </ADDRESS> <TEST_NAME> Tlf </TEST_NAME> <NAME> Roche_Austria </NAME> <TEST_NAME> GmbH </TEST_NAME> <PHONE_OR_FAX> 48_-_22_345_18 </PHONE_OR_FAX> <TEST_NAME> España_Roche_Farma </TEST_NAME> <NAME> Roche_Farma </NAME> <NAME> Roche_România </NAME> <ADDRESS> Ireland </ADDRESS> <NAME> Slovenija_Roche </NAME> <PHONE_OR_FAX> 354_540_8000 </PHONE_OR_FAX> <NAME> Roche_Slovensko </NAME> <NAME> Tel </NAME> <PHONE_OR_FAX> 421_-_2_52638201 </PHONE_OR_FAX> <NAME> Italia_Roche </NAME> <ADDRESS> S.p.A. </ADDRESS> <PHONE_OR_FAX> 39_-_039_2471 </PHONE_OR_FAX> <NAME> Suomi/Finland_Roche </NAME> <NAME> Stamatis </NAME> <PHONE_OR_FAX> 357_-_22_76_62_76 </PHONE_OR_FAX> <NAME> Roche_AB_Tel </NAME> <NAME> Latvija_Roche </NAME> <ADDRESS> Latvija_SIA_Tel </ADDRESS> <PHONE_OR_FAX> 371_-6_7_039831 </PHONE_OR_FAX> <ADDRESS> United_Kingdom_Roche </ADDRESS> <ADDRESS> Lietuva_UAB_“Roche_Lietuva”_Tel </ADDRESS> <PHONE_OR_FAX> 370_5_2546799 </PHONE_OR_FAX>
<GENERIC_NAME> volanesorsen </GENERIC_NAME> <DX_NAME> familial_chylomicronemia_syndrome </DX_NAME> <DX_NAME> genetic_disease </DX_NAME> <TEST_NAME> triglycerides </TEST_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <BRAND_NAME> waylivra </BRAND_NAME> <TEST_NAME> genetic_testing </TEST_NAME> <DX_NAME> pancreatitis </DX_NAME> <BRAND_NAME> waylivra </BRAND_NAME> <AGE> 18 </AGE>
<GENERIC_NAME> romosozumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> broken_bone </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> fracture </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> thin </DX_NAME> <DX_NAME> fragile </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> fractures </DX_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> sclerostin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> fractures </DX_NAME>
<GENERIC_NAME> spinraza </GENERIC_NAME> <GENERIC_NAME> spinraza </GENERIC_NAME> <DX_NAME> genetic_disease </DX_NAME> <DX_NAME> spinal_muscular_atrophy </DX_NAME> <SYSTEM_ORGAN_SITE> sma </SYSTEM_ORGAN_SITE> <DX_NAME> spinal_muscular_atrophy </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> loss_of_nerve_cells </DX_NAME> <SYSTEM_ORGAN_SITE> nerve_cells </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> weakness </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> shoulders </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hips </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> thighs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing </DX_NAME> <GENERIC_NAME> spinraza </GENERIC_NAME> <DX_NAME> loss_of_nerve_cells </DX_NAME> <SYSTEM_ORGAN_SITE> nerve_cells </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> belantamab_mafodotin </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <DX_NAME> myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> myeloma </DX_NAME>
<SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> ‘neurotrophic_keratitis’ </DX_NAME> <SYSTEM_ORGAN_SITE> cornea </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> defects </DX_NAME> <SYSTEM_ORGAN_SITE> surface_of_the_cornea </SYSTEM_ORGAN_SITE> <DX_NAME> corneal_ulcers </DX_NAME> <SYSTEM_ORGAN_SITE> cornea </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <GENERIC_NAME> eerithroepoehtin </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <GENERIC_NAME> erythropoietin </GENERIC_NAME> <DX_NAME> red_cell_production </DX_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> solid_tumours </DX_NAME> <DX_NAME> malignant_lymphoma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> bone_marrow_cancer </DX_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> knee_replacement_operations </PROCEDURE_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> bone_marrow_disorder </DX_NAME> <DX_NAME> disruption </DX_NAME> <DX_NAME> myelodysplastic_syndromes </DX_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME>
<GENERIC_NAME> glycopyrronium_bromide </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficult </DX_NAME> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> copd </DX_NAME>
<GENERIC_NAME> buprenorphine </GENERIC_NAME> <GENERIC_NAME> opioid_medicine </GENERIC_NAME> <TREATMENT_NAME> opioid_medicine </TREATMENT_NAME> <DX_NAME> opioid_dependence </DX_NAME> <AGE> 16 </AGE>
<DX_NAME> inherited_disease_hypophosphatasia </DX_NAME> <GENERIC_NAME> asfotase_alfa </GENERIC_NAME> <DX_NAME> hypophosphatasia </DX_NAME> <DX_NAME> hypophosphatasia </DX_NAME> <TEST_NAME> alkaline_phosphatase </TEST_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> teeth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <DX_NAME> difficulty_walking </DX_NAME> <DX_NAME> difficulties_with_breathing </DX_NAME> <DX_NAME> seizures </DX_NAME> <GENERIC_NAME> strensiq </GENERIC_NAME> <TEST_NAME> alkaline_phosphatase </TEST_NAME> <DX_NAME> hypophosphatasia </DX_NAME> <TREATMENT_NAME> enzyme_replacement_treatment </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> skeleton </SYSTEM_ORGAN_SITE>
<TEST_NAME> ultrasound </TEST_NAME> <GENERIC_NAME> sulphur_hexafluoride </GENERIC_NAME> <TEST_NAME> ultrasound </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> urinary_tract </SYSTEM_ORGAN_SITE>
<BRAND_NAME> kaletra </BRAND_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> kaletra </BRAND_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> kaletra </BRAND_NAME> <DX_NAME> hiv_infection </DX_NAME> <BRAND_NAME> kaletra </BRAND_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <BRAND_NAME> kaletra </BRAND_NAME> <GENERIC_NAME> lopinavir </GENERIC_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <BRAND_NAME> kaletra </BRAND_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <BRAND_NAME> kaletra </BRAND_NAME> <TREATMENT_NAME> antiviral_medicines </TREATMENT_NAME>
<GENERIC_NAME> eptifibatide </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> coronary_insufficiency_defined </DX_NAME> <TIME_TO_DX_NAME> recent </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> recent </TIME_TO_DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> electrocardiographic_abnormalities </DX_NAME> <GENERIC_NAME> aspirin </GENERIC_NAME> <GENERIC_NAME> unfractionated_heparin </GENERIC_NAME>
<GENERIC_NAME> afatinib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<BRAND_NAME> samsca </BRAND_NAME> <GENERIC_NAME> tolvaptan </GENERIC_NAME> <GENERIC_NAME> vasopressin_antagonists </GENERIC_NAME> <GENERIC_NAME> vasopressin </GENERIC_NAME> <TREATMENT_NAME> hormone </TREATMENT_NAME> <DX_NAME> loss_of_water </DX_NAME> <GENERIC_NAME> vasopressin </GENERIC_NAME> <TEST_NAME> serum_sodium_levels </TEST_NAME> <TEST_NAME> sodium_level </TEST_NAME> <DX_NAME> siadh </DX_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> hormone_vasopressin </TREATMENT_NAME> <GENERIC_NAME> vasopressin </GENERIC_NAME> <TEST_NAME> sodium_levels </TEST_NAME> <DX_NAME> hyponatremia </DX_NAME> <DX_NAME> difficulties_in_concentration_and_memory </DX_NAME>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <TEST_NAME> platelets </TEST_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_k_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> anticoagulants’ </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> tacrolimus </GENERIC_NAME> <TREATMENT_NAME> immunosuppressant </TREATMENT_NAME> <PROCEDURE_NAME> organ_transplant </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> transplanted </PROCEDURE_NAME> <DX_NAME> rejection </DX_NAME> <PROCEDURE_NAME> transplanted </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> transplantation </PROCEDURE_NAME>
<URL> http://www.ema.europa.eu/docs/en </URL> <DATE> 2013/03/wc500139752.doc_26 </DATE> <GENERIC_NAME> sodium_chloride </GENERIC_NAME> <DATE> 1097 </DATE> <NAME> jb_amsterdam </NAME> <ADDRESS> netherlands_manufacturer_molmed_spa </ADDRESS> <ADDRESS> 58_via_olgettina_20132 </ADDRESS> <ADDRESS> milan_italy </ADDRESS>
<GENERIC_NAME> budesonide </GENERIC_NAME> <GENERIC_NAME> formoterol_fumarate_dihydrate </GENERIC_NAME> <GENERIC_NAME> budesonide </GENERIC_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <GENERIC_NAME> formoterol_fumarate_dihydrate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <AGE> 13 </AGE> <AGE> 17 </AGE> <DX_NAME> asthma </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> asthma </DX_NAME> <BRAND_NAME> spiromax </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <TREATMENT_NAME> asthma_inhalers </TREATMENT_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME> <BRAND_NAME> biresp_spiromax </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> asthma </DX_NAME> <BRAND_NAME> biresp_spiromax </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <BRAND_NAME> biresp_spiromax </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <BRAND_NAME> biresp_spiromax </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> cough </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_discomfort </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> copd </DX_NAME>
<GENERIC_NAME> leflunomide </GENERIC_NAME> <TREATMENT_NAME> antirheumatic_medicines </TREATMENT_NAME> <GENERIC_NAME> leflunomide </GENERIC_NAME> <GENERIC_NAME> leflunomide </GENERIC_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> difficulty_moving </DX_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> loss_of_appetite </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> loss_of_energy </DX_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> lack_of_red_blood_cells </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> difficulty_in_moving </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> patches_of_red </DX_NAME> <DX_NAME> scaly_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_lesions </DX_NAME>
<GENERIC_NAME> “rituximab” </GENERIC_NAME> <GENERIC_NAME> rituximab </GENERIC_NAME> <DX_NAME> nonhodgkin’s_lymphoma </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> “chemotherapy” </TREATMENT_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> cll </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cll </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <DX_NAME> cll </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> truxima </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis_truxima </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> truxima </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> side_effects </DX_NAME> <DX_NAME> truxima </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <TEST_NAME> blood_test </TEST_NAME> <TEST_NAME> rheumatoid_factor </TEST_NAME> <TEST_NAME> anticyclic_citrullinated_peptide </TEST_NAME> <TEST_NAME> anticcp </TEST_NAME> <TEST_NAME> tests </TEST_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> d </DX_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis_truxima </DX_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> wegener’s_granulomatosis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> pemphigus_vulgaris_truxima </DX_NAME> <DX_NAME> pemphigus_vulgaris </DX_NAME> <DX_NAME> pemphigus_vulgaris </DX_NAME> <DX_NAME> autoimmune_condition </DX_NAME> <DX_NAME> painful_blisters </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lining_of_the_mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> genitals </SYSTEM_ORGAN_SITE>
<BRAND_NAME> adcirca </BRAND_NAME> <GENERIC_NAME> tadalafil </GENERIC_NAME> <BRAND_NAME> adcirca </BRAND_NAME> <DX_NAME> pulmonary_arterial_hypertension </DX_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_(pde5)_inhibitors </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> ertugliflozin </GENERIC_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> ertugliflozin </GENERIC_NAME> <GENERIC_NAME> sodium_glucose_cotransporter2 </GENERIC_NAME> <GENERIC_NAME> sglt2 </GENERIC_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> dipeptidyl_peptidase4 </GENERIC_NAME> <AGE> 18 </AGE> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> steglujan </GENERIC_NAME> <GENERIC_NAME> ertugliflozin </GENERIC_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> steglujan </GENERIC_NAME> <GENERIC_NAME> steglujan </GENERIC_NAME> <GENERIC_NAME> steglujan </GENERIC_NAME> <GENERIC_NAME> ertugliflozin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> poor_circulation </DX_NAME>
<BRAND_NAME> vizamyl </BRAND_NAME> <GENERIC_NAME> flutemetamol </GENERIC_NAME> <AGE> 18f </AGE> <DX_NAME> alzheimer’s_disease </DX_NAME> <DX_NAME> memory_loss </DX_NAME> <TREATMENT_NAME> radiopharmaceutical_product </TREATMENT_NAME> <BRAND_NAME> vizamyl </BRAND_NAME> <DX_NAME> alzheimer’s_disease </DX_NAME> <DX_NAME> memory_loss </DX_NAME> <DX_NAME> memory_problems </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <TEST_NAME> brain_scan </TEST_NAME> <TEST_NAME> positronemission_tomography_(pet)_scan </TEST_NAME> <TEST_NAME> scan </TEST_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <TEST_NAME> brain_function_tests </TEST_NAME> <DX_NAME> plaques </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> plaques </DX_NAME> <DX_NAME> dementias </DX_NAME> <DX_NAME> alzheimer’s_disease </DX_NAME> <BRAND_NAME> vizamyl </BRAND_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<BRAND_NAME> cialis </BRAND_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <DX_NAME> cannot_get </DX_NAME> <DX_NAME> erect_penis_suitable_for_sexual_activity </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <BRAND_NAME> cialis </BRAND_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <BRAND_NAME> cialis </BRAND_NAME> <GENERIC_NAME> tadalafil </GENERIC_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_inhibitors </TREATMENT_NAME> <BRAND_NAME> cialis </BRAND_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <DX_NAME> erectile_function </DX_NAME> <BRAND_NAME> cialis </BRAND_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <BRAND_NAME> cialis </BRAND_NAME> <DX_NAME> erectile_dysfunction </DX_NAME>
<GENERIC_NAME> pramipexole </GENERIC_NAME> <GENERIC_NAME> dopamine_agonists </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> primary_parkinson’s_disease </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> restless_legs_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> prucalopride </GENERIC_NAME> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscle_wall </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> constipation </DX_NAME>
<BRAND_NAME> tezacaftor </BRAND_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cells_to_work_better </DX_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> cf </DX_NAME> <DX_NAME> cf </DX_NAME> <DX_NAME> inherited_condition </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> digestive_system </SYSTEM_ORGAN_SITE> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> mutation_in_the_cftr_gene </DX_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <DX_NAME> cf </DX_NAME> <DX_NAME> genetic_mutations </DX_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_function </DX_NAME> <DX_NAME> ill </DX_NAME> <DX_NAME> gain_weight </DX_NAME>
<URL> http://www.ema.europa.eu/docs/en </URL> <DATE> 2013/03/wc500139752.doc_73 </DATE> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> actraphane </GENERIC_NAME> <GENERIC_NAME> soluble_human_insulin </GENERIC_NAME> <GENERIC_NAME> isophane_human_insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> zinc_chloride </GENERIC_NAME> <GENERIC_NAME> glycerol </GENERIC_NAME> <GENERIC_NAME> metacresol </GENERIC_NAME> <GENERIC_NAME> phenol </GENERIC_NAME> <GENERIC_NAME> disodium_phosphate_dihydrate </GENERIC_NAME> <GENERIC_NAME> sodium_hydroxide </GENERIC_NAME> <GENERIC_NAME> hydrochloric_acid </GENERIC_NAME> <GENERIC_NAME> protamine_sulfate </GENERIC_NAME> <GENERIC_NAME> actraphane </GENERIC_NAME>
<GENERIC_NAME> alpelisib </GENERIC_NAME> <GENERIC_NAME> phosphatidylinositol-3-kinase </GENERIC_NAME> <DX_NAME> postmenopausal </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> fulvestrant </GENERIC_NAME> <TREATMENT_NAME> hormonal_anticancer_therapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> hormonal_treatments </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> Piqray </BRAND_NAME> <GENERIC_NAME> phosphatidylinositol-3-kinases </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> karvezide </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <DX_NAME> angiotensinii </DX_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <TREATMENT_NAME> diuretics </TREATMENT_NAME> <DX_NAME> increased_urine_output </DX_NAME> <BRAND_NAME> karvezide </BRAND_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME>
<BRAND_NAME> jakavi </BRAND_NAME> <NAME> jakavi </NAME> <GENERIC_NAME> ruxolitinib </GENERIC_NAME> <BRAND_NAME> jakavi </BRAND_NAME> <NAME> jakavi </NAME> <DX_NAME> enlarged_spleen </DX_NAME> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <DX_NAME> myelofibrosis </DX_NAME> <DX_NAME> blood_cancer </DX_NAME> <BRAND_NAME> jakavi </BRAND_NAME> <NAME> jakavi </NAME> <GENERIC_NAME> polycythaemia_vera </GENERIC_NAME> <DX_NAME> polycythaemia_vera </DX_NAME> <GENERIC_NAME> hydroxyurea </GENERIC_NAME> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <DX_NAME> myelofibrosis </DX_NAME> <DX_NAME> myelofibrosis </DX_NAME> <DX_NAME> disorder </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> scar_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <DX_NAME> enlarged </DX_NAME> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <DX_NAME> myelofibrosis </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> night_sweats </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <DX_NAME> weight_loss </DX_NAME> <DX_NAME> myelofibrosis </DX_NAME> <DX_NAME> blood_or_vascular_complications </DX_NAME> <DX_NAME> polycythaemia_vera </DX_NAME> <DX_NAME> disorder </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <DX_NAME> polycythaemia_vera </DX_NAME> <DX_NAME> blood_or_vascular_complications </DX_NAME>
<TEST_NAME> ultrasound </TEST_NAME> <TEST_NAME> scan </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TEST_NAME> echocardiography </TEST_NAME> <TEST_NAME> image </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TEST_NAME> ultrasound </TEST_NAME> <SYSTEM_ORGAN_SITE> cardiac_walls </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> walls </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> veins </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> aripiprazole </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> aripiprazole </GENERIC_NAME> <DX_NAME> disease_characterised </DX_NAME> <DX_NAME> mistaken_beliefs </DX_NAME> <DX_NAME> incoherent_speech_and_behaviour </DX_NAME> <DX_NAME> emotional_flatness </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <GENERIC_NAME> aripiprazole </GENERIC_NAME> <DX_NAME> aripiprazole_zentiva </DX_NAME> <AGE> 13 </AGE> <DX_NAME> condition_with_symptoms </DX_NAME> <DX_NAME> feeling_“high” </DX_NAME> <DX_NAME> excessive_amounts_of_energy </DX_NAME> <DX_NAME> needing_much_less_sleep_than_usual </DX_NAME> <DX_NAME> racing_ideas </DX_NAME> <DX_NAME> irritability </DX_NAME> <GENERIC_NAME> aripiprazole </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME>
<TREATMENT_NAME> antibiotic_medicine </TREATMENT_NAME> <GENERIC_NAME> antibiotic_medicine </GENERIC_NAME> <GENERIC_NAME> levofloxacin </GENERIC_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME> <GENERIC_NAME> fluoroquinolones </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_infections </DX_NAME> <DX_NAME> pseudomonas_aeruginosa </DX_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <TREATMENT_NAME> antibiotic_medicine </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> improve_breathing </DX_NAME> <DX_NAME> cystic_fibrosis </DX_NAME>
<NAME> maviret </NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <AGE> 18 </AGE> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> infectious_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_c_virus </DX_NAME> <GENERIC_NAME> glecaprevir </GENERIC_NAME> <GENERIC_NAME> pibrentasvir </GENERIC_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> generalised_anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> peripheral_neuropathic_pain </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> cramping </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> tingling </DX_NAME> <DX_NAME> numbness </DX_NAME> <DX_NAME> pins_and_needles </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> mood_changes </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> epilepsy_pregabalin_zentiva </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_seizures </DX_NAME> <GENERIC_NAME> pregabalin_zentiva </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin_zentiva </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> current </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <TREATMENT_NAME> antiepileptic_treatment </TREATMENT_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> worry </DX_NAME> <DX_NAME> difficult_to_control </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> restlessness </DX_NAME> <DX_NAME> feeling_keyed_up </DX_NAME> <DX_NAME> fatigued </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> difficulty_concentrating </DX_NAME> <DX_NAME> mind_going_blank </DX_NAME> <DX_NAME> feeling_irritable </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_tension </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME>
<DX_NAME> infections </DX_NAME> <DX_NAME> frequent_infections </DX_NAME> <DX_NAME> inflammatory_disorders </DX_NAME> <DX_NAME> autoimmune_diseases </DX_NAME> <TREATMENT_NAME> replacement_therapy </TREATMENT_NAME> <DX_NAME> inborn_lack_of_antibody_production </DX_NAME> <DX_NAME> primary_immunodeficiency_syndromes </DX_NAME>
<GENERIC_NAME> capecitabine </GENERIC_NAME> <TREATMENT_NAME> cytostatic_medicines </TREATMENT_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <TREATMENT_NAME> cytostatic_medicine </TREATMENT_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> rectal </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> cancers </DX_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <DX_NAME> colon_cancer </DX_NAME> <PROCEDURE_NAME> removal_of_the_tumour </PROCEDURE_NAME> <DX_NAME> tumour </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME>
<GENERIC_NAME> repaglinide </GENERIC_NAME> <TREATMENT_NAME> oral_antidiabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> antidiabetic_medicine </GENERIC_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TEST_NAME> glucose </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> weight_reduction </TREATMENT_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> topotecan_actavis </GENERIC_NAME> <GENERIC_NAME> topotecan </GENERIC_NAME> <GENERIC_NAME> topotecan_actavis </GENERIC_NAME> <DX_NAME> small_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cervical_cancer </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <GENERIC_NAME> topotecan_actavis </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME>
<BRAND_NAME> prometax </BRAND_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> nerve_cells_die </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> acetylcholinesterase </GENERIC_NAME> <GENERIC_NAME> butyrylcholinesterase </GENERIC_NAME> <BRAND_NAME> prometax </BRAND_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> alzheimer’s_disease </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <BRAND_NAME> prometax </BRAND_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_disorder </DX_NAME> <DX_NAME> memory </DX_NAME> <DX_NAME> intellectual_ability_and_behaviour </DX_NAME> <GENERIC_NAME> oral_solution </GENERIC_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME>
<TEST_NAME> flebogamma_dif </TEST_NAME> <TEST_NAME> flebogamma_dif </TEST_NAME> <TEST_NAME> immunoglobulin </TEST_NAME> <TREATMENT_NAME> replacement_therapy </TREATMENT_NAME> <DX_NAME> immunodeficiency_syndromes </DX_NAME> <DX_NAME> pid </DX_NAME> <DX_NAME> inborn_lack_of_antibodies </DX_NAME> <DX_NAME> immunodeficiency_syndromes </DX_NAME> <DX_NAME> recurrent_infections </DX_NAME> <TREATMENT_NAME> antimicrobial_treatment </TREATMENT_NAME> <DX_NAME> antibody_failure </DX_NAME> <TEST_NAME> serum_igg_level </TEST_NAME> <DX_NAME> failure </DX_NAME> <TREATMENT_NAME> pneumococcal_polysaccharide </TREATMENT_NAME> <TREATMENT_NAME> polypeptide_antigen_vaccines </TREATMENT_NAME> <DX_NAME> autoimmune_disorders </DX_NAME> <TREATMENT_NAME> immunomodulation </TREATMENT_NAME> <DX_NAME> immunomodulation </DX_NAME> <DX_NAME> immune_thrombocytopenia </DX_NAME> <DX_NAME> itp </DX_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> unwanted_bleeding </DX_NAME> <DX_NAME> bruising </DX_NAME> <DX_NAME> bleeding </DX_NAME> <TIME_TO_PROCEDURE_NAME> prior </TIME_TO_PROCEDURE_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <DX_NAME> guillain_barré_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> kawasaki_disease </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <TREATMENT_NAME> acetylsalicylic_acid_therapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> enlarged </DX_NAME> <DX_NAME> inflammatory_demyelinating_polyradiculoneuropathy </DX_NAME> <DX_NAME> cidp </DX_NAME> <DX_NAME> progressive_disease </DX_NAME> <SYSTEM_ORGAN_SITE> limb </SYSTEM_ORGAN_SITE> <DX_NAME> limb_weakness </DX_NAME> <DX_NAME> numbness </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> multifocal_motor_neuropathy </DX_NAME> <DX_NAME> rare_disease </DX_NAME> <DX_NAME> asymmetric_limb_weakness </DX_NAME> <SYSTEM_ORGAN_SITE> limb </SYSTEM_ORGAN_SITE> <DX_NAME> sensory_loss </DX_NAME>
<GENERIC_NAME> rivastigmine_actavis </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> nerve_cells_die </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> acetylcholinesterase </GENERIC_NAME> <GENERIC_NAME> butyrylcholinesterase </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> alzheimer’s_disease </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_disorder </DX_NAME> <DX_NAME> affects_memory </DX_NAME> <DX_NAME> intellectual_ability_and_behaviour </DX_NAME> <GENERIC_NAME> oral_solution </GENERIC_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME>
<GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> taxoids </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <GENERIC_NAME> prednisolone </GENERIC_NAME>
<GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_complications </DX_NAME> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_metastases </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> primary_site </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <DX_NAME> tumour </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> hypercalcaemia </DX_NAME>
<GENERIC_NAME> tildrakizumab </GENERIC_NAME> <GENERIC_NAME> tildrakizumab </GENERIC_NAME> <GENERIC_NAME> il </GENERIC_NAME> <DX_NAME> psoriasis </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_condition </DX_NAME> <DX_NAME> plaque_psoriasis </DX_NAME> <BRAND_NAME> ilumetri </BRAND_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> capecitabine </GENERIC_NAME> <TREATMENT_NAME> cytostatic_medicines </TREATMENT_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <TREATMENT_NAME> cytostatic_medicine </TREATMENT_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> rectal </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> cancers </DX_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <DX_NAME> colon_cancer </DX_NAME> <PROCEDURE_NAME> removal_of_the_tumour </PROCEDURE_NAME> <DX_NAME> tumour </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME>
<DX_NAME> lymphomatous_meningitis </DX_NAME> <DX_NAME> lymphomatous_meningitis </DX_NAME> <SYSTEM_ORGAN_SITE> membranes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <AGE> 18 </AGE> <GENERIC_NAME> pegylated_liposomal_doxorubicin </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <GENERIC_NAME> melphalan </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <TIME_TO_TREATMENT_NAME> previously </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> thalidomide </GENERIC_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <TREATMENT_NAME> induction_treatment </TREATMENT_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <DX_NAME> mantle_cell_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <GENERIC_NAME> rituximab </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME>
<BRAND_NAME> plavix </BRAND_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <BRAND_NAME> plavix </BRAND_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <BRAND_NAME> plavix </BRAND_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_k_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> anticoagulants’ </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <BRAND_NAME> plavix </BRAND_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <BRAND_NAME> plavix </BRAND_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> anticoagulants’ </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> pegylated_liposomal </GENERIC_NAME> <GENERIC_NAME> pegylated_liposomal </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> irinotecan </GENERIC_NAME> <GENERIC_NAME> irinotecan </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> pegylated_liposomal </GENERIC_NAME> <GENERIC_NAME> pegylated_liposomal </GENERIC_NAME> <DX_NAME> pancreatic_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> gemcitabine </GENERIC_NAME> <GENERIC_NAME> onivyde_pegylated_liposomal </GENERIC_NAME> <TREATMENT_NAME> cancer_medicines </TREATMENT_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <GENERIC_NAME> leucovorin </GENERIC_NAME> <GENERIC_NAME> pegylated_liposomal </GENERIC_NAME>
<BRAND_NAME> taxotere </BRAND_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> taxoids </GENERIC_NAME> <BRAND_NAME> taxotere </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <DX_NAME> head_and_neck_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <BRAND_NAME> taxotere </BRAND_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_node </SYSTEM_ORGAN_SITE> <BRAND_NAME> taxotere </BRAND_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <BRAND_NAME> taxotere </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <BRAND_NAME> taxotere </BRAND_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <GENERIC_NAME> prednisolone </GENERIC_NAME> <DX_NAME> gastric_cancer </DX_NAME> <BRAND_NAME> taxotere </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> neck_cancer </DX_NAME> <BRAND_NAME> taxotere </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME>
<DX_NAME> tumor </DX_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> melphalan </GENERIC_NAME> <DX_NAME> soft_tissue_sarcoma </DX_NAME> <SYSTEM_ORGAN_SITE> arms </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> tumour </DX_NAME> <PROCEDURE_NAME> removal_of_the_tumor </PROCEDURE_NAME> <DX_NAME> tumor </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arm </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> leg </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> leg_amputation </PROCEDURE_NAME>
<NAME> sonata </NAME> <BRAND_NAME> sonata </BRAND_NAME> <DX_NAME> sleeping_problems </DX_NAME> <DX_NAME> problems_sleeping </DX_NAME>
<GENERIC_NAME> azilsartan_medoxomil </GENERIC_NAME> <BRAND_NAME> aiiras </BRAND_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <TREATMENT_NAME> ipreziv_blocks </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <TIME_TO_DX_NAME> over_18 </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> over_18 </TIME_TO_DX_NAME>
<NAME> zabdeno_zabdeno </NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> ebola_virus_disease </DX_NAME> <TIME_TO_DX_NAME> in_the_future </TIME_TO_DX_NAME> <DX_NAME> ebola_virus </DX_NAME> <NAME> zabdeno </NAME> <TREATMENT_NAME> vaccinations </TREATMENT_NAME> <DX_NAME> ebola_virus_disease </DX_NAME> <GENERIC_NAME> filovirus </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <GENERIC_NAME> filovirus </GENERIC_NAME> <BRAND_NAME> zabdeno </BRAND_NAME> <DX_NAME> ebola_virus </DX_NAME> <DX_NAME> ebola_virus_disease </DX_NAME> <TREATMENT_NAME> vaccinations </TREATMENT_NAME> <TREATMENT_NAME> zabdeno_vaccine </TREATMENT_NAME> <GENERIC_NAME> zabdeno_vaccine </GENERIC_NAME> <TIME_TO_TREATMENT_NAME> 8_weeks_later </TIME_TO_TREATMENT_NAME> <TIME_TO_MEDICATION_NAME> 8_weeks_later </TIME_TO_MEDICATION_NAME> <TREATMENT_NAME> mvabea_vaccine </TREATMENT_NAME> <GENERIC_NAME> mvabea_vaccine </GENERIC_NAME> <TREATMENT_NAME> zabdeno </TREATMENT_NAME> <BRAND_NAME> zabdeno </BRAND_NAME> <TREATMENT_NAME> mvabea_vaccination </TREATMENT_NAME> <GENERIC_NAME> mvabea_vaccination </GENERIC_NAME> <DX_NAME> ebola_virus </DX_NAME> <TREATMENT_NAME> vaccinations </TREATMENT_NAME> <TREATMENT_NAME> vaccination </TREATMENT_NAME> <DX_NAME> ebola_virus_disease </DX_NAME> <BRAND_NAME> zabdeno </BRAND_NAME> <BRAND_NAME> mvabea </BRAND_NAME> <TREATMENT_NAME> vaccinations </TREATMENT_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> ebola_virus </DX_NAME> <DX_NAME> died </DX_NAME> <ADDRESS> ebola </ADDRESS> <DX_NAME> vomit </DX_NAME> <DX_NAME> sweat </DX_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> ebola_virus </DX_NAME> <DX_NAME> ebola_virus_disease </DX_NAME> <DX_NAME> high_fever </DX_NAME> <DX_NAME> clotting </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemorrhagic_fever’ </DX_NAME> <DX_NAME> illness </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> feeling_tired </DX_NAME> <DX_NAME> weak </DX_NAME> <DX_NAME> dizzy </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_aches </DX_NAME> <DX_NAME> bleeding </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> ears </SYSTEM_ORGAN_SITE> <DX_NAME> diarrhea </DX_NAME> <DX_NAME> sudden_drop_in_blood_pressure_or_blood_flow </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> shock </DX_NAME> <DX_NAME> permanent_damage </DX_NAME> <DX_NAME> confusion </DX_NAME> <DX_NAME> delirium </DX_NAME> <DX_NAME> seizures </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <DX_NAME> coma </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <BRAND_NAME> zabdeno </BRAND_NAME> <BRAND_NAME> mvabea </BRAND_NAME> <DX_NAME> ebola_infection </DX_NAME> <DX_NAME> ebola_virus_disease </DX_NAME> <TIME_TO_DX_NAME> in_the_future </TIME_TO_DX_NAME>
<GENERIC_NAME> kyprolis </GENERIC_NAME> <GENERIC_NAME> carfilzomib </GENERIC_NAME> <GENERIC_NAME> carfilzomib </GENERIC_NAME> <DX_NAME> breakdown_of_proteins_in_cancer_cells </DX_NAME> <DX_NAME> abnormal_proteins </DX_NAME> <DX_NAME> kyprolis </DX_NAME> <GENERIC_NAME> kyprolis </GENERIC_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> kyprolis </DX_NAME> <GENERIC_NAME> kyprolis </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> plasma_cells </TREATMENT_NAME> <GENERIC_NAME> kyprolis </GENERIC_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME>
<GENERIC_NAME> repaglinide </GENERIC_NAME> <TREATMENT_NAME> oral_antidiabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> antidiabetic_medicine </GENERIC_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TEST_NAME> glucose </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> weight_reduction </TREATMENT_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<PROCEDURE_NAME> injecting </PROCEDURE_NAME> <TEST_NAME> tevagrastim </TEST_NAME> <TEST_NAME> tevagrastim </TEST_NAME> <TEST_NAME> white_blood_cell_growth_factor </TEST_NAME> <TEST_NAME> granulocyte_colony_stimulating_factor </TEST_NAME> <GENERIC_NAME> tevagrastim </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TEST_NAME> bone_marrow </TEST_NAME> <DX_NAME> neutropenia </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> tevagrastim </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplant </PROCEDURE_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> bone_marrow </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> neutropenia </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> infections </DX_NAME>
<GENERIC_NAME> efavirenz_teva </GENERIC_NAME> <GENERIC_NAME> efavirenz </GENERIC_NAME> <TREATMENT_NAME> nonnucleoside_reverse_transcriptase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> nonnucleoside_reverse_transcriptase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> efavirenz_teva </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> efavirenz_teva </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicines </GENERIC_NAME> <DX_NAME> virus_in_the_blood </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME>
<GENERIC_NAME> lidocaine </GENERIC_NAME> <GENERIC_NAME> prilocaine </GENERIC_NAME> <GENERIC_NAME> local_anaesthetics </GENERIC_NAME> <PROCEDURE_NAME> local_anaesthetics </PROCEDURE_NAME> <DX_NAME> premature_ejaculation </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> entecavir </GENERIC_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> entecavir </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <GENERIC_NAME> entecavir </GENERIC_NAME> <DX_NAME> hbv_infection </DX_NAME> <TIME_TO_MEDICATION_NAME> less_than_18_years </TIME_TO_MEDICATION_NAME> <TIME_TO_DX_NAME> less_than_18_years </TIME_TO_DX_NAME> <AGE> 18 </AGE> <GENERIC_NAME> entecavir </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> entecavir </GENERIC_NAME> <DX_NAME> virus_in_your_body </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE>
<BRAND_NAME> zyprexa </BRAND_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <BRAND_NAME> zyprexa </BRAND_NAME> <TREATMENT_NAME> antipsychotics </TREATMENT_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> manic_episodes </DX_NAME> <DX_NAME> excitement </DX_NAME> <DX_NAME> euphoria </DX_NAME> <BRAND_NAME> zyprexa </BRAND_NAME> <DX_NAME> recurrence </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> manic_episode </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME>
<TREATMENT_NAME> immunosuppressants </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> kidney_transplant </PROCEDURE_NAME> <TREATMENT_NAME> immunosuppressants </TREATMENT_NAME> <PROCEDURE_NAME> transplanted </PROCEDURE_NAME> <PROCEDURE_NAME> transplanted </PROCEDURE_NAME> <GENERIC_NAME> simulect </GENERIC_NAME> <TIME_TO_PROCEDURE_NAME> around_the_time </TIME_TO_PROCEDURE_NAME> <TIME_TO_PROCEDURE_NAME> around_the_time </TIME_TO_PROCEDURE_NAME> <PROCEDURE_NAME> transplant </PROCEDURE_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <PROCEDURE_NAME> transplant </PROCEDURE_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> ciclosporin </TREATMENT_NAME> <GENERIC_NAME> ciclosporin </GENERIC_NAME> <TREATMENT_NAME> corticosteroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME>
<GENERIC_NAME> mifamurtide </GENERIC_NAME> <DX_NAME> bacteria </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> osteosarcoma </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_cancer </DX_NAME> <TIME_TO_DX_NAME> 2_and_30_years </TIME_TO_DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> remove_the_tumour </PROCEDURE_NAME> <DX_NAME> tumour </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE>
<BRAND_NAME> kigabeq </BRAND_NAME> <GENERIC_NAME> vigabatrin </GENERIC_NAME> <DX_NAME> infantile_spasms </DX_NAME> <DX_NAME> west’s_syndrome </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_epilepsy </DX_NAME>
<GENERIC_NAME> betaferon </GENERIC_NAME> <GENERIC_NAME> betaferon </GENERIC_NAME> <GENERIC_NAME> betaferon </GENERIC_NAME> <GENERIC_NAME> interferon </GENERIC_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> attacks </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> viral_infections </DX_NAME> <GENERIC_NAME> betaferon </GENERIC_NAME> <DX_NAME> sclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> central_nervous_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cns </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> protective_sheath </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cns </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> demyelination </DX_NAME> <DX_NAME> abnormal_response </DX_NAME> <SYSTEM_ORGAN_SITE> cns </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> cns </SYSTEM_ORGAN_SITE> <DX_NAME> attack </DX_NAME> <DX_NAME> relapse </DX_NAME> <DX_NAME> disability </DX_NAME> <DX_NAME> difficulty_walking </DX_NAME> <GENERIC_NAME> interferon_beta1b </GENERIC_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> disease_activity </DX_NAME> <GENERIC_NAME> betaferon </GENERIC_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <GENERIC_NAME> betaferon </GENERIC_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> relapsingremitting </DX_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> relapses </DX_NAME> <GENERIC_NAME> betaferon </GENERIC_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> relapsingremitting </DX_NAME> <DX_NAME> relapses </DX_NAME> <GENERIC_NAME> betaferon </GENERIC_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> disability </DX_NAME> <GENERIC_NAME> betaferon </GENERIC_NAME> <GENERIC_NAME> betaferon </GENERIC_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> relapsingremitting_multiple_sclerosis </DX_NAME> <DX_NAME> relapses </DX_NAME> <TIME_TO_DX_NAME> last_two_years </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> last_two_years </TIME_TO_DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> active_disease </DX_NAME> <DX_NAME> relapses </DX_NAME>
<GENERIC_NAME> nicotinic_acid </GENERIC_NAME> <DX_NAME> flushing </DX_NAME> <DX_NAME> side_effect </DX_NAME> <GENERIC_NAME> nicotinic_acid </GENERIC_NAME> <TEST_NAME> cholesterol_level </TEST_NAME> <TEST_NAME> total_cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> apo_b </TEST_NAME> <TEST_NAME> ldl </TEST_NAME> <TEST_NAME> raise_levels </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <TEST_NAME> apo_ai </TEST_NAME> <TEST_NAME> hdl </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> total_cholesterol </TEST_NAME> <TEST_NAME> ldl </TEST_NAME> <TEST_NAME> hdl </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <DX_NAME> plaque </DX_NAME> <DX_NAME> plaque </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> hdl_cholesterol </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <TEST_NAME> triglycerides </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_problems </DX_NAME> <DX_NAME> cholesterol_problems </DX_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> simple_blood_test </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME> <DX_NAME> dyslipidaemia </DX_NAME> <TEST_NAME> cholesterol_levels </TEST_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TREATMENT_NAME> cholesterollowering_medicines </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> dic </DX_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TEST_NAME> mixed_dyslipidaemia </TEST_NAME> <DX_NAME> dyslipidaemia </DX_NAME> <DX_NAME> high_blood_levels_of_‘bad’_ldl_cholesterol_and_triglycerides </DX_NAME> <TEST_NAME> blood_levels </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> levels </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME> <TEST_NAME> cholesterol </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME>
<BRAND_NAME> coagadex </BRAND_NAME> <DX_NAME> human_coagulation_factor_x </DX_NAME> <DX_NAME> blood_to_clot </DX_NAME> <BRAND_NAME> coagadex </BRAND_NAME> <PROCEDURE_NAME> extracted </PROCEDURE_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> factor_x_deficiency </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <DX_NAME> factor_x_deficiency </DX_NAME> <DX_NAME> bleeding </DX_NAME> <BRAND_NAME> coagadex </BRAND_NAME> <TEST_NAME> coagadex_replaces </TEST_NAME> <DX_NAME> clot_normally </DX_NAME>
<GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> taxoids </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <DX_NAME> head_and_neck_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_node </SYSTEM_ORGAN_SITE> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <GENERIC_NAME> prednisolone </GENERIC_NAME> <DX_NAME> gastric_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> neck_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME>
<BRAND_NAME> kadcyla </BRAND_NAME> <BRAND_NAME> kadcyla </BRAND_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> emtansine </GENERIC_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <DX_NAME> die </DX_NAME> <BRAND_NAME> kadcyla </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> kadcyla </BRAND_NAME> <BRAND_NAME> kadcyla </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> taxane </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> adjuvant_therapy </TREATMENT_NAME>
<BRAND_NAME> neupro </BRAND_NAME> <BRAND_NAME> neupro </BRAND_NAME> <GENERIC_NAME> rotigotine </GENERIC_NAME> <GENERIC_NAME> ‘dopamine </GENERIC_NAME> <GENERIC_NAME> dopamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <BRAND_NAME> neupro </BRAND_NAME> <BRAND_NAME> neupro </BRAND_NAME> <DX_NAME> restless_legs_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> rls </DX_NAME> <DX_NAME> discomfort </DX_NAME> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arms </SYSTEM_ORGAN_SITE> <DX_NAME> urges_to_move_around </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME> <DX_NAME> feeling_tired </DX_NAME> <DX_NAME> sleepy </DX_NAME> <BRAND_NAME> neupro </BRAND_NAME> <TREATMENT_NAME> neupro_treatment </TREATMENT_NAME>
<GENERIC_NAME> teriparatide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> movymia </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> thin </DX_NAME> <DX_NAME> fragile </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME>
<BRAND_NAME> januvia </BRAND_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <TREATMENT_NAME> dpp4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <TREATMENT_NAME> dipeptidyl_peptidase4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <DX_NAME> type_2_diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylureas </GENERIC_NAME> <GENERIC_NAME> glitazones </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> glucose </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <PROCEDURE_NAME> amputation </PROCEDURE_NAME> <DX_NAME> amputation </DX_NAME>
<GENERIC_NAME> fosaprepitant </GENERIC_NAME> <GENERIC_NAME> aprepitant </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> nausea </DX_NAME> <DX_NAME> vomiting </DX_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> vomiting </DX_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> vomiting </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> cancer_treatment </TREATMENT_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> vomiting </DX_NAME>
<GENERIC_NAME> epoetin_zeta </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> renal_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <PROCEDURE_NAME> peritoneal_dialysis </PROCEDURE_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> renal_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> renal_insufficiency </DX_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> solid_tumours </DX_NAME> <DX_NAME> malignant_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymphatic_system </SYSTEM_ORGAN_SITE> <DX_NAME> myeloma </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> bone_marrow_cancer </DX_NAME> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TIME_TO_PROCEDURE_NAME> prior </TIME_TO_PROCEDURE_NAME> <PROCEDURE_NAME> donate_blood </PROCEDURE_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> autologous_predonation </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> knee_replacement_operations </PROCEDURE_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <DX_NAME> myelodysplastic_syndrome </DX_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME>
<GENERIC_NAME> rolufta_ellipta </GENERIC_NAME> <GENERIC_NAME> rolufta_ellipta </GENERIC_NAME> <GENERIC_NAME> rolufta_ellipta </GENERIC_NAME> <GENERIC_NAME> umeclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <GENERIC_NAME> rolufta_ellipta </GENERIC_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> difficulties_in_breathing </DX_NAME> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> copd </DX_NAME> <GENERIC_NAME> rolufta_ellipta </GENERIC_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> attack </DX_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME>
<GENERIC_NAME> Clopidogrel </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <TEST_NAME> Platelets </TEST_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <GENERIC_NAME> Clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <GENERIC_NAME> Clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_K_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> Clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> Clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> anticoagulants’ </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<BRAND_NAME> prialt </BRAND_NAME> <GENERIC_NAME> ziconotide </GENERIC_NAME> <TREATMENT_NAME> analgesics </TREATMENT_NAME> <BRAND_NAME> prialt </BRAND_NAME> <DX_NAME> pain </DX_NAME> <PROCEDURE_NAME> intrathecal_injection </PROCEDURE_NAME> <PROCEDURE_NAME> injection </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE>
<BRAND_NAME> duotrav </BRAND_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <GENERIC_NAME> travoprost </GENERIC_NAME> <GENERIC_NAME> timolol </GENERIC_NAME> <GENERIC_NAME> travoprost </GENERIC_NAME> <GENERIC_NAME> prostaglandin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <GENERIC_NAME> timolol </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <BRAND_NAME> duotrav </BRAND_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> glaucoma </DX_NAME>
<BRAND_NAME> lemtrada </BRAND_NAME> <GENERIC_NAME> alemtuzumab </GENERIC_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <BRAND_NAME> lemtrada </BRAND_NAME> <BRAND_NAME> lemtrada </BRAND_NAME> <DX_NAME> relapses </DX_NAME> <DX_NAME> disability </DX_NAME> <GENERIC_NAME> betainterferon </GENERIC_NAME> <BRAND_NAME> lemtrada </BRAND_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> autoimmune_disease </DX_NAME> <SYSTEM_ORGAN_SITE> central_nervous_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve_fibres </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> relapses </DX_NAME> <SYSTEM_ORGAN_SITE> central_nervous_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> damage </DX_NAME> <BRAND_NAME> lemtrada </BRAND_NAME> <BRAND_NAME> lemtrada </BRAND_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nervous_system </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> pioglitazone </GENERIC_NAME> <GENERIC_NAME> glimepiride </GENERIC_NAME> <TREATMENT_NAME> antidiabetic_medicines </TREATMENT_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> type_2 </DX_NAME> <DX_NAME> noninsulin_dependent </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TREATMENT_NAME> hormone_that_controls_blood_sugar_levels </TREATMENT_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME>
<TREATMENT_NAME> “chemotherapy” </TREATMENT_NAME> <TREATMENT_NAME> firstline_treatment </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer” </DX_NAME>
<GENERIC_NAME> tenofovir_alafenamide </GENERIC_NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <TREATMENT_NAME> nucleotide_reverse_transcriptase_inhibitor </TREATMENT_NAME> <DX_NAME> hepatitis </DX_NAME> <TEST_NAME> weigh </TEST_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> hepatitis_b </DX_NAME> <DX_NAME> infection </DX_NAME>
<GENERIC_NAME> tadalafil </GENERIC_NAME> <DX_NAME> pulmonary_arterial_hypertension </DX_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_(pde5)_inhibitors </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> pasireotide </GENERIC_NAME> <DX_NAME> cushing’s_disease </DX_NAME> <DX_NAME> cushing’s_disease </DX_NAME> <DX_NAME> enlargement </DX_NAME> <SYSTEM_ORGAN_SITE> pituitary_gland </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gland </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> base_of_the_brain </SYSTEM_ORGAN_SITE> <DX_NAME> pituitary_adenoma </DX_NAME> <TEST_NAME> adrenocorticotropic_hormone </TEST_NAME> <TEST_NAME> acth </TEST_NAME> <GENERIC_NAME> pasireotide </GENERIC_NAME> <DX_NAME> cushing’s_disease </DX_NAME>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <BRAND_NAME> zyllt </BRAND_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_k_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <BRAND_NAME> zyllt </BRAND_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <BRAND_NAME> zyllt </BRAND_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> anticoagulants’ </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> memantine_hydrochloride </GENERIC_NAME> <DX_NAME> memory_loss </DX_NAME> <DX_NAME> alzheimer’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> memantine_ratiopharm </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <GENERIC_NAME> memantine </GENERIC_NAME> <DX_NAME> alzheimer’s_disease </DX_NAME>
<BRAND_NAME> inomax </BRAND_NAME> <GENERIC_NAME> nitric_oxide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_failure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> hypoxic_respiratory_failure </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> heart_surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME>
<BRAND_NAME> gazyvaro </BRAND_NAME> <GENERIC_NAME> obinutuzumab </GENERIC_NAME> <GENERIC_NAME> histidine </GENERIC_NAME> <GENERIC_NAME> histidine_hydrochloride_monohydrate </GENERIC_NAME> <GENERIC_NAME> trehalose_dihydrate </GENERIC_NAME> <GENERIC_NAME> poloxamer </GENERIC_NAME> <BRAND_NAME> gazyvaro </BRAND_NAME> <BRAND_NAME> gazyvaro </BRAND_NAME> <BRAND_NAME> gazyvaro </BRAND_NAME> <URL> https://www.ema.europa.eu/documents/templateform/appendixvadversedrugreactionreportingdetails_en.doc_51_marketing_authorisation_holder_roche_registration_gmbh_emilbarellstrasse </URL> <ADDRESS> 79639_grenzachwyhlen_germany </ADDRESS> <NAME> roche_pharma </NAME> <ADDRESS> emilbarellstrasse_1_d79639 </ADDRESS> <ADDRESS> grenzachwyhlen_germany </ADDRESS> <ID> 525_82_11 </ID> <PHONE_OR_FAX> 370_5_2546799 </PHONE_OR_FAX> <NAME> republika_roche </NAME> <NAME> s._r. </NAME> <NAME> o._tel </NAME> <ID> 20382111 </ID> <ADDRESS> magyarország_roche </ADDRESS> <NAME> danmark_roche </NAME> <ADDRESS> malta </ADDRESS> <ADDRESS> ireland)_deutschland_roche_pharma </ADDRESS> <NAME> roche </NAME> <PHONE_OR_FAX> 438050 </PHONE_OR_FAX> <ADDRESS> eesti_roche_eesti </ADDRESS> <PHONE_OR_FAX> 372_6_177_380 </PHONE_OR_FAX> <NAME> roche_austria </NAME> <ADDRESS> españa_roche_farma_s.a._tel </ADDRESS> <PHONE_OR_FAX> 351_21_425_70_00_hrvatska </PHONE_OR_FAX> <NAME> roche_d.o.o. </NAME> <PHONE_OR_FAX> 385_1_47_22_333 </PHONE_OR_FAX> <NAME> roche_românia </NAME> <NAME> tel </NAME> <AGE> 206_47_01_52 </AGE> <NAME> ireland </NAME> <NAME> slovenija_roche </NAME> <PHONE_OR_FAX> 354_540_8000 </PHONE_OR_FAX> <NAME> roche_slovensko </NAME> <PHONE_OR_FAX> 421_2_52638201 </PHONE_OR_FAX> <NAME> italia_roche </NAME> <NAME> roche </NAME> <NAME> latvija_roche </NAME> <NAME> latvija_sia </NAME> <PHONE_OR_FAX> 371_6_7039831 </PHONE_OR_FAX> <ADDRESS> united_kingdom_roche </ADDRESS>
<GENERIC_NAME> antithrombin_alfa </GENERIC_NAME> <TEST_NAME> antithrombin_blocks </TEST_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> inborn_deficiency </DX_NAME> <TEST_NAME> blood_level </TEST_NAME> <TEST_NAME> antithrombin </TEST_NAME> <DX_NAME> clots </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> deep_vein </SYSTEM_ORGAN_SITE> <DX_NAME> deep_vein_thrombosis </DX_NAME> <SYSTEM_ORGAN_SITE> vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> thromboembolism </DX_NAME> <DX_NAME> clot </DX_NAME> <TEST_NAME> antithrombin_blood_level </TEST_NAME> <DX_NAME> ‘congenital_antithrombin_deficiency’ </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> heparin </GENERIC_NAME> <GENERIC_NAME> heparin </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME>
<GENERIC_NAME> cariprazine </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> Schizophrenia </DX_NAME> <DX_NAME> hallucination </DX_NAME> <DX_NAME> mistaken_beliefs </DX_NAME> <DX_NAME> incoherent_speech_and_behaviour </DX_NAME> <DX_NAME> emotional_flatness </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> lack_of_emotional_response </DX_NAME>
<GENERIC_NAME> aliskiren </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <GENERIC_NAME> aliskiren </GENERIC_NAME> <GENERIC_NAME> renin_inhibitors </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> calcium_channel_blockers </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <GENERIC_NAME> thiazide </GENERIC_NAME> <TREATMENT_NAME> diuretics </TREATMENT_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> damage_the_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> disorders </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> aliskiren </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> le </SYSTEM_ORGAN_SITE> <DX_NAME> mi </DX_NAME> <SYSTEM_ORGAN_SITE> le </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> thalidomide </GENERIC_NAME> <GENERIC_NAME> thalidomide </GENERIC_NAME> <GENERIC_NAME> thalidomide </GENERIC_NAME> <GENERIC_NAME> thalidomide </GENERIC_NAME> <GENERIC_NAME> thalidomide </GENERIC_NAME> <GENERIC_NAME> ‘melphalan’ </GENERIC_NAME> <GENERIC_NAME> ‘prednisone’ </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <AGE> 65 </AGE> <AGE> 65 </AGE> <TREATMENT_NAME> high_dose_chemotherapy </TREATMENT_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> myeloma </DX_NAME> <GENERIC_NAME> thalidomide </GENERIC_NAME> <GENERIC_NAME> thalidomide </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME>
<TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> complications </DX_NAME> <PROCEDURE_NAME> injection </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> flu_infection </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TIME_TO_TREATMENT_NAME> 23_weeks </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> vaccination </TREATMENT_NAME>
<GENERIC_NAME> atazanavir </GENERIC_NAME> <NAME> krka </NAME> <TREATMENT_NAME> antiviral </TREATMENT_NAME> <TREATMENT_NAME> antiretroviral)_medicine </TREATMENT_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <GENERIC_NAME> atazanavir </GENERIC_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> immunodeficiency_syndrome </DX_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME>
<BRAND_NAME> cymbalta </BRAND_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <BRAND_NAME> cymbalta </BRAND_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <GENERIC_NAME> noradrenaline </GENERIC_NAME> <BRAND_NAME> cymbalta </BRAND_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> feeling_of_anxiety </DX_NAME> <DX_NAME> nervousness </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> stabbing </DX_NAME> <DX_NAME> stinging </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> electric_shock </DX_NAME> <DX_NAME> loss_of_feeling </DX_NAME> <SYSTEM_ORGAN_SITE> affected_area </SYSTEM_ORGAN_SITE> <DX_NAME> cold </DX_NAME> <DX_NAME> pain </DX_NAME> <BRAND_NAME> cymbalta </BRAND_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety </DX_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <BRAND_NAME> cymbalta </BRAND_NAME> <DX_NAME> feeling_better </DX_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME>
<GENERIC_NAME> lusduna </GENERIC_NAME> <GENERIC_NAME> insulin_glargine </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> lusduna </GENERIC_NAME> <NAME> lusduna </NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_glargine </GENERIC_NAME>
<BRAND_NAME> kalydeco </BRAND_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> fibrosis </DX_NAME> <DX_NAME> cf </DX_NAME> <BRAND_NAME> kalydeco </BRAND_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> cf </DX_NAME> <TEST_NAME> cftr_gene </TEST_NAME> <BRAND_NAME> kalydeco </BRAND_NAME> <AGE> 18 </AGE> <BRAND_NAME> kalydeco </BRAND_NAME> <BRAND_NAME> tezacaftor </BRAND_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <AGE> 12 </AGE> <DX_NAME> f508del_mutations </DX_NAME> <DX_NAME> f508del_mutation </DX_NAME> <BRAND_NAME> kalydeco </BRAND_NAME> <BRAND_NAME> tezacaftor </BRAND_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <BRAND_NAME> tezacaftor </BRAND_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME>
<BRAND_NAME> zavesca </BRAND_NAME> <GENERIC_NAME> miglustat </GENERIC_NAME> <BRAND_NAME> zavesca </BRAND_NAME> <DX_NAME> type_1_gaucher_disease </DX_NAME> <DX_NAME> gaucher_disease </DX_NAME> <GENERIC_NAME> glucosylceramide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <DX_NAME> changes_in_the_blood </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_disease </DX_NAME> <DX_NAME> type_1_gaucher_disease </DX_NAME> <TREATMENT_NAME> enzyme_replacement_therapy </TREATMENT_NAME> <BRAND_NAME> zavesca </BRAND_NAME> <TREATMENT_NAME> enzyme_replacement_therapy </TREATMENT_NAME> <BRAND_NAME> zavesca </BRAND_NAME> <DX_NAME> neurological_symptoms </DX_NAME> <DX_NAME> type_c_disease </DX_NAME> <DX_NAME> niemannpick_type_c_disease </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> slow_eye_movements </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> balance </DX_NAME> <DX_NAME> swallowing </DX_NAME> <DX_NAME> memory </DX_NAME> <DX_NAME> seizures </DX_NAME> <BRAND_NAME> zavesca </BRAND_NAME> <GENERIC_NAME> ‘glucosylceramide </GENERIC_NAME>
<BRAND_NAME> veyvondi </BRAND_NAME> <GENERIC_NAME> vonicog_alfa </GENERIC_NAME> <DX_NAME> von_willebrand_factor </DX_NAME> <DX_NAME> von_willebrand_factor </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> wounds </DX_NAME> <DX_NAME> blood_clot </DX_NAME> <DX_NAME> lack_of_vwf </DX_NAME> <DX_NAME> bleed </DX_NAME> <BRAND_NAME> veyvondi </BRAND_NAME> <DX_NAME> control_bleeding </DX_NAME> <DX_NAME> bleeding </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <AGE> 18 </AGE> <DX_NAME> von_willebrand_disease </DX_NAME> <GENERIC_NAME> desmopressin </GENERIC_NAME> <DX_NAME> von_willebrand_disease </DX_NAME> <DX_NAME> bleeding_disorder </DX_NAME> <DX_NAME> von_willebrand_factor </DX_NAME> <DX_NAME> disease_the_blood </DX_NAME> <DX_NAME> clot </DX_NAME> <DX_NAME> prolonged_bleeding_time </DX_NAME> <TEST_NAME> von_willebrand_factor </TEST_NAME> <DX_NAME> von_willebrand_factor </DX_NAME> <TEST_NAME> vwf </TEST_NAME> <TEST_NAME> von_willebrand_factor_deficiency </TEST_NAME> <DX_NAME> von_willebrand_factor_deficiency </DX_NAME>
<NAME> rienso </NAME> <GENERIC_NAME> iron </GENERIC_NAME> <GENERIC_NAME> ferumoxytol </GENERIC_NAME> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <DX_NAME> iron_deficiency_anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_function </DX_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> iron </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> rienso_therapy </TREATMENT_NAME> <TEST_NAME> iron_stores </TEST_NAME>
<GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> hospira </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <DX_NAME> malignant_pleural_mesothelioma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> hospira </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> ‘trastuzumab’ </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <TIME_TO_MEDICATION_NAME> previously </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME>
<GENERIC_NAME> pregabalin </GENERIC_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> generalised_anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> peripheral_neuropathic_pain </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> cramping </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> tingling </DX_NAME> <DX_NAME> numbness </DX_NAME> <DX_NAME> pins_and_needles </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> mood_changes </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_seizures </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_treatment </TREATMENT_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> worry </DX_NAME> <DX_NAME> difficult_to_control </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> restlessness </DX_NAME> <DX_NAME> feeling_keyed_up </DX_NAME> <DX_NAME> fatigued </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> difficulty_concentrating </DX_NAME> <DX_NAME> mind_going_blank </DX_NAME> <DX_NAME> feeling_irritable </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_tension </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME>
<BRAND_NAME> levitra </BRAND_NAME> <GENERIC_NAME> vardenafil </GENERIC_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_inhibitors </TREATMENT_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <DX_NAME> difficulties_in_getting_or_keeping_an_erection </DX_NAME> <DX_NAME> trouble_getting_or_keeping_an_erection </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_and_blood_vessel_changes </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <BRAND_NAME> levitra </BRAND_NAME> <DX_NAME> sexually_stimulated </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> erections </DX_NAME> <BRAND_NAME> levitra </BRAND_NAME> <DX_NAME> erection </DX_NAME>
<BRAND_NAME> azarga </BRAND_NAME> <GENERIC_NAME> brinzolamide </GENERIC_NAME> <GENERIC_NAME> timolol </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <BRAND_NAME> azarga </BRAND_NAME> <DX_NAME> high_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> glaucoma </DX_NAME> <DX_NAME> ocular_hypertension </DX_NAME> <DX_NAME> high_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> ristempa </GENERIC_NAME> <GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> febrile_neutropenia </DX_NAME> <DX_NAME> low_white_blood_cell_count </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> fever </DX_NAME> <TREATMENT_NAME> cytotoxic_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME>
<GENERIC_NAME> trametinib </GENERIC_NAME> <GENERIC_NAME> dabrafenib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <GENERIC_NAME> dabrafenib </GENERIC_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <GENERIC_NAME> dabrafenib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> nsclc </DX_NAME> <DX_NAME> cancers </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> NINLARO </GENERIC_NAME> <GENERIC_NAME> NINLARO </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> ixazomib </GENERIC_NAME> <GENERIC_NAME> NINLARO </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> myeloma </DX_NAME> <GENERIC_NAME> ixazomib </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <GENERIC_NAME> NINLARO </GENERIC_NAME> <GENERIC_NAME> NINLARO </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <GENERIC_NAME> NINLARO </GENERIC_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> Multiple_myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> myeloma </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> myeloma </DX_NAME>
<GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicine </TREATMENT_NAME> <GENERIC_NAME> antiepileptic_medicine </GENERIC_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> seizure </DX_NAME> <DX_NAME> generalisation </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> myoclonic_seizures </DX_NAME> <DX_NAME> shocklike_jerks </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <AGE> 12 </AGE> <DX_NAME> myoclonic_epilepsy </DX_NAME> <DX_NAME> generalised_tonicclonic_seizures </DX_NAME> <DX_NAME> loss_of_consciousness </DX_NAME> <AGE> 12 </AGE> <TIME_TO_DX_NAME> 12 </TIME_TO_DX_NAME> <DX_NAME> generalised_epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME>
<DX_NAME> cancer </DX_NAME> <GENERIC_NAME> polatuzumab_vedotin </GENERIC_NAME> <DX_NAME> bcell_lymphoma” </DX_NAME> <PROCEDURE_NAME> stem_cell_transplant </PROCEDURE_NAME> <DX_NAME> bcell_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <GENERIC_NAME> rituximab </GENERIC_NAME> <GENERIC_NAME> bendamustine </GENERIC_NAME>
<GENERIC_NAME> crixivan </GENERIC_NAME> <GENERIC_NAME> crixivan </GENERIC_NAME> <GENERIC_NAME> indinavir </GENERIC_NAME> <GENERIC_NAME> crixivan </GENERIC_NAME> <BRAND_NAME> crixivan </BRAND_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> crixivan </GENERIC_NAME> <TREATMENT_NAME> hiv_treatments </TREATMENT_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicines </GENERIC_NAME> <GENERIC_NAME> antiretroviral </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_therapy </TREATMENT_NAME> <GENERIC_NAME> crixivan </GENERIC_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <GENERIC_NAME> crixivan </GENERIC_NAME> <GENERIC_NAME> crixivan </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv_particles </DX_NAME> <GENERIC_NAME> crixivan </GENERIC_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> crixivan </GENERIC_NAME>
<GENERIC_NAME> prepandrix </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <AGE> 18 </AGE> <TREATMENT_NAME> influenza_(flu </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> pandemic_flu </DX_NAME> <TREATMENT_NAME> pandemic_flu </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <TREATMENT_NAME> pandemic_flu </TREATMENT_NAME> <DX_NAME> pandemic_flu </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> vaccines </TREATMENT_NAME>
<DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> walking_disability </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_weakness </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_stiffness </DX_NAME> <DX_NAME> difficulty_walking </DX_NAME> <GENERIC_NAME> fampridine </GENERIC_NAME> <GENERIC_NAME> potassium_channel_blockers </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nerve_cells </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> arsenic_trioxide </GENERIC_NAME> <GENERIC_NAME> arsenic_trioxide </GENERIC_NAME> <DX_NAME> promyelocytic_leukaemia </DX_NAME> <DX_NAME> apl </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> abnormal_white_blood_cells </DX_NAME> <DX_NAME> abnormal_bleeding </DX_NAME> <DX_NAME> bruising </DX_NAME>
<GENERIC_NAME> chlormethine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> mycosis_fungoidestype_cutaneous_tcell_lymphoma </DX_NAME> <DX_NAME> ctcl </DX_NAME> <DX_NAME> ctcl </DX_NAME> <DX_NAME> cancerous </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> chlormethine </GENERIC_NAME>
<GENERIC_NAME> deferiprone </GENERIC_NAME> <GENERIC_NAME> deferiprone </GENERIC_NAME> <GENERIC_NAME> deferiprone </GENERIC_NAME> <GENERIC_NAME> iron_chelator </GENERIC_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <GENERIC_NAME> deferiprone </GENERIC_NAME> <DX_NAME> iron_overload </DX_NAME> <TREATMENT_NAME> frequent_blood_transfusions </TREATMENT_NAME> <DX_NAME> thalassaemia </DX_NAME> <TIME_TO_TREATMENT_NAME> current </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chelation_therapy </TREATMENT_NAME>
<GENERIC_NAME> mannitol </GENERIC_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> inherited_disease </DX_NAME> <SYSTEM_ORGAN_SITE> glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> clear_mucus_more_easily </DX_NAME> <DX_NAME> improve_the_condition </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> cough’ </DX_NAME> <DX_NAME> mucus_from_your_lungs </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> melatonin </GENERIC_NAME> <GENERIC_NAME> melatonin </GENERIC_NAME> <AGE> 18 </AGE> <DX_NAME> autism_spectrum_disorder </DX_NAME> <DX_NAME> asd </DX_NAME> <DX_NAME> smithmagenis_syndrome </DX_NAME> <DX_NAME> neurogenetic_disease </DX_NAME> <DX_NAME> inherited_condition </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> fall_asleep </DX_NAME> <DX_NAME> lengthens_the_duration_of_sleep </DX_NAME> <DX_NAME> insomnia </DX_NAME> <DX_NAME> sleeplessness </DX_NAME> <DX_NAME> fall_asleep </DX_NAME>
<DX_NAME> diabetes_mellitus </DX_NAME> <AGE> 2 </AGE> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> basal_insulin </GENERIC_NAME> <GENERIC_NAME> insulin_degludec </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_aspart </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME>
<GENERIC_NAME> caffeine_citrate </GENERIC_NAME> <DX_NAME> apnoea </DX_NAME> <DX_NAME> premature_newborns </DX_NAME> <DX_NAME> short_periods </DX_NAME> <DX_NAME> premature_babies_stop_breathing </DX_NAME> <DX_NAME> baby’s_breathing </DX_NAME> <DX_NAME> fully_developed </DX_NAME> <DX_NAME> interrupted_breathing </DX_NAME> <DX_NAME> premature_newborns </DX_NAME>
<BRAND_NAME> jyseleca </BRAND_NAME> <GENERIC_NAME> filgotinib </GENERIC_NAME> <GENERIC_NAME> kinase_inhibitors </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <BRAND_NAME> jyseleca </BRAND_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <BRAND_NAME> jyseleca </BRAND_NAME> <DX_NAME> arthritis </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <BRAND_NAME> jyseleca </BRAND_NAME> <SYSTEM_ORGAN_SITE> jyseleca </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> stiffness </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE>
<DX_NAME> osteoporosis </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> fractures </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> thin </DX_NAME> <DX_NAME> fragile </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> break_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hips </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE> <DX_NAME> back_pain </DX_NAME> <DX_NAME> loss_of_height </DX_NAME> <DX_NAME> breaking_spinal_bones </DX_NAME> <SYSTEM_ORGAN_SITE> spinal_bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> breaking_your_hip </DX_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> antihistamine </GENERIC_NAME> <GENERIC_NAME> pseudoephedrine_sulphate </GENERIC_NAME> <GENERIC_NAME> antihistamines </GENERIC_NAME> <DX_NAME> allergic_symptoms </DX_NAME> <GENERIC_NAME> histamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> decongestants </GENERIC_NAME> <DX_NAME> nasal_congestion </DX_NAME> <DX_NAME> blocked/stuffy_nose </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <GENERIC_NAME> aerinaze </GENERIC_NAME> <DX_NAME> seasonal_allergic_rhinitis </DX_NAME> <DX_NAME> hay_fever </DX_NAME> <DX_NAME> sneezing </DX_NAME> <DX_NAME> runny </DX_NAME> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> nasal_congestion </DX_NAME> <AGE> 12 </AGE>
<GENERIC_NAME> abilify_maintena </GENERIC_NAME> <GENERIC_NAME> aripiprazole </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> mistaken_beliefs </DX_NAME> <DX_NAME> incoherent_speech_and_behaviour </DX_NAME> <DX_NAME> emotional_flatness </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <GENERIC_NAME> abilify_maintena </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <GENERIC_NAME> aripiprazole </GENERIC_NAME>
<GENERIC_NAME> lanadelumab </GENERIC_NAME> <AGE> 12 </AGE> <DX_NAME> angioedema_attacks </DX_NAME> <DX_NAME> hereditary_angioedema </DX_NAME> <DX_NAME> ‘plasma </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> hands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> feet </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyelids </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lips </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tongue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> larynx </SYSTEM_ORGAN_SITE> <GENERIC_NAME> plasma_kallikrein </GENERIC_NAME>
<TREATMENT_NAME> autologous_cultured_cartilage_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <TEST_NAME> biopsy </TEST_NAME> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> repair </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <DX_NAME> defects </DX_NAME> <SYSTEM_ORGAN_SITE> femoral_condyle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <DX_NAME> trauma </DX_NAME> <DX_NAME> fall </DX_NAME> <DX_NAME> trauma </DX_NAME> <DX_NAME> overweight </DX_NAME> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <DX_NAME> knee_deformity </DX_NAME> <SYSTEM_ORGAN_SITE> femoral_condyle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> thigh_bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE>
<BRAND_NAME> fotivda </BRAND_NAME> <GENERIC_NAME> tivozanib </GENERIC_NAME> <GENERIC_NAME> tivozanib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cancer </DX_NAME>
<GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <DX_NAME> nerve_cells_die </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> acetylcholinesterase </GENERIC_NAME> <GENERIC_NAME> butyrylcholinesterase </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> alzheimer’s_disease </DX_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_disorder </DX_NAME> <DX_NAME> memory </DX_NAME> <DX_NAME> intellectual_ability_and_behaviour </DX_NAME>
<GENERIC_NAME> peginterferon_alfa2b </GENERIC_NAME> <GENERIC_NAME> interferons </GENERIC_NAME> <GENERIC_NAME> interferons </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> diseases </DX_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> viral_infection </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> boceprevir </GENERIC_NAME> <DX_NAME> hepatitis_c_virus_infection </DX_NAME> <DX_NAME> hcv_infection </DX_NAME> <AGE> 18 </AGE> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <DX_NAME> hcv_infection </DX_NAME> <GENERIC_NAME> interferons </GENERIC_NAME> <TREATMENT_NAME> pegylated_interferons </TREATMENT_NAME> <GENERIC_NAME> pegylated_interferons </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <AGE> 18 </AGE> <DX_NAME> infected </DX_NAME> <DX_NAME> stable_hiv </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <GENERIC_NAME> interferon_alpha </GENERIC_NAME> <GENERIC_NAME> peginterferon_alpha </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> interferon_alpha </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <DX_NAME> hepatitis_c. </DX_NAME>
<BRAND_NAME> invokana </BRAND_NAME> <GENERIC_NAME> canagliflozin </GENERIC_NAME> <BRAND_NAME> invokana </BRAND_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <DX_NAME> type_2_diabetes_mellitus </DX_NAME> <DX_NAME> t2dm </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_function </DX_NAME> <DX_NAME> t2dm </DX_NAME> <BRAND_NAME> invokana </BRAND_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> saxagliptin </GENERIC_NAME> <GENERIC_NAME> linagliptin </GENERIC_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <GENERIC_NAME> glimepiride </GENERIC_NAME> <GENERIC_NAME> glipizide </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> amputation </DX_NAME> <PROCEDURE_NAME> amputation </PROCEDURE_NAME>
<GENERIC_NAME> naloxone </GENERIC_NAME> <GENERIC_NAME> naloxone </GENERIC_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <GENERIC_NAME> methadone </GENERIC_NAME> <GENERIC_NAME> fentanyl </GENERIC_NAME> <GENERIC_NAME> oxycodone </GENERIC_NAME> <GENERIC_NAME> buprenorphine </GENERIC_NAME> <GENERIC_NAME> morphine </GENERIC_NAME> <GENERIC_NAME> nyxoid </GENERIC_NAME> <DX_NAME> opioid_overdose </DX_NAME> <DX_NAME> opioid_overdose </DX_NAME> <DX_NAME> overdose </DX_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> sleepiness </DX_NAME> <DX_NAME> opioid_overdose </DX_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <ADDRESS> emergency_medical_care </ADDRESS>
<GENERIC_NAME> peginterferon_alfa2b </GENERIC_NAME> <GENERIC_NAME> interferons </GENERIC_NAME> <GENERIC_NAME> interferons </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> diseases </DX_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> viral_infection </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> boceprevir </GENERIC_NAME> <DX_NAME> hepatitis_c_virus_infection </DX_NAME> <DX_NAME> hcv_infection </DX_NAME> <AGE> 18 </AGE> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <DX_NAME> hcv_infection </DX_NAME> <GENERIC_NAME> interferons </GENERIC_NAME> <TREATMENT_NAME> pegylated_interferons </TREATMENT_NAME> <GENERIC_NAME> pegylated_interferons </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <AGE> 18 </AGE> <DX_NAME> infected </DX_NAME> <DX_NAME> stable_hiv </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <GENERIC_NAME> interferon_alpha </GENERIC_NAME> <GENERIC_NAME> peginterferon_alpha </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> interferon_alpha </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <TIME_TO_TEST_NAME> previously </TIME_TO_TEST_NAME> <TEST_NAME> chronic_hepatitis_c. </TEST_NAME> <DX_NAME> hepatitis_c. </DX_NAME>
<GENERIC_NAME> dexmedetomidine </GENERIC_NAME> <GENERIC_NAME> dexmedetomidine </GENERIC_NAME> <PROCEDURE_NAME> sedation </PROCEDURE_NAME> <DX_NAME> calm </DX_NAME> <DX_NAME> drowsiness </DX_NAME> <DX_NAME> sleep </DX_NAME> <TREATMENT_NAME> intensive_care </TREATMENT_NAME> <PROCEDURE_NAME> sedation </PROCEDURE_NAME> <PROCEDURE_NAME> surgical_procedures </PROCEDURE_NAME>
<GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <DX_NAME> angiotensinii </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_function </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <DX_NAME> irbesartan_zentiva </DX_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> impaired_kidney_function </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <GENERIC_NAME> human_protein_erythropoietin </GENERIC_NAME> <GENERIC_NAME> eerithroepoehtin </GENERIC_NAME> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <PROCEDURE_NAME> peritoneal_dialysis </PROCEDURE_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <GENERIC_NAME> erythropoietin </GENERIC_NAME> <DX_NAME> red_cell_production </DX_NAME> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <TREATMENT_NAME> epoetin_alfa_hexal </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> solid_tumours </DX_NAME> <DX_NAME> malignant_lymphoma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> bone_marrow_cancer </DX_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <TREATMENT_NAME> epoetin_alfa_hexal </TREATMENT_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <TREATMENT_NAME> epoetin_alfa_hexal </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <TREATMENT_NAME> epoetin_alfa_hexal </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> knee_replacement_operations </PROCEDURE_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <TREATMENT_NAME> epoetin_alfa_hexal </TREATMENT_NAME> <DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> bone_marrow_disorder </DX_NAME> <DX_NAME> disruption </DX_NAME> <DX_NAME> myelodysplastic_syndromes </DX_NAME> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <TREATMENT_NAME> epoetin_alfa_hexal </TREATMENT_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME>
<GENERIC_NAME> gefitinib </GENERIC_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE>
<DX_NAME> pompe_disease </DX_NAME> <DX_NAME> pompe_disease </DX_NAME> <DX_NAME> pompe_disease </DX_NAME> <GENERIC_NAME> myozyme_contains_an_artificial_enzyme </GENERIC_NAME> <TREATMENT_NAME> artificial_enzyme </TREATMENT_NAME> <GENERIC_NAME> alglucosidase_alfa </GENERIC_NAME> <GENERIC_NAME> natural_enzyme </GENERIC_NAME> <DX_NAME> pompe_disease </DX_NAME>
<DX_NAME> osteoporosis </DX_NAME> <DX_NAME> postmenopausal </DX_NAME> <DX_NAME> fracture </DX_NAME> <DX_NAME> postmenopausal </DX_NAME> <DX_NAME> fracture </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone_tissue </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> fragile </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hips </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_diseases </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> fracture </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> cancidas </GENERIC_NAME> <GENERIC_NAME> cancidas </GENERIC_NAME> <GENERIC_NAME> caspofungin </GENERIC_NAME> <GENERIC_NAME> cancidas </GENERIC_NAME> <GENERIC_NAME> cancidas </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> fungal_infections </DX_NAME> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <DX_NAME> fungal </DX_NAME> <DX_NAME> yeast </DX_NAME> <DX_NAME> infection </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <DX_NAME> weak </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> chills </DX_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> antibiotic </GENERIC_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> fungal_infections </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nasal_sinuses </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> antifungal_treatments </TREATMENT_NAME> <DX_NAME> side_effects </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <PROCEDURE_NAME> transplant </PROCEDURE_NAME> <DX_NAME> fungal_infections </DX_NAME> <DX_NAME> fever </DX_NAME> <TEST_NAME> white_cell_count </TEST_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <DX_NAME> fungal_infection </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <DX_NAME> fungal_cells_fragile </DX_NAME> <DX_NAME> fungus </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> infection </DX_NAME>
<GENERIC_NAME> cablivi </GENERIC_NAME> <GENERIC_NAME> caplacizumab </GENERIC_NAME> <DX_NAME> thrombotic_thrombocytopenic_purpura </DX_NAME> <DX_NAME> blood_clotting_disorder </DX_NAME> <DX_NAME> clots </DX_NAME> <SYSTEM_ORGAN_SITE> small_blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> clots </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> blood_clots </DX_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <GENERIC_NAME> cablivi </GENERIC_NAME>
<GENERIC_NAME> avelumab </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> merkel_cell_carcinoma </DX_NAME> <DX_NAME> mcc </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> renal_cell_carcinoma </DX_NAME> <DX_NAME> rcc </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> renal_cell_cancer </DX_NAME> <GENERIC_NAME> axitinib </GENERIC_NAME> <GENERIC_NAME> axitinib </GENERIC_NAME> <GENERIC_NAME> axitinib </GENERIC_NAME>
<BRAND_NAME> Actos </BRAND_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <TREATMENT_NAME> anti-diabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> anti-diabetic_medicine </GENERIC_NAME> <DX_NAME> non-insulin_dependent </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <BRAND_NAME> Actos </BRAND_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <BRAND_NAME> Actos </BRAND_NAME> <TIME_TO_MEDICATION_NAME> 3_to_6_months </TIME_TO_MEDICATION_NAME> <BRAND_NAME> Actos </BRAND_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME>
<GENERIC_NAME> asenapine </GENERIC_NAME> <DX_NAME> manic </DX_NAME> <DX_NAME> bipolar_i_disorder </DX_NAME> <TREATMENT_NAME> antipsychotic_medicines </TREATMENT_NAME> <DX_NAME> illnesses </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> bipolar_i_disorder </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> dopamine </GENERIC_NAME> <GENERIC_NAME> serotonin </GENERIC_NAME> <DX_NAME> imbalances </DX_NAME> <DX_NAME> manic </DX_NAME> <DX_NAME> bipolar_i_disorder </DX_NAME> <DX_NAME> condition_with_symptoms </DX_NAME> <DX_NAME> feeling_“high” </DX_NAME> <DX_NAME> excessive_amounts_of_energy </DX_NAME> <DX_NAME> needing_much_less_sleep_than_usual </DX_NAME> <DX_NAME> racing_ideas </DX_NAME> <DX_NAME> irritability </DX_NAME>
<GENERIC_NAME> dupilumab </GENERIC_NAME> <GENERIC_NAME> dupilumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <DX_NAME> atopic_dermatitis </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> rhinosinusitis </DX_NAME> <DX_NAME> nasal_polyposis </DX_NAME> <GENERIC_NAME> dupixent </GENERIC_NAME> <DX_NAME> atopic_dermatitis </DX_NAME> <DX_NAME> atopic_eczema </DX_NAME> <GENERIC_NAME> dupixent </GENERIC_NAME> <DX_NAME> eczema </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> dupixent </GENERIC_NAME> <DX_NAME> asthma </DX_NAME> <TREATMENT_NAME> asthma_medicines </TREATMENT_NAME> <TREATMENT_NAME> maintenance_treatment </TREATMENT_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <TIME_TO_DX_NAME> current </TIME_TO_DX_NAME> <TIME_TO_TREATMENT_NAME> current </TIME_TO_TREATMENT_NAME> <DX_NAME> asthma </DX_NAME> <TREATMENT_NAME> asthma_medicines </TREATMENT_NAME> <GENERIC_NAME> dupixent </GENERIC_NAME> <TREATMENT_NAME> maintenance_treatment </TREATMENT_NAME> <GENERIC_NAME> dupixent </GENERIC_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> systemic_corticosteroid </TREATMENT_NAME> <GENERIC_NAME> corticosteroid </GENERIC_NAME> <GENERIC_NAME> dupixent </GENERIC_NAME> <GENERIC_NAME> dupixent </GENERIC_NAME> <DX_NAME> atopic_dermatitis </DX_NAME> <DX_NAME> atopic_eczema </DX_NAME> <DX_NAME> improve_the_condition </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> itching </DX_NAME> <BRAND_NAME> dupixent </BRAND_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> atopic_dermatitis </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME> <DX_NAME> asthma_attacks </DX_NAME> <DX_NAME> improve_your_breathing </DX_NAME> <GENERIC_NAME> dupixent </GENERIC_NAME> <DX_NAME> asthma </DX_NAME> <TREATMENT_NAME> oral_corticosteroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> improving_your_breathing </DX_NAME>
<BRAND_NAME> vorapaxar </BRAND_NAME> <TREATMENT_NAME> platelet_medicines </TREATMENT_NAME> <TREATMENT_NAME> Platelets </TREATMENT_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> blood_clot </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> poor_circulation </DX_NAME> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> dying </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <TREATMENT_NAME> anti-platelet_agents </TREATMENT_NAME> <DX_NAME> dic </DX_NAME>
<GENERIC_NAME> trastuzumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <TEST_NAME> monoclonal_antibodies </TEST_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_and_gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> tumour </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <TREATMENT_NAME> aromatase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> aromatase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> hormone_receptorpositive </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <DX_NAME> high_levels_of_her2 </DX_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> 5flououracil </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME>
<BRAND_NAME> atripla </BRAND_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> nonnucleoside_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> emtricitabine </GENERIC_NAME> <TREATMENT_NAME> nucleoside_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <TREATMENT_NAME> nucleotide_reverse_transcriptase_inhibitor </TREATMENT_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <BRAND_NAME> atripla </BRAND_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <AGE> 18 </AGE> <TIME_TO_TREATMENT_NAME> previously </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> failure </DX_NAME> <TREATMENT_NAME> hiv_therapy </TREATMENT_NAME>
<GENERIC_NAME> xaluprine </GENERIC_NAME> <GENERIC_NAME> mercaptopurine </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> xaluprine </GENERIC_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> fastgrowing_disease </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> febrile_neutropenia </DX_NAME> <DX_NAME> low_white_blood_cell_count </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> fever </DX_NAME> <TREATMENT_NAME> cytotoxic_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME>
<GENERIC_NAME> prezista </GENERIC_NAME> <GENERIC_NAME> prezista </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> prezista </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <GENERIC_NAME> prezista </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> prezista </GENERIC_NAME> <DX_NAME> hiv_infected </DX_NAME> <DX_NAME> hiv_infected </DX_NAME> <GENERIC_NAME> prezista </GENERIC_NAME> <GENERIC_NAME> prezista </GENERIC_NAME> <GENERIC_NAME> cobicistat </GENERIC_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME>
<GENERIC_NAME> brolucizumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> eye_disorder </DX_NAME> <DX_NAME> neovascular </DX_NAME> <DX_NAME> macular_degeneration </DX_NAME> <DX_NAME> abnormal_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> clear_vision </DX_NAME> <DX_NAME> abnormal_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> leak_fluid </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> decreased_vision </DX_NAME> <DX_NAME> growth_of_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> abnormal_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> leakage_of_fluid </DX_NAME> <DX_NAME> blood_in_the_eye </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> down_disease_progression </DX_NAME> <DX_NAME> abnormal_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> leak_fluid </DX_NAME> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> pioglitazone </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <GENERIC_NAME> antidiabetic_medicine </GENERIC_NAME> <TREATMENT_NAME> antidiabetic_medicine </TREATMENT_NAME> <DX_NAME> non_insulin_dependent </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> 3_to_6_months </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME>
<TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> emtricitabine </GENERIC_NAME> <GENERIC_NAME> rilpivirine </GENERIC_NAME> <GENERIC_NAME> tenofovir_alafenamide </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <AGE> 12 </AGE> <TEST_NAME> weigh </TEST_NAME>
<GENERIC_NAME> orfadin </GENERIC_NAME> <GENERIC_NAME> nitisinone </GENERIC_NAME> <DX_NAME> hereditary_tyrosinemia </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> orfadin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> tyrosine </GENERIC_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME> <GENERIC_NAME> amino_acid </GENERIC_NAME>
<GENERIC_NAME> victrelis </GENERIC_NAME> <GENERIC_NAME> victrelis </GENERIC_NAME> <GENERIC_NAME> boceprevir </GENERIC_NAME> <DX_NAME> hepatitis_c_infection </DX_NAME> <GENERIC_NAME> virus_multiplying </GENERIC_NAME> <GENERIC_NAME> victrelis </GENERIC_NAME> <GENERIC_NAME> peginterferon_alfa </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> victrelis </GENERIC_NAME> <GENERIC_NAME> victrelis </GENERIC_NAME> <GENERIC_NAME> peginterferon_alfa </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <DX_NAME> hepatitis_c_virus_infection </DX_NAME> <DX_NAME> hcv_infection </DX_NAME> <GENERIC_NAME> victrelis </GENERIC_NAME> <DX_NAME> hcv_infection </DX_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> zimbus_breezhaler </GENERIC_NAME> <GENERIC_NAME> indacaterol </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> mometasone_furoate_indacaterol </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <GENERIC_NAME> mometasone </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <GENERIC_NAME> steroids </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_problems </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> attacks_of_asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> tight </DX_NAME> <DX_NAME> bronchoconstriction </DX_NAME> <DX_NAME> inflamed </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> wheezing </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_tightness </DX_NAME> <DX_NAME> cough </DX_NAME> <GENERIC_NAME> zimbus_breezhaler </GENERIC_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME>
<GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> insulatard_is_an_isophane </GENERIC_NAME> <GENERIC_NAME> nph)_human_insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> zinc_chloride </GENERIC_NAME> <GENERIC_NAME> glycerol </GENERIC_NAME> <GENERIC_NAME> metacresol </GENERIC_NAME> <GENERIC_NAME> phenol </GENERIC_NAME> <GENERIC_NAME> disodium_phosphate_dihydrate </GENERIC_NAME> <GENERIC_NAME> sodium_hydroxide </GENERIC_NAME> <GENERIC_NAME> hydrochloric_acid </GENERIC_NAME> <GENERIC_NAME> protamine_sulfate </GENERIC_NAME>
<BRAND_NAME> emadine </BRAND_NAME> <DX_NAME> seasonal_allergic_conjunctivitis </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> allergic_conditions </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> allergic_reaction </DX_NAME> <DX_NAME> allergic_conjunctivitis </DX_NAME> <DX_NAME> allergic_reactions </DX_NAME> <DX_NAME> itching </DX_NAME> <DX_NAME> redness </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> surface_of_your_eye </SYSTEM_ORGAN_SITE> <DX_NAME> feel_worse </DX_NAME>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <BRAND_NAME> teva_pharma </BRAND_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <TEST_NAME> platelets </TEST_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_k_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <BRAND_NAME> teva_pharma </BRAND_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> anticoagulants’ </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<BRAND_NAME> dectova </BRAND_NAME> <GENERIC_NAME> zanamivir </GENERIC_NAME> <TREATMENT_NAME> antivirals </TREATMENT_NAME> <BRAND_NAME> dectova </BRAND_NAME> <NAME> dectova </NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> influenza_virus_infection </DX_NAME> <TREATMENT_NAME> flu_treatments </TREATMENT_NAME> <BRAND_NAME> dectova </BRAND_NAME>
<BRAND_NAME> Zinforo </BRAND_NAME> <BRAND_NAME> Zinforo </BRAND_NAME> <TREATMENT_NAME> antibiotic_medicine </TREATMENT_NAME> <GENERIC_NAME> antibiotic_medicine </GENERIC_NAME> <GENERIC_NAME> ceftaroline_fosamil </GENERIC_NAME> <TREATMENT_NAME> ‘cephalosporin_antibiotics </TREATMENT_NAME> <GENERIC_NAME> ‘cephalosporin_antibiotics </GENERIC_NAME> <BRAND_NAME> Zinforo </BRAND_NAME> <BRAND_NAME> Zinforo </BRAND_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <BRAND_NAME> Zinforo </BRAND_NAME> <BRAND_NAME> Zinforo </BRAND_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME>
<GENERIC_NAME> trastuzumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <TEST_NAME> monoclonal_antibodies </TEST_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <DX_NAME> die </DX_NAME> <DX_NAME> herzuma </DX_NAME> <BRAND_NAME> herzuma </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> tumour </DX_NAME> <DX_NAME> high_levels_of_her2 </DX_NAME> <DX_NAME> herzuma </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <TREATMENT_NAME> aromatase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> aromatase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> hormone_receptorpositive </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <DX_NAME> high_levels_of_her2 </DX_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME>
<DX_NAME> dupuytren’s_contracture </DX_NAME> <DX_NAME> palpable_cord_and_peyronie’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> cord </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> dupuytren’s </SYSTEM_ORGAN_SITE> <DX_NAME> dupuytren’s_contracture </DX_NAME> <SYSTEM_ORGAN_SITE> finger </SYSTEM_ORGAN_SITE> <DX_NAME> contracture </DX_NAME> <DX_NAME> abnormal_formation </DX_NAME> <SYSTEM_ORGAN_SITE> cord </SYSTEM_ORGAN_SITE> <DX_NAME> cord_containing_collagen </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> contracture </DX_NAME> <SYSTEM_ORGAN_SITE> hands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <DX_NAME> change_in_the_shape_of_the_erect_penis </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <DX_NAME> abnormal_buildup </DX_NAME> <DX_NAME> scar_tissue </DX_NAME> <SYSTEM_ORGAN_SITE> scar_tissue </SYSTEM_ORGAN_SITE> <DX_NAME> plaque </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <DX_NAME> plaque </DX_NAME> <DX_NAME> straight_erection </DX_NAME> <DX_NAME> plaque </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <DX_NAME> peyronie’s_disease </DX_NAME> <DX_NAME> erection </DX_NAME> <DX_NAME> clostridium_histolyticum </DX_NAME> <SYSTEM_ORGAN_SITE> cord </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> finger </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hand </SYSTEM_ORGAN_SITE> <DX_NAME> plaque </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cord </SYSTEM_ORGAN_SITE> <DX_NAME> plaque </DX_NAME> <SYSTEM_ORGAN_SITE> dupuytren’s </SYSTEM_ORGAN_SITE> <DX_NAME> dupuytren’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> cord </SYSTEM_ORGAN_SITE> <DX_NAME> contracture </DX_NAME> <SYSTEM_ORGAN_SITE> finger </SYSTEM_ORGAN_SITE> <DX_NAME> peyronie’s_disease </DX_NAME> <DX_NAME> breaks_down_the_collagen </DX_NAME> <DX_NAME> plaque </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <DX_NAME> erection </DX_NAME>
<GENERIC_NAME> taxespira </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> taxoids </GENERIC_NAME> <GENERIC_NAME> taxespira </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <DX_NAME> head_and_neck_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> taxespira </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_node </SYSTEM_ORGAN_SITE> <GENERIC_NAME> taxespira </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> taxespira </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <GENERIC_NAME> taxespira </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <GENERIC_NAME> prednisolone </GENERIC_NAME> <DX_NAME> gastric_cancer </DX_NAME> <GENERIC_NAME> taxespira </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> neck_cancer </DX_NAME> <GENERIC_NAME> taxespira </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME>
<GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicine </TREATMENT_NAME> <GENERIC_NAME> antiepileptic_medicine </GENERIC_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> seizure </DX_NAME> <DX_NAME> generalisation </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> myoclonic_seizures </DX_NAME> <DX_NAME> shocklike_jerks </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <AGE> 12 </AGE> <DX_NAME> myoclonic_epilepsy </DX_NAME> <DX_NAME> generalised_tonicclonic_seizures </DX_NAME> <DX_NAME> loss_of_consciousness </DX_NAME> <AGE> 12 </AGE> <TIME_TO_DX_NAME> 12 </TIME_TO_DX_NAME> <DX_NAME> generalised_epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <GENERIC_NAME> concentrate </GENERIC_NAME> <TREATMENT_NAME> infusion </TREATMENT_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME>
<GENERIC_NAME> metalyse_powder </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <GENERIC_NAME> recombinant_fibrinspecific_plasminogen_activator </GENERIC_NAME> <DX_NAME> myocardial_infarctions </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attacks </DX_NAME> <TIME_TO_DX_NAME> within_6_hours </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> within_6_hours </TIME_TO_DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attacks </DX_NAME>
<GENERIC_NAME> thorinane </GENERIC_NAME> <GENERIC_NAME> enoxaparin_sodium </GENERIC_NAME> <GENERIC_NAME> heparin </GENERIC_NAME> <GENERIC_NAME> lmwh </GENERIC_NAME> <GENERIC_NAME> thorinane </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <GENERIC_NAME> thorinane </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <DX_NAME> illness </DX_NAME> <DX_NAME> unstable_angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_problems </DX_NAME>
<GENERIC_NAME> voriconazole </GENERIC_NAME> <GENERIC_NAME> voriconazole </GENERIC_NAME> <GENERIC_NAME> voriconazole </GENERIC_NAME> <TREATMENT_NAME> antifungal_medicine </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <AGE> 2 </AGE> <DX_NAME> aspergillosis </DX_NAME> <DX_NAME> fungal_infection </DX_NAME> <DX_NAME> candidaemia </DX_NAME> <DX_NAME> fungal_infection </DX_NAME> <DX_NAME> nonneutropenic </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> candida_sp._infections </DX_NAME> <GENERIC_NAME> fluconazole </GENERIC_NAME> <TREATMENT_NAME> antifungal_medicine </TREATMENT_NAME> <GENERIC_NAME> antifungal_medicine </GENERIC_NAME> <DX_NAME> fungal_infections </DX_NAME> <GENERIC_NAME> scedosporium </GENERIC_NAME> <GENERIC_NAME> fusarium </GENERIC_NAME> <GENERIC_NAME> voriconazole </GENERIC_NAME> <DX_NAME> lifethreatening </DX_NAME> <DX_NAME> fungal_infections </DX_NAME> <DX_NAME> fungal_infections </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE>
<NAME> mektovi </NAME> <GENERIC_NAME> binimetinib </GENERIC_NAME> <GENERIC_NAME> encorafenib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <DX_NAME> melanoma </DX_NAME> <GENERIC_NAME> encorafenib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> loxapine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> dopamine </GENERIC_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <DX_NAME> calming_effects </DX_NAME> <DX_NAME> aggressive_behaviour </DX_NAME> <DX_NAME> agitation </DX_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> diseases_characterised_by_symptoms </DX_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> mistaken_beliefs </DX_NAME> <DX_NAME> incoherent_speech_and_behaviour </DX_NAME> <DX_NAME> emotional_flatness </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> feeling_“high” </DX_NAME> <DX_NAME> excessive_amounts_of_energy </DX_NAME> <DX_NAME> needing_much_less_sleep_than_usual </DX_NAME> <DX_NAME> racing_ideas </DX_NAME> <DX_NAME> irritability </DX_NAME>
<GENERIC_NAME> prasugrel </GENERIC_NAME> <TREATMENT_NAME> anti_platelet_agents </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <DX_NAME> blood_clot </DX_NAME> <DX_NAME> thrombus </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> clots </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> myocardial_infarction </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> unstable_angina </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> blood_clot </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> unstable_angina </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> narrowed_artery_supplying_blood </DX_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> dying </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> aspirin </GENERIC_NAME> <TREATMENT_NAME> anti_platelet_agent </TREATMENT_NAME>
<GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> ‘azacitidine’ </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <PROCEDURE_NAME> stem_cell_transplantation </PROCEDURE_NAME> <DX_NAME> higherrisk_myelodysplastic_syndromes </DX_NAME> <DX_NAME> mds </DX_NAME> <DX_NAME> myelomonocytic_leukaemia </DX_NAME> <DX_NAME> cmml </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> aml </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <TEST_NAME> ribonucleic_acid </TEST_NAME> <TEST_NAME> rna) </TEST_NAME> <TEST_NAME> deoxyribonucleic_acid </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> myelodysplastic_disorders </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME>
<GENERIC_NAME> sevelamer_carbonate </GENERIC_NAME> <GENERIC_NAME> sevelamer_carbonate </GENERIC_NAME> <DX_NAME> hyperphosphataemia </DX_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <TREATMENT_NAME> blood_clearance_technique </TREATMENT_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <PROCEDURE_NAME> peritoneal_dialysis </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> abdomen </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> internal_body_membrane </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <TEST_NAME> serum_(blood) </TEST_NAME> <TEST_NAME> phosphorus_level </TEST_NAME> <GENERIC_NAME> calcium_supplements </GENERIC_NAME> <GENERIC_NAME> vitamin_d </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_disease </DX_NAME> <DX_NAME> hard_deposits </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> calcification </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> itchy_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> red_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <DX_NAME> fractures </DX_NAME>
<GENERIC_NAME> posaconazole </GENERIC_NAME> <GENERIC_NAME> posaconazole </GENERIC_NAME> <DX_NAME> fungal_infections </DX_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> posaconazole </GENERIC_NAME> <DX_NAME> fungal_infections </DX_NAME> <TREATMENT_NAME> antifungal_medicines </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> antifungal_medicines </TREATMENT_NAME> <GENERIC_NAME> antifungal_medicines </GENERIC_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> fusarium </GENERIC_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> “mycetoma” </DX_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> fungus </DX_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <GENERIC_NAME> fluconazole </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat_area </SYSTEM_ORGAN_SITE> <DX_NAME> fungal_infections </DX_NAME> <DX_NAME> fungal_infection </DX_NAME> <DX_NAME> weak_immune_system </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> “acute_myelogenous_leukemia” </DX_NAME> <DX_NAME> aml </DX_NAME> <DX_NAME> “myelodysplastic_syndromes” </DX_NAME> <DX_NAME> mds </DX_NAME> <TREATMENT_NAME> immunosuppressive_therapy” </TREATMENT_NAME> <TREATMENT_NAME> “hematopoietic_stem_cell_transplant” </TREATMENT_NAME> <TREATMENT_NAME> hsct </TREATMENT_NAME>
<BRAND_NAME> cometriq </BRAND_NAME> <BRAND_NAME> cometriq </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> cabozantinib </GENERIC_NAME> <GENERIC_NAME> malate </GENERIC_NAME> <DX_NAME> medullary_thyroid_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> thyroid </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> thyroid </SYSTEM_ORGAN_SITE> <DX_NAME> thyroid_cancer </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <BRAND_NAME> cometriq </BRAND_NAME> <BRAND_NAME> cometriq </BRAND_NAME> <BRAND_NAME> cometriq </BRAND_NAME> <BRAND_NAME> cometriq </BRAND_NAME> <DX_NAME> medullary_thyroid_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> thyroid </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> fasenra </GENERIC_NAME> <GENERIC_NAME> fasenra </GENERIC_NAME> <GENERIC_NAME> benralizumab </GENERIC_NAME> <GENERIC_NAME> benralizumab </GENERIC_NAME> <GENERIC_NAME> fasenra </GENERIC_NAME> <DX_NAME> eosinophilic_asthma </DX_NAME> <DX_NAME> eosinophilic_asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> asthma </DX_NAME> <GENERIC_NAME> ‘corticosteroid </GENERIC_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma_inflammation </DX_NAME> <GENERIC_NAME> fasenra_fasenra </GENERIC_NAME> <DX_NAME> asthma_attacks </DX_NAME> <DX_NAME> asthma </DX_NAME> <GENERIC_NAME> fasenra </GENERIC_NAME> <TREATMENT_NAME> oral_corticosteroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> asthma </DX_NAME>
<GENERIC_NAME> febuxostat </GENERIC_NAME> <DX_NAME> gout </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> redness </DX_NAME> <DX_NAME> warmth </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> gout_attack </DX_NAME> <SYSTEM_ORGAN_SITE> tophi </SYSTEM_ORGAN_SITE> <DX_NAME> tophi </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tophi </SYSTEM_ORGAN_SITE> <DX_NAME> tophi </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> joint_and_bone_damage </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <TEST_NAME> uric_acid_levels </TEST_NAME> <TEST_NAME> uric_acid_levels </TEST_NAME> <DX_NAME> shrink_tophi </DX_NAME> <DX_NAME> high_blood_levels </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> blood_cancers </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> uric_acid_levels </TEST_NAME>
<GENERIC_NAME> pemetrexed </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <DX_NAME> malignant_pleural_mesothelioma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> cml </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> myelodysplastic/myeloproliferative_diseases </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> hypereosinophilic_syndrome </DX_NAME> <DX_NAME> eosinophilic_leukaemia </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> dermatofibrosarcoma_protuberans </DX_NAME> <DX_NAME> dfsp </DX_NAME> <DX_NAME> dfsp </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME>
<BRAND_NAME> jalra </BRAND_NAME> <GENERIC_NAME> vildagliptin </GENERIC_NAME> <NAME> jalra </NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <BRAND_NAME> jalra </BRAND_NAME> <TREATMENT_NAME> antidiabetic_medicines </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<TEST_NAME> human_von_willebrand_factor </TEST_NAME> <TEST_NAME> vwf </TEST_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> lack_of_vwf </DX_NAME> <DX_NAME> von_willebrand_disease </DX_NAME> <DX_NAME> vwd </DX_NAME> <DX_NAME> lack_of_fviii </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <GENERIC_NAME> desmopressin </GENERIC_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> clot </DX_NAME> <DX_NAME> bleed </DX_NAME> <PROCEDURE_NAME> replacement_of_vwf </PROCEDURE_NAME> <PROCEDURE_NAME> temporarily_repair </PROCEDURE_NAME> <TREATMENT_NAME> blood_clotting_mechanisms </TREATMENT_NAME> <DX_NAME> haemophilia </DX_NAME>
<BRAND_NAME> kineret </BRAND_NAME> <GENERIC_NAME> anakinra </GENERIC_NAME> <TREATMENT_NAME> immunosuppressive_agent </TREATMENT_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> fever_syndromes </DX_NAME> <DX_NAME> cryopyrinassociated_periodic_syndromes </DX_NAME> <DX_NAME> multisystem_inflammatory_disease </DX_NAME> <DX_NAME> infantile_neurological,_cutaneous </DX_NAME> <DX_NAME> articular_syndrome </DX_NAME> <DX_NAME> cinca </DX_NAME> <SYSTEM_ORGAN_SITE> mucklewells </SYSTEM_ORGAN_SITE> <DX_NAME> mucklewells_syndrome </DX_NAME> <DX_NAME> familial_cold_autoinflammatory_syndrome </DX_NAME> <DX_NAME> familial_mediterranean_fever </DX_NAME> <DX_NAME> fmf </DX_NAME> <DX_NAME> still´s_disease </DX_NAME> <DX_NAME> juvenile_idiopathic_arthritis </DX_NAME> <DX_NAME> sjia </DX_NAME> <DX_NAME> adultonset_still’s_disease </DX_NAME> <DX_NAME> aosd </DX_NAME> <DX_NAME> inflammation </DX_NAME> <BRAND_NAME> kineret </BRAND_NAME> <GENERIC_NAME> anakinra </GENERIC_NAME> <BRAND_NAME> kineret </BRAND_NAME> <AGE> 18 </AGE> <GENERIC_NAME> methotrexate </GENERIC_NAME> <BRAND_NAME> kineret </BRAND_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <BRAND_NAME> kineret </BRAND_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> rash </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> joint_pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> headache </DX_NAME> <DX_NAME> fatigue </DX_NAME> <AGE> 29 </AGE> <DX_NAME> fmf </DX_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> abdominal_pain </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_or_joint_pain </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> rash </DX_NAME> <BRAND_NAME> kineret </BRAND_NAME> <GENERIC_NAME> colchicine </GENERIC_NAME> <DX_NAME> still´s_disease </DX_NAME> <BRAND_NAME> kineret </BRAND_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> rash </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> joint_pain </DX_NAME> <DX_NAME> fever </DX_NAME>
<GENERIC_NAME> fenofibrate </GENERIC_NAME> <GENERIC_NAME> simvastatin </GENERIC_NAME> <TEST_NAME> total_cholesterol </TEST_NAME> <TEST_NAME> “bad”_cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> raise_levels </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> total_cholesterol </TEST_NAME> <TEST_NAME> ldl </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <DX_NAME> plaque </DX_NAME> <DX_NAME> plaque </DX_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <TEST_NAME> triglycerides </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_problems </DX_NAME> <TEST_NAME> cholesterol </TEST_NAME> <DX_NAME> cholesterol_or_triglycerides_problems </DX_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> lipids </TEST_NAME> <TEST_NAME> simple_blood_test </TEST_NAME> <TEST_NAME> lipids_level </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <TEST_NAME> blood_levels </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <GENERIC_NAME> simvastatin </GENERIC_NAME> <TREATMENT_NAME> low_fat_diet </TREATMENT_NAME> <TREATMENT_NAME> weight_reduction </TREATMENT_NAME> <GENERIC_NAME> cholib </GENERIC_NAME>
<GENERIC_NAME> topotecan </GENERIC_NAME> <TREATMENT_NAME> infusion </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <GENERIC_NAME> topotecan </GENERIC_NAME> <DX_NAME> ovarian_cancer </DX_NAME> <DX_NAME> small_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cervical_cancer </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <DX_NAME> cervical_cancer </DX_NAME> <GENERIC_NAME> topotecan </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> topotecan </GENERIC_NAME> <TREATMENT_NAME> topotecan_hospira_therapy </TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> weakness </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <TEST_NAME> haemoglobin_level </TEST_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <AGE> 18 </AGE> <TREATMENT_NAME> natural_hormone_erythropoietin </TREATMENT_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <TEST_NAME> haemoglobin_level </TEST_NAME>
<GENERIC_NAME> “rituximab” </GENERIC_NAME> <GENERIC_NAME> rituximab </GENERIC_NAME> <DX_NAME> Non-Hodgkin’s_Lymphoma </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <NAME> Blitzima </NAME> <TREATMENT_NAME> “chemotherapy” </TREATMENT_NAME> <NAME> Blitzima </NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> CLL </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> CLL </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <DX_NAME> CLL </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> Granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> Wegener’s_granulomatosis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> Granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <TEST_NAME> B-lymphocytes </TEST_NAME> <DX_NAME> Pemphigus_vulgaris_Blitzima </DX_NAME> <DX_NAME> pemphigus_vulgaris </DX_NAME> <DX_NAME> Pemphigus_vulgaris </DX_NAME> <DX_NAME> autoimmune_condition </DX_NAME> <DX_NAME> painful_blisters </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lining_of_the_mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> genitals </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> sildenafil </GENERIC_NAME> <GENERIC_NAME> sildenafil </GENERIC_NAME> <GENERIC_NAME> sildenafil </GENERIC_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_(pde5)_inhibitors </TREATMENT_NAME> <DX_NAME> erections </DX_NAME> <GENERIC_NAME> sildenafil </GENERIC_NAME> <DX_NAME> sexually_stimulated </DX_NAME> <GENERIC_NAME> sildenafil </GENERIC_NAME> <GENERIC_NAME> sildenafil </GENERIC_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <DX_NAME> cannot_get_or_keep_a_hard </DX_NAME> <DX_NAME> erect_penis_suitable_for_sexual_activity </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> retigabine </GENERIC_NAME> <TREATMENT_NAME> antiepileptics </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_overactivity </DX_NAME> <DX_NAME> epileptic_seizures </DX_NAME> <DX_NAME> seizures </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> partial_seizure </DX_NAME> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME> <DX_NAME> seizures </DX_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME>
<GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <AGE> 18 </AGE> <GENERIC_NAME> pegylated_liposomal_doxorubicin </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <GENERIC_NAME> melphalan </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <TIME_TO_TREATMENT_NAME> previously </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> thalidomide </GENERIC_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <TREATMENT_NAME> induction_treatment </TREATMENT_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <DX_NAME> mantle_cell_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <GENERIC_NAME> rituximab </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME>
<BRAND_NAME> JEVTANA </BRAND_NAME> <GENERIC_NAME> cabazitaxel </GENERIC_NAME> <DX_NAME> cancers </DX_NAME> <BRAND_NAME> JEVTANA </BRAND_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> corticosteroid_medicine </TREATMENT_NAME> <GENERIC_NAME> corticosteroid_medicine </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <GENERIC_NAME> prednisolone </GENERIC_NAME>
<GENERIC_NAME> carmustine </GENERIC_NAME> <GENERIC_NAME> carmustine </GENERIC_NAME> <GENERIC_NAME> carmustine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> carmustine </GENERIC_NAME> <DX_NAME> neoplasms </DX_NAME> <TREATMENT_NAME> antineoplastic_agents </TREATMENT_NAME> <TREATMENT_NAME> therapeutic_measures </TREATMENT_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_tumours </DX_NAME> <DX_NAME> glioblastoma </DX_NAME> <SYSTEM_ORGAN_SITE> brainstem </SYSTEM_ORGAN_SITE> <DX_NAME> brainstem_gliomas </DX_NAME> <DX_NAME> medulloblastoma </DX_NAME> <DX_NAME> astrocytoma </DX_NAME> <DX_NAME> ependymoma </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_metastases </DX_NAME> <DX_NAME> nonhodgkin’s_lymphoma </DX_NAME> <DX_NAME> hodgkin’s_disease </DX_NAME> <TREATMENT_NAME> conditioning_treatment </TREATMENT_NAME> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> autologous_haematopoietic_progenitor_cell_transplantation </TREATMENT_NAME> <DX_NAME> haematological_diseases </DX_NAME> <DX_NAME> hodgkin’s_disease </DX_NAME> <DX_NAME> nonhodgkin’s_lymphoma </DX_NAME>
<BRAND_NAME> byetta </BRAND_NAME> <GENERIC_NAME> exenatide </GENERIC_NAME> <GENERIC_NAME> medicine </GENERIC_NAME> <GENERIC_NAME> noninsulin </GENERIC_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <BRAND_NAME> byetta </BRAND_NAME> <TREATMENT_NAME> diabetic_medicines </TREATMENT_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylureas </GENERIC_NAME> <GENERIC_NAME> thiazolidinediones </GENERIC_NAME> <GENERIC_NAME> basal_or_long_acting_insulins </GENERIC_NAME> <BRAND_NAME> byetta </BRAND_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <BRAND_NAME> byetta </BRAND_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME>
<GENERIC_NAME> etravirine </GENERIC_NAME> <TREATMENT_NAME> nonnucleoside_reverse_transcriptase_inhibitors </TREATMENT_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> antihiv_medicines </TREATMENT_NAME>
<BRAND_NAME> ameluz </BRAND_NAME> <GENERIC_NAME> 5aminolaevulinic_acid </GENERIC_NAME> <DX_NAME> actinic_keratoses </DX_NAME> <DX_NAME> actinic_keratoses </DX_NAME> <DX_NAME> actinic_keratoses </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> nodular_basal_cell_carcinoma </DX_NAME> <DX_NAME> poor_cosmetic_outcome </DX_NAME> <DX_NAME> basal_cell_carcinoma </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> scaly_patches </DX_NAME> <DX_NAME> bumps </DX_NAME> <DX_NAME> bleed </DX_NAME> <BRAND_NAME> ameluz </BRAND_NAME> <DX_NAME> reactive_oxygencontaining_molecules </DX_NAME> <TREATMENT_NAME> photodynamic_therapy </TREATMENT_NAME>
<GENERIC_NAME> Pioglitazone </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <TREATMENT_NAME> anti-diabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> anti-diabetic_medicine </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> Pioglitazone </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> Pioglitazone </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> 3_to_6_months </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> Pioglitazone </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulfonylurea </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME>
<BRAND_NAME> tarceva </BRAND_NAME> <GENERIC_NAME> erlotinib </GENERIC_NAME> <BRAND_NAME> tarceva </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> tarceva </BRAND_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> gemcitabine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> gefitinib </GENERIC_NAME> <GENERIC_NAME> gefitinib </GENERIC_NAME> <GENERIC_NAME> gefitinib </GENERIC_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE>
<BRAND_NAME> zydelig </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> idelalisib </GENERIC_NAME> <BRAND_NAME> zydelig </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> zydelig </BRAND_NAME> <DX_NAME> cancers </DX_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> cll </DX_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> rituximab </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> follicular_lymphoma </DX_NAME> <DX_NAME> follicular_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> follicular_lymphoma </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> cancer_treatments </TREATMENT_NAME>
<GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> taxoids </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <DX_NAME> head_and_neck_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_node </SYSTEM_ORGAN_SITE> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <GENERIC_NAME> prednisolone </GENERIC_NAME> <DX_NAME> gastric_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> neck_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME>
<GENERIC_NAME> Insulin_aspart_Sanofi </GENERIC_NAME> <GENERIC_NAME> modern_insulin </GENERIC_NAME> <GENERIC_NAME> insulin_analogue </GENERIC_NAME> <GENERIC_NAME> rapid-acting_effect </GENERIC_NAME> <GENERIC_NAME> Modern_insulin_products </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> Insulin_aspart_Sanofi </GENERIC_NAME> <DX_NAME> high_blood_sugar_level </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> Diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TREATMENT_NAME> Insulin_aspart_Sanofi </TREATMENT_NAME> <GENERIC_NAME> Insulin_aspart_Sanofi </GENERIC_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> Insulin_aspart_Sanofi </GENERIC_NAME> <TREATMENT_NAME> Insulin_aspart_Sanofi </TREATMENT_NAME> <PROCEDURE_NAME> injection </PROCEDURE_NAME> <GENERIC_NAME> Insulin_aspart_Sanofi </GENERIC_NAME> <GENERIC_NAME> long-acting_insulin </GENERIC_NAME>
<NAME> ervebo </NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <AGE> 18 </AGE> <NAME> ervebo </NAME> <DX_NAME> ebola_virus_disease </DX_NAME> <DX_NAME> ebola_virus </DX_NAME> <DX_NAME> ebola_virus </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> ebola_virus </DX_NAME> <DX_NAME> whole_ebola_virus </DX_NAME> <DX_NAME> ebola_virus_disease </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> ebola_virus_disease </DX_NAME> <NAME> ebola </NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> died </DX_NAME> <ADDRESS> ebola </ADDRESS> <DX_NAME> vomit </DX_NAME> <DX_NAME> sweat </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> infected </DX_NAME> <DX_NAME> ebola_virus </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME>
<GENERIC_NAME> leflunomide </GENERIC_NAME> <TREATMENT_NAME> antirheumatic_medicines </TREATMENT_NAME> <GENERIC_NAME> leflunomide </GENERIC_NAME> <GENERIC_NAME> leflunomide </GENERIC_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> arthritis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> difficulty_moving </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> loss_of_appetite </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> loss_of_energy </DX_NAME> <DX_NAME> anemia </DX_NAME> <DX_NAME> lack_of_red_blood_cells </DX_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME>
<GENERIC_NAME> potactasol </GENERIC_NAME> <GENERIC_NAME> topotecan </GENERIC_NAME> <GENERIC_NAME> potactasol </GENERIC_NAME> <DX_NAME> ovarian_cancer </DX_NAME> <DX_NAME> small_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cervical_cancer </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <GENERIC_NAME> potactasol </GENERIC_NAME> <TREATMENT_NAME> potactasol_treatment </TREATMENT_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME>
<GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide_zentiva </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <DX_NAME> angiotensinii </DX_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> increased_urine_output </DX_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide_zentiva </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME>
<PROCEDURE_NAME> injecting </PROCEDURE_NAME> <BRAND_NAME> aranesp </BRAND_NAME> <BRAND_NAME> aranesp </BRAND_NAME> <BRAND_NAME> aranesp </BRAND_NAME> <GENERIC_NAME> antianaemic </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> weakness </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <BRAND_NAME> aranesp </BRAND_NAME> <GENERIC_NAME> erythropoietin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <BRAND_NAME> aranesp </BRAND_NAME> <GENERIC_NAME> darbepoetin_alfa </GENERIC_NAME> <DX_NAME> renal_failure </DX_NAME> <BRAND_NAME> aranesp </BRAND_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> renal_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> natural_hormone_erythropoietin </TREATMENT_NAME> <GENERIC_NAME> erythropoietin </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <BRAND_NAME> aranesp </BRAND_NAME> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <BRAND_NAME> aranesp </BRAND_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancers </DX_NAME> <DX_NAME> nonmyeloid_malignancies </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> side_effects </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> red_blood_cell_count </TEST_NAME> <DX_NAME> red_blood_cell_count </DX_NAME> <DX_NAME> fall </DX_NAME> <DX_NAME> anaemic </DX_NAME>
<GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicine </TREATMENT_NAME> <GENERIC_NAME> antiepileptic_medicine </GENERIC_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <BRAND_NAME> keppra </BRAND_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> seizure </DX_NAME> <DX_NAME> generalisation </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> myoclonic_seizures </DX_NAME> <DX_NAME> shocklike_jerks </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <AGE> 12 </AGE> <DX_NAME> myoclonic_epilepsy </DX_NAME> <DX_NAME> tonicclonic_seizures </DX_NAME> <DX_NAME> loss_of_consciousness </DX_NAME> <AGE> 12 </AGE> <DX_NAME> generalised_epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME>
<GENERIC_NAME> dafiro </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessel_wall </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME>
<GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> nerve_cells_die </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> acetylcholinesterase </GENERIC_NAME> <GENERIC_NAME> butyrylcholinesterase </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> alzheimer’s_disease </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_disorder </DX_NAME> <DX_NAME> memory </DX_NAME> <DX_NAME> intellectual_ability_and_behaviour </DX_NAME> <GENERIC_NAME> oral_solution </GENERIC_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME>
<GENERIC_NAME> tobramycin </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <AGE> 6 </AGE> <DX_NAME> cystic_fibrosis </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_infections </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> pseudomonas_aeruginosa </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> improve_your_breathing </DX_NAME> <DX_NAME> pseudomonas_aeruginosa </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> problems_to_your_breathing </DX_NAME>
<GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessels_to_narrow </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <DX_NAME> hypertension </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attacks </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> strokes </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> reduced_or_blocked_blood_supply </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<BRAND_NAME> zaltrap </BRAND_NAME> <BRAND_NAME> zaltrap </BRAND_NAME> <GENERIC_NAME> aflibercept </GENERIC_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <BRAND_NAME> zaltrap </BRAND_NAME> <BRAND_NAME> zaltrap </BRAND_NAME> <BRAND_NAME> zaltrap </BRAND_NAME> <DX_NAME> cancers </DX_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> rectum </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> large_intestine </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> ‘chemotherapy’ </TREATMENT_NAME>
<GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hbv_infection </DX_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <TREATMENT_NAME> nucleotide_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <BRAND_NAME> mylan </BRAND_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> hiv_medicines </TREATMENT_NAME> <DX_NAME> side_effects </DX_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <BRAND_NAME> mylan </BRAND_NAME> <DX_NAME> hepatitis_b </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME>
<NAME> aflunov </NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> zoonotic_influenza_viruses </DX_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> h5n1_viruses </DX_NAME> <DX_NAME> influenza_viruses </DX_NAME> <DX_NAME> infect_humans </DX_NAME> <DX_NAME> upper_respiratory_infection </DX_NAME> <SYSTEM_ORGAN_SITE> respiratory </SYSTEM_ORGAN_SITE> <DX_NAME> fever </DX_NAME> <DX_NAME> cough </DX_NAME> <DX_NAME> pneumonia </DX_NAME> <DX_NAME> respiratory_distress_syndrome </DX_NAME> <DX_NAME> shock </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> human_infections </DX_NAME> <DX_NAME> strain </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> vaccines </TREATMENT_NAME>
<BRAND_NAME> zutectra </BRAND_NAME> <BRAND_NAME> zutectra </BRAND_NAME> <BRAND_NAME> zutectra </BRAND_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_b_virus </DX_NAME> <BRAND_NAME> zutectra </BRAND_NAME> <BRAND_NAME> zutectra </BRAND_NAME> <DX_NAME> reinfection </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> liver_transplant </PROCEDURE_NAME> <TIME_TO_PROCEDURE_NAME> least </TIME_TO_PROCEDURE_NAME> <TIME_TO_PROCEDURE_NAME> 1_week_ago </TIME_TO_PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_failure </DX_NAME> <DX_NAME> hepatitis_b </DX_NAME>
<BRAND_NAME> xtandi </BRAND_NAME> <GENERIC_NAME> enzalutamide </GENERIC_NAME> <BRAND_NAME> xtandi </BRAND_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <TREATMENT_NAME> androgen_deprivation_therapy </TREATMENT_NAME> <BRAND_NAME> xtandi </BRAND_NAME> <BRAND_NAME> xtandi </BRAND_NAME> <GENERIC_NAME> testosterone </GENERIC_NAME> <GENERIC_NAME> enzalutamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME>
<BRAND_NAME> trevicta </BRAND_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME> <TREATMENT_NAME> antipsychotic_medicines </TREATMENT_NAME> <TREATMENT_NAME> maintenance_treatment </TREATMENT_NAME> <DX_NAME> schizophrenia </DX_NAME> <GENERIC_NAME> paliperidone_palmitate </GENERIC_NAME> <TREATMENT_NAME> paliperidone_palmitate_injection </TREATMENT_NAME> <BRAND_NAME> trevicta </BRAND_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> hallucinations </DX_NAME> <DX_NAME> delusions </DX_NAME> <DX_NAME> lack_of_behaviours </DX_NAME> <DX_NAME> feelings_that_are_normally_present </DX_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> trouble_speaking_in_a_clear_and_logical_way </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> tense </DX_NAME>
<GENERIC_NAME> Olanzapine </GENERIC_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <GENERIC_NAME> Olanzapine </GENERIC_NAME> <GENERIC_NAME> Olanzapine </GENERIC_NAME> <DX_NAME> Schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> manic_episodes </DX_NAME> <DX_NAME> excitement </DX_NAME> <DX_NAME> euphoria </DX_NAME> <GENERIC_NAME> Olanzapine </GENERIC_NAME> <DX_NAME> recurrence </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> manic_episode </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME>
<GENERIC_NAME> nintedanib </GENERIC_NAME> <DX_NAME> idiopathic_pulmonary_fibrosis </DX_NAME> <DX_NAME> ipf </DX_NAME> <DX_NAME> fibrosing_interstitial_lung_diseases </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> systemic_sclerosis </DX_NAME> <DX_NAME> interstitial_lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> idiopathic_pulmonary_fibrosis </DX_NAME> <DX_NAME> ipf </DX_NAME> <DX_NAME> ipf_is_a_condition </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> stiff </DX_NAME> <DX_NAME> scarred </DX_NAME> <DX_NAME> scarring </DX_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> difficult_to_breathe_deeply </DX_NAME> <DX_NAME> scarring </DX_NAME> <DX_NAME> stiffening </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> fibrosing_interstitial_lung_diseases </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> ipf </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> thickened </DX_NAME> <DX_NAME> stiff </DX_NAME> <DX_NAME> scarred </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_fibrosis </DX_NAME> <DX_NAME> hypersensitivity_pneumonitis </DX_NAME> <DX_NAME> autoimmune_ilds </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> interstitial_pneumonia </DX_NAME> <DX_NAME> unclassifiable_idiopathic_interstitial_pneumonia </DX_NAME> <DX_NAME> scarring </DX_NAME> <DX_NAME> stiffening </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> systemic_sclerosis </DX_NAME> <DX_NAME> interstitial_lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> systemic_sclerosis </DX_NAME> <DX_NAME> scleroderma </DX_NAME> <DX_NAME> autoimmune_disease </DX_NAME> <SYSTEM_ORGAN_SITE> connective_tissue </SYSTEM_ORGAN_SITE> <DX_NAME> connective_tissue </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> fibrosis </DX_NAME> <DX_NAME> scarring </DX_NAME> <DX_NAME> stiffening </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> internal_organs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> fibrosis </DX_NAME> <DX_NAME> interstitial_lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> ild </DX_NAME> <DX_NAME> fibrosis </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> breathing_capacity_is_reduced </DX_NAME> <DX_NAME> scarring </DX_NAME> <DX_NAME> stiffening </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> dapagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <TREATMENT_NAME> oral_antidiabetics </TREATMENT_NAME> <GENERIC_NAME> antidiabetics </GENERIC_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes” </DX_NAME> <AGE> 18 </AGE> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> dapagliflozin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <TREATMENT_NAME> glp1_receptor_agonist </TREATMENT_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> dapagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> overdose </DX_NAME> <GENERIC_NAME> dapagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <BRAND_NAME> ebymect </BRAND_NAME>
<GENERIC_NAME> ibandronic_acid </GENERIC_NAME> <GENERIC_NAME> ibandronic_acid </GENERIC_NAME> <GENERIC_NAME> sodium_monohydrate </GENERIC_NAME> <GENERIC_NAME> lactose_monohydrate </GENERIC_NAME> <GENERIC_NAME> povidone </GENERIC_NAME> <GENERIC_NAME> cellulose_microcrystalline </GENERIC_NAME> <GENERIC_NAME> crospovidone </GENERIC_NAME> <GENERIC_NAME> stearic_acid_purified </GENERIC_NAME> <GENERIC_NAME> silica_colloidal_anhydrous_tablet </GENERIC_NAME> <GENERIC_NAME> hypromellose </GENERIC_NAME> <GENERIC_NAME> titanium_dioxide </GENERIC_NAME> <GENERIC_NAME> E_171 </GENERIC_NAME> <GENERIC_NAME> macrogol </GENERIC_NAME> <ADDRESS> Netherlands_B.V._Strawinskylaan </ADDRESS> <ADDRESS> 3127_1077 </ADDRESS> <ADDRESS> Netherlands_Manufacturer_Waymade </ADDRESS> <ADDRESS> Sovereign_House,_Miles_Gray_Road,_http </ADDRESS> <URL> www.ema.europa.eu/docs/en </URL> <DATE> 2013 </DATE> <DATE> 03/WC500139752.doc_47 </DATE> <ADDRESS> Basildon,_Essex,_SS14_3FR_United_Kingdom </ADDRESS> <ADDRESS> Waymade_PLC_Josselin_Road_Burnt_Mills_Industrial_Estate_Basildon </ADDRESS> <ADDRESS> SS13_1QF_United_Kingdom </ADDRESS> <NAME> GmbH_Marie </NAME> <ADDRESS> Curie-Strasse_8_Lörrach_Baden </ADDRESS> <ADDRESS> Württemberg_79539 </ADDRESS> <ADDRESS> Germany </ADDRESS>
<BRAND_NAME> revatio </BRAND_NAME> <GENERIC_NAME> sildenafil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> pulmonary_arterial_hypertension </DX_NAME>
<GENERIC_NAME> ibandronic_acid_sandoz </GENERIC_NAME> <GENERIC_NAME> ibandronic_acid </GENERIC_NAME> <GENERIC_NAME> ibandronic_acid_sandoz </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_problems </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <DX_NAME> lost_from_your_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME>
<DX_NAME> clots </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> inborn_factor_viii_deficiency </DX_NAME> <DX_NAME> factor_viii_is_missing </DX_NAME> <DX_NAME> vihuma </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME>
<GENERIC_NAME> cayston </GENERIC_NAME> <GENERIC_NAME> aztreonam </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> antibiotic </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_infection </DX_NAME> <DX_NAME> pseudomonas_aeruginosa </DX_NAME> <AGE> 6 </AGE> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> mucoviscidosis </DX_NAME> <DX_NAME> inherited_disease </DX_NAME> <SYSTEM_ORGAN_SITE> mucus_glands </SYSTEM_ORGAN_SITE> <DX_NAME> mucus_glands_of_internal_organs </DX_NAME> <SYSTEM_ORGAN_SITE> internal_organs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> digestive_system </SYSTEM_ORGAN_SITE> <DX_NAME> cystic_fibrosis </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> hard_to_breathe </DX_NAME>
<BRAND_NAME> tafinlar </BRAND_NAME> <GENERIC_NAME> dabrafenib </GENERIC_NAME> <GENERIC_NAME> trametinib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <BRAND_NAME> tafinlar </BRAND_NAME> <GENERIC_NAME> trametinib </GENERIC_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <BRAND_NAME> tafinlar </BRAND_NAME> <GENERIC_NAME> trametinib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> nsclc </DX_NAME> <DX_NAME> cancers </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME>
<TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> herpes_zoster </DX_NAME> <DX_NAME> postherpetic_neuralgia </DX_NAME> <DX_NAME> phn </DX_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> nerve_pain </DX_NAME> <DX_NAME> shingles </DX_NAME> <GENERIC_NAME> shingrix </GENERIC_NAME> <GENERIC_NAME> shingrix </GENERIC_NAME> <DX_NAME> chickenpox </DX_NAME> <DX_NAME> varicella </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> rash </DX_NAME> <DX_NAME> blisters </DX_NAME> <DX_NAME> painful </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> shingles </DX_NAME> <DX_NAME> chickenpox </DX_NAME> <DX_NAME> chickenpox </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve_cells </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> illness </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> shingles_shingles </DX_NAME> <DX_NAME> shingles </DX_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> nerve_pain </DX_NAME> <DX_NAME> postherpetic_neuralgia </DX_NAME> <DX_NAME> phn </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> blisters </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> scars </DX_NAME> <DX_NAME> blisters </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_infections </DX_NAME> <DX_NAME> weakness </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_paralysis </DX_NAME> <DX_NAME> loss_of_hearing_or_vision </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> shingles </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> shingles </DX_NAME>
<BRAND_NAME> champix </BRAND_NAME> <GENERIC_NAME> varenicline </GENERIC_NAME> <BRAND_NAME> champix </BRAND_NAME> <BRAND_NAME> champix </BRAND_NAME> <DX_NAME> craving </DX_NAME> <DX_NAME> withdrawal_symptoms </DX_NAME> <BRAND_NAME> champix </BRAND_NAME>
<GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <GENERIC_NAME> Pegfilgrastim </GENERIC_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> febrile_neutropenia </DX_NAME> <DX_NAME> low_white_blood_cell_count </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> fever </DX_NAME> <TREATMENT_NAME> cytotoxic_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> White_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME>
<GENERIC_NAME> duoplavin </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> asa </GENERIC_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> blood_clotting </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> atherothrombosis </DX_NAME> <GENERIC_NAME> duoplavin </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <GENERIC_NAME> duoplavin </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> asa </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> myocardial_infarction </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_flow </TEST_NAME>
<NAME> kivexa </NAME> <BRAND_NAME> kivexa </BRAND_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> abacavir </GENERIC_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> nucleoside_analogue_reverse_transcriptase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> nucleoside_analogue_reverse_transcriptase_inhibitors </GENERIC_NAME> <BRAND_NAME> kivexa </BRAND_NAME> <DX_NAME> hiv_infection </DX_NAME> <TREATMENT_NAME> cd4_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> kivexa </BRAND_NAME>
<GENERIC_NAME> xalkori </GENERIC_NAME> <GENERIC_NAME> crizotinib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> anaplastic_lymphoma </DX_NAME> <GENERIC_NAME> xalkori </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> xalkori </GENERIC_NAME> <GENERIC_NAME> xalkori </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> xalkori </GENERIC_NAME>
<BRAND_NAME> perjeta </BRAND_NAME> <GENERIC_NAME> pertuzumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> anticancer_medicines </TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> neoadjuvant_therapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> adjuvant_therapy </TREATMENT_NAME> <BRAND_NAME> perjeta </BRAND_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <BRAND_NAME> perjeta </BRAND_NAME> <BRAND_NAME> perjeta </BRAND_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> perjeta </BRAND_NAME> <TREATMENT_NAME> her2_cancer_cells </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME>
<BRAND_NAME> invega </BRAND_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME> <TREATMENT_NAME> antipsychotic_medicines </TREATMENT_NAME> <BRAND_NAME> invega </BRAND_NAME> <DX_NAME> schizophrenia </DX_NAME> <AGE> 15 </AGE> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disorder </DX_NAME> <DX_NAME> incoherent_speech </DX_NAME> <DX_NAME> behaviour </DX_NAME> <DX_NAME> emotional_flatness </DX_NAME> <DX_NAME> disorder </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> tense </DX_NAME> <BRAND_NAME> invega </BRAND_NAME> <DX_NAME> schizoaffective_disorder </DX_NAME> <DX_NAME> schizoaffective_disorder </DX_NAME> <DX_NAME> mental_condition </DX_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> mood_disorder </DX_NAME> <DX_NAME> feeling_very_high </DX_NAME> <DX_NAME> feeling_sad </DX_NAME> <DX_NAME> feeling_agitated </DX_NAME> <DX_NAME> distracted </DX_NAME> <DX_NAME> sleeplessness </DX_NAME> <DX_NAME> talkativeness </DX_NAME> <DX_NAME> losing_interest_in_everyday_activities </DX_NAME> <DX_NAME> sleeping_too_much_or_too_little </DX_NAME> <DX_NAME> eating_too_much_or_too_little </DX_NAME> <DX_NAME> thoughts_of_suicide </DX_NAME> <BRAND_NAME> invega </BRAND_NAME>
<GENERIC_NAME> eklira_genuair </GENERIC_NAME> <GENERIC_NAME> aclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bronchioles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eklira </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <BRAND_NAME> eklira </BRAND_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> effects_of_the_disease </DX_NAME> <DX_NAME> copd_symptoms </DX_NAME>
<GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> sandoz </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> nerve_cells_die </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> acetylcholinesterase </GENERIC_NAME> <GENERIC_NAME> butyrylcholinesterase </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> alzheimer’s_disease </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_disorder </DX_NAME> <DX_NAME> memory </DX_NAME> <DX_NAME> intellectual_ability_and_behaviour </DX_NAME> <GENERIC_NAME> oral_solution </GENERIC_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME>
<BRAND_NAME> faslodex </BRAND_NAME> <GENERIC_NAME> fulvestrant </GENERIC_NAME> <TREATMENT_NAME> estrogen_blockers </TREATMENT_NAME> <GENERIC_NAME> estrogen_blockers </GENERIC_NAME> <GENERIC_NAME> estrogens </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <BRAND_NAME> faslodex </BRAND_NAME> <DX_NAME> postmenopausal </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> palbociclib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <TREATMENT_NAME> luteinizing_hormone_releasing_hormone </TREATMENT_NAME> <TREATMENT_NAME> lhrh)_agonist </TREATMENT_NAME> <BRAND_NAME> faslodex </BRAND_NAME> <GENERIC_NAME> palbociclib </GENERIC_NAME> <GENERIC_NAME> palbociclib </GENERIC_NAME> <GENERIC_NAME> palbociclib </GENERIC_NAME>
<GENERIC_NAME> ertugliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> ertugliflozin </GENERIC_NAME> <GENERIC_NAME> sodium_glucose_cotransporter2 </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <AGE> 18 </AGE> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> ertugliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> ertugliflozin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <GENERIC_NAME> metformin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> poor_circulation </DX_NAME>
<GENERIC_NAME> human_fibrinogen </GENERIC_NAME> <GENERIC_NAME> human_thrombin </GENERIC_NAME> <DX_NAME> clot </DX_NAME> <PROCEDURE_NAME> surgical_operations </PROCEDURE_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> bleeding </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME>
<GENERIC_NAME> tipranavir </GENERIC_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <TREATMENT_NAME> hiv_medicines </TREATMENT_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> hiv_medicines </TREATMENT_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <TEST_NAME> blood_samples </TEST_NAME> <DX_NAME> hiv </DX_NAME> <TEST_NAME> hiv </TEST_NAME> <TEST_NAME> tests </TEST_NAME> <DX_NAME> hiv </DX_NAME> <TEST_NAME> hiv </TEST_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <TREATMENT_NAME> aptivus_treatment </TREATMENT_NAME> <TREATMENT_NAME> antiretroviral_therapy </TREATMENT_NAME>
<GENERIC_NAME> raltegravir </GENERIC_NAME> <GENERIC_NAME> isentress </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> immune_deficiency_syndrome </DX_NAME> <GENERIC_NAME> isentress </GENERIC_NAME> <GENERIC_NAME> isentress </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> isentress </GENERIC_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> isentress </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME>
<GENERIC_NAME> instanyl </GENERIC_NAME> <GENERIC_NAME> fentanyl </GENERIC_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> instanyl </GENERIC_NAME> <DX_NAME> breakthrough_pain </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> breakthrough_pain </DX_NAME> <DX_NAME> pain </DX_NAME> <GENERIC_NAME> opioid </GENERIC_NAME> <TREATMENT_NAME> opioid_pain_relieving_medicines </TREATMENT_NAME> <DX_NAME> pain </DX_NAME>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_k_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> anticoagulants’ </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> indacaterol </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> walls </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> small_air_passages </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficult </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE>
<BRAND_NAME> azopt </BRAND_NAME> <GENERIC_NAME> brinzolamide </GENERIC_NAME> <GENERIC_NAME> carbonic_anhydrase_inhibitors </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <BRAND_NAME> azopt </BRAND_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> high_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> glaucoma </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <DX_NAME> sight </DX_NAME>
<GENERIC_NAME> entacapone </GENERIC_NAME> <GENERIC_NAME> entacapone </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> entacapone </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson's_disease </DX_NAME> <GENERIC_NAME> entacapone </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME>
<GENERIC_NAME> arsenic </GENERIC_NAME> <GENERIC_NAME> trioxide </GENERIC_NAME> <GENERIC_NAME> arsenic_trioxide </GENERIC_NAME> <GENERIC_NAME> arsenic </GENERIC_NAME> <GENERIC_NAME> trioxide </GENERIC_NAME> <GENERIC_NAME> arsenic </GENERIC_NAME> <GENERIC_NAME> trioxide </GENERIC_NAME> <DX_NAME> promyelocytic_leukaemia </DX_NAME> <DX_NAME> apl </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> abnormal_white_blood_cells </DX_NAME> <DX_NAME> abnormal_bleeding </DX_NAME> <DX_NAME> bruising </DX_NAME>
<GENERIC_NAME> osimertinib </GENERIC_NAME> <TREATMENT_NAME> protein_kinase_inhibitors </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> protein_kinase_inhibitor_medicines </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> tumour </DX_NAME> <TREATMENT_NAME> protein_kinase_inhibitor_medicine </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> defects </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> protein_kinase_inhibitor_medicines </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> protein_kinase_medicines </TREATMENT_NAME>
<GENERIC_NAME> pravafenix </GENERIC_NAME> <GENERIC_NAME> pravastatin </GENERIC_NAME> <GENERIC_NAME> fenofibrate </GENERIC_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> total_cholesterol </TEST_NAME> <TEST_NAME> ldl </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <DX_NAME> plaque </DX_NAME> <DX_NAME> plaque </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <TEST_NAME> triglycerides </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_problems </DX_NAME> <DX_NAME> cholesterol_problems </DX_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> simple_blood_test </TEST_NAME> <TEST_NAME> cholesterol_level </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> triglycerides_fat_levels </TEST_NAME> <TEST_NAME> cholesterol_levels </TEST_NAME> <GENERIC_NAME> pravastatin </GENERIC_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TREATMENT_NAME> cholesterollowering_medicine </TREATMENT_NAME>
<BRAND_NAME> fareston </BRAND_NAME> <GENERIC_NAME> toremifene </GENERIC_NAME> <GENERIC_NAME> antiestrogen </GENERIC_NAME> <BRAND_NAME> fareston </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_tumour </DX_NAME> <DX_NAME> menopause </DX_NAME>
<GENERIC_NAME> beclometasone_dipropionate </GENERIC_NAME> <GENERIC_NAME> formoterol_fumarate_dihydrate </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> beclometasone_dipropionate </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <GENERIC_NAME> formoterol </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> longacting_bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> regular_treatment </TREATMENT_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> cough </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> trydonis </DX_NAME> <DX_NAME> flareups </DX_NAME> <DX_NAME> copd_symptoms </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> long_term_disease </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> difficulty_breathing </DX_NAME>
<BRAND_NAME> aloxi </BRAND_NAME> <GENERIC_NAME> palonosetron </GENERIC_NAME> <GENERIC_NAME> ‘serotonin </GENERIC_NAME> <GENERIC_NAME> 5ht3 </GENERIC_NAME> <BRAND_NAME> aloxi </BRAND_NAME> <DX_NAME> sick </DX_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> vomiting </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> sick </DX_NAME> <DX_NAME> vomit </DX_NAME>
<GENERIC_NAME> vildagliptin </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> antidiabetic_medicines </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> antihistamine </GENERIC_NAME> <TREATMENT_NAME> antiallergy_medicine </TREATMENT_NAME> <DX_NAME> drowsy </DX_NAME> <DX_NAME> allergic_reaction </DX_NAME> <DX_NAME> allergic_rhinitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> nasal_passages </SYSTEM_ORGAN_SITE> <DX_NAME> allergy </DX_NAME> <DX_NAME> hay_fever </DX_NAME> <DX_NAME> allergy </DX_NAME> <AGE> 12 </AGE> <DX_NAME> sneezing </DX_NAME> <DX_NAME> runny </DX_NAME> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> palate </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <DX_NAME> red </DX_NAME> <DX_NAME> watery_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> urticaria </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_condition </DX_NAME> <DX_NAME> allergy </DX_NAME> <DX_NAME> itching </DX_NAME> <DX_NAME> hives </DX_NAME>
<DX_NAME> mucopolysaccharidosis </DX_NAME> <GENERIC_NAME> αliduronidase </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> artificial_enzyme </GENERIC_NAME> <TREATMENT_NAME> artificial_enzyme </TREATMENT_NAME> <GENERIC_NAME> laronidase </GENERIC_NAME>
<DX_NAME> clot </DX_NAME> <DX_NAME> novoeight </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> inborn_factor_viii_deficiency </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> factor_viii_is_missing </DX_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> bleeding </DX_NAME>
<TREATMENT_NAME> injectable_diabetes_medicine </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin_glargine </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> lixisenatide </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TREATMENT_NAME> anti_diabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> suliqua </GENERIC_NAME>
<GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> cml </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> myelodysplastic/myeloproliferative_diseases </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> hypereosinophilic_syndrome </DX_NAME> <DX_NAME> eosinophilic_leukaemia </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> gist </DX_NAME> <DX_NAME> gist </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowels </SYSTEM_ORGAN_SITE> <DX_NAME> dermatofibrosarcoma_protuberans </DX_NAME> <DX_NAME> dfsp </DX_NAME> <DX_NAME> dfsp </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> lysine </GENERIC_NAME> <GENERIC_NAME> amino_acids </GENERIC_NAME> <DX_NAME> side_effects </DX_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> radiation </TREATMENT_NAME> <GENERIC_NAME> lutathera </GENERIC_NAME> <TREATMENT_NAME> lutathera </TREATMENT_NAME> <TREATMENT_NAME> lutetium </TREATMENT_NAME> <GENERIC_NAME> lutetium </GENERIC_NAME> <GENERIC_NAME> oxodotreotide </GENERIC_NAME> <TREATMENT_NAME> radioactive_medicine </TREATMENT_NAME> <GENERIC_NAME> radioactive_medicine </GENERIC_NAME>
<GENERIC_NAME> infliximab </GENERIC_NAME> <GENERIC_NAME> infliximab </GENERIC_NAME> <DX_NAME> inflammatory_diseases </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> bechterew’s_disease </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> remsima </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> bechterew’s_disease </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> psoriasis_psoriasis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> plaque_psoriasis </DX_NAME> <TREATMENT_NAME> phototherapy </TREATMENT_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> abnormal_openings </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME>
<GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> taxoids </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <DX_NAME> head_and_neck_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_node </SYSTEM_ORGAN_SITE> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <GENERIC_NAME> prednisolone </GENERIC_NAME> <DX_NAME> gastric_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> neck_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME>
<TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> flu) </TREATMENT_NAME> <DATE> 2009 </DATE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME>
<GENERIC_NAME> temozolomide </GENERIC_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> glioblastoma_multiforme </DX_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <DX_NAME> malignant_glioma </DX_NAME> <DX_NAME> glioblastoma_multiforme </DX_NAME> <DX_NAME> anaplastic_astrocytoma </DX_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME>
<NAME> jylamvo </NAME> <BRAND_NAME> jylamvo </BRAND_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> unwanted_reactions </DX_NAME> <TREATMENT_NAME> immunosuppressive_agent </TREATMENT_NAME> <DX_NAME> antiinflammatory_effect </DX_NAME> <BRAND_NAME> jylamvo </BRAND_NAME> <DX_NAME> rheumatic </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_diseases </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> polyarthritic </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> idiopathic_arthritis </DX_NAME> <DX_NAME> jia </DX_NAME> <TREATMENT_NAME> nonsteroidal_antiinflammatory_drugs </TREATMENT_NAME> <GENERIC_NAME> nonsteroidal_antiinflammatory_drugs </GENERIC_NAME> <TREATMENT_NAME> nsaids </TREATMENT_NAME> <GENERIC_NAME> nsaids </GENERIC_NAME> <DX_NAME> inadequate_o_severe </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <TREATMENT_NAME> phototherapy </TREATMENT_NAME> <TREATMENT_NAME> psoralen </TREATMENT_NAME> <TREATMENT_NAME> ultraviolet_a_radiation </TREATMENT_NAME> <TREATMENT_NAME> puva)_therapy </TREATMENT_NAME> <GENERIC_NAME> retinoids </GENERIC_NAME> <DX_NAME> psoriasis </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> feel_better </DX_NAME>
<TEST_NAME> helicobacter_test </TEST_NAME> <TEST_NAME> breath_test </TEST_NAME> <AGE> 12 </AGE> <DX_NAME> bacterium_helicobacter_pylori </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <TEST_NAME> helicobacter_test </TEST_NAME> <DX_NAME> gastric_infection </DX_NAME> <DX_NAME> helicobacter_pylori </DX_NAME> <TEST_NAME> helicobacter_test </TEST_NAME> <DX_NAME> helicobacter_pylori_infection </DX_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> helicobacter_pylori </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> helicobacter_pylori </DX_NAME>
<BRAND_NAME> kevzara </BRAND_NAME> <BRAND_NAME> kevzara </BRAND_NAME> <GENERIC_NAME> sarilumab </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <BRAND_NAME> kevzara </BRAND_NAME> <BRAND_NAME> kevzara </BRAND_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <BRAND_NAME> kevzara </BRAND_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <BRAND_NAME> kevzara </BRAND_NAME> <BRAND_NAME> kevzara </BRAND_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> swollen </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> stiffness </DX_NAME> <DX_NAME> fatigue </DX_NAME>
<BRAND_NAME> renagel </BRAND_NAME> <GENERIC_NAME> sevelamer </GENERIC_NAME> <SYSTEM_ORGAN_SITE> digestive_tract </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <TREATMENT_NAME> peritoneal_dialysis </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <PROCEDURE_NAME> peritoneal_dialysis </PROCEDURE_NAME> <DX_NAME> hyperphosphataemia </DX_NAME> <DX_NAME> hard_deposits </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> calcification </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> itchy_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> red_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <DX_NAME> fractures </DX_NAME> <BRAND_NAME> renagel </BRAND_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <TREATMENT_NAME> vitamin_d_supplements </TREATMENT_NAME> <GENERIC_NAME> vitamin_d_supplements </GENERIC_NAME> <DX_NAME> renal_bone_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> betapharm </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> betapharm </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> betapharm </GENERIC_NAME> <GENERIC_NAME> ‘azacitidine’ </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> betapharm </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <PROCEDURE_NAME> stem_cell_transplantation </PROCEDURE_NAME> <DX_NAME> higherrisk_myelodysplastic_syndromes </DX_NAME> <DX_NAME> mds </DX_NAME> <DX_NAME> myelomonocytic_leukaemia </DX_NAME> <DX_NAME> cmml </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> aml </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <TEST_NAME> ribonucleic_acid </TEST_NAME> <TEST_NAME> rna) </TEST_NAME> <TEST_NAME> deoxyribonucleic_acid </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> myelodysplastic_disorders </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME>
<GENERIC_NAME> fetcroja </GENERIC_NAME> <GENERIC_NAME> cefiderocol </GENERIC_NAME> <TREATMENT_NAME> antibiotic_medicine </TREATMENT_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME> <GENERIC_NAME> cephalosporins </GENERIC_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME> <GENERIC_NAME> antibiotics </GENERIC_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> fetcroja </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> bacteria </DX_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME> <GENERIC_NAME> antibiotics </GENERIC_NAME>
<GENERIC_NAME> eltrombopag </GENERIC_NAME> <TREATMENT_NAME> thrombopoietin_receptor_agonists </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> bleeding_disorder </DX_NAME> <DX_NAME> thrombocytopenia </DX_NAME> <DX_NAME> itp </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TREATMENT_NAME> corticosteroids </TREATMENT_NAME> <DX_NAME> itp </DX_NAME> <DX_NAME> low_blood_platelet_count </DX_NAME> <TEST_NAME> blood_platelet_count </TEST_NAME> <DX_NAME> thrombocytopenia </DX_NAME> <DX_NAME> itp </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> itp </DX_NAME> <DX_NAME> petechiae </DX_NAME> <DX_NAME> spots </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> bruising </DX_NAME> <DX_NAME> nosebleeds </DX_NAME> <DX_NAME> bleeding_gums </DX_NAME> <SYSTEM_ORGAN_SITE> gums </SYSTEM_ORGAN_SITE> <DX_NAME> bleeding </DX_NAME> <DX_NAME> injured </DX_NAME> <DX_NAME> low_platelet_count </DX_NAME> <DX_NAME> thrombocytopenia </DX_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <DX_NAME> hcv </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> side_effects </DX_NAME> <GENERIC_NAME> interferon </GENERIC_NAME> <TREATMENT_NAME> interferon_treatment </TREATMENT_NAME> <TEST_NAME> hepatitis_c </TEST_NAME> <DX_NAME> hepatitis_c </DX_NAME> <TEST_NAME> platelet_counts </TEST_NAME> <TREATMENT_NAME> antiviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <GENERIC_NAME> peginterferon </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <DX_NAME> aplastic_anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> deficiency </DX_NAME> <DX_NAME> anaemia </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> leukopenia </DX_NAME> <TEST_NAME> platelets </TEST_NAME> <DX_NAME> thrombocytopenia </DX_NAME>
<GENERIC_NAME> fortacin </GENERIC_NAME> <GENERIC_NAME> lidocaine </GENERIC_NAME> <GENERIC_NAME> prilocaine </GENERIC_NAME> <GENERIC_NAME> local_anaesthetics </GENERIC_NAME> <PROCEDURE_NAME> local_anaesthetics </PROCEDURE_NAME> <GENERIC_NAME> fortacin </GENERIC_NAME> <DX_NAME> premature_ejaculation </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> insulin_glargine </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_glargine </GENERIC_NAME>
<GENERIC_NAME> Pramipexole </GENERIC_NAME> <BRAND_NAME> Teva </BRAND_NAME> <GENERIC_NAME> pramipexole </GENERIC_NAME> <GENERIC_NAME> dopamine_agonists </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> dopamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> Pramipexole </GENERIC_NAME> <BRAND_NAME> Teva </BRAND_NAME> <DX_NAME> primary_Parkinson’s_disease </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> Parkinson’s_disease </DX_NAME> <DX_NAME> Restless_Legs_Syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> Legs </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <TEST_NAME> platelets </TEST_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_k_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> anticoagulants’ </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> febrile_neutropenia </DX_NAME> <DX_NAME> low_white_blood_cell_count </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> fever </DX_NAME> <TREATMENT_NAME> cytotoxic_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME>
<DX_NAME> parkinson´s_disease </DX_NAME> <DX_NAME> product_levodopa </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> levodopa </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> benserazide </DX_NAME> <GENERIC_NAME> benserazide </GENERIC_NAME> <DX_NAME> levodopa/carbidopa </DX_NAME> <GENERIC_NAME> levodopa/carbidopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> benserazide </GENERIC_NAME> <GENERIC_NAME> levodopa/carbidopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME>
<BRAND_NAME> truvada </BRAND_NAME> <GENERIC_NAME> emtricitabine </GENERIC_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> emtricitabine </GENERIC_NAME> <TREATMENT_NAME> nucleoside_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <TREATMENT_NAME> nucleotide_reverse_transcriptase_inhibitor </TREATMENT_NAME> <BRAND_NAME> truvada </BRAND_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <TEST_NAME> weigh </TEST_NAME> <TREATMENT_NAME> hiv_medicines </TREATMENT_NAME> <DX_NAME> side_effects </DX_NAME> <BRAND_NAME> truvada </BRAND_NAME> <DX_NAME> hiv_infection </DX_NAME> <BRAND_NAME> truvada </BRAND_NAME> <GENERIC_NAME> emtricitabine </GENERIC_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> antiretroviral_therapy </TREATMENT_NAME> <DX_NAME> hiv_infection </DX_NAME> <BRAND_NAME> truvada </BRAND_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <BRAND_NAME> truvada </BRAND_NAME> <DX_NAME> hiv1_infection </DX_NAME> <AGE> 12 </AGE> <AGE> 18 </AGE> <TEST_NAME> weigh </TEST_NAME> <DX_NAME> hiv_infection </DX_NAME>
<BRAND_NAME> protopic </BRAND_NAME> <GENERIC_NAME> tacrolimus_monohydrate </GENERIC_NAME> <GENERIC_NAME> immunomodulating_agent </GENERIC_NAME> <BRAND_NAME> protopic </BRAND_NAME> <DX_NAME> atopic_dermatitis </DX_NAME> <DX_NAME> eczema </DX_NAME> <TREATMENT_NAME> topical_corticosteroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TREATMENT_NAME> topical_corticosteroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> atopic_dermatitis </DX_NAME> <TIME_TO_DX_NAME> 6_weeks </TIME_TO_DX_NAME> <DX_NAME> flare </DX_NAME> <DX_NAME> flares </DX_NAME> <DX_NAME> flares </DX_NAME> <DX_NAME> flares </DX_NAME> <BRAND_NAME> protopic </BRAND_NAME> <DX_NAME> atopic_dermatitis </DX_NAME> <SYSTEM_ORGAN_SITE> skin’s </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_inflammation </DX_NAME> <DX_NAME> itchiness </DX_NAME> <DX_NAME> redness </DX_NAME> <DX_NAME> dryness </DX_NAME> <BRAND_NAME> protopic </BRAND_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_inflammation </DX_NAME> <DX_NAME> itch </DX_NAME>
<BRAND_NAME> xerava </BRAND_NAME> <BRAND_NAME> xerava </BRAND_NAME> <GENERIC_NAME> antibiotic_medicine </GENERIC_NAME> <TREATMENT_NAME> antibiotic_medicine </TREATMENT_NAME> <GENERIC_NAME> eravacycline </GENERIC_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME> <DX_NAME> infectious_bacteria </DX_NAME> <BRAND_NAME> xerava </BRAND_NAME> <BRAND_NAME> xerava </BRAND_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> abdomen </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> beclometasone_dipropionate </GENERIC_NAME> <GENERIC_NAME> formoterol_fumarate_dihydrate </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> beclometasone_dipropionate </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <GENERIC_NAME> formoterol </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> longacting_bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> regular_treatment </TREATMENT_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> cough </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> flareups </DX_NAME> <DX_NAME> copd_symptoms </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> long_term_disease </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> difficulty_breathing </DX_NAME>
<GENERIC_NAME> “rituximab” </GENERIC_NAME> <GENERIC_NAME> rituximab </GENERIC_NAME> <BRAND_NAME> Riximyo </BRAND_NAME> <BRAND_NAME> Riximyo </BRAND_NAME> <DX_NAME> Non-Hodgkin’s_Lymphoma </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <BRAND_NAME> Riximyo </BRAND_NAME> <TREATMENT_NAME> “chemotherapy” </TREATMENT_NAME> <TREATMENT_NAME> Riximyo </TREATMENT_NAME> <BRAND_NAME> Riximyo </BRAND_NAME> <TREATMENT_NAME> maintenance_treatment </TREATMENT_NAME> <TIME_TO_TREATMENT_NAME> 2_years </TIME_TO_TREATMENT_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> CLL </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> CLL </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <DX_NAME> CLL </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> Granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> Wegener’s_granulomatosis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> Granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> Pemphigus_vulgaris </DX_NAME> <DX_NAME> pemphigus_vulgaris </DX_NAME> <DX_NAME> Pemphigus_vulgaris </DX_NAME> <DX_NAME> autoimmune_condition </DX_NAME> <DX_NAME> painful_blisters </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lining_of_the_mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> genitals </SYSTEM_ORGAN_SITE>
<TREATMENT_NAME> izba_contains_travoprost </TREATMENT_NAME> <GENERIC_NAME> travoprost </GENERIC_NAME> <GENERIC_NAME> prostaglandin_analogues </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> glaucoma </DX_NAME>
<SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessels_to_narrow </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> hypertension </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> reduced_or_blocked_blood_supply </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> olanzapine_apotex </GENERIC_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> manic_episodes </DX_NAME> <DX_NAME> excitement </DX_NAME> <DX_NAME> euphoria </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <DX_NAME> recurrence </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> manic_episode </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME>
<GENERIC_NAME> halaven </GENERIC_NAME> <GENERIC_NAME> eribulin </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> tumour </DX_NAME> <DX_NAME> lost_its_effect </DX_NAME> <DX_NAME> metastatic_liposarcoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> fat_tissue </SYSTEM_ORGAN_SITE> <DX_NAME> lost_its_effect </DX_NAME>
<GENERIC_NAME> idefirix </GENERIC_NAME> <TREATMENT_NAME> immunosuppressants </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> kidney_transplantation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> streptococcus_pyogenes </DX_NAME>
<GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> relvar_ellipta </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <DATE> 92/22 </DATE> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <TIME_TO_DX_NAME> 12 </TIME_TO_DX_NAME> <DX_NAME> copd </DX_NAME> <GENERIC_NAME> relvar_ellipta </GENERIC_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> attack </DX_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TREATMENT_NAME> steroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <SYSTEM_ORGAN_SITE> small_air_passages </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_problems </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> copd </DX_NAME> <GENERIC_NAME> long_acting_bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> small_air_passages </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> asthma </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> tight </DX_NAME> <DX_NAME> bronchoconstriction </DX_NAME> <DX_NAME> swollen </DX_NAME> <DX_NAME> irritated </DX_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> wheezing </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_tightness </DX_NAME> <DX_NAME> cough </DX_NAME> <GENERIC_NAME> ellipta </GENERIC_NAME> <DX_NAME> flareups </DX_NAME> <BRAND_NAME> flareups </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> inflamed </DX_NAME> <DX_NAME> thickened </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> cough </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_discomfort </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> flareups </DX_NAME> <DX_NAME> copd_symptoms </DX_NAME>
<GENERIC_NAME> copalia_tablets </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessel_wall </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME>
<GENERIC_NAME> adynovi </GENERIC_NAME> <GENERIC_NAME> alfa_pegol </GENERIC_NAME> <GENERIC_NAME> pegylated_human </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> bleeding_disorder </DX_NAME> <DX_NAME> lack_of_factor_viii </DX_NAME>
<BRAND_NAME> rebetol </BRAND_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <BRAND_NAME> rebetol </BRAND_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <DX_NAME> hepatitis_c_infection </DX_NAME> <BRAND_NAME> rebetol </BRAND_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> hcv </DX_NAME> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME>
<BRAND_NAME> praxbind </BRAND_NAME> <BRAND_NAME> praxbind </BRAND_NAME> <GENERIC_NAME> idarucizumab </GENERIC_NAME> <GENERIC_NAME> idarucizumab </GENERIC_NAME> <GENERIC_NAME> dabigatran </GENERIC_NAME> <BRAND_NAME> pradaxa </BRAND_NAME> <TREATMENT_NAME> blood_thinner_medicine </TREATMENT_NAME> <DX_NAME> blood_clot_formation </DX_NAME> <BRAND_NAME> praxbind </BRAND_NAME> <GENERIC_NAME> dabigatran </GENERIC_NAME> <BRAND_NAME> praxbind </BRAND_NAME> <BRAND_NAME> praxbind </BRAND_NAME> <BRAND_NAME> pradaxa </BRAND_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> encorafenib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> binimetinib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <GENERIC_NAME> binimetinib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> cetuximab </GENERIC_NAME> <DX_NAME> intestine_cancer </DX_NAME> <GENERIC_NAME> braftovi </GENERIC_NAME> <GENERIC_NAME> cetuximab </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME>
<BRAND_NAME> gardasil </BRAND_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccination </TREATMENT_NAME> <BRAND_NAME> gardasil </BRAND_NAME> <DX_NAME> human_papillomavirus </DX_NAME> <DX_NAME> hpv </DX_NAME> <DATE> 11,_16 </DATE> <DX_NAME> precancerous_lesions </DX_NAME> <SYSTEM_ORGAN_SITE> genitals </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cervix </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vulva </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> pre_cancerous_lesions </DX_NAME> <SYSTEM_ORGAN_SITE> anus </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> genital </SYSTEM_ORGAN_SITE> <DX_NAME> genital_warts </DX_NAME> <SYSTEM_ORGAN_SITE> cervical </SYSTEM_ORGAN_SITE> <DX_NAME> cervical_and_anal_cancers </DX_NAME> <SYSTEM_ORGAN_SITE> anal </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <DX_NAME> anal_cancer </DX_NAME> <DX_NAME> precancerous_lesions </DX_NAME> <SYSTEM_ORGAN_SITE> vulva </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> hpv </DX_NAME> <DX_NAME> precancerous_lesions </DX_NAME> <SYSTEM_ORGAN_SITE> anus </SYSTEM_ORGAN_SITE> <DX_NAME> genital_wart </DX_NAME> <BRAND_NAME> gardasil </BRAND_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> hpv_related_diseases </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <BRAND_NAME> gardasil </BRAND_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <BRAND_NAME> gardasil </BRAND_NAME> <TREATMENT_NAME> gardasil_produces_typespecific_antibodies </TREATMENT_NAME> <TREATMENT_NAME> clinical_trials </TREATMENT_NAME> <DX_NAME> hpv </DX_NAME> <DATE> 6,_11,_16 </DATE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TIME_TO_TREATMENT_NAME> 9 </TIME_TO_TREATMENT_NAME> <BRAND_NAME> gardasil </BRAND_NAME>
<GENERIC_NAME> methylthioninium_chloride </GENERIC_NAME> <GENERIC_NAME> methylthioninium_chloride </GENERIC_NAME> <GENERIC_NAME> methylene_blue </GENERIC_NAME> <GENERIC_NAME> blue_dye </GENERIC_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <TEST_NAME> colonoscopy </TEST_NAME> <SYSTEM_ORGAN_SITE> rectum </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <DX_NAME> abnormalities </DX_NAME>
<GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> rectal </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> cancers </DX_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <DX_NAME> colon_cancer </DX_NAME> <PROCEDURE_NAME> removal_of_the_tumour </PROCEDURE_NAME> <DX_NAME> tumour </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME>
<GENERIC_NAME> raxone </GENERIC_NAME> <GENERIC_NAME> idebenone </GENERIC_NAME> <NAME> idebenone </NAME> <DX_NAME> vision_impairment </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> eye_disease </DX_NAME> <DX_NAME> hereditary_optic_neuropathy </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> “genetic_mutation” </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> loss_of_eyesight </DX_NAME> <DX_NAME> improvement_in_lost_eyesight </DX_NAME>
<GENERIC_NAME> rilonacept </GENERIC_NAME> <AGE> 12 </AGE> <DX_NAME> familial_cold_autoinflammatory_syndrome </DX_NAME> <DX_NAME> fcas)_and_mucklewells_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> mucklewells </SYSTEM_ORGAN_SITE> <GENERIC_NAME> interleukin_inhibitors </GENERIC_NAME> <TREATMENT_NAME> interleukin_inhibitors </TREATMENT_NAME> <GENERIC_NAME> rilonacept </GENERIC_NAME> <TREATMENT_NAME> rilonacept_regeneron_blocks </TREATMENT_NAME> <GENERIC_NAME> interleukin1_beta </GENERIC_NAME> <GENERIC_NAME> il1_beta </GENERIC_NAME> <GENERIC_NAME> il1_beta </GENERIC_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> headache </DX_NAME> <DX_NAME> fatigue </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_rash </DX_NAME> <DX_NAME> painful </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <GENERIC_NAME> il1_beta </GENERIC_NAME> <GENERIC_NAME> rilonacept </GENERIC_NAME> <GENERIC_NAME> rilonacept </GENERIC_NAME>
<BRAND_NAME> nexium </BRAND_NAME> <BRAND_NAME> nexium </BRAND_NAME> <GENERIC_NAME> esomeprazole </GENERIC_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> reflux_symptoms </DX_NAME> <DX_NAME> heartburn </DX_NAME> <DX_NAME> acid_regurgitation </DX_NAME> <DX_NAME> reflux </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> inflamed </DX_NAME> <DX_NAME> painful </DX_NAME> <DX_NAME> painful_sensation </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <DX_NAME> heartburn </DX_NAME> <DX_NAME> sour_taste </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> acid_regurgitation </DX_NAME> <BRAND_NAME> nexium </BRAND_NAME>
<NAME> mimpara </NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> parathyroid_glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> parathyroids </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> small_glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> thyroid_gland </SYSTEM_ORGAN_SITE> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <DX_NAME> high_levels_of_calcium </DX_NAME> <DX_NAME> hypercalcaemia </DX_NAME> <DX_NAME> parathyroid_cancer </DX_NAME> <DX_NAME> high_levels_of_calcium </DX_NAME> <DX_NAME> hypercalcaemia </DX_NAME> <DX_NAME> primary_hyperparathyroidism </DX_NAME> <PROCEDURE_NAME> removal_of_the_gland </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> gland </SYSTEM_ORGAN_SITE> <AGE> 18 </AGE> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> parathyroid_glands </SYSTEM_ORGAN_SITE> <DX_NAME> hyperparathyroidism </DX_NAME> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> hyperparathyroidism </DX_NAME> <DX_NAME> loss_of_calcium </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <DX_NAME> fractures </DX_NAME> <DX_NAME> problems_with_blood_and_heart_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_stones </DX_NAME> <DX_NAME> mental_illness </DX_NAME> <DX_NAME> coma </DX_NAME>
<DX_NAME> urea_cycle_disorders </DX_NAME> <DX_NAME> rare_disorders </DX_NAME> <DX_NAME> deficiency </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <TEST_NAME> liver_enzymes </TEST_NAME> <GENERIC_NAME> nitrogen </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> coma </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> ammonia </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> dexrazoxane </GENERIC_NAME> <GENERIC_NAME> anthracyclines </GENERIC_NAME> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <DX_NAME> accident </DX_NAME> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> surrounding_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> surrounding_tissue </SYSTEM_ORGAN_SITE> <DX_NAME> extravasation </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <DX_NAME> tissue_damage </DX_NAME> <DX_NAME> anthracyline_extravasation </DX_NAME> <DX_NAME> tissue_damage </DX_NAME> <GENERIC_NAME> anthracycline </GENERIC_NAME> <DX_NAME> anthracycline_extravasation </DX_NAME>
<GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicine </TREATMENT_NAME> <GENERIC_NAME> antiepileptic_medicine </GENERIC_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> seizure </DX_NAME> <DX_NAME> generalisation </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> myoclonic_seizures </DX_NAME> <DX_NAME> shocklike_jerks </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <AGE> 12 </AGE> <DX_NAME> myoclonic_epilepsy </DX_NAME> <DX_NAME> tonicclonic_seizures </DX_NAME> <DX_NAME> loss_of_consciousness </DX_NAME> <AGE> 12 </AGE> <DX_NAME> generalised_epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME>
<TREATMENT_NAME> antiplatelet_medicine </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> clot </DX_NAME> <DX_NAME> clots </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> clot </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> myocardial_infarction </DX_NAME> <DX_NAME> blood_clot </DX_NAME> <DX_NAME> blocked_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> coronary_artery </SYSTEM_ORGAN_SITE> <DX_NAME> coronary_artery_disease </DX_NAME> <PROCEDURE_NAME> percutaneous_coronary_intervention </PROCEDURE_NAME> <PROCEDURE_NAME> pci </PROCEDURE_NAME> <PROCEDURE_NAME> remove_the_blockage </PROCEDURE_NAME> <DX_NAME> blockage </DX_NAME> <PROCEDURE_NAME> stent_inserted </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <BRAND_NAME> kengrexal </BRAND_NAME> <DX_NAME> clot </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE>
<BRAND_NAME> Arzerra </BRAND_NAME> <GENERIC_NAME> ofatumumab </GENERIC_NAME> <BRAND_NAME> Arzerra </BRAND_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> CLL </DX_NAME> <DX_NAME> CLL </DX_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> white_blood_cell_called_lymphocytes </TEST_NAME> <BRAND_NAME> Arzerra </BRAND_NAME> <DX_NAME> die </DX_NAME>
<TREATMENT_NAME> radiopharmaceutical_product </TREATMENT_NAME> <GENERIC_NAME> striascan </GENERIC_NAME> <GENERIC_NAME> ioflupane </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> striascan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> parkinsonism </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> dementia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> striascan </GENERIC_NAME> <DX_NAME> radioactivity </DX_NAME> <TEST_NAME> xray </TEST_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<GENERIC_NAME> zoledronic_acid_hospira </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_complications </DX_NAME> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_metastases </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> primary_site </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <DX_NAME> tumour </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> hypercalcaemia </DX_NAME>
<SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cartilage_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> surface_of_bone_ends </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> cartilage_area </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> defect_site </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> repair </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <DX_NAME> defects </DX_NAME> <DX_NAME> injury </DX_NAME> <DX_NAME> fall </DX_NAME> <DX_NAME> injury </DX_NAME> <DX_NAME> incorrect_weight_bearing </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> defects </DX_NAME>
<BRAND_NAME> Vivanza </BRAND_NAME> <GENERIC_NAME> vardenafil </GENERIC_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_inhibitors </TREATMENT_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <DX_NAME> difficulties_in_getting_or_keeping_an_erection </DX_NAME> <DX_NAME> trouble_getting_or_keeping_an_erection </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_and_blood_vessel_changes </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <BRAND_NAME> Vivanza </BRAND_NAME> <DX_NAME> sexually_stimulated </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> erections </DX_NAME> <BRAND_NAME> Vivanza </BRAND_NAME> <DX_NAME> erection </DX_NAME>
<GENERIC_NAME> lixiana </GENERIC_NAME> <GENERIC_NAME> edoxaban </GENERIC_NAME> <GENERIC_NAME> anticoagulants </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <GENERIC_NAME> lixiana </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> irregular_heart_rhythm </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> nonvalvular_atrial_fibrillation </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> veins </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> deep_vein </SYSTEM_ORGAN_SITE> <DX_NAME> deep_vein_thrombosis </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> pulmonary_embolism </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE>
<BRAND_NAME> travatan </BRAND_NAME> <GENERIC_NAME> travoprost </GENERIC_NAME> <GENERIC_NAME> prostaglandin_analogues </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <BRAND_NAME> travatan </BRAND_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> glaucoma </DX_NAME>
<TREATMENT_NAME> pandemic_influenza_vaccine </TREATMENT_NAME> <GENERIC_NAME> influenza_vaccine </GENERIC_NAME> <TREATMENT_NAME> pandemic_influenza_vaccine </TREATMENT_NAME> <GENERIC_NAME> influenza_vaccine </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <TREATMENT_NAME> influenza_(flu </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> pandemic_flu </TREATMENT_NAME> <DX_NAME> pandemic_flu </DX_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> pandemic_flu </DX_NAME> <DX_NAME> flu </DX_NAME>
<NAME> kyntheum </NAME> <GENERIC_NAME> brodalumab </GENERIC_NAME> <GENERIC_NAME> brodalumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <DX_NAME> psoriasis </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_condition </DX_NAME> <DX_NAME> “plaque_psoriasis” </DX_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> scaly_plaque </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kyntheum </SYSTEM_ORGAN_SITE> <DX_NAME> plaque_psoriasis </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> itch </DX_NAME> <DX_NAME> redness </DX_NAME> <DX_NAME> scaling </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> stinging </DX_NAME> <DX_NAME> cracking </DX_NAME> <DX_NAME> flaking </DX_NAME> <DX_NAME> pain </DX_NAME>
<BRAND_NAME> levemir </BRAND_NAME> <GENERIC_NAME> modern_insulin </GENERIC_NAME> <GENERIC_NAME> insulin_analogue </GENERIC_NAME> <GENERIC_NAME> insulin_products </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <BRAND_NAME> levemir </BRAND_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <BRAND_NAME> levemir </BRAND_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> type_2_diabetes_mellitus </DX_NAME> <BRAND_NAME> levemir </BRAND_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <BRAND_NAME> levemir </BRAND_NAME> <BRAND_NAME> levemir </BRAND_NAME> <GENERIC_NAME> basal_insulin </GENERIC_NAME>
<BRAND_NAME> jentadueto </BRAND_NAME> <GENERIC_NAME> linagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> linagliptin </GENERIC_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> biguanides </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> sulphonylureas </GENERIC_NAME> <DX_NAME> sulphonylureas </DX_NAME> <GENERIC_NAME> empagliflozin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> glucose </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> amputation </DX_NAME> <PROCEDURE_NAME> amputation </PROCEDURE_NAME>
<GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> inability_to_move </DX_NAME>
<BRAND_NAME> lonsurf </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> cancer_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> cytostatic_antimetabolite_medicines </TREATMENT_NAME> <GENERIC_NAME> lonsurf </GENERIC_NAME> <GENERIC_NAME> trifluridine </GENERIC_NAME> <GENERIC_NAME> tipiracil </GENERIC_NAME> <GENERIC_NAME> trifluridine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> tipiracil </GENERIC_NAME> <GENERIC_NAME> trifluridine </GENERIC_NAME> <GENERIC_NAME> trifluridine </GENERIC_NAME> <BRAND_NAME> lonsurf </BRAND_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <DX_NAME> rectal_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> stomach_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> junction </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> oesophagus </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> ulunar_breezhaler </GENERIC_NAME> <GENERIC_NAME> indacaterol </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficult </DX_NAME> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> copd </DX_NAME>
<GENERIC_NAME> nicotinic_acid </GENERIC_NAME> <DX_NAME> flushing </DX_NAME> <DX_NAME> side_effect </DX_NAME> <GENERIC_NAME> nicotinic_acid </GENERIC_NAME> <TEST_NAME> cholesterol_level </TEST_NAME> <TEST_NAME> total_cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> apo_b </TEST_NAME> <TEST_NAME> ldl </TEST_NAME> <TEST_NAME> raise_levels </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <TEST_NAME> apo_ai </TEST_NAME> <TEST_NAME> hdl </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> total_cholesterol </TEST_NAME> <TEST_NAME> ldl </TEST_NAME> <TEST_NAME> hdl </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <DX_NAME> plaque </DX_NAME> <DX_NAME> plaque </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> hdl_cholesterol </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <TEST_NAME> triglycerides </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_problems </DX_NAME> <DX_NAME> cholesterol_problems </DX_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> simple_blood_test </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME> <DX_NAME> dyslipidaemia </DX_NAME> <TEST_NAME> cholesterol_levels </TEST_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TREATMENT_NAME> cholesterollowering_medicines </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> dic </DX_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TEST_NAME> mixed_dyslipidaemia </TEST_NAME> <DX_NAME> dyslipidaemia </DX_NAME> <DX_NAME> high_blood_levels_of_‘bad’_ldl_cholesterol_and_triglycerides </DX_NAME> <TEST_NAME> blood_levels </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> levels </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME> <TEST_NAME> cholesterol </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME>
<GENERIC_NAME> thiotepa </GENERIC_NAME> <GENERIC_NAME> alkylating_agents </GENERIC_NAME> <GENERIC_NAME> tepadina </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplantation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> transplantation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_cells </PROCEDURE_NAME> <TREATMENT_NAME> haematopoietic_progenitor_cells </TREATMENT_NAME>
<GENERIC_NAME> introna </GENERIC_NAME> <GENERIC_NAME> interferon_alfa2b </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> diseases </DX_NAME> <DX_NAME> introna </DX_NAME> <DX_NAME> disorders </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lymph_glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> hairy_cell_leukaemia </DX_NAME> <DX_NAME> myelogenous_leukaemia </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> follicular_lymphoma </DX_NAME> <DX_NAME> carcinoid_tumour </DX_NAME> <DX_NAME> malignant_melanoma </DX_NAME> <DX_NAME> introna </DX_NAME> <DX_NAME> hepatitis_b </DX_NAME> <DX_NAME> c </DX_NAME> <DX_NAME> viral_infections </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> introna </DX_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <DX_NAME> hepatitis_c </DX_NAME>
<DX_NAME> hiv </DX_NAME> <DX_NAME> immunodeficiency_virus’ </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> doravirine </GENERIC_NAME> <TREATMENT_NAME> nonnucleoside_reverse_transcriptase_inhibitor </TREATMENT_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> immune_deficiency_syndrome’ </DX_NAME> <GENERIC_NAME> pifeltro </GENERIC_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> doravirine </GENERIC_NAME> <GENERIC_NAME> pifeltro </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> pifeltro </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> early_death </DX_NAME> <DX_NAME> catching_infections </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> immune_system_is_weak </DX_NAME>
<TREATMENT_NAME> angiotensin_receptor_neprilysin_inhibitor </TREATMENT_NAME> <GENERIC_NAME> sacubitril </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME> <GENERIC_NAME> entresto </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> weak </DX_NAME> <DX_NAME> cannot_pump_enough_blood </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <SYSTEM_ORGAN_SITE> ankle </SYSTEM_ORGAN_SITE> <DX_NAME> ankle_swelling </DX_NAME>
<GENERIC_NAME> sodium_chloride </GENERIC_NAME> <GENERIC_NAME> sucrose </GENERIC_NAME> <GENERIC_NAME> polysorbate_20 </GENERIC_NAME> <GENERIC_NAME> lhistidine </GENERIC_NAME> <GENERIC_NAME> hydrochloric_acid </GENERIC_NAME> <GENERIC_NAME> sodium_hydroxide </GENERIC_NAME> <ID> dk2880 </ID>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_k_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> grepid </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> grepid </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> anticoagulants’ </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<BRAND_NAME> tivicay </BRAND_NAME> <GENERIC_NAME> dolutegravir </GENERIC_NAME> <GENERIC_NAME> dolutegravir </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> integrase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> integrase_inhibitors </GENERIC_NAME> <BRAND_NAME> tivicay </BRAND_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <TREATMENT_NAME> cd4_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> tivicay </BRAND_NAME> <BRAND_NAME> tivicay </BRAND_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicines </GENERIC_NAME> <TREATMENT_NAME> combination_therapy </TREATMENT_NAME> <DX_NAME> hiv_infection </DX_NAME>
<GENERIC_NAME> midostaurin </GENERIC_NAME> <TREATMENT_NAME> protein_kinase_inhibitors </TREATMENT_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> aml </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> systemic_mastocytosis </DX_NAME> <DX_NAME> systemic_mastocytosis </DX_NAME> <DX_NAME> haematological_neoplasm </DX_NAME> <DX_NAME> mast_cell_leukaemia </DX_NAME> <DX_NAME> disorders </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <GENERIC_NAME> midostaurin </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessels_to_narrow </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <DX_NAME> hypertension </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attacks </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> strokes </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> reduced_or_blocked_blood_supply </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> darolutamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME>
<BRAND_NAME> pandemrix </BRAND_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <TREATMENT_NAME> influenza_(flu </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <DATE> 2009 </DATE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> trivalent/quadrivalent_influenza_vaccine </TREATMENT_NAME> <GENERIC_NAME> quadrivalent_influenza_vaccine </GENERIC_NAME> <GENERIC_NAME> pandemrix </GENERIC_NAME> <GENERIC_NAME> trivalent </GENERIC_NAME> <TREATMENT_NAME> trivalent/quadrivalent_vaccines </TREATMENT_NAME> <GENERIC_NAME> quadrivalent_vaccines </GENERIC_NAME> <GENERIC_NAME> pandemrix </GENERIC_NAME> <GENERIC_NAME> pandemrix </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME>
<DX_NAME> zeposia </DX_NAME> <DX_NAME> zeposia </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <TEST_NAME> lymphocytes </TEST_NAME> <DX_NAME> zeposia </DX_NAME> <DX_NAME> zeposia </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> active_disease </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> body’s_defenses </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> numbness </DX_NAME> <DX_NAME> difficulty_in_walking </DX_NAME> <DX_NAME> problems_with_vision_and_balance </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> attacks </DX_NAME> <SYSTEM_ORGAN_SITE> nerve_cells </SYSTEM_ORGAN_SITE> <DX_NAME> disappear </DX_NAME> <DX_NAME> periods </DX_NAME> <DX_NAME> zeposia </DX_NAME> <DX_NAME> zeposia </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> coating </DX_NAME>
<BRAND_NAME> onduarp </BRAND_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessel_wall </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME>
<GENERIC_NAME> episalvan </GENERIC_NAME> <GENERIC_NAME> herbal_medicinal_product </GENERIC_NAME> <GENERIC_NAME> birch_bark </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_wounds </DX_NAME> <DX_NAME> burn_wounds </DX_NAME> <PROCEDURE_NAME> surgical_skin_graft_transplantation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> episalvan </GENERIC_NAME> <DX_NAME> wounds </DX_NAME> <DX_NAME> diabetic_foot_ulcers </DX_NAME> <SYSTEM_ORGAN_SITE> foot </SYSTEM_ORGAN_SITE> <DX_NAME> venous_leg_ulcers </DX_NAME> <SYSTEM_ORGAN_SITE> leg </SYSTEM_ORGAN_SITE>
<BRAND_NAME> zejula </BRAND_NAME> <BRAND_NAME> zejula </BRAND_NAME> <GENERIC_NAME> niraparib </GENERIC_NAME> <GENERIC_NAME> niraparib </GENERIC_NAME> <TREATMENT_NAME> parp_inhibitor </TREATMENT_NAME> <TREATMENT_NAME> parp_inhibitors_block </TREATMENT_NAME> <GENERIC_NAME> adenosine </GENERIC_NAME> <TREATMENT_NAME> parp_helps_cells_repair </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <PROCEDURE_NAME> repaired </PROCEDURE_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> zejula </BRAND_NAME> <BRAND_NAME> zejula </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> ovary </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> fallopian_tubes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> female_reproductive_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> uterus </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> peritoneum </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> membrane </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> abdomen </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> platinumbased_chemotherapy </TREATMENT_NAME>
<GENERIC_NAME> cyramza </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> ramucirumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> cyramza </GENERIC_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> stomach_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> junction </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> oesophagus </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> cyramza </GENERIC_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> stomach_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> junction </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> oesophagus </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> cyramza </GENERIC_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <BRAND_NAME> cyramza </BRAND_NAME> <DX_NAME> cancers </DX_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> rectum </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> large_intestine </SYSTEM_ORGAN_SITE> <GENERIC_NAME> ‘folfiri </GENERIC_NAME> <TREATMENT_NAME> ‘folfiri_chemotherapy’ </TREATMENT_NAME> <GENERIC_NAME> ‘irinotecan’ </GENERIC_NAME> <GENERIC_NAME> cyramza </GENERIC_NAME> <GENERIC_NAME> erlotinib </GENERIC_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> cyramza </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> cyramza </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_cancer </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <GENERIC_NAME> sorafenib </GENERIC_NAME> <TEST_NAME> level_of_a_particular_protein </TEST_NAME> <TEST_NAME> blood_(alpha_fetoprotein </TEST_NAME>
<DX_NAME> Zolgensma </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> motor_neurons </DX_NAME> <DX_NAME> die </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> weak </DX_NAME> <DX_NAME> wasting_away </DX_NAME> <DX_NAME> loss_of_movement </DX_NAME> <DX_NAME> disease_in_humans </DX_NAME>
<SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <DX_NAME> defects </DX_NAME> <SYSTEM_ORGAN_SITE> knee_joint </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> ends_of_bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> allows_joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <TEST_NAME> biopsy </TEST_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<BRAND_NAME> Atectura_Breezhaler </BRAND_NAME> <GENERIC_NAME> indacaterol </GENERIC_NAME> <GENERIC_NAME> mometasone_furoate </GENERIC_NAME> <GENERIC_NAME> Indacaterol </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <GENERIC_NAME> Mometasone_furoate </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <GENERIC_NAME> steroids </GENERIC_NAME> <GENERIC_NAME> Corticosteroids </GENERIC_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_problems </DX_NAME> <GENERIC_NAME> Corticosteroids </GENERIC_NAME> <DX_NAME> attacks_of_asthma </DX_NAME> <BRAND_NAME> Atectura </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> Asthma </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> tight </DX_NAME> <DX_NAME> bronchoconstriction </DX_NAME> <DX_NAME> inflamed </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> wheezing </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_tightness </DX_NAME> <DX_NAME> cough </DX_NAME> <BRAND_NAME> Atectura </BRAND_NAME> <BRAND_NAME> Breezhaler </BRAND_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME>
<GENERIC_NAME> epoetin_theta </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> anaemia </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> weakness </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> renal_failure </DX_NAME> <DX_NAME> nonmyeloid_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> menveo </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> active_immunization </TREATMENT_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> meningitis </DX_NAME> <DX_NAME> sepsis </DX_NAME> <DX_NAME> blood_poisoning </DX_NAME> <GENERIC_NAME> menveo </GENERIC_NAME> <DX_NAME> bacterial_meningitis </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <ID> crm197 </ID> <DX_NAME> bacteria </DX_NAME> <DX_NAME> diphtheria </DX_NAME> <GENERIC_NAME> menveo </GENERIC_NAME> <DX_NAME> diphtheria </DX_NAME> <TREATMENT_NAME> vaccines </TREATMENT_NAME> <DX_NAME> diphtheria </DX_NAME>
<BRAND_NAME> abraxane </BRAND_NAME> <BRAND_NAME> abraxane </BRAND_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> side_effects </DX_NAME> <DX_NAME> side_effects </DX_NAME> <BRAND_NAME> abraxane </BRAND_NAME> <BRAND_NAME> abraxane </BRAND_NAME> <BRAND_NAME> abraxane </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <BRAND_NAME> abraxane </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <BRAND_NAME> abraxane </BRAND_NAME> <DX_NAME> pancreatic_cancer </DX_NAME> <BRAND_NAME> abraxane </BRAND_NAME> <GENERIC_NAME> gemcitabine </GENERIC_NAME> <DX_NAME> metastatic_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <DX_NAME> pancreatic_cancer </DX_NAME> <DX_NAME> pancreatic_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <BRAND_NAME> abraxane </BRAND_NAME> <GENERIC_NAME> gemcitabine </GENERIC_NAME> <GENERIC_NAME> gemcitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <BRAND_NAME> abraxane </BRAND_NAME> <GENERIC_NAME> carboplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> “nonsmall_cell_lung_cancer” </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <BRAND_NAME> abraxane </BRAND_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME>
<NAME> fluenz </NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> flu) </TREATMENT_NAME> <AGE> 18 </AGE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza_virus </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza_virus </DX_NAME> <TIME_TO_DX_NAME> each_year </TIME_TO_DX_NAME> <TIME_TO_TREATMENT_NAME> each_year </TIME_TO_TREATMENT_NAME>
<BRAND_NAME> prolia </BRAND_NAME> <BRAND_NAME> prolia </BRAND_NAME> <GENERIC_NAME> denosumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <BRAND_NAME> prolia </BRAND_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <TREATMENT_NAME> oestrogen_level_drops </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> thin </DX_NAME> <DX_NAME> fragile </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <TREATMENT_NAME> glucocorticoids </TREATMENT_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> breaking_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hips </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_or_prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> break_more_easily </DX_NAME> <BRAND_NAME> prolia </BRAND_NAME> <BRAND_NAME> prolia </BRAND_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> postmenopausal </DX_NAME> <DX_NAME> fracture </DX_NAME> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nonspinal </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> hip_fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <PROCEDURE_NAME> reduction </PROCEDURE_NAME> <TREATMENT_NAME> hormone </TREATMENT_NAME> <TREATMENT_NAME> testosterone </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <TREATMENT_NAME> glucocorticoids </TREATMENT_NAME> <DX_NAME> fracture </DX_NAME>
<GENERIC_NAME> insulin_human </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> high_blood_sugar </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> hyperglycaemic_coma </DX_NAME> <DX_NAME> coma </DX_NAME> <DX_NAME> blood_sugar </DX_NAME> <DX_NAME> ketoacidosis </DX_NAME> <DX_NAME> buildup_of_acid </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME>
<BRAND_NAME> afinitor </BRAND_NAME> <GENERIC_NAME> everolimus </GENERIC_NAME> <GENERIC_NAME> everolimus </GENERIC_NAME> <DX_NAME> tumour </DX_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> afinitor </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> postmenopausal </DX_NAME> <TREATMENT_NAME> “nonsteroidal_aromatase_inhibitors” </TREATMENT_NAME> <GENERIC_NAME> exemestane </GENERIC_NAME> <GENERIC_NAME> steroidal </GENERIC_NAME> <TREATMENT_NAME> steroidal_aromatase_inhibitor </TREATMENT_NAME> <TREATMENT_NAME> hormonal_anticancer_therapy </TREATMENT_NAME> <DX_NAME> neuroendocrine_tumours </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cancer </DX_NAME> <DX_NAME> renal_cell_carcinoma </DX_NAME> <TREATMENT_NAME> “vegftargeted_therapy” </TREATMENT_NAME>
<TEST_NAME> blood_phosphorus_levels </TEST_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <DX_NAME> poor_kidney_function </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_phosphorus_levels </DX_NAME> <TEST_NAME> blood_phosphorus_levels </TEST_NAME> <DX_NAME> hyperphosphataemia </DX_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <DX_NAME> hyperphosphataemia </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> itchy_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> red_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_fractures </DX_NAME> <SYSTEM_ORGAN_SITE> digestive_tract </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> faeces </SYSTEM_ORGAN_SITE>
<BRAND_NAME> MYLOTARG </BRAND_NAME> <GENERIC_NAME> gemtuzumab_ozogamicin </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <BRAND_NAME> MYLOTARG </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> AML </DX_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TEST_NAME> white_blood_cells </TEST_NAME> <BRAND_NAME> MYLOTARG </BRAND_NAME> <DX_NAME> AML </DX_NAME> <AGE> 15 </AGE> <BRAND_NAME> MYLOTARG </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> promyelocytic_leukaemia </DX_NAME> <DX_NAME> APL </DX_NAME>
<GENERIC_NAME> mirapexin </GENERIC_NAME> <GENERIC_NAME> pramipexole </GENERIC_NAME> <GENERIC_NAME> dopamine_agonists </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> mirapexin </GENERIC_NAME> <DX_NAME> primary_parkinson’s_disease </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> restless_legs_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE>
<BRAND_NAME> cabometyx </BRAND_NAME> <BRAND_NAME> cabometyx </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> cabozantinib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cancer </DX_NAME> <DX_NAME> renal_cell_carcinoma </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_cancer </DX_NAME> <GENERIC_NAME> sorafenib </GENERIC_NAME> <BRAND_NAME> cabometyx </BRAND_NAME> <GENERIC_NAME> cabometyx </GENERIC_NAME> <BRAND_NAME> cabometyx </BRAND_NAME>
<GENERIC_NAME> inflectra </GENERIC_NAME> <GENERIC_NAME> infliximab </GENERIC_NAME> <GENERIC_NAME> infliximab </GENERIC_NAME> <DX_NAME> inflammatory_diseases </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> bechterew’s_disease </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> inflectra </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <BRAND_NAME> inflectra </BRAND_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <BRAND_NAME> inflectra </BRAND_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> bechterew’s_disease </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <BRAND_NAME> inflectra </BRAND_NAME> <DX_NAME> psoriasis_psoriasis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> plaque_psoriasis </DX_NAME> <TREATMENT_NAME> phototherapy </TREATMENT_NAME> <BRAND_NAME> inflectra </BRAND_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> ulcerative_colitis </DX_NAME> <BRAND_NAME> inflectra </BRAND_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> crohn’s_disease </DX_NAME> <BRAND_NAME> inflectra </BRAND_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> abnormal_openings </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME>
<BRAND_NAME> Myfenax </BRAND_NAME> <NAME> Myfenax </NAME> <GENERIC_NAME> mycophenolate_mofetil </GENERIC_NAME> <BRAND_NAME> Myfenax </BRAND_NAME> <PROCEDURE_NAME> transplanted </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> ciclosporin </GENERIC_NAME> <TREATMENT_NAME> ciclosporin </TREATMENT_NAME> <TREATMENT_NAME> corticosteroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME>
<BRAND_NAME> lumigan </BRAND_NAME> <BRAND_NAME> lumigan </BRAND_NAME> <GENERIC_NAME> prostamides </GENERIC_NAME> <BRAND_NAME> lumigan </BRAND_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> high_pressure </DX_NAME> <DX_NAME> glaucoma </DX_NAME> <TIME_TO_DX_NAME> eventually </TIME_TO_DX_NAME> <DX_NAME> damage_your_sight </DX_NAME>
<TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> oritavancin </GENERIC_NAME> <GENERIC_NAME> oritavancin </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> antibiotic </GENERIC_NAME> <GENERIC_NAME> lipoglycopeptide </GENERIC_NAME> <TREATMENT_NAME> lipoglycopeptide_antibiotic </TREATMENT_NAME> <GENERIC_NAME> antibiotic </GENERIC_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> underlying_tissues </SYSTEM_ORGAN_SITE> <GENERIC_NAME> orbactiv </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> bacteria </DX_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME>
<BRAND_NAME> fabrazyme </BRAND_NAME> <GENERIC_NAME> agalsidase_beta </GENERIC_NAME> <DX_NAME> fabry_disease </DX_NAME> <DX_NAME> fabry_disease </DX_NAME> <GENERIC_NAME> globotriaosylceramide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> walls </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <BRAND_NAME> fabrazyme </BRAND_NAME> <TREATMENT_NAME> enzyme_replacement_therapy </TREATMENT_NAME> <DX_NAME> fabry_disease </DX_NAME> <BRAND_NAME> fabrazyme </BRAND_NAME>
<GENERIC_NAME> tracleer </GENERIC_NAME> <GENERIC_NAME> bosentan </GENERIC_NAME> <DX_NAME> blood_vessels </DX_NAME> <DX_NAME> pulmonary_arterial_hypertension </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> narrowing_of_the_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> pulmonary_arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> pulmonary_arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> pah </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> limitation_of_physical_activity </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> scleroderma </DX_NAME> <DX_NAME> systemic_sclerosis </DX_NAME> <DX_NAME> abnormal_growth </DX_NAME> <SYSTEM_ORGAN_SITE> connective_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> congenital_(inborn </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_defects </DX_NAME> <DX_NAME> shunts </DX_NAME> <DX_NAME> abnormal_passageways </DX_NAME> <DX_NAME> abnormal_flow_of_blood </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> ulcers </DX_NAME> <DX_NAME> sores </DX_NAME> <SYSTEM_ORGAN_SITE> fingers </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> toes </SYSTEM_ORGAN_SITE> <DX_NAME> scleroderma </DX_NAME> <SYSTEM_ORGAN_SITE> finger </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> toe </SYSTEM_ORGAN_SITE> <DX_NAME> ulcers </DX_NAME>
<BRAND_NAME> zevalin </BRAND_NAME> <TREATMENT_NAME> radiopharmaceutical_product </TREATMENT_NAME> <BRAND_NAME> zevalin </BRAND_NAME> <GENERIC_NAME> ibritumomab_tiuxetan </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <BRAND_NAME> zevalin </BRAND_NAME> <TREATMENT_NAME> irradiation </TREATMENT_NAME> <BRAND_NAME> zevalin </BRAND_NAME> <DX_NAME> nonhodgkin’s_lymphoma </DX_NAME> <GENERIC_NAME> rituximab </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <DX_NAME> relapsed_disease </DX_NAME> <BRAND_NAME> zevalin </BRAND_NAME> <TIME_TO_MEDICATION_NAME> previously </TIME_TO_MEDICATION_NAME> <DX_NAME> follicular_lymphoma </DX_NAME> <TREATMENT_NAME> consolidation_therapy </TREATMENT_NAME> <DX_NAME> lymphoma_cells </DX_NAME> <TREATMENT_NAME> chemotherapy_regimen </TREATMENT_NAME> <BRAND_NAME> zevalin </BRAND_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<BRAND_NAME> tysabri </BRAND_NAME> <GENERIC_NAME> natalizumab </GENERIC_NAME> <BRAND_NAME> tysabri </BRAND_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve_cells </SYSTEM_ORGAN_SITE> <BRAND_NAME> tysabri </BRAND_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> nerve_damage </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> walking_problems </DX_NAME> <DX_NAME> numbness </DX_NAME> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arms </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> tiredness </DX_NAME> <DX_NAME> feeling_offbalance_or_light_headed </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> bladder_and_bowel_problems </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> difficulty_in_thinking_and_concentrating </DX_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> sexual_problems </DX_NAME> <DX_NAME> stiffness </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_spasms </DX_NAME> <DX_NAME> flare_up </DX_NAME> <DX_NAME> relapse </DX_NAME> <DX_NAME> exacerbation_or_an_attack </DX_NAME> <DX_NAME> relapse </DX_NAME> <BRAND_NAME> tysabri </BRAND_NAME> <BRAND_NAME> tysabri </BRAND_NAME> <BRAND_NAME> tysabri </BRAND_NAME>
<BRAND_NAME> zynteglo </BRAND_NAME> <NAME> zynteglo </NAME> <DX_NAME> genetic_disease </DX_NAME> <DX_NAME> betathalassaemia </DX_NAME> <DX_NAME> betathalassaemia </DX_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <GENERIC_NAME> betaglobin </GENERIC_NAME> <DX_NAME> gene_defect </DX_NAME> <DX_NAME> defect </DX_NAME> <TREATMENT_NAME> frequent_blood_transfusions </TREATMENT_NAME> <TREATMENT_NAME> gene_therapy </TREATMENT_NAME> <TREATMENT_NAME> autologous)_blood_stem_cells </TREATMENT_NAME> <GENERIC_NAME> betaglobin </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME>
<GENERIC_NAME> temozolomide </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_tumours </DX_NAME> <DX_NAME> glioblastoma_multiforme </DX_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <DX_NAME> malignant_glioma </DX_NAME> <DX_NAME> glioblastoma_multiforme </DX_NAME> <DX_NAME> anaplastic_astrocytoma </DX_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME>
<GENERIC_NAME> “rituximab” </GENERIC_NAME> <GENERIC_NAME> rituximab </GENERIC_NAME> <DX_NAME> nonhodgkin’s_lymphoma </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> “chemotherapy” </TREATMENT_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> wegener’s_granulomatosis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> pemphigus_vulgaris </DX_NAME> <DX_NAME> pemphigus_vulgaris </DX_NAME> <DX_NAME> pemphigus_vulgaris </DX_NAME> <DX_NAME> autoimmune_condition </DX_NAME> <DX_NAME> painful_blisters </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lining_of_the_mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> genitals </SYSTEM_ORGAN_SITE>
<BRAND_NAME> hizentra </BRAND_NAME> <GENERIC_NAME> hizentra </GENERIC_NAME> <TEST_NAME> blood_proteins </TEST_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> hizentra </GENERIC_NAME> <GENERIC_NAME> hizentra </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> bacteria </DX_NAME> <BRAND_NAME> hizentra </BRAND_NAME> <TREATMENT_NAME> replacement_therapy </TREATMENT_NAME> <BRAND_NAME> hizentra </BRAND_NAME> <TEST_NAME> immunoglobulin_levels </TEST_NAME> <TEST_NAME> blood_to_normal_levels </TEST_NAME> <TREATMENT_NAME> replacement_therapy </TREATMENT_NAME> <DX_NAME> inability_to_produce_immunoglobulins </DX_NAME> <DX_NAME> immunodeficiencies </DX_NAME> <DX_NAME> low_immunoglobulin_levels </DX_NAME> <TEST_NAME> immunoglobulin_levels </TEST_NAME> <TEST_NAME> hypogammaglobulinaemia </TEST_NAME> <DX_NAME> hypogammaglobulinaemia </DX_NAME> <TEST_NAME> immunoglobulins </TEST_NAME> <DX_NAME> agammaglobulinaemia </DX_NAME> <TEST_NAME> immunoglobulin_levels </TEST_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> inability_to_produce_adequate_amounts_of_antibodies </DX_NAME> <TREATMENT_NAME> vaccination </TREATMENT_NAME> <DX_NAME> immunodeficiency </DX_NAME> <DX_NAME> nonfunctional_immune_cells </DX_NAME> <DX_NAME> immunodeficiency </DX_NAME> <DX_NAME> immunoglobulin_g_subclasses </DX_NAME> <DX_NAME> recurrent_infections </DX_NAME>
<TEST_NAME> blood_proteins </TEST_NAME> <DX_NAME> infections </DX_NAME> <TEST_NAME> immunoglobulin_levels </TEST_NAME> <TEST_NAME> blood_to_normal_levels </TEST_NAME> <TREATMENT_NAME> replacement_therapy </TREATMENT_NAME> <DX_NAME> inability_to_produce_immunoglobulins </DX_NAME> <DX_NAME> immunodeficiencies </DX_NAME> <DX_NAME> pid </DX_NAME>
<GENERIC_NAME> sodium_zirconium_cyclosilicate </GENERIC_NAME> <DX_NAME> hyperkalaemia </DX_NAME> <DX_NAME> hyperkalaemia </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> potassium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> myasthenic_syndrome </DX_NAME> <DX_NAME> lems </DX_NAME> <DX_NAME> disorder </DX_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_weakness </DX_NAME> <DX_NAME> tumour </DX_NAME> <DX_NAME> paraneoplastic_form_of_lems </DX_NAME> <DX_NAME> nonparaneoplastic </DX_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve's_signals </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve_signals </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> paliperidone </GENERIC_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME> <TREATMENT_NAME> antipsychotic_medicines </TREATMENT_NAME> <DX_NAME> schizophrenia </DX_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME> <GENERIC_NAME> risperidone </GENERIC_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME> <GENERIC_NAME> risperidone </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> in_the_past </TIME_TO_MEDICATION_NAME> <TIME_TO_MEDICATION_NAME> in_the_past </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> prior </TIME_TO_MEDICATION_NAME> <TIME_TO_MEDICATION_NAME> prior </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME> <GENERIC_NAME> risperidone </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> hallucinations </DX_NAME> <DX_NAME> delusions </DX_NAME> <DX_NAME> lack_of_behaviours </DX_NAME> <DX_NAME> feelings_that_are_normally_present </DX_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> trouble_speaking_in_a_clear_and_logical_way </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> tense </DX_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME>
<GENERIC_NAME> tadalafil </GENERIC_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <DX_NAME> cannot_get </DX_NAME> <DX_NAME> erect_penis_suitable_for_sexual_activity </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <GENERIC_NAME> tadalafil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <GENERIC_NAME> tadalafil </GENERIC_NAME> <GENERIC_NAME> tadalafil </GENERIC_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_inhibitors </TREATMENT_NAME> <GENERIC_NAME> tadalafil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <DX_NAME> erectile_function </DX_NAME> <GENERIC_NAME> tadalafil </GENERIC_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <GENERIC_NAME> tadalafil </GENERIC_NAME> <DX_NAME> erectile_dysfunction </DX_NAME>
<GENERIC_NAME> febuxostat </GENERIC_NAME> <BRAND_NAME> mylan </BRAND_NAME> <GENERIC_NAME> febuxostat </GENERIC_NAME> <DX_NAME> gout </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> redness </DX_NAME> <DX_NAME> warmth </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> gout_attack </DX_NAME> <DX_NAME> tophi </DX_NAME> <SYSTEM_ORGAN_SITE> tophi </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> tophi </DX_NAME> <SYSTEM_ORGAN_SITE> tophi </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> joint_and_bone_damage </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> febuxostat </GENERIC_NAME> <GENERIC_NAME> febuxostat </GENERIC_NAME> <TEST_NAME> uric_acid_levels </TEST_NAME> <DX_NAME> shrink_tophi </DX_NAME> <GENERIC_NAME> febuxostat </GENERIC_NAME> <BRAND_NAME> mylan </BRAND_NAME> <DX_NAME> high_blood_levels </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> blood_cancers </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> uric_acid_levels </TEST_NAME> <GENERIC_NAME> febuxostat </GENERIC_NAME>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <TEST_NAME> platelets </TEST_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_k_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> anticoagulants’ </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> nalmefene </GENERIC_NAME> <DX_NAME> alcohol_dependence </DX_NAME> <DX_NAME> alcohol_dependence </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE>
<BRAND_NAME> ravicti </BRAND_NAME> <GENERIC_NAME> ‘glycerol </GENERIC_NAME> <DX_NAME> deficiencies </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> carbamoyl_phosphate_synthetase_i </GENERIC_NAME> <TREATMENT_NAME> ornithine_carbamoyltransferase </TREATMENT_NAME> <GENERIC_NAME> ornithine_carbamoyltransferase </GENERIC_NAME> <GENERIC_NAME> argininosuccinate_synthetase </GENERIC_NAME> <GENERIC_NAME> argininosuccinate_lyase </GENERIC_NAME> <DX_NAME> deficiency_hyperornithinaemiahyperammonaemia </DX_NAME> <DX_NAME> homocitrullinuria_syndrome </DX_NAME> <BRAND_NAME> ravicti </BRAND_NAME> <TREATMENT_NAME> supplements </TREATMENT_NAME> <GENERIC_NAME> arginine </GENERIC_NAME> <GENERIC_NAME> citrulline </GENERIC_NAME> <GENERIC_NAME> nitrogen </GENERIC_NAME> <GENERIC_NAME> nitrogen </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> nitrogen </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> low_levels_of_consciousness </DX_NAME> <DX_NAME> coma </DX_NAME> <DX_NAME> urea_cycle_disorders </DX_NAME> <BRAND_NAME> ravicti </BRAND_NAME> <BRAND_NAME> ravicti </BRAND_NAME> <GENERIC_NAME> nitrogen </GENERIC_NAME> <DX_NAME> ammonia </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> lenvatinib </GENERIC_NAME> <GENERIC_NAME> everolimus </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cancer </DX_NAME> <DX_NAME> renal_cell_carcinoma </DX_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME>
<BRAND_NAME> velphoro </BRAND_NAME> <GENERIC_NAME> sucroferric_oxyhydroxide </GENERIC_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <GENERIC_NAME> sucrose </GENERIC_NAME> <BRAND_NAME> velphoro </BRAND_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <PROCEDURE_NAME> peritoneal_dialysis </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TEST_NAME> phosphorus_level </TEST_NAME> <DX_NAME> hyperphosphataemia </DX_NAME> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <DX_NAME> calcification </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> calcium_deposits </DX_NAME> <SYSTEM_ORGAN_SITE> soft_tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> red_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> itchy_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <SYSTEM_ORGAN_SITE> digestive_tract </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> intestines </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> somatropin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> turner_syndrome </DX_NAME> <DX_NAME> turner_syndrome </DX_NAME> <DX_NAME> genetic_abnormality </DX_NAME> <DX_NAME> sexual_chromosome </DX_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TEST_NAME> glucose_levels </TEST_NAME>
<GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <TREATMENT_NAME> thiazide_diuretics </TREATMENT_NAME> <TEST_NAME> urine_output </TEST_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME>
<GENERIC_NAME> pantoprazole </GENERIC_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> reflux_symptoms </DX_NAME> <DX_NAME> heartburn </DX_NAME> <DX_NAME> acid_regurgitation </DX_NAME> <DX_NAME> reflux </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> inflamed </DX_NAME> <DX_NAME> painful </DX_NAME> <DX_NAME> painful_burning_sensation </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <DX_NAME> heartburn </DX_NAME> <DX_NAME> sour_taste </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> acid_regurgitation </DX_NAME> <DX_NAME> acid_reflux </DX_NAME> <DX_NAME> heartburn </DX_NAME> <TIME_TO_MEDICATION_NAME> one_day </TIME_TO_MEDICATION_NAME> <TIME_TO_TREATMENT_NAME> one_day </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> controloc_control </TREATMENT_NAME> <GENERIC_NAME> controloc_control </GENERIC_NAME> <DX_NAME> feel_worse </DX_NAME>
<GENERIC_NAME> palynziq </GENERIC_NAME> <GENERIC_NAME> pegvaliase </GENERIC_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME> <NAME> palynziq </NAME> <AGE> 16 </AGE> <DX_NAME> phenylketonuria </DX_NAME> <DX_NAME> inherited_disorder </DX_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME> <GENERIC_NAME> palynziq </GENERIC_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME> <TEST_NAME> blood_phenylalanine_levels </TEST_NAME> <GENERIC_NAME> micromol/l </GENERIC_NAME>
<GENERIC_NAME> rasagiline </GENERIC_NAME> <GENERIC_NAME> ratiopharm </GENERIC_NAME> <GENERIC_NAME> rasagiline </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> loss_of_cells </DX_NAME> <GENERIC_NAME> dopamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> dopamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> rasagiline </GENERIC_NAME> <GENERIC_NAME> dopamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> Trelegy_Ellipta </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> umeclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> Fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TREATMENT_NAME> steroids </TREATMENT_NAME> <GENERIC_NAME> Umeclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <TREATMENT_NAME> bronchodilators </TREATMENT_NAME> <GENERIC_NAME> Trelegy_Ellipta </GENERIC_NAME> <GENERIC_NAME> Trelegy_Ellipta </GENERIC_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> COPD </DX_NAME> <DX_NAME> COPD </DX_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> COPD </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficult </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <SYSTEM_ORGAN_SITE> small_air_passages </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> COPD </DX_NAME> <GENERIC_NAME> Trelegy_Ellipta </GENERIC_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> COPD </DX_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> attack </DX_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME>
<BRAND_NAME> xiliarx </BRAND_NAME> <GENERIC_NAME> vildagliptin </GENERIC_NAME> <BRAND_NAME> xiliarx </BRAND_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <BRAND_NAME> xiliarx </BRAND_NAME> <TREATMENT_NAME> antidiabetic_medicines </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <BRAND_NAME> xiliarx </BRAND_NAME> <BRAND_NAME> xiliarx </BRAND_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> carbidopa </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> ‘dopamine’ </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> dopamine </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> carbidopa </GENERIC_NAME> <GENERIC_NAME> ‘aromatic_amino_acid_decarboxylase </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> parkinson’s_disease </DX_NAME>
<GENERIC_NAME> pheburane </GENERIC_NAME> <GENERIC_NAME> sodium_phenylbutyrate </GENERIC_NAME> <DX_NAME> urea_cycle_disorders </DX_NAME> <DX_NAME> rare_disorders </DX_NAME> <DX_NAME> deficiency </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <TEST_NAME> liver_enzymes </TEST_NAME> <DX_NAME> ammonia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> coma </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<BRAND_NAME> quofenix </BRAND_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> antibiotic </GENERIC_NAME> <GENERIC_NAME> delafloxacin </GENERIC_NAME> <GENERIC_NAME> fluoroquinolones </GENERIC_NAME> <DX_NAME> shortterm_infections </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME> <GENERIC_NAME> antibiotics </GENERIC_NAME> <DX_NAME> infection </DX_NAME>
<BRAND_NAME> neulasta </BRAND_NAME> <GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <BRAND_NAME> neulasta </BRAND_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> febrile_neutropenia </DX_NAME> <DX_NAME> low_white_blood_cell_count </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> fever </DX_NAME> <TREATMENT_NAME> cytotoxic_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> neulasta </BRAND_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME>
<GENERIC_NAME> brintellix </GENERIC_NAME> <GENERIC_NAME> vortioxetine </GENERIC_NAME> <GENERIC_NAME> brintellix </GENERIC_NAME> <DX_NAME> major_depressive </DX_NAME> <GENERIC_NAME> brintellix </GENERIC_NAME> <DX_NAME> depressive_symptoms </DX_NAME> <DX_NAME> sadness </DX_NAME> <DX_NAME> inner_tension </DX_NAME> <DX_NAME> feeling_anxious </DX_NAME> <DX_NAME> sleep_disturbances </DX_NAME> <DX_NAME> reduced_sleep </DX_NAME> <DX_NAME> reduced_appetite </DX_NAME> <DX_NAME> difficulty_in_concentrating </DX_NAME> <DX_NAME> feelings_of_worthlessness </DX_NAME> <DX_NAME> loss_of_interest_in_favourite_activities </DX_NAME> <DX_NAME> feeling_of_being_slowed_down </DX_NAME>
<GENERIC_NAME> human_fibrinogen </GENERIC_NAME> <GENERIC_NAME> human_thrombin </GENERIC_NAME> <DX_NAME> clot </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> oozing </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> blood_vessel_surgery </PROCEDURE_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> abdominal_wall </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cerebral_envelopes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> dura_mater </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> posaconazole </GENERIC_NAME> <GENERIC_NAME> posaconazole </GENERIC_NAME> <DX_NAME> fungal_infections </DX_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> posaconazole </GENERIC_NAME> <DX_NAME> fungal_infections </DX_NAME> <TREATMENT_NAME> antifungal_medicines </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> antifungal_medicines </TREATMENT_NAME> <GENERIC_NAME> antifungal_medicines </GENERIC_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> fusarium </GENERIC_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> “mycetoma” </DX_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> fungus </DX_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <GENERIC_NAME> fluconazole </GENERIC_NAME> <DX_NAME> fungal_infections </DX_NAME> <DX_NAME> fungal_infection </DX_NAME> <DX_NAME> weak_immune_system </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> “acute_myelogenous_leukemia” </DX_NAME> <DX_NAME> aml </DX_NAME> <DX_NAME> “myelodysplastic_syndromes” </DX_NAME> <DX_NAME> mds </DX_NAME> <TREATMENT_NAME> immunosuppressive_therapy” </TREATMENT_NAME> <TREATMENT_NAME> “hematopoietic_stem_cell_transplant” </TREATMENT_NAME> <TREATMENT_NAME> hsct </TREATMENT_NAME>
<GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> ‘azacitidine’ </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <PROCEDURE_NAME> stem_cell_transplantation </PROCEDURE_NAME> <DX_NAME> myelodysplastic_syndromes </DX_NAME> <DX_NAME> mds </DX_NAME> <DX_NAME> myelomonocytic_leukaemia </DX_NAME> <DX_NAME> cmml </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> aml </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <TEST_NAME> ribonucleic_acid </TEST_NAME> <TEST_NAME> rna) </TEST_NAME> <TEST_NAME> deoxyribonucleic_acid </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> myelodysplastic_disorders </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME>
<GENERIC_NAME> imatinib_medac </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> cml </DX_NAME> <DX_NAME> blast_crisis </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> cml </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> cml </DX_NAME> <DX_NAME> failure </DX_NAME> <TREATMENT_NAME> interferonalpha_therapy </TREATMENT_NAME> <DX_NAME> blast_crisis </DX_NAME> <DX_NAME> dic </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> myelodysplastic/myeloproliferative_diseases </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> hypereosinophilic_syndrome </DX_NAME> <DX_NAME> eosinophilic_leukaemia </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> dermatofibrosarcoma_protuberans </DX_NAME> <DX_NAME> dfsp </DX_NAME> <DX_NAME> dfsp </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME>
<GENERIC_NAME> benepali </GENERIC_NAME> <GENERIC_NAME> benepali </GENERIC_NAME> <GENERIC_NAME> etanercept </GENERIC_NAME> <GENERIC_NAME> benepali </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <GENERIC_NAME> benepali </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <AGE> 18 </AGE> <GENERIC_NAME> benepali </GENERIC_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> axial_spondyloarthritis </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <GENERIC_NAME> benepali </GENERIC_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <GENERIC_NAME> benepali </GENERIC_NAME> <DX_NAME> benepali </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> benepali </GENERIC_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> painful </DX_NAME> <DX_NAME> swollen </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> feet </SYSTEM_ORGAN_SITE> <DX_NAME> structural_damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> idiopathic_arthritis </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> polyarthritis </DX_NAME> <TEST_NAME> rheumatoid_factor </TEST_NAME> <DX_NAME> rheumatoid_factor_positive </DX_NAME> <DX_NAME> extended_oligoarthritis </DX_NAME> <AGE> 2 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <AGE> 12 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> enthesitisrelated_arthritis </DX_NAME> <AGE> 12 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> psoriasis </DX_NAME> <AGE> 6 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> inadequate_response </DX_NAME> <TREATMENT_NAME> phototherapies </TREATMENT_NAME> <TREATMENT_NAME> systemic_therapies </TREATMENT_NAME>
<GENERIC_NAME> ebilfumin </GENERIC_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> flu_symptoms </DX_NAME> <DX_NAME> flu_virus </DX_NAME> <TREATMENT_NAME> flu_virus </TREATMENT_NAME> <GENERIC_NAME> ebilfumin </GENERIC_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> flu </DX_NAME> <GENERIC_NAME> ebilfumin </GENERIC_NAME> <TREATMENT_NAME> preventive_treatment </TREATMENT_NAME> <TREATMENT_NAME> global_epidemic_of_flu </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> flu_pandemic </TREATMENT_NAME> <GENERIC_NAME> flu_pandemic </GENERIC_NAME> <TREATMENT_NAME> seasonal_flu_vaccine </TREATMENT_NAME> <GENERIC_NAME> flu_vaccine </GENERIC_NAME> <GENERIC_NAME> ebilfumin </GENERIC_NAME> <GENERIC_NAME> oseltamivir </GENERIC_NAME> <GENERIC_NAME> neuraminidase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> neuraminidase_inhibitors </TREATMENT_NAME> <DX_NAME> flu_virus </DX_NAME> <TREATMENT_NAME> flu_virus </TREATMENT_NAME> <DX_NAME> flu_virus_infection </DX_NAME> <TREATMENT_NAME> flu_virus_infection </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> cough </DX_NAME> <DX_NAME> runny </DX_NAME> <DX_NAME> stuffy_nose </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <DX_NAME> headaches </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_aches </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> influenza_infection </DX_NAME> <DX_NAME> flu_viruses </DX_NAME> <DX_NAME> epidemic_periods </DX_NAME> <DX_NAME> flulike_symptoms </DX_NAME>
<GENERIC_NAME> krystexxa </GENERIC_NAME> <GENERIC_NAME> pegloticase </GENERIC_NAME> <GENERIC_NAME> pegloticase </GENERIC_NAME> <GENERIC_NAME> pegloticase </GENERIC_NAME> <DX_NAME> gout </DX_NAME> <DX_NAME> painful_deposits </DX_NAME> <DX_NAME> uric_acid_crystals </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> krystexxa </GENERIC_NAME> <DX_NAME> gout </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> uric_acid_deposits </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> redness </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> inflammation </DX_NAME> <GENERIC_NAME> krystexxa </GENERIC_NAME> <GENERIC_NAME> allantoin </GENERIC_NAME>
<BRAND_NAME> envarsus </BRAND_NAME> <GENERIC_NAME> tacrolimus </GENERIC_NAME> <TREATMENT_NAME> immunosuppressant </TREATMENT_NAME> <GENERIC_NAME> immunosuppressant </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> kidney_or_liver_transplant </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <BRAND_NAME> envarsus </BRAND_NAME> <PROCEDURE_NAME> transplanted </PROCEDURE_NAME> <BRAND_NAME> envarsus </BRAND_NAME> <DX_NAME> rejection </DX_NAME> <PROCEDURE_NAME> transplanted </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> transplantation </PROCEDURE_NAME> <BRAND_NAME> envarsus </BRAND_NAME>
<BRAND_NAME> XELJANZ </BRAND_NAME> <GENERIC_NAME> tofacitinib </GENERIC_NAME> <BRAND_NAME> XELJANZ </BRAND_NAME> <DX_NAME> inflammatory_diseases </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> Rheumatoid_arthritis </DX_NAME> <BRAND_NAME> XELJANZ </BRAND_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> long-term_disease </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <BRAND_NAME> XELJANZ </BRAND_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <TREATMENT_NAME> rheumatoid_arthritis_treatment </TREATMENT_NAME> <BRAND_NAME> XELJANZ </BRAND_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <TREATMENT_NAME> methotrexate_treatment </TREATMENT_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <BRAND_NAME> XELJANZ </BRAND_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> Psoriatic_arthritis </DX_NAME> <BRAND_NAME> XELJANZ </BRAND_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <BRAND_NAME> XELJANZ </BRAND_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <BRAND_NAME> XELJANZ </BRAND_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> Ulcerative_colitis </DX_NAME> <DX_NAME> Ulcerative_colitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <BRAND_NAME> XELJANZ </BRAND_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME>
<BRAND_NAME> ziagen </BRAND_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> ziagen </BRAND_NAME> <GENERIC_NAME> abacavir </GENERIC_NAME> <GENERIC_NAME> abacavir </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> nucleoside_analogue_reverse_transcriptase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> nucleoside_analogue_reverse_transcriptase_inhibitors </GENERIC_NAME> <BRAND_NAME> ziagen </BRAND_NAME> <DX_NAME> hiv_infection </DX_NAME> <TREATMENT_NAME> cd4_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> ziagen </BRAND_NAME>
<GENERIC_NAME> etelcalcetide </GENERIC_NAME> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> parathyroid_glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> small_glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> hyperparathyroidism </DX_NAME> <DX_NAME> loss_of_calcium </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <DX_NAME> fractures </DX_NAME> <DX_NAME> problems_with_blood_and_heart_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> trisenox </GENERIC_NAME> <DX_NAME> promyelocytic_leukaemia </DX_NAME> <DX_NAME> apl </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> abnormal_white_blood_cells </DX_NAME> <DX_NAME> abnormal_bleeding </DX_NAME> <DX_NAME> bruising </DX_NAME>
<DX_NAME> blood_coagulation_factor </DX_NAME> <DX_NAME> blood_clot </DX_NAME> <DX_NAME> bleeding </DX_NAME> <GENERIC_NAME> novoseven </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> excessive_bleeding </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <GENERIC_NAME> novoseven </GENERIC_NAME> <DX_NAME> bleed </DX_NAME> <DX_NAME> bleeds </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> joint_bleeds </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> factor_vii_deficiency </DX_NAME> <DX_NAME> thrombasthenia </DX_NAME> <DX_NAME> bleeding_disorder </DX_NAME> <TREATMENT_NAME> platelet_transfusion </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME>
<GENERIC_NAME> desloratadine </GENERIC_NAME> <BRAND_NAME> actavis </BRAND_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <BRAND_NAME> actavis </BRAND_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> antihistamine </GENERIC_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> actavis </GENERIC_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> actavis </GENERIC_NAME> <GENERIC_NAME> antiallergy_medicine </GENERIC_NAME> <DX_NAME> drowsy </DX_NAME> <DX_NAME> allergic_reaction </DX_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <BRAND_NAME> actavis </BRAND_NAME> <GENERIC_NAME> desloratadine </GENERIC_NAME> <DX_NAME> allergic_rhinitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> nasal_passages </SYSTEM_ORGAN_SITE> <DX_NAME> allergy </DX_NAME> <DX_NAME> hay_fever </DX_NAME> <DX_NAME> allergy </DX_NAME> <AGE> 12 </AGE> <DX_NAME> sneezing </DX_NAME> <DX_NAME> runny </DX_NAME> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> palate </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <DX_NAME> red </DX_NAME> <DX_NAME> watery_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <GENERIC_NAME> desloratadine_actavis </GENERIC_NAME> <DX_NAME> urticaria </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_condition </DX_NAME> <DX_NAME> allergy </DX_NAME> <DX_NAME> itching </DX_NAME> <DX_NAME> hives </DX_NAME>
<GENERIC_NAME> ocaliva </GENERIC_NAME> <GENERIC_NAME> obeticholic_acid </GENERIC_NAME> <GENERIC_NAME> farnesoid_xreceptor_agonist </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <DX_NAME> biliary_cholangitis </DX_NAME> <DX_NAME> biliary_cirrhosis </DX_NAME> <GENERIC_NAME> ursodeoxycholic_acid </GENERIC_NAME>
<BRAND_NAME> erbitux </BRAND_NAME> <BRAND_NAME> erbitux </BRAND_NAME> <GENERIC_NAME> cetuximab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <TEST_NAME> monoclonal_antibodies </TEST_NAME> <GENERIC_NAME> cetuximab </GENERIC_NAME> <TEST_NAME> egfr_activates_proteins </TEST_NAME> <TEST_NAME> ras_proteins </TEST_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> metastasis </DX_NAME> <BRAND_NAME> erbitux </BRAND_NAME> <BRAND_NAME> erbitux </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> metastatic_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> large_intestine </SYSTEM_ORGAN_SITE> <BRAND_NAME> erbitux </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> squamous_cell_cancer </DX_NAME> <BRAND_NAME> erbitux </BRAND_NAME> <TREATMENT_NAME> radiation_therapy </TREATMENT_NAME>
<BRAND_NAME> Rubraca </BRAND_NAME> <BRAND_NAME> Rubraca </BRAND_NAME> <GENERIC_NAME> rucaparib </GENERIC_NAME> <BRAND_NAME> Rubraca </BRAND_NAME> <GENERIC_NAME> ribose_polymerase </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> Rubraca_blocks </TEST_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> death </DX_NAME> <BRAND_NAME> Rubraca </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> ovary </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <BRAND_NAME> Rubraca </BRAND_NAME> <TREATMENT_NAME> maintenance_therapy </TREATMENT_NAME> <TIME_TO_TREATMENT_NAME> immediately </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> tumour </DX_NAME> <BRAND_NAME> Rubraca </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> abnormality </DX_NAME> <DX_NAME> BRCA_gene </DX_NAME> <BRAND_NAME> Rubraca </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> clinical_test </TEST_NAME> <DX_NAME> abnormality </DX_NAME> <DX_NAME> BRCA_gene </DX_NAME>
<GENERIC_NAME> thyrotropin_alfa </GENERIC_NAME> <SYSTEM_ORGAN_SITE> thyroid </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> thyroid_stimulating_hormone </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> thyroid </SYSTEM_ORGAN_SITE> <DX_NAME> thyroid_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> thyroid_gland </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> thyroid_gland_removed </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> thyroid </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> thyroid_tissue </SYSTEM_ORGAN_SITE> <TEST_NAME> radioiodine_imaging </TEST_NAME> <TEST_NAME> thyroglobulin </TEST_NAME> <SYSTEM_ORGAN_SITE> thyroid </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> thyroid_tissue </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> radioiodine_treatment </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> thyroid_tissue </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgical_removal </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> thyroid_gland </SYSTEM_ORGAN_SITE> <DX_NAME> cancer_growths </DX_NAME> <DX_NAME> metastases </DX_NAME> <SYSTEM_ORGAN_SITE> thyroid </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> thyroid_hormone </TREATMENT_NAME>
<BRAND_NAME> evista </BRAND_NAME> <GENERIC_NAME> raloxifene_hydrochloride </GENERIC_NAME> <BRAND_NAME> evista </BRAND_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> postmenopausal </DX_NAME> <BRAND_NAME> evista </BRAND_NAME> <DX_NAME> vertebral_fractures </DX_NAME> <DX_NAME> postmenopausal_osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> hip_fractures </DX_NAME> <BRAND_NAME> evista </BRAND_NAME> <BRAND_NAME> evista </BRAND_NAME> <TREATMENT_NAME> nonhormonal_medicines </TREATMENT_NAME> <TREATMENT_NAME> selective_oestrogen_receptor_modulators </TREATMENT_NAME> <DX_NAME> menopause </DX_NAME> <BRAND_NAME> evista </BRAND_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> thin </DX_NAME> <DX_NAME> fragile </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hips </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE> <DX_NAME> back_pain </DX_NAME> <DX_NAME> loss_of_height </DX_NAME>
<GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessel_wall </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME>
<TREATMENT_NAME> radiopharmaceutical_product </TREATMENT_NAME> <GENERIC_NAME> edotreotide </GENERIC_NAME> <GENERIC_NAME> gallium </GENERIC_NAME> <GENERIC_NAME> chloride </GENERIC_NAME> <GENERIC_NAME> gallium </GENERIC_NAME> <GENERIC_NAME> edotreotide </GENERIC_NAME> <GENERIC_NAME> gallium </GENERIC_NAME> <GENERIC_NAME> edotreotide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body_areas </SYSTEM_ORGAN_SITE> <TEST_NAME> positron_emission_tomography </TEST_NAME> <TEST_NAME> pet </TEST_NAME> <TEST_NAME> images </TEST_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<GENERIC_NAME> pramipexole </GENERIC_NAME> <GENERIC_NAME> dopamine_agonists </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> dopamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> parkinson's_disease </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> restless_legs_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE>
<PROCEDURE_NAME> stepbystep_injection </PROCEDURE_NAME> <GENERIC_NAME> bulevirtide </GENERIC_NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <DX_NAME> hepatitis_delta_virus </DX_NAME> <DX_NAME> hdv </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> bulevirtide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hdv </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME>
<GENERIC_NAME> cobimetinib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <GENERIC_NAME> vemurafenib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> melanoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> vemurafenib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME>
<NAME> dovato </NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> dolutegravir </GENERIC_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <GENERIC_NAME> dolutegravir </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> integrase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> integrase_inhibitors </GENERIC_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> nucleoside </GENERIC_NAME> <TREATMENT_NAME> nucleoside_analogue_reverse_transcriptase_inhibitors </TREATMENT_NAME> <DX_NAME> hiv </DX_NAME> <TEST_NAME> weigh </TEST_NAME> <DX_NAME> hiv_infection </DX_NAME> <TREATMENT_NAME> cd4_cells </TREATMENT_NAME> <TREATMENT_NAME> cd4_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> dovato </BRAND_NAME>
<DX_NAME> cancer </DX_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> folic_acid_analogues </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <DX_NAME> pleural_mesothelioma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<GENERIC_NAME> “follitropin </GENERIC_NAME> <GENERIC_NAME> “lutropin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <DX_NAME> pregnant </DX_NAME> <AGE> 18 </AGE> <DX_NAME> low_levels </DX_NAME> <DX_NAME> deficiency </DX_NAME> <TREATMENT_NAME> hormone_“human_chorionic_gonadotropin </TREATMENT_NAME> <DX_NAME> pregnant </DX_NAME>
<NAME> ciambra </NAME> <BRAND_NAME> ciambra </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <NAME> ciambra </NAME> <BRAND_NAME> ciambra </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <DX_NAME> malignant_pleural_mesothelioma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lining_of_the_lung </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <NAME> ciambra </NAME> <BRAND_NAME> ciambra </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <BRAND_NAME> ciambra </BRAND_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <NAME> ciambra </NAME> <BRAND_NAME> ciambra </BRAND_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<GENERIC_NAME> telbivudine </GENERIC_NAME> <TREATMENT_NAME> antiviral_medicines </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <GENERIC_NAME> sebivo </GENERIC_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_damage </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_damage </DX_NAME> <DX_NAME> improved_liver_function </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> besponsa </GENERIC_NAME> <TREATMENT_NAME> inotuzumab_ozogamicin </TREATMENT_NAME> <GENERIC_NAME> inotuzumab_ozogamicin </GENERIC_NAME> <TREATMENT_NAME> cancer_cells </TREATMENT_NAME> <TREATMENT_NAME> antineoplastic_agents </TREATMENT_NAME> <GENERIC_NAME> besponsa </GENERIC_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> besponsa </GENERIC_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME>
<GENERIC_NAME> tacrolimus </GENERIC_NAME> <TREATMENT_NAME> immunosuppressant </TREATMENT_NAME> <PROCEDURE_NAME> organ_transplant </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> transplanted </PROCEDURE_NAME> <BRAND_NAME> advagraf </BRAND_NAME> <DX_NAME> rejection </DX_NAME> <PROCEDURE_NAME> transplanted </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> transplantation </PROCEDURE_NAME> <BRAND_NAME> advagraf </BRAND_NAME>
<GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <TREATMENT_NAME> dpp4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <TREATMENT_NAME> dipeptidyl_peptidase4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> sulphonylureas </GENERIC_NAME> <DX_NAME> sulphonylureas </DX_NAME> <GENERIC_NAME> glitazones </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> glucose </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> amputation </DX_NAME> <PROCEDURE_NAME> amputation </PROCEDURE_NAME>
<BRAND_NAME> latuda </BRAND_NAME> <GENERIC_NAME> lurasidone </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <AGE> 18 </AGE> <GENERIC_NAME> lurasidone </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> dopamine </GENERIC_NAME> <GENERIC_NAME> serotonin_attach </GENERIC_NAME> <GENERIC_NAME> dopamine </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <GENERIC_NAME> lurasidone </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disorder </DX_NAME> <DX_NAME> incoherent_speech_and_behaviour </DX_NAME> <DX_NAME> emotional_flatness </DX_NAME> <DX_NAME> disorder </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> schizophrenia </DX_NAME>
<GENERIC_NAME> hydroxocobalamin </GENERIC_NAME> <DX_NAME> cyanokit </DX_NAME> <DX_NAME> cyanide_poisoning </DX_NAME> <DX_NAME> cyanokit </DX_NAME> <DX_NAME> cyanide_poisoning </DX_NAME> <DX_NAME> breathing_or_swallowing_cyanide </DX_NAME> <DX_NAME> contact_with_cyanide </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> ibandronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <DX_NAME> tumour </DX_NAME> <DX_NAME> lost_from_your_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME>
<TREATMENT_NAME> antirheumatic_medicines </TREATMENT_NAME> <GENERIC_NAME> leflunomide </GENERIC_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> arthritis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> difficulty_moving </DX_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> loss_of_appetite </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> loss_of_energy </DX_NAME> <DX_NAME> anemia </DX_NAME> <DX_NAME> lack_of_red_blood_cells </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> arthritis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> difficulty_moving </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> patches_of_red </DX_NAME> <DX_NAME> scaly_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_lesions </DX_NAME>
<GENERIC_NAME> roactemra </GENERIC_NAME> <GENERIC_NAME> tocilizumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <GENERIC_NAME> roactemra </GENERIC_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> autoimmune_disease </DX_NAME> <GENERIC_NAME> roactemra </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> roactemra </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> roactemra </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <TREATMENT_NAME> methotrexate_treatment </TREATMENT_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> idiopathic_arthritis </DX_NAME> <DX_NAME> sjia </DX_NAME> <SYSTEM_ORGAN_SITE> sjia </SYSTEM_ORGAN_SITE> <DX_NAME> inflammatory_disease </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> fever </DX_NAME> <DX_NAME> rash </DX_NAME> <GENERIC_NAME> roactemra </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> roactemra </GENERIC_NAME> <DX_NAME> polyarticular_juvenile_idiopathic_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <GENERIC_NAME> roactemra </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> cytokine_release_syndrome </DX_NAME> <DX_NAME> crs </DX_NAME> <TREATMENT_NAME> chimeric_antigen_receptor </TREATMENT_NAME> <TREATMENT_NAME> car)_tcell_therapies </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME>
<BRAND_NAME> sylvant </BRAND_NAME> <BRAND_NAME> sylvant </BRAND_NAME> <GENERIC_NAME> siltuximab </GENERIC_NAME> <GENERIC_NAME> siltuximab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <DX_NAME> multicentric_castleman’s_disease </DX_NAME> <DX_NAME> mcd </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> human_herpesvirus8 </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> multicentric_castleman’s_disease </DX_NAME> <DX_NAME> benign_tumours </DX_NAME> <DX_NAME> noncancerous_growths </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> feeling_tired </DX_NAME> <DX_NAME> sweating </DX_NAME> <TIME_TO_DX_NAME> at_night </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> at_night </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> at_night </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> at_night </TIME_TO_DX_NAME> <DX_NAME> tingling_feeling </DX_NAME> <DX_NAME> loss_of_appetite </DX_NAME> <DX_NAME> abnormal_growth </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <GENERIC_NAME> siltuximab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> olanzapine </GENERIC_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> manic_episodes </DX_NAME> <DX_NAME> excitement </DX_NAME> <DX_NAME> euphoria </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <DX_NAME> recurrence </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> manic_episode </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME>
<GENERIC_NAME> vildagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> vildagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> vildagliptin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<BRAND_NAME> cerdelga </BRAND_NAME> <GENERIC_NAME> eliglustat </GENERIC_NAME> <DX_NAME> gaucher_disease </DX_NAME> <DX_NAME> gaucher_disease </DX_NAME> <DX_NAME> inherited_condition </DX_NAME> <GENERIC_NAME> glucosylceramide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <GENERIC_NAME> eliglustat </GENERIC_NAME> <GENERIC_NAME> glucosylceramide </GENERIC_NAME> <BRAND_NAME> cerdelga </BRAND_NAME> <DX_NAME> poor_metabolisers </DX_NAME> <BRAND_NAME> cerdelga </BRAND_NAME> <DX_NAME> gaucher_disease </DX_NAME>
<GENERIC_NAME> human_fibrinogen </GENERIC_NAME> <GENERIC_NAME> human_thrombin </GENERIC_NAME> <DX_NAME> clot </DX_NAME> <DX_NAME> clot </DX_NAME> <SYSTEM_ORGAN_SITE> surrounding_tissue </SYSTEM_ORGAN_SITE> <DX_NAME> bleeding </DX_NAME> <DX_NAME> oozing </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <DX_NAME> bleeding </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> steglatro </GENERIC_NAME> <GENERIC_NAME> steglatro </GENERIC_NAME> <GENERIC_NAME> ertugliflozin </GENERIC_NAME> <GENERIC_NAME> steglatro </GENERIC_NAME> <GENERIC_NAME> sodium_glucose_cotransporter2 </GENERIC_NAME> <GENERIC_NAME> sglt2 </GENERIC_NAME> <GENERIC_NAME> steglatro </GENERIC_NAME> <AGE> 18 </AGE> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> steglatro </GENERIC_NAME> <GENERIC_NAME> steglatro </GENERIC_NAME> <GENERIC_NAME> steglatro </GENERIC_NAME> <GENERIC_NAME> ertugliflozin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> poor_circulation </DX_NAME>
<GENERIC_NAME> “follitropin </GENERIC_NAME> <GENERIC_NAME> follitropin_alfa </GENERIC_NAME> <SYSTEM_ORGAN_SITE> ovary </SYSTEM_ORGAN_SITE> <GENERIC_NAME> “clomiphene </GENERIC_NAME> <SYSTEM_ORGAN_SITE> ovary </SYSTEM_ORGAN_SITE> <DX_NAME> pregnant </DX_NAME> <TEST_NAME> chorionic_gonadotropin” </TEST_NAME> <TEST_NAME> hcg </TEST_NAME>
<BRAND_NAME> zomarist </BRAND_NAME> <GENERIC_NAME> vildagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> vildagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> vildagliptin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<BRAND_NAME> zurampic </BRAND_NAME> <BRAND_NAME> lesinurad </BRAND_NAME> <DX_NAME> gout </DX_NAME> <BRAND_NAME> zurampic </BRAND_NAME> <GENERIC_NAME> allopurinol </GENERIC_NAME> <GENERIC_NAME> febuxostat </GENERIC_NAME> <GENERIC_NAME> ‘xanthine_oxidase_inhibitors’ </GENERIC_NAME> <DX_NAME> gout </DX_NAME> <BRAND_NAME> zurampic </BRAND_NAME> <TIME_TO_MEDICATION_NAME> current </TIME_TO_MEDICATION_NAME> <DX_NAME> gout </DX_NAME> <GENERIC_NAME> allopurinol </GENERIC_NAME> <GENERIC_NAME> febuxostat </GENERIC_NAME> <BRAND_NAME> zurampic </BRAND_NAME> <DX_NAME> gout </DX_NAME> <DX_NAME> arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <BRAND_NAME> zurampic </BRAND_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> joint_damage </DX_NAME>
<DX_NAME> human_clotting </DX_NAME> <BRAND_NAME> afstyla </BRAND_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> inborn_factor_viii_deficiency </DX_NAME> <DX_NAME> factor_viii </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> clot </DX_NAME> <DX_NAME> bleed </DX_NAME> <DX_NAME> factor_viii </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> clot </DX_NAME> <BRAND_NAME> afstyla </BRAND_NAME>
<GENERIC_NAME> duloxetine </GENERIC_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <GENERIC_NAME> noradrenaline </GENERIC_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> feeling_of_anxiety </DX_NAME> <DX_NAME> nervousness </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> stabbing </DX_NAME> <DX_NAME> stinging </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> electric_shock </DX_NAME> <DX_NAME> loss_of_feeling </DX_NAME> <SYSTEM_ORGAN_SITE> affected_area </SYSTEM_ORGAN_SITE> <DX_NAME> cold </DX_NAME> <DX_NAME> pain </DX_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety </DX_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <DX_NAME> feeling_better </DX_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <TIME_TO_DX_NAME> some_weeks </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> some_weeks </TIME_TO_DX_NAME>
<GENERIC_NAME> insulin_glargine </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_glargine </GENERIC_NAME>
<GENERIC_NAME> riluzole </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> riluzole </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> riluzole </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nervous_system </SYSTEM_ORGAN_SITE> <GENERIC_NAME> riluzole </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> riluzole </GENERIC_NAME> <DX_NAME> amyotrophic_lateral_sclerosis </DX_NAME> <DX_NAME> motor_neurone_disease </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> weakness </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_waste </DX_NAME> <DX_NAME> paralysis </DX_NAME> <SYSTEM_ORGAN_SITE> nerve_cells </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <GENERIC_NAME> riluzole </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE>
<BRAND_NAME> jorveza </BRAND_NAME> <NAME> jorveza </NAME> <GENERIC_NAME> budesonide </GENERIC_NAME> <GENERIC_NAME> corticosteroid_medicine </GENERIC_NAME> <TREATMENT_NAME> corticosteroid_medicine </TREATMENT_NAME> <DX_NAME> inflammation </DX_NAME> <AGE> 18 </AGE> <DX_NAME> eosinophilic_oesophagitis </DX_NAME> <DX_NAME> inflammatory_condition </DX_NAME> <DX_NAME> swallowing_food </DX_NAME>
<SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <TREATMENT_NAME> immune_cells </TREATMENT_NAME> <TREATMENT_NAME> autologous_immune_cells </TREATMENT_NAME> <TREATMENT_NAME> immune_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> infusion </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> hormone_testosterone </TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<GENERIC_NAME> chenodeoxycholic_acid_leadiant </GENERIC_NAME> <GENERIC_NAME> chenodeoxycholic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> chenodeoxycholic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> affected_areas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> chenodeoxycholic_acid_leadiant </GENERIC_NAME> <GENERIC_NAME> ctx </GENERIC_NAME> <GENERIC_NAME> chenodeoxycholic_acid </GENERIC_NAME> <DX_NAME> fatty_deposits </DX_NAME> <GENERIC_NAME> chenodeoxycholic_acid_leadiant </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> age </TIME_TO_MEDICATION_NAME>
<GENERIC_NAME> febuxostat </GENERIC_NAME> <GENERIC_NAME> febuxostat </GENERIC_NAME> <DX_NAME> gout </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> redness </DX_NAME> <DX_NAME> warmth </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> gout_attack </DX_NAME> <DX_NAME> tophi </DX_NAME> <SYSTEM_ORGAN_SITE> tophi </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> tophi </DX_NAME> <SYSTEM_ORGAN_SITE> tophi </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> joint_and_bone_damage </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> febuxostat </GENERIC_NAME> <TEST_NAME> uric_acid_levels </TEST_NAME> <GENERIC_NAME> febuxostat </GENERIC_NAME> <TEST_NAME> uric_acid_levels </TEST_NAME> <DX_NAME> shrink_tophi </DX_NAME> <GENERIC_NAME> febuxostat_krka </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> blood_cancers </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> uric_acid_levels </TEST_NAME> <GENERIC_NAME> febuxostat </GENERIC_NAME>
<GENERIC_NAME> Capecitabine </GENERIC_NAME> <TREATMENT_NAME> cytostatic_medicines </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> Capecitabine </GENERIC_NAME> <BRAND_NAME> Teva </BRAND_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <TREATMENT_NAME> cytostatic_medicine </TREATMENT_NAME> <GENERIC_NAME> Capecitabine </GENERIC_NAME> <BRAND_NAME> Teva </BRAND_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> rectal </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancers </DX_NAME> <GENERIC_NAME> Capecitabine </GENERIC_NAME> <BRAND_NAME> Teva </BRAND_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <DX_NAME> colon_cancer </DX_NAME> <PROCEDURE_NAME> removal_of_the_tumour </PROCEDURE_NAME> <DX_NAME> tumour </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <GENERIC_NAME> Capecitabine </GENERIC_NAME> <BRAND_NAME> Teva </BRAND_NAME>
<NAME> juluca </NAME> <BRAND_NAME> juluca </BRAND_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> dolutegravir </GENERIC_NAME> <GENERIC_NAME> rilpivirine </GENERIC_NAME> <GENERIC_NAME> dolutegravir </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> integrase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> integrase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> rilpivirine </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> non_nucleoside_reverse_transcriptase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> nucleoside_reverse_transcriptase_inhibitors </GENERIC_NAME> <BRAND_NAME> juluca </BRAND_NAME> <DX_NAME> hiv </DX_NAME> <AGE> 18 </AGE> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <TIME_TO_DX_NAME> least_6_months </TIME_TO_DX_NAME> <BRAND_NAME> juluca </BRAND_NAME> <TIME_TO_TREATMENT_NAME> current </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <BRAND_NAME> juluca </BRAND_NAME> <DX_NAME> hiv_virus </DX_NAME> <TREATMENT_NAME> cd4_cells </TREATMENT_NAME> <TREATMENT_NAME> cd4_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME>
<GENERIC_NAME> olanzapine </GENERIC_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> manic_episodes </DX_NAME> <DX_NAME> excitement </DX_NAME> <DX_NAME> euphoria </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <DX_NAME> recurrence </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> manic_episode </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME>
<BRAND_NAME> stalevo </BRAND_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> carbidopa </GENERIC_NAME> <GENERIC_NAME> entacapone </GENERIC_NAME> <BRAND_NAME> stalevo </BRAND_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> dopamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> dopamine </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> carbidopa </GENERIC_NAME> <GENERIC_NAME> entacapone </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME>
<GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicine </TREATMENT_NAME> <GENERIC_NAME> antiepileptic_medicine </GENERIC_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> seizure </DX_NAME> <DX_NAME> generalisation </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> myoclonic_seizures </DX_NAME> <DX_NAME> shocklike_jerks </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <AGE> 12 </AGE> <DX_NAME> myoclonic_epilepsy </DX_NAME> <DX_NAME> tonicclonic_seizures </DX_NAME> <DX_NAME> loss_of_consciousness </DX_NAME> <AGE> 12 </AGE> <DX_NAME> generalised_epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME>
<SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessels_to_narrow </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> blood_pressure </DX_NAME> <TEST_NAME> tolura_blocks </TEST_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> hypertension </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> reduced_or_blocked_blood_supply </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> imprida </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessel_wall </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME>
<GENERIC_NAME> ferric_citrate </GENERIC_NAME> <DX_NAME> impaired_kidney_function </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_phosphorus_levels </TEST_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> itchy_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> red_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_fractures </DX_NAME> <SYSTEM_ORGAN_SITE> digestive_tract </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> faeces </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> pemetrexed </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <DX_NAME> malignant_pleural_mesothelioma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<BRAND_NAME> targretin </BRAND_NAME> <GENERIC_NAME> bexarotene </GENERIC_NAME> <GENERIC_NAME> retinoids </GENERIC_NAME> <GENERIC_NAME> vitamin </GENERIC_NAME> <GENERIC_NAME> targretin </GENERIC_NAME> <DX_NAME> cutaneous_tcell_lymphoma </DX_NAME> <DX_NAME> ctcl </DX_NAME> <DX_NAME> ctcl </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_system </SYSTEM_ORGAN_SITE> <DX_NAME> cancerous </DX_NAME> <DX_NAME> affect_the_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> tenofovir </GENERIC_NAME> <GENERIC_NAME> disoproxil_zentiva </GENERIC_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <GENERIC_NAME> disoproxil_zentiva </GENERIC_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <GENERIC_NAME> disoproxil_zentiva </GENERIC_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hbv_infection </DX_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <TREATMENT_NAME> nucleotide_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <GENERIC_NAME> disoproxil_zentiva </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <DX_NAME> tenofovir_disoproxil_zentiva </DX_NAME> <GENERIC_NAME> disoproxil_zentiva </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> hiv_medicines </TREATMENT_NAME> <DX_NAME> side_effects </DX_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <DX_NAME> tenofovir_disoproxil_zentiva </DX_NAME> <GENERIC_NAME> disoproxil_zentiva </GENERIC_NAME> <DX_NAME> hepatitis_b </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <GENERIC_NAME> disoproxil_zentiva </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> tenofovir </GENERIC_NAME> <GENERIC_NAME> disoproxil_zentiva </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME>
<BRAND_NAME> thymanax </BRAND_NAME> <GENERIC_NAME> agomelatine </GENERIC_NAME> <TREATMENT_NAME> antidepressants </TREATMENT_NAME> <BRAND_NAME> thymanax </BRAND_NAME> <DX_NAME> depression </DX_NAME> <BRAND_NAME> thymanax </BRAND_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> disturbance_of_mood </DX_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> deep_sadness </DX_NAME> <DX_NAME> feelings_of_worthlessness </DX_NAME> <DX_NAME> loss_of_interest_in_favourite_activities </DX_NAME> <DX_NAME> sleep_disturbances </DX_NAME> <DX_NAME> feeling_of_being_slowed_down </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> changes_in_weight </DX_NAME> <BRAND_NAME> thymanax </BRAND_NAME> <DX_NAME> depression </DX_NAME>
<BRAND_NAME> Extavia </BRAND_NAME> <BRAND_NAME> Extavia </BRAND_NAME> <BRAND_NAME> Extavia </BRAND_NAME> <GENERIC_NAME> interferon </GENERIC_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> attacks </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> viral_infections </DX_NAME> <BRAND_NAME> Extavia </BRAND_NAME> <DX_NAME> sclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> central_nervous_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> CNS </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> protective_sheath </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> CNS </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> demyelination </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> CNS </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> CNS </SYSTEM_ORGAN_SITE> <DX_NAME> attack </DX_NAME> <DX_NAME> relapse </DX_NAME> <DX_NAME> disability </DX_NAME> <DX_NAME> difficulty_walking </DX_NAME> <GENERIC_NAME> Interferon_beta-1b </GENERIC_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> disease_activity </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <BRAND_NAME> Extavia </BRAND_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> Relapsing-remitting_multiple_sclerosis </DX_NAME> <DX_NAME> relapsing-remitting </DX_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> relapses </DX_NAME> <BRAND_NAME> Extavia </BRAND_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> relapsing-remitting </DX_NAME> <DX_NAME> relapses </DX_NAME> <BRAND_NAME> Extavia </BRAND_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> disability </DX_NAME> <BRAND_NAME> Extavia </BRAND_NAME> <BRAND_NAME> Extavia </BRAND_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> relapsing-remitting_multiple_sclerosis </DX_NAME> <DX_NAME> relapses </DX_NAME> <TIME_TO_DX_NAME> last_two_years </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> last_two_years </TIME_TO_DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> active_disease </DX_NAME> <DX_NAME> relapses </DX_NAME>
<GENERIC_NAME> duloxetine </GENERIC_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <BRAND_NAME> mylan </BRAND_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <GENERIC_NAME> noradrenaline </GENERIC_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> feeling_of_anxiety </DX_NAME> <DX_NAME> nervousness </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> stabbing </DX_NAME> <DX_NAME> stinging </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> electric_shock </DX_NAME> <DX_NAME> loss_of_feeling </DX_NAME> <SYSTEM_ORGAN_SITE> affected_area </SYSTEM_ORGAN_SITE> <DX_NAME> cold </DX_NAME> <DX_NAME> pain </DX_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety </DX_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <DX_NAME> feeling_better </DX_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <TIME_TO_DX_NAME> some_weeks </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> some_weeks </TIME_TO_DX_NAME>
<BRAND_NAME> NEVANAC </BRAND_NAME> <GENERIC_NAME> nepafenac </GENERIC_NAME> <TREATMENT_NAME> nonsteroidal_anti-inflammatory_drugs </TREATMENT_NAME> <GENERIC_NAME> nonsteroidal_anti-inflammatory_drugs </GENERIC_NAME> <TREATMENT_NAME> NSAIDs </TREATMENT_NAME> <GENERIC_NAME> NSAIDs </GENERIC_NAME> <BRAND_NAME> NEVANAC </BRAND_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> eye_pain </DX_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> cataract </DX_NAME> <PROCEDURE_NAME> cataract_surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> macular_oedema </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> cataract </DX_NAME> <PROCEDURE_NAME> cataract_surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> diabetic </DX_NAME>
<GENERIC_NAME> tigecycline </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> antibiotic </GENERIC_NAME> <GENERIC_NAME> glycylcycline </GENERIC_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> tigecycline </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> soft_tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> diabetic_foot_infections </DX_NAME> <SYSTEM_ORGAN_SITE> foot </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> abdomen </SYSTEM_ORGAN_SITE> <GENERIC_NAME> tigecycline </GENERIC_NAME> <GENERIC_NAME> antibiotics </GENERIC_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME>
<BRAND_NAME> tasigna </BRAND_NAME> <BRAND_NAME> tasigna </BRAND_NAME> <GENERIC_NAME> nilotinib </GENERIC_NAME> <BRAND_NAME> tasigna </BRAND_NAME> <BRAND_NAME> tasigna </BRAND_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> phpositive_cml </DX_NAME> <DX_NAME> cml </DX_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> tasigna </BRAND_NAME> <DX_NAME> cml </DX_NAME> <DX_NAME> cml </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> side_effects </DX_NAME> <BRAND_NAME> tasigna </BRAND_NAME> <DX_NAME> cml </DX_NAME> <DX_NAME> abnormal_white_blood_cells </DX_NAME> <BRAND_NAME> tasigna </BRAND_NAME> <BRAND_NAME> tasigna </BRAND_NAME> <TEST_NAME> blood_tests </TEST_NAME> <TEST_NAME> tests </TEST_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <BRAND_NAME> tasigna </BRAND_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <BRAND_NAME> tasigna </BRAND_NAME> <TEST_NAME> electrolytes </TEST_NAME> <GENERIC_NAME> potassium </GENERIC_NAME> <TEST_NAME> potassium </TEST_NAME> <GENERIC_NAME> magnesium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TEST_NAME> heart_rate </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <BRAND_NAME> tasigna </BRAND_NAME> <DX_NAME> cml </DX_NAME> <BRAND_NAME> tasigna </BRAND_NAME> <BRAND_NAME> tasigna </BRAND_NAME>
<BRAND_NAME> olazax </BRAND_NAME> <GENERIC_NAME> disperzi </GENERIC_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <BRAND_NAME> olazax </BRAND_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> manic_episodes </DX_NAME> <DX_NAME> excitement </DX_NAME> <DX_NAME> euphoria </DX_NAME> <DX_NAME> recurrence </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> manic_episode </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME>
<GENERIC_NAME> solriamfetol </GENERIC_NAME> <GENERIC_NAME> Solriamfetol </GENERIC_NAME> <GENERIC_NAME> natural_substances_dopamine </GENERIC_NAME> <GENERIC_NAME> norepinephrine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <BRAND_NAME> Sunosi </BRAND_NAME> <DX_NAME> sleepy </DX_NAME> <DX_NAME> narcolepsy </DX_NAME> <DX_NAME> sleepy </DX_NAME> <DX_NAME> narcolepsy </DX_NAME> <DX_NAME> cataplexy </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> weak_in_response_to_emotions </DX_NAME> <DX_NAME> anger </DX_NAME> <DX_NAME> fear </DX_NAME> <DX_NAME> laughter </DX_NAME> <DX_NAME> collapse </DX_NAME> <DX_NAME> improve_wakefulness </DX_NAME> <DX_NAME> excessive_daytime_sleepiness </DX_NAME> <DX_NAME> EDS </DX_NAME> <DX_NAME> obstructive_sleep_apnoea </DX_NAME> <DX_NAME> OSA </DX_NAME> <DX_NAME> EDS </DX_NAME> <DX_NAME> OSA </DX_NAME> <TREATMENT_NAME> OSA_therapy </TREATMENT_NAME>
<GENERIC_NAME> rilpivirine </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> hiv_medicines </TREATMENT_NAME> <GENERIC_NAME> nonnucleoside_reverse_transcriptase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> nonnucleoside_reverse_transcriptase_inhibitors </TREATMENT_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> hiv_medicines </TREATMENT_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> hiv_medicines </TREATMENT_NAME>
<BRAND_NAME> jetrea </BRAND_NAME> <GENERIC_NAME> ocriplasmin </GENERIC_NAME> <BRAND_NAME> jetrea </BRAND_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> eye_disease </DX_NAME> <DX_NAME> vitreomacular_traction </DX_NAME> <DX_NAME> hole </DX_NAME> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> vitreous_humour </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <DX_NAME> distorted </DX_NAME> <DX_NAME> decreased_vision </DX_NAME> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <DX_NAME> macular_hole </DX_NAME> <DX_NAME> vitreous_humour </DX_NAME> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <DX_NAME> macular_hole </DX_NAME> <DX_NAME> vmt </DX_NAME>
<BRAND_NAME> tamiflu </BRAND_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> flu_symptoms </DX_NAME> <DX_NAME> flu_virus </DX_NAME> <TREATMENT_NAME> flu_virus </TREATMENT_NAME> <BRAND_NAME> tamiflu </BRAND_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> flu </DX_NAME> <BRAND_NAME> tamiflu </BRAND_NAME> <TREATMENT_NAME> preventive_treatment </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> flu_pandemic </TREATMENT_NAME> <GENERIC_NAME> flu_pandemic </GENERIC_NAME> <TREATMENT_NAME> seasonal_flu_vaccine </TREATMENT_NAME> <GENERIC_NAME> flu_vaccine </GENERIC_NAME> <BRAND_NAME> tamiflu </BRAND_NAME> <GENERIC_NAME> oseltamivir </GENERIC_NAME> <TREATMENT_NAME> neuraminidase_inhibitors </TREATMENT_NAME> <DX_NAME> flu_virus </DX_NAME> <TREATMENT_NAME> flu_virus </TREATMENT_NAME> <DX_NAME> flu_virus_infection </DX_NAME> <TREATMENT_NAME> flu_virus_infection </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> cough </DX_NAME> <DX_NAME> runny </DX_NAME> <DX_NAME> stuffy_nose </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <DX_NAME> headaches </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_aches </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> influenza_infection </DX_NAME> <DX_NAME> flu_viruses </DX_NAME> <DX_NAME> epidemic_periods </DX_NAME> <DX_NAME> flulike_symptoms </DX_NAME>
<TREATMENT_NAME> gene_therapy </TREATMENT_NAME> <TEST_NAME> lipoprotein_lipase </TEST_NAME> <DX_NAME> lipoprotein_lipase_deficiency </DX_NAME> <DX_NAME> genetic_defect </DX_NAME> <DX_NAME> hyperchylomicronemia </DX_NAME> <DX_NAME> lipoprotein_lipase_deficiency </DX_NAME> <DX_NAME> pancreatitis_attacks </DX_NAME> <TEST_NAME> genetic_testing </TEST_NAME> <TEST_NAME> lpl_protein </TEST_NAME>
<BRAND_NAME> zostavax </BRAND_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> zoster </DX_NAME> <DX_NAME> postherpetic_neuralgia </DX_NAME> <DX_NAME> phn </DX_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> nerve_pain </DX_NAME> <DX_NAME> shingles </DX_NAME> <BRAND_NAME> zostavax </BRAND_NAME> <AGE> 50 </AGE> <BRAND_NAME> zostavax </BRAND_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> painful </DX_NAME> <DX_NAME> blistering_rash </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> longlasting_pain </DX_NAME> <DX_NAME> scarring </DX_NAME> <DX_NAME> bacterial_skin_infections </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> weakness </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_paralysis </DX_NAME> <DX_NAME> loss_of_hearing </DX_NAME> <DX_NAME> vision_can_occur </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> chickenpox </DX_NAME> <DX_NAME> chickenpox </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> shingles </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> blisters </DX_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> nerve_pain </DX_NAME> <DX_NAME> postherpetic_neuralgia </DX_NAME> <DX_NAME> phn </DX_NAME>
<DX_NAME> lyxumia </DX_NAME> <GENERIC_NAME> lixisenatide </GENERIC_NAME> <GENERIC_NAME> medicine </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> lyxumia </DX_NAME> <DX_NAME> diabetes </DX_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TREATMENT_NAME> oral_antidiabetics </TREATMENT_NAME> <GENERIC_NAME> antidiabetics </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <GENERIC_NAME> sulphonylurea_medicines </GENERIC_NAME> <GENERIC_NAME> basal_insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME>
<BRAND_NAME> xydalba </BRAND_NAME> <GENERIC_NAME> dalbavancin </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> glycopeptide </GENERIC_NAME> <BRAND_NAME> xydalba </BRAND_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> bacterial_cell_walls </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME> <BRAND_NAME> xydalba </BRAND_NAME>
<DX_NAME> cancer </DX_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <DX_NAME> cancers </DX_NAME> <GENERIC_NAME> carboplatin </GENERIC_NAME> <DX_NAME> epithelial_ovarian_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> ovary </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> organ </SYSTEM_ORGAN_SITE> <DX_NAME> peritoneal_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> wall_of_the_belly </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> internal_organs </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> fallopian_tubes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> atazanavir </GENERIC_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <GENERIC_NAME> atazanavir </GENERIC_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> immunodeficiency_syndrome </DX_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME>
<GENERIC_NAME> radium_Ra_223_dichloride </GENERIC_NAME> <GENERIC_NAME> radium-223_dichloride </GENERIC_NAME> <BRAND_NAME> Xofigo </BRAND_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> male_hormone </TREATMENT_NAME> <TREATMENT_NAME> hormone_therapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> cancer_treatment </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gland </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> reproductive_system </SYSTEM_ORGAN_SITE> <BRAND_NAME> Xofigo </BRAND_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <BRAND_NAME> Xofigo </BRAND_NAME> <GENERIC_NAME> radium-223 </GENERIC_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <GENERIC_NAME> radium-223 </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME> <GENERIC_NAME> alpha_particles </GENERIC_NAME>
<GENERIC_NAME> spiromax </GENERIC_NAME> <GENERIC_NAME> salmeterol </GENERIC_NAME> <GENERIC_NAME> fluticasone_propionate </GENERIC_NAME> <GENERIC_NAME> salmeterol </GENERIC_NAME> <GENERIC_NAME> longacting_bronchodilator </GENERIC_NAME> <TREATMENT_NAME> bronchodilators </TREATMENT_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <GENERIC_NAME> fluticasone_propionate </GENERIC_NAME> <GENERIC_NAME> corticosteroid </GENERIC_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> asthma </DX_NAME> <DX_NAME> attacks_of_breathlessness </DX_NAME> <DX_NAME> wheeziness </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <GENERIC_NAME> aerivio_spiromax </GENERIC_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> copd </DX_NAME> <GENERIC_NAME> spiromax </GENERIC_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> wheeziness </DX_NAME> <BRAND_NAME> spiromax </BRAND_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME> <DX_NAME> fastacting </DX_NAME> <BRAND_NAME> spiromax </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <AGE> 18 </AGE> <DX_NAME> copd </DX_NAME>
<GENERIC_NAME> Temozolomide </GENERIC_NAME> <BRAND_NAME> Sandoz </BRAND_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME> <GENERIC_NAME> Temozolomide </GENERIC_NAME> <NAME> Sandoz </NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> glioblastoma_multiforme </DX_NAME> <GENERIC_NAME> Temozolomide </GENERIC_NAME> <NAME> Sandoz </NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <DX_NAME> malignant_glioma </DX_NAME> <DX_NAME> glioblastoma_multiforme </DX_NAME> <DX_NAME> anaplastic_astrocytoma </DX_NAME> <GENERIC_NAME> Temozolomide </GENERIC_NAME>
<BRAND_NAME> onglyza </BRAND_NAME> <GENERIC_NAME> saxagliptin </GENERIC_NAME> <BRAND_NAME> onglyza </BRAND_NAME> <AGE> 18 </AGE> <TREATMENT_NAME> oral_antidiabetic_medicine </TREATMENT_NAME> <BRAND_NAME> onglyza </BRAND_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TREATMENT_NAME> antidiabetic_medicines </TREATMENT_NAME>
<GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> epoetin_alfa </GENERIC_NAME> <GENERIC_NAME> eerithroepoehtin </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <GENERIC_NAME> erythropoietin </GENERIC_NAME> <DX_NAME> red_cell_production </DX_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> solid_tumours </DX_NAME> <DX_NAME> malignant_lymphoma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> bone_marrow_cancer </DX_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> knee_replacement_operations </PROCEDURE_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> bone_marrow_disorder </DX_NAME> <DX_NAME> disruption </DX_NAME> <DX_NAME> myelodysplastic_syndromes </DX_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME>
<NAME> zoely </NAME> <TREATMENT_NAME> contraceptive_pill </TREATMENT_NAME> <DX_NAME> pregnancy </DX_NAME> <GENERIC_NAME> nomegestrol_acetate </GENERIC_NAME> <GENERIC_NAME> progestogen </GENERIC_NAME> <GENERIC_NAME> estradiol </GENERIC_NAME> <GENERIC_NAME> oestrogen </GENERIC_NAME> <GENERIC_NAME> placebo </GENERIC_NAME> <TREATMENT_NAME> contraceptive_pills </TREATMENT_NAME> <GENERIC_NAME> contraceptive_pills </GENERIC_NAME> <GENERIC_NAME> estradiol </GENERIC_NAME> <GENERIC_NAME> oestrogen </GENERIC_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <GENERIC_NAME> nomegestrol_acetate </GENERIC_NAME> <GENERIC_NAME> progestogen </GENERIC_NAME> <TREATMENT_NAME> hormone_progesterone </TREATMENT_NAME> <GENERIC_NAME> progesterone </GENERIC_NAME> <GENERIC_NAME> progesterone </GENERIC_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <DX_NAME> menstrual_cycle </DX_NAME>
<GENERIC_NAME> deferasirox </GENERIC_NAME> <GENERIC_NAME> deferasirox </GENERIC_NAME> <GENERIC_NAME> deferasirox </GENERIC_NAME> <GENERIC_NAME> iron_chelator </GENERIC_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <DX_NAME> iron_overload </DX_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <GENERIC_NAME> deferasirox </GENERIC_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> thalassaemia </DX_NAME> <DX_NAME> sickle_cell_disease </DX_NAME> <DX_NAME> myelodysplastic_syndromes </DX_NAME> <DX_NAME> mds </DX_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <DX_NAME> thalassaemia_syndromes </DX_NAME> <DX_NAME> iron_overload </DX_NAME> <GENERIC_NAME> dietary_iron </GENERIC_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <GENERIC_NAME> iron_chelators </GENERIC_NAME> <DX_NAME> organ_damage </DX_NAME> <GENERIC_NAME> deferasirox </GENERIC_NAME> <DX_NAME> iron_overload </DX_NAME> <TREATMENT_NAME> frequent_blood_transfusions </TREATMENT_NAME> <DX_NAME> thalassaemia </DX_NAME> <GENERIC_NAME> deferasirox </GENERIC_NAME> <DX_NAME> iron_overload </DX_NAME> <GENERIC_NAME> deferoxamine </GENERIC_NAME> <TREATMENT_NAME> deferoxamine_therapy </TREATMENT_NAME> <DX_NAME> iron_overload </DX_NAME> <TREATMENT_NAME> infrequent_blood_transfusions </TREATMENT_NAME> <DX_NAME> anaemias </DX_NAME> <GENERIC_NAME> deferasirox </GENERIC_NAME> <GENERIC_NAME> deferoxamine </GENERIC_NAME> <TREATMENT_NAME> deferoxamine_therapy </TREATMENT_NAME> <AGE> 10 </AGE> <DX_NAME> iron_overload </DX_NAME> <DX_NAME> thalassaemia_syndromes </DX_NAME> <TREATMENT_NAME> transfusion </TREATMENT_NAME> <DX_NAME> transfusion_dependent </DX_NAME>
<DX_NAME> leukaemia </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> cml </DX_NAME> <DX_NAME> blood_cancer </DX_NAME> <DX_NAME> abnormal_white_blood_cells </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_cells </TEST_NAME> <TEST_NAME> philadelphiachromosome </TEST_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <TEST_NAME> blood_forming_bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> abnormal_chromosome </DX_NAME> <DX_NAME> cml </DX_NAME> <DX_NAME> abnormal_white_blood_cells </DX_NAME>
<GENERIC_NAME> entacapone </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson's_disease </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME>
<GENERIC_NAME> baricitinib </GENERIC_NAME> <GENERIC_NAME> kinase_inhibitors </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <GENERIC_NAME> methotrexate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> stiffness </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> tiredness </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME>
<GENERIC_NAME> glidipion </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <TREATMENT_NAME> antidiabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> antidiabetic_medicine </GENERIC_NAME> <DX_NAME> type_2 </DX_NAME> <GENERIC_NAME> noninsulin </GENERIC_NAME> <DX_NAME> noninsulin_dependent </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glidipion </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME>
<GENERIC_NAME> methylnaltrexone_bromide </GENERIC_NAME> <GENERIC_NAME> opioid </GENERIC_NAME> <TREATMENT_NAME> opioid_pain_medicines </TREATMENT_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> constipation </DX_NAME> <DX_NAME> pain </DX_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <GENERIC_NAME> morphine </GENERIC_NAME> <GENERIC_NAME> codeine </GENERIC_NAME> <DX_NAME> constipation </DX_NAME> <TREATMENT_NAME> laxatives </TREATMENT_NAME> <GENERIC_NAME> laxatives </GENERIC_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <GENERIC_NAME> opioids </GENERIC_NAME> <TREATMENT_NAME> usual_laxatives </TREATMENT_NAME> <GENERIC_NAME> laxatives </GENERIC_NAME>
<BRAND_NAME> sugammadex </BRAND_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> rocuronium_bromide </TREATMENT_NAME> <GENERIC_NAME> rocuronium_bromide </GENERIC_NAME> <GENERIC_NAME> vecuronium_bromide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <PROCEDURE_NAME> general_anaesthetic </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> muscle_relaxants </TREATMENT_NAME> <GENERIC_NAME> rocuronium_bromide </GENERIC_NAME> <TREATMENT_NAME> rocuronium_bromide </TREATMENT_NAME> <TREATMENT_NAME> vecuronium_bromide </TREATMENT_NAME> <GENERIC_NAME> vecuronium_bromide </GENERIC_NAME> <TREATMENT_NAME> breathing_muscles_relax </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> artificial_ventilation </TREATMENT_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <TREATMENT_NAME> bridion </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <TREATMENT_NAME> rocuronium_bromide </TREATMENT_NAME> <GENERIC_NAME> rocuronium_bromide </GENERIC_NAME> <GENERIC_NAME> vecuronium_bromide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> rocuronium_bromide </GENERIC_NAME> <GENERIC_NAME> vecuronium_bromide </GENERIC_NAME> <TREATMENT_NAME> rocuronium_bromide </TREATMENT_NAME> <GENERIC_NAME> rocuronium_bromide </GENERIC_NAME> <TREATMENT_NAME> relaxation </TREATMENT_NAME>
<BRAND_NAME> entyvio </BRAND_NAME> <BRAND_NAME> entyvio </BRAND_NAME> <GENERIC_NAME> ‘vedolizumab’ </GENERIC_NAME> <GENERIC_NAME> vedolizumab </GENERIC_NAME> <BRAND_NAME> entyvio </BRAND_NAME> <BRAND_NAME> entyvio </BRAND_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> inflammation </DX_NAME> <BRAND_NAME> entyvio </BRAND_NAME> <BRAND_NAME> entyvio </BRAND_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> large_bowel </SYSTEM_ORGAN_SITE> <DX_NAME> ulcerative_colitis </DX_NAME> <BRAND_NAME> entyvio </BRAND_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> digestive_system </SYSTEM_ORGAN_SITE> <DX_NAME> crohn’s_disease </DX_NAME> <BRAND_NAME> entyvio </BRAND_NAME>
<TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> influenza_(flu </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> pandemic_flu </DX_NAME> <TREATMENT_NAME> pandemic_flu </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> pandemic_flu </DX_NAME> <TREATMENT_NAME> pandemic_flu </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> vaccines </TREATMENT_NAME>
<BRAND_NAME> humalog </BRAND_NAME> <DX_NAME> diabetes </DX_NAME> <BRAND_NAME> humalog </BRAND_NAME> <GENERIC_NAME> normal_human_insulin </GENERIC_NAME> <GENERIC_NAME> insulin_molecule </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <BRAND_NAME> humalog </BRAND_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <BRAND_NAME> humalog </BRAND_NAME> <BRAND_NAME> humalog </BRAND_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <BRAND_NAME> humalog </BRAND_NAME>
<BRAND_NAME> vidaza </BRAND_NAME> <BRAND_NAME> vidaza </BRAND_NAME> <BRAND_NAME> vidaza </BRAND_NAME> <GENERIC_NAME> ‘azacitidine’ </GENERIC_NAME> <BRAND_NAME> vidaza </BRAND_NAME> <BRAND_NAME> vidaza </BRAND_NAME> <PROCEDURE_NAME> stem_cell_transplantation </PROCEDURE_NAME> <DX_NAME> higherrisk_myelodysplastic_syndromes </DX_NAME> <DX_NAME> mds </DX_NAME> <DX_NAME> myelomonocytic_leukaemia </DX_NAME> <DX_NAME> cmml </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> aml </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <BRAND_NAME> vidaza </BRAND_NAME> <BRAND_NAME> vidaza </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <TEST_NAME> ribonucleic_acid </TEST_NAME> <TEST_NAME> rna) </TEST_NAME> <TEST_NAME> deoxyribonucleic_acid </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> myelodysplastic_disorders </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <BRAND_NAME> vidaza </BRAND_NAME>
<GENERIC_NAME> synflorix </GENERIC_NAME> <TREATMENT_NAME> pneumococcal_conjugate_vaccine </TREATMENT_NAME> <GENERIC_NAME> pneumococcal_conjugate_vaccine </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> pneumoniae’ </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> meningitis </DX_NAME> <DX_NAME> sepsis </DX_NAME> <DX_NAME> bacteraemia </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> blood_stream </DX_NAME> <SYSTEM_ORGAN_SITE> ear </SYSTEM_ORGAN_SITE> <DX_NAME> ear_infection </DX_NAME> <DX_NAME> pneumonia </DX_NAME> <GENERIC_NAME> synflorix </GENERIC_NAME> <GENERIC_NAME> synflorix </GENERIC_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> dinutuximab_beta </GENERIC_NAME> <GENERIC_NAME> dinutuximab_beta_binds </GENERIC_NAME> <GENERIC_NAME> disialoganglioside </GENERIC_NAME> <NAME> qarziba </NAME> <DX_NAME> neuroblastoma </DX_NAME> <PROCEDURE_NAME> stem_cell_transplantation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> neuroblastoma </DX_NAME> <TIME_TO_DX_NAME> prior </TIME_TO_DX_NAME> <DX_NAME> neuroblastoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> neuroblastoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> nerve_cells </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> cancers </DX_NAME> <URL> http://en.wikipedia.org/wiki/cancer_http://en.wikipedia.org/wiki/cancer_26 </URL>
<GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <TREATMENT_NAME> thiazide_diuretics </TREATMENT_NAME> <TEST_NAME> urine_output </TEST_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME>
<SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <GENERIC_NAME> ranibizumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> eye_diseases </DX_NAME> <DX_NAME> vision_impairment </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> abnormal_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> macular_degeneration </DX_NAME> <DX_NAME> proliferative_diabetic_retinopathy </DX_NAME> <DX_NAME> pdr </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> choroidal_neovascularisation </DX_NAME> <DX_NAME> pathologic_myopia </DX_NAME> <DX_NAME> angioid_streaks </DX_NAME> <DX_NAME> central_serous_chorioretinopathy </DX_NAME> <DX_NAME> inflammatory_cnv </DX_NAME> <DX_NAME> macular_oedema </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> centre_of_the_retina </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetic_macular_oedema </DX_NAME> <DX_NAME> blockage_of_retinal_veins </DX_NAME> <SYSTEM_ORGAN_SITE> retinal_veins </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> retinal_vein </SYSTEM_ORGAN_SITE> <DX_NAME> retinal_vein_occlusion </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> abnormal_blood_vessel_growth </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> impairment_of_vision </DX_NAME> <DX_NAME> abnormal_growth </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> lucentis </DX_NAME> <DX_NAME> improve_your_vision </DX_NAME>
<NAME> sialanar </NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> ammonium_anticholinergics </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> excessive_production_of_saliva </DX_NAME> <DX_NAME> sialorrhoea </DX_NAME> <DX_NAME> sialorrhoea </DX_NAME> <DX_NAME> drooling </DX_NAME> <DX_NAME> excessive_salivation </DX_NAME> <DX_NAME> diseases </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> poor_control_of_muscles </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE> <DX_NAME> sialorrhoea </DX_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> dental_infections </DX_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> salivary_glands </SYSTEM_ORGAN_SITE> <DX_NAME> production_of_saliva </DX_NAME>
<BRAND_NAME> torisel </BRAND_NAME> <GENERIC_NAME> temsirolimus </GENERIC_NAME> <GENERIC_NAME> temsirolimus </GENERIC_NAME> <TREATMENT_NAME> selective_inhibitor </TREATMENT_NAME> <BRAND_NAME> rapamycin </BRAND_NAME> <BRAND_NAME> torisel </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> renal_cancer </DX_NAME> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <DX_NAME> mantle_cell_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> ziextenzo </GENERIC_NAME> <GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <GENERIC_NAME> ziextenzo </GENERIC_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> febrile_neutropenia </DX_NAME> <DX_NAME> low_white_blood_cell_count </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> fever </DX_NAME> <TREATMENT_NAME> cytotoxic_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> ziextenzo </GENERIC_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME>
<BRAND_NAME> velcade </BRAND_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <BRAND_NAME> velcade </BRAND_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <AGE> 18 </AGE> <GENERIC_NAME> pegylated_liposomal_doxorubicin </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <GENERIC_NAME> melphalan </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <TIME_TO_TREATMENT_NAME> previously </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> thalidomide </GENERIC_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <TREATMENT_NAME> induction_treatment </TREATMENT_NAME> <BRAND_NAME> velcade </BRAND_NAME> <DX_NAME> mantle_cell_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <GENERIC_NAME> rituximab </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME>
<GENERIC_NAME> proteolytic_enzymes_enriched </GENERIC_NAME> <DX_NAME> wounds </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgical_removal </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> skin_transplantation </PROCEDURE_NAME>
<GENERIC_NAME> bazedoxifene </GENERIC_NAME> <TREATMENT_NAME> nonhormonal_medicines </TREATMENT_NAME> <TREATMENT_NAME> selective_estrogen_receptor_modulators </TREATMENT_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME>
<GENERIC_NAME> olanzapine </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> manic_episodes </DX_NAME> <DX_NAME> excitement </DX_NAME> <DX_NAME> euphoria </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <DX_NAME> recurrence </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> manic_episode </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME>
<GENERIC_NAME> rilutek </GENERIC_NAME> <GENERIC_NAME> riluzole </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nervous_system </SYSTEM_ORGAN_SITE> <DX_NAME> amyotrophic_lateral_sclerosis </DX_NAME> <DX_NAME> motor_neurone_disease </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> weakness </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_waste </DX_NAME> <DX_NAME> paralysis </DX_NAME> <SYSTEM_ORGAN_SITE> nerve_cells </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> baraclude </GENERIC_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <DX_NAME> hbv_infection </DX_NAME> <TIME_TO_DX_NAME> less_than_18_years </TIME_TO_DX_NAME> <AGE> 18 </AGE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> virus_in_your_body </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE>
<BRAND_NAME> zebinix </BRAND_NAME> <GENERIC_NAME> eslicarbazepine_acetate </GENERIC_NAME> <BRAND_NAME> zebinix </BRAND_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <BRAND_NAME> zebinix </BRAND_NAME> <DX_NAME> epilepsy </DX_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME> <TREATMENT_NAME> adjunctive_therapy </TREATMENT_NAME> <DX_NAME> seizures </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> partial_seizure </DX_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> seizure </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> generalisation </DX_NAME> <BRAND_NAME> zebinix </BRAND_NAME> <DX_NAME> seizures </DX_NAME>
<GENERIC_NAME> dasabuvir </GENERIC_NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> infectious_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_c_virus </DX_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <GENERIC_NAME> ombitasvir </GENERIC_NAME> <GENERIC_NAME> paritaprevir </GENERIC_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <TREATMENT_NAME> antiviral_medicines </TREATMENT_NAME>
<BRAND_NAME> viekirax </BRAND_NAME> <GENERIC_NAME> ombitasvir </GENERIC_NAME> <GENERIC_NAME> paritaprevir </GENERIC_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> infectious_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_c_virus </DX_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <GENERIC_NAME> ombitasvir </GENERIC_NAME> <GENERIC_NAME> paritaprevir </GENERIC_NAME> <TREATMENT_NAME> paritaprevir_block </TREATMENT_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <GENERIC_NAME> paritaprevir </GENERIC_NAME> <BRAND_NAME> viekirax </BRAND_NAME> <TREATMENT_NAME> antiviral_medicines </TREATMENT_NAME> <GENERIC_NAME> dasabuvir </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <BRAND_NAME> viekirax </BRAND_NAME> <TREATMENT_NAME> antiviral_medicines </TREATMENT_NAME> <BRAND_NAME> viekirax </BRAND_NAME>
<BRAND_NAME> vimizim </BRAND_NAME> <GENERIC_NAME> elosulfase_alfa </GENERIC_NAME> <TREATMENT_NAME> enzyme_replacement_therapies </TREATMENT_NAME> <DX_NAME> mucopolysaccharidosis_type_iva </DX_NAME> <DX_NAME> iva_disease </DX_NAME> <DX_NAME> morquio_a_syndrome </DX_NAME> <DX_NAME> iva_disease </DX_NAME> <GENERIC_NAME> nacetylgalactosamine6_sulfatase </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> keratan_sulphate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <DX_NAME> difficulty_walking </DX_NAME> <DX_NAME> trouble_breathing </DX_NAME> <DX_NAME> short_height </DX_NAME> <DX_NAME> hearing_loss </DX_NAME> <TREATMENT_NAME> natural_enzyme_nacetylgalactosamine6sulfatase </TREATMENT_NAME> <GENERIC_NAME> keratan_sulphate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<BRAND_NAME> Zelboraf </BRAND_NAME> <GENERIC_NAME> vemurafenib </GENERIC_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> melanoma </DX_NAME> <DX_NAME> cancer </DX_NAME>
<DX_NAME> swelling_attacks </DX_NAME> <DX_NAME> angioedema </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> stomach_pains </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> hands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> feet </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyelids </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lips </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tongue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> larynx </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> dental_procedures </TREATMENT_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> attacks </DX_NAME>
<BRAND_NAME> zalviso </BRAND_NAME> <GENERIC_NAME> sufentanil </GENERIC_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <DX_NAME> pain </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME>
<BRAND_NAME> xgeva </BRAND_NAME> <GENERIC_NAME> denosumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_metastasis </DX_NAME> <DX_NAME> giant_cell_tumour </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <BRAND_NAME> xgeva </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_metastasis </DX_NAME> <DX_NAME> fracture </DX_NAME> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> radiation_therapy </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <BRAND_NAME> xgeva </BRAND_NAME> <DX_NAME> giant_cell_tumour </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE>
<TREATMENT_NAME> protein_kinase_inihibitors </TREATMENT_NAME> <GENERIC_NAME> gilteritinib </GENERIC_NAME> <GENERIC_NAME> xospata </GENERIC_NAME> <GENERIC_NAME> xospata </GENERIC_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> aml </DX_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <GENERIC_NAME> xospata </GENERIC_NAME> <DX_NAME> aml </DX_NAME> <GENERIC_NAME> xospata </GENERIC_NAME> <DX_NAME> abnormal_white_blood_cells </DX_NAME> <GENERIC_NAME> gilteritinib </GENERIC_NAME> <TEST_NAME> gilteritinib_blocks </TEST_NAME> <DX_NAME> abnormal_cells </DX_NAME> <DX_NAME> cancer </DX_NAME>
<BRAND_NAME> exjade </BRAND_NAME> <BRAND_NAME> exjade </BRAND_NAME> <GENERIC_NAME> deferasirox </GENERIC_NAME> <GENERIC_NAME> iron_chelator </GENERIC_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <DX_NAME> iron_overload </DX_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <BRAND_NAME> exjade </BRAND_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> thalassaemia </DX_NAME> <DX_NAME> sickle_cell_disease </DX_NAME> <DX_NAME> myelodysplastic_syndromes </DX_NAME> <DX_NAME> mds </DX_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <DX_NAME> thalassaemia_syndromes </DX_NAME> <DX_NAME> iron_overload </DX_NAME> <GENERIC_NAME> dietary_iron </GENERIC_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <GENERIC_NAME> iron_chelators </GENERIC_NAME> <DX_NAME> organ_damage </DX_NAME> <BRAND_NAME> exjade </BRAND_NAME> <DX_NAME> iron_overload </DX_NAME> <TREATMENT_NAME> frequent_blood_transfusions </TREATMENT_NAME> <DX_NAME> thalassaemia </DX_NAME> <BRAND_NAME> exjade </BRAND_NAME> <DX_NAME> iron_overload </DX_NAME> <GENERIC_NAME> deferoxamine </GENERIC_NAME> <TREATMENT_NAME> deferoxamine_therapy </TREATMENT_NAME> <TREATMENT_NAME> beta_thalassaemia_major </TREATMENT_NAME> <DX_NAME> iron_overload </DX_NAME> <TREATMENT_NAME> infrequent_blood_transfusions </TREATMENT_NAME> <DX_NAME> anaemias </DX_NAME> <BRAND_NAME> exjade </BRAND_NAME> <GENERIC_NAME> deferoxamine </GENERIC_NAME> <TREATMENT_NAME> deferoxamine_therapy </TREATMENT_NAME> <AGE> 10 </AGE> <DX_NAME> iron_overload </DX_NAME> <DX_NAME> thalassaemia_syndromes </DX_NAME> <TREATMENT_NAME> transfusion </TREATMENT_NAME> <DX_NAME> transfusion_dependent </DX_NAME>
<GENERIC_NAME> conjugated_oestrogens </GENERIC_NAME> <GENERIC_NAME> bazedoxifene </GENERIC_NAME> <GENERIC_NAME> conjugated_oestrogens </GENERIC_NAME> <TREATMENT_NAME> hormone_replacement_therapy </TREATMENT_NAME> <TREATMENT_NAME> hrt </TREATMENT_NAME> <GENERIC_NAME> bazedoxifene </GENERIC_NAME> <TREATMENT_NAME> nonhormonal_medicines </TREATMENT_NAME> <TREATMENT_NAME> selective_estrogen_receptor_modulators </TREATMENT_NAME> <DX_NAME> postmenopausal </DX_NAME> <SYSTEM_ORGAN_SITE> uterus </SYSTEM_ORGAN_SITE> <DX_NAME> natural_period </DX_NAME> <TIME_TO_DX_NAME> last_12_months </TIME_TO_DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> menopause </DX_NAME> <TREATMENT_NAME> woman’s_body_drops </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME>
<GENERIC_NAME> mirabegron </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <GENERIC_NAME> bladder_muscle_relaxant </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> beta_3adrenoceptor_agonist </TREATMENT_NAME> <GENERIC_NAME> beta_3adrenoceptor_agonist </GENERIC_NAME> <DX_NAME> overactive_bladder </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> betmiga </DX_NAME> <BRAND_NAME> betmiga </BRAND_NAME> <DX_NAME> overactive_bladder </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> urgency </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> urinary_frequency </DX_NAME> <DX_NAME> able_to_control </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> urgency_incontinence </DX_NAME>
<BRAND_NAME> emend </BRAND_NAME> <GENERIC_NAME> aprepitant </GENERIC_NAME> <TREATMENT_NAME> antiemetics </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> nausea </DX_NAME> <DX_NAME> vomiting </DX_NAME> <BRAND_NAME> emend </BRAND_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> vomiting </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME>
<GENERIC_NAME> antibiotic </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <DX_NAME> tuberculosis </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME> <GENERIC_NAME> antibiotics </GENERIC_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME> <DX_NAME> tuberculosis </DX_NAME>
<GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> ‘lenalidomide’ </GENERIC_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> follicular_lymphoma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> myeloma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplant </PROCEDURE_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <TREATMENT_NAME> maintenance_therapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplant </PROCEDURE_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplant </PROCEDURE_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> ‘bortezomib’ </GENERIC_NAME> <GENERIC_NAME> antiinflammatory_medicine </GENERIC_NAME> <GENERIC_NAME> ‘dexamethasone’ </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> chemotherapy_medicine </GENERIC_NAME> <GENERIC_NAME> ‘melphalan’ </GENERIC_NAME> <TREATMENT_NAME> immunosuppressant </TREATMENT_NAME> <GENERIC_NAME> immunosuppressant_medicine </GENERIC_NAME> <GENERIC_NAME> ‘prednisone’ </GENERIC_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <AGE> 75 </AGE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_problems </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> ‘dexamethasone’ </GENERIC_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> follicular_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> ‘rituximab’ </GENERIC_NAME> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <DX_NAME> follicular_lymphoma </DX_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME>
<NAME> caprelsa </NAME> <AGE> 5 </AGE> <DX_NAME> medullary_thyroid_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> thyroid </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> cancers </DX_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME>
<GENERIC_NAME> pioglitazone </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <TREATMENT_NAME> antidiabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> antidiabetic_medicine </GENERIC_NAME> <DX_NAME> non_insulin_dependent </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> 3_to_6_months </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME>
<GENERIC_NAME> cladribine </GENERIC_NAME> <GENERIC_NAME> cladribine </GENERIC_NAME> <DX_NAME> cancerous </DX_NAME> <DX_NAME> hairy_cell_leukaemia </DX_NAME>
<GENERIC_NAME> cubicin </GENERIC_NAME> <GENERIC_NAME> daptomycin </GENERIC_NAME> <GENERIC_NAME> daptomycin </GENERIC_NAME> <DX_NAME> bacteria </DX_NAME> <GENERIC_NAME> cubicin </GENERIC_NAME> <AGE> 17 </AGE> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_infection </DX_NAME> <GENERIC_NAME> cubicin </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME> <DX_NAME> staphylococcus_aureus </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> bacteria </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_infection </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> antibacterials </GENERIC_NAME> <GENERIC_NAME> cubicin </GENERIC_NAME>
<GENERIC_NAME> padeliporfin </GENERIC_NAME> <GENERIC_NAME> potassium_salt </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lobe </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> general_anaesthetic </PROCEDURE_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> discomfort </DX_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> mepolizumab </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> white_blood_cell </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> eosinophilic_asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma_attacks </DX_NAME> <TREATMENT_NAME> high_dose_inhalers </TREATMENT_NAME> <DX_NAME> asthma </DX_NAME> <TREATMENT_NAME> oral_corticosteroids </TREATMENT_NAME> <GENERIC_NAME> oral_corticosteroids </GENERIC_NAME> <BRAND_NAME> nucala </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <GENERIC_NAME> mepolizumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> romiplostim </GENERIC_NAME> <DX_NAME> thrombocytopenic_purpura </DX_NAME> <DX_NAME> itp </DX_NAME> <DX_NAME> itp </DX_NAME> <TREATMENT_NAME> immune_system_destroys </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> bruising </DX_NAME> <DX_NAME> bleeding </DX_NAME> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> spleen_removed </PROCEDURE_NAME> <DX_NAME> itp </DX_NAME> <TIME_TO_MEDICATION_NAME> previously </TIME_TO_MEDICATION_NAME> <TIME_TO_TREATMENT_NAME> previously </TIME_TO_TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TREATMENT_NAME> corticosteroids </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bruising </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> itp </DX_NAME>
<GENERIC_NAME> xenleta </GENERIC_NAME> <TREATMENT_NAME> antibiotic_medicine </TREATMENT_NAME> <GENERIC_NAME> antibiotic_medicine </GENERIC_NAME> <GENERIC_NAME> lefamulin </GENERIC_NAME> <GENERIC_NAME> lefamulin </GENERIC_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME> <BRAND_NAME> xenleta </BRAND_NAME> <DX_NAME> bacterial_infections </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> pneumonia </DX_NAME> <DX_NAME> pneumonia </DX_NAME>
<GENERIC_NAME> effentora </GENERIC_NAME> <GENERIC_NAME> fentanyl_citrate </GENERIC_NAME> <GENERIC_NAME> effentora </GENERIC_NAME> <DX_NAME> breakthrough_pain </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> opioid_pain_medicines </TREATMENT_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> breakthrough_pain </DX_NAME> <DX_NAME> pain </DX_NAME> <GENERIC_NAME> opioid </GENERIC_NAME> <TREATMENT_NAME> opioid_painrelieving_medicines </TREATMENT_NAME>
<GENERIC_NAME> alfa_pegol </GENERIC_NAME> <DX_NAME> clot </DX_NAME> <GENERIC_NAME> alfa_pegol </GENERIC_NAME> <GENERIC_NAME> pegylated </GENERIC_NAME> <NAME> jivi </NAME> <DX_NAME> bleeding </DX_NAME> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> hereditary_factor_viii_deficiency </DX_NAME> <AGE> 12 </AGE>
<GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> generalised_anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> peripheral_neuropathic_pain </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> pain_sensations </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> cramping </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> tingling </DX_NAME> <DX_NAME> numbness </DX_NAME> <DX_NAME> pins_and_needles </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> mood_changes </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> epilepsy_pregabalin_zentiva </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_seizures </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <TREATMENT_NAME> antiepileptic_treatment </TREATMENT_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> worry </DX_NAME> <DX_NAME> difficult_to_control </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> restlessness </DX_NAME> <DX_NAME> feeling_keyed_up </DX_NAME> <DX_NAME> fatigued </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> difficulty_concentrating </DX_NAME> <DX_NAME> mind_going_blank </DX_NAME> <DX_NAME> feeling_irritable </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_tension </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME>
<GENERIC_NAME> patisiran </GENERIC_NAME> <GENERIC_NAME> onpattro </GENERIC_NAME> <DX_NAME> hereditary_attr </DX_NAME> <DX_NAME> amyloidosis </DX_NAME> <DX_NAME> amyloidosis </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> amyloid </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> amyloid </DX_NAME>
<GENERIC_NAME> ferriprox </GENERIC_NAME> <GENERIC_NAME> deferiprone </GENERIC_NAME> <GENERIC_NAME> ferriprox </GENERIC_NAME> <GENERIC_NAME> iron_chelator </GENERIC_NAME> <GENERIC_NAME> iron </GENERIC_NAME> <GENERIC_NAME> ferriprox </GENERIC_NAME> <DX_NAME> iron_overload </DX_NAME> <TREATMENT_NAME> frequent_blood_transfusions </TREATMENT_NAME> <DX_NAME> thalassaemia </DX_NAME> <TIME_TO_TREATMENT_NAME> current </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chelation_therapy </TREATMENT_NAME>
<GENERIC_NAME> botulinum_toxin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> contracting </DX_NAME> <DX_NAME> paralysis </DX_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyebrows </SYSTEM_ORGAN_SITE>
<NAME> Silgard </NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> Vaccination </TREATMENT_NAME> <DX_NAME> Human_Papillomavirus </DX_NAME> <DX_NAME> HPV </DX_NAME> <DX_NAME> pre-cancerous_lesions </DX_NAME> <SYSTEM_ORGAN_SITE> genitals </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cervix </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vulva </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> lesions </DX_NAME> <SYSTEM_ORGAN_SITE> anus </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> genital </SYSTEM_ORGAN_SITE> <DX_NAME> genital_warts </DX_NAME> <SYSTEM_ORGAN_SITE> cervical </SYSTEM_ORGAN_SITE> <DX_NAME> cervical_and_anal_cancers </DX_NAME> <SYSTEM_ORGAN_SITE> anal </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <DX_NAME> anal_cancer </DX_NAME> <DX_NAME> pre-cancerous_lesions </DX_NAME> <SYSTEM_ORGAN_SITE> vulva </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> HPV </DX_NAME> <DX_NAME> pre-cancerous_lesions </DX_NAME> <SYSTEM_ORGAN_SITE> anus </SYSTEM_ORGAN_SITE> <DX_NAME> genital_wart_cases </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> HPV </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> HPV </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> HPV </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> clinical_trials </TREATMENT_NAME> <DX_NAME> HPV </DX_NAME> <TIME_TO_DX_NAME> 11 </TIME_TO_DX_NAME> <DATE> 11-,_16 </DATE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <AGE> 9 </AGE> <TIME_TO_TREATMENT_NAME> 9- </TIME_TO_TREATMENT_NAME> <AGE> 15 </AGE>
<GENERIC_NAME> bexsero </GENERIC_NAME> <TREATMENT_NAME> bexsero </TREATMENT_NAME> <TREATMENT_NAME> meningococcal_group_b_vaccine </TREATMENT_NAME> <GENERIC_NAME> meningococcal_group_b_vaccine </GENERIC_NAME> <TREATMENT_NAME> bexsero </TREATMENT_NAME> <GENERIC_NAME> bexsero </GENERIC_NAME> <TREATMENT_NAME> bacteria_neisseria </TREATMENT_NAME> <TREATMENT_NAME> bexsero </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> meningitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <DX_NAME> sepsis </DX_NAME> <DX_NAME> blood_poisoning </DX_NAME>
<BRAND_NAME> micardis </BRAND_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessels_to_narrow </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <BRAND_NAME> micardis </BRAND_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <BRAND_NAME> micardis </BRAND_NAME> <DX_NAME> hypertension </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME> <BRAND_NAME> micardis </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> reduced_or_blocked_blood_supply </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> antihistamine </GENERIC_NAME> <TREATMENT_NAME> antiallergy_medicine </TREATMENT_NAME> <DX_NAME> drowsy </DX_NAME> <DX_NAME> allergic_reaction </DX_NAME> <BRAND_NAME> azomyr </BRAND_NAME> <BRAND_NAME> azomyr </BRAND_NAME> <DX_NAME> allergic_rhinitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> nasal_passages </SYSTEM_ORGAN_SITE> <DX_NAME> allergy </DX_NAME> <DX_NAME> hay_fever </DX_NAME> <DX_NAME> allergy </DX_NAME> <AGE> 12 </AGE> <DX_NAME> sneezing </DX_NAME> <DX_NAME> runny </DX_NAME> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> palate </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <DX_NAME> red </DX_NAME> <DX_NAME> watery_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> urticaria </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_condition </DX_NAME> <DX_NAME> allergy </DX_NAME> <DX_NAME> itching </DX_NAME> <DX_NAME> hives </DX_NAME>
<DX_NAME> cancer </DX_NAME> <GENERIC_NAME> venetoclax </GENERIC_NAME> <BRAND_NAME> venclyxto </BRAND_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> cll </DX_NAME> <BRAND_NAME> venclyxto </BRAND_NAME> <DX_NAME> cll </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <DX_NAME> cll </DX_NAME>
<DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> nevirapine </GENERIC_NAME> <GENERIC_NAME> nevirapine </GENERIC_NAME> <TREATMENT_NAME> nonnucleoside_reverse_transcriptase_inhibitors </TREATMENT_NAME> <TREATMENT_NAME> reverse_transcriptase </TREATMENT_NAME> <GENERIC_NAME> nevirapine </GENERIC_NAME> <TREATMENT_NAME> reverse_transcriptase </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <BRAND_NAME> viramune </BRAND_NAME>
<GENERIC_NAME> albiglutide </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> diabetes_medicine </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> diabetes_medicines </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> thiazolidinediones </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> dic </DX_NAME> <BRAND_NAME> eperzan </BRAND_NAME>
<GENERIC_NAME> fostamatinib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> bleeding </DX_NAME> <DX_NAME> immune_thrombocytopenia </DX_NAME> <DX_NAME> itp </DX_NAME> <DX_NAME> itp </DX_NAME> <DX_NAME> itp </DX_NAME> <DX_NAME> autoimmune_disease </DX_NAME> <DX_NAME> immune_system_attacks </DX_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> bleeding </DX_NAME>
<TREATMENT_NAME> coagulation_factor_ix_product </TREATMENT_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> rixubis </TREATMENT_NAME> <DX_NAME> rixubis </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> christmas_disease </DX_NAME> <DX_NAME> bleeding_disorder </DX_NAME> <DX_NAME> lack_of_factor_ix </DX_NAME> <DX_NAME> factor_ix_to_enable_the_patient’s_blood_to_clot </DX_NAME> <TREATMENT_NAME> rixubis </TREATMENT_NAME> <DX_NAME> rixubis </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME>
<GENERIC_NAME> elaprase </GENERIC_NAME> <TREATMENT_NAME> enzyme_replacement_therapy </TREATMENT_NAME> <DX_NAME> hunter_syndrome </DX_NAME> <DX_NAME> mucopolysaccharidosis </DX_NAME> <DX_NAME> hunter_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <DX_NAME> tissue_destruction </DX_NAME> <DX_NAME> organ_malfunction </DX_NAME> <DX_NAME> failure </DX_NAME> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> connective_tissue </SYSTEM_ORGAN_SITE> <GENERIC_NAME> glycosaminoglycan_accumulates </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> elaprase </GENERIC_NAME> <GENERIC_NAME> idursulfase </GENERIC_NAME> <TREATMENT_NAME> enzyme_replacement_therapy </TREATMENT_NAME>
<GENERIC_NAME> alirocumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <TEST_NAME> monoclonal_antibodies </TEST_NAME> <GENERIC_NAME> alirocumab </GENERIC_NAME> <TEST_NAME> protein_secreted </TEST_NAME> <TEST_NAME> liver_cells </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <TEST_NAME> cholesterol_levels </TEST_NAME> <DX_NAME> high_cholesterol_levels </DX_NAME> <TEST_NAME> cholesterol_levels </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME> <DX_NAME> heterozygous_familial </DX_NAME> <DX_NAME> nonfamilial]_or_mixed_dyslipidaemia </DX_NAME> <DX_NAME> high_cholesterol_levels </DX_NAME> <TEST_NAME> cholesterol_levels </TEST_NAME> <DX_NAME> cardiovascular_disease </DX_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <DX_NAME> high_cholesterol </DX_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TREATMENT_NAME> cholesterol_lowering_medicines </TREATMENT_NAME> <TREATMENT_NAME> statins </TREATMENT_NAME> <GENERIC_NAME> statins </GENERIC_NAME> <TREATMENT_NAME> cholesterollowering_diet </TREATMENT_NAME>
<BRAND_NAME> harvoni </BRAND_NAME> <BRAND_NAME> harvoni </BRAND_NAME> <BRAND_NAME> harvoni </BRAND_NAME> <GENERIC_NAME> sofosbuvir </GENERIC_NAME> <BRAND_NAME> harvoni </BRAND_NAME> <DX_NAME> hepatitis_c_virus_infection </DX_NAME> <DX_NAME> hepatitis_c </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <BRAND_NAME> harvoni </BRAND_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <BRAND_NAME> harvoni </BRAND_NAME>
<GENERIC_NAME> pantoloc </GENERIC_NAME> <GENERIC_NAME> pantoprazole </GENERIC_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <GENERIC_NAME> pantoloc </GENERIC_NAME> <DX_NAME> reflux_symptoms </DX_NAME> <DX_NAME> heartburn </DX_NAME> <DX_NAME> acid_regurgitation </DX_NAME> <DX_NAME> reflux </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> inflamed </DX_NAME> <DX_NAME> painful </DX_NAME> <DX_NAME> painful_burning_sensation </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <DX_NAME> heartburn </DX_NAME> <DX_NAME> sour_taste </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> acid_regurgitation </DX_NAME> <DX_NAME> acid_reflux </DX_NAME> <DX_NAME> heartburn </DX_NAME> <TIME_TO_MEDICATION_NAME> one_day_of </TIME_TO_MEDICATION_NAME> <TIME_TO_TREATMENT_NAME> one_day_of </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> pantoloc_control </TREATMENT_NAME> <GENERIC_NAME> pantoloc_control </GENERIC_NAME> <DX_NAME> feel_worse </DX_NAME> <TIME_TO_DX_NAME> 2 </TIME_TO_DX_NAME>
<NAME> gliolan </NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> malignant_glioma </DX_NAME> <PROCEDURE_NAME> tumour_surgery </PROCEDURE_NAME> <GENERIC_NAME> aminolevulinic_acid </GENERIC_NAME> <GENERIC_NAME> 5ala </GENERIC_NAME> <DX_NAME> tumour </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> remove_the_tumour </PROCEDURE_NAME> <DX_NAME> tumour </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> ibandronic_acid </GENERIC_NAME> <GENERIC_NAME> ibandronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> ‘bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <DX_NAME> tumour </DX_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <DX_NAME> lost_from_your_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME>
<GENERIC_NAME> celvapan </GENERIC_NAME> <NAME> celvapan </NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> flu) </TREATMENT_NAME> <DATE> 2009 </DATE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME>
<BRAND_NAME> Apidra </BRAND_NAME> <DX_NAME> high_blood_sugar </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> Diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME>
<TREATMENT_NAME> oral_vaccine </TREATMENT_NAME> <DX_NAME> gastroenteritis </DX_NAME> <DX_NAME> diarrhoea </DX_NAME> <DX_NAME> vomiting </DX_NAME> <DX_NAME> rotavirus_infection </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> gastroenteritis </DX_NAME>
<GENERIC_NAME> zoledronic_acid_medac </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_complications </DX_NAME> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_metastases </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> primary_site </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <DX_NAME> tumour </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> hypercalcaemia </DX_NAME>
<GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicine </TREATMENT_NAME> <GENERIC_NAME> antiepileptic_medicine </GENERIC_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> seizure </DX_NAME> <DX_NAME> generalisation </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> myoclonic_seizures </DX_NAME> <DX_NAME> shocklike_jerks </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <AGE> 12 </AGE> <DX_NAME> myoclonic_epilepsy </DX_NAME> <DX_NAME> tonicclonic_seizures </DX_NAME> <DX_NAME> loss_of_consciousness </DX_NAME> <AGE> 12 </AGE> <DX_NAME> generalised_epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME>
<BRAND_NAME> zypadhera </BRAND_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> zypadhera </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME>
<GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicine </TREATMENT_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> seizure </DX_NAME> <DX_NAME> generalisation </DX_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> myoclonic_seizures </DX_NAME> <DX_NAME> shocklike_jerks </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <AGE> 12 </AGE> <DX_NAME> myoclonic_epilepsy </DX_NAME> <DX_NAME> generalised_tonicclonic_seizures </DX_NAME> <DX_NAME> loss_of_consciousness </DX_NAME> <AGE> 12 </AGE> <DX_NAME> generalised_epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <TEST_NAME> genetic_cause </TEST_NAME>
<BRAND_NAME> doribax </BRAND_NAME> <GENERIC_NAME> doripenem </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <BRAND_NAME> doribax </BRAND_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> pneumonia </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_infection </DX_NAME> <DX_NAME> pneumonia </DX_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> abdominal_infections </DX_NAME> <SYSTEM_ORGAN_SITE> urinary_tract </SYSTEM_ORGAN_SITE> <DX_NAME> urinary_tract_infections </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_infections </DX_NAME>
<GENERIC_NAME> trumenba </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> meningococcal_disease </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> meningitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <DX_NAME> sepsis </DX_NAME> <DX_NAME> blood_poisoning </DX_NAME>
<GENERIC_NAME> ivabradine_anpharm </GENERIC_NAME> <BRAND_NAME> ivabradine </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> heart_medicine </TREATMENT_NAME> <DX_NAME> angina_pectoris </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_rate </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> heart_medicines </TREATMENT_NAME> <GENERIC_NAME> betablockers </GENERIC_NAME> <GENERIC_NAME> betablocker </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_rate </DX_NAME> <GENERIC_NAME> betablocker </GENERIC_NAME> <TREATMENT_NAME> betablocker_therapy </TREATMENT_NAME> <DX_NAME> angina_pectoris </DX_NAME> <DX_NAME> stable_angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> angina </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> discomfort </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <SYSTEM_ORGAN_SITE> ankle </SYSTEM_ORGAN_SITE> <DX_NAME> ankle_swelling </DX_NAME> <BRAND_NAME> ivabradine </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <BRAND_NAME> ivabradine </BRAND_NAME> <DX_NAME> angina_attacks </DX_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME>
<BRAND_NAME> hbvaxpro </BRAND_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> hepatitis_b_virus_infection </DX_NAME> <AGE> 15 </AGE> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> hepatitis_d </DX_NAME> <BRAND_NAME> hbvaxpro </BRAND_NAME> <DX_NAME> hepatitis_d </DX_NAME> <DX_NAME> hepatitis_b_infection </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis_a </DX_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> hepatitis_e </DX_NAME> <DX_NAME> infect_the_liver </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE>
<DX_NAME> wilson’s_disease </DX_NAME> <AGE> 5 </AGE> <GENERIC_NAME> dpenicillamine </GENERIC_NAME> <DX_NAME> side_effects </DX_NAME> <GENERIC_NAME> trientine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<NAME> erleada </NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> apalutamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <NAME> erleada </NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> apalutamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME>
<GENERIC_NAME> alogliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> alogliptin </GENERIC_NAME> <TREATMENT_NAME> dpp4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <TREATMENT_NAME> dipeptidyl_peptidase4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <GENERIC_NAME> alogliptin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <TREATMENT_NAME> “oral_antidiabetics” </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> niddm </DX_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TREATMENT_NAME> antidiabetic_medicines </TREATMENT_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <GENERIC_NAME> alogliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> vipdomet </GENERIC_NAME>
<GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> taxoids </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <DX_NAME> head_and_neck_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_node </SYSTEM_ORGAN_SITE> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <GENERIC_NAME> prednisolone </GENERIC_NAME> <DX_NAME> gastric_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> neck_cancer </DX_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME>
<GENERIC_NAME> ondexxya </GENERIC_NAME> <GENERIC_NAME> andexanet_alfa </GENERIC_NAME> <GENERIC_NAME> anticoagulants </GENERIC_NAME> <TREATMENT_NAME> anticoagulants </TREATMENT_NAME> <TREATMENT_NAME> factor_xa_inhibitors </TREATMENT_NAME> <GENERIC_NAME> apixaban </GENERIC_NAME> <GENERIC_NAME> rivaroxaban </GENERIC_NAME> <TREATMENT_NAME> factor_xa_inhibitors </TREATMENT_NAME> <DX_NAME> clots </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> ondexxya </TREATMENT_NAME> <TREATMENT_NAME> anticoagulant </TREATMENT_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <DX_NAME> type_2_diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylureas </GENERIC_NAME> <GENERIC_NAME> glitazones </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> glucose </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <PROCEDURE_NAME> amputation </PROCEDURE_NAME> <DX_NAME> amputation </DX_NAME>
<GENERIC_NAME> coaprovel </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <DX_NAME> angiotensinii </DX_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <TREATMENT_NAME> diuretics </TREATMENT_NAME> <DX_NAME> increased_urine_output </DX_NAME> <DX_NAME> blood_pressure </DX_NAME> <GENERIC_NAME> coaprovel </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME>
<GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> inflammatory_diseases </DX_NAME> <DX_NAME> range_of_inflammatory_diseases </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammatory_condition </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> idiopathic_arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> polyarthritic </DX_NAME> <DX_NAME> inadequate_response </DX_NAME> <TREATMENT_NAME> nonsteroidal_antiinflammatory_drugs </TREATMENT_NAME> <GENERIC_NAME> nonsteroidal_antiinflammatory_drugs </GENERIC_NAME> <TREATMENT_NAME> nsaids </TREATMENT_NAME> <GENERIC_NAME> nsaids </GENERIC_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> inadequate_response </DX_NAME> <TREATMENT_NAME> phototherapy </TREATMENT_NAME> <TREATMENT_NAME> light_therapy </TREATMENT_NAME> <TREATMENT_NAME> puva </TREATMENT_NAME> <TREATMENT_NAME> ultraviolet_light_therapy </TREATMENT_NAME> <GENERIC_NAME> retinoids </GENERIC_NAME> <GENERIC_NAME> vitamin_a </GENERIC_NAME>
<DX_NAME> clots </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> inborn_factor_viii_deficiency </DX_NAME> <DX_NAME> factor_viii_is_missing </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME>
<BRAND_NAME> Epivir </BRAND_NAME> <DX_NAME> HIV </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> Epivir </BRAND_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <BRAND_NAME> Epivir </BRAND_NAME> <GENERIC_NAME> nucleoside </GENERIC_NAME> <TREATMENT_NAME> nucleoside_analogue_reverse_transcriptase_inhibitors </TREATMENT_NAME> <BRAND_NAME> Epivir </BRAND_NAME> <DX_NAME> HIV_infection </DX_NAME> <TEST_NAME> CD4_cell_count </TEST_NAME> <TREATMENT_NAME> CD4_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> Epivir </BRAND_NAME>
<GENERIC_NAME> tachosil </GENERIC_NAME> <GENERIC_NAME> saline </GENERIC_NAME> <SYSTEM_ORGAN_SITE> tissue_surface </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_coagulates </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> tachosil </GENERIC_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <DX_NAME> bleeding </DX_NAME> <SYSTEM_ORGAN_SITE> tissue_surfaces </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> internal_organs </SYSTEM_ORGAN_SITE>
<PROCEDURE_NAME> injecting </PROCEDURE_NAME> <GENERIC_NAME> filgrastim </GENERIC_NAME> <GENERIC_NAME> filgrastim </GENERIC_NAME> <GENERIC_NAME> filgrastim </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> biograstim </TREATMENT_NAME> <GENERIC_NAME> biograstim </GENERIC_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <TEST_NAME> biograstim </TEST_NAME> <GENERIC_NAME> biograstim </GENERIC_NAME> <TEST_NAME> biograstim </TEST_NAME> <GENERIC_NAME> biograstim </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplantation </PROCEDURE_NAME> <DX_NAME> neutropenia </DX_NAME> <DX_NAME> low_white_blood_cell_count </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> neutropenia </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <TREATMENT_NAME> peripheral_blood_stem_cell_mobilisation </TREATMENT_NAME> <TREATMENT_NAME> blood_stem_cell_donation </TREATMENT_NAME>
<GENERIC_NAME> ultibro_breezhaler </GENERIC_NAME> <GENERIC_NAME> indacaterol </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficult </DX_NAME> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> copd </DX_NAME>
<BRAND_NAME> unituxin </BRAND_NAME> <BRAND_NAME> unituxin </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> dinutuximab </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> unituxin </BRAND_NAME> <BRAND_NAME> unituxin </BRAND_NAME> <DX_NAME> neuroblastoma’ </DX_NAME> <DX_NAME> neuroblastoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> abnormal_nerve_cells </DX_NAME> <SYSTEM_ORGAN_SITE> nerve_cells </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> neuroblastomas </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> neuroblastomas </DX_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> unituxin </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> autologous_(selfdonating)_blood_cell_transplant </PROCEDURE_NAME> <BRAND_NAME> unituxin </BRAND_NAME> <BRAND_NAME> unituxin </BRAND_NAME> <BRAND_NAME> unituxin </BRAND_NAME> <BRAND_NAME> unituxin </BRAND_NAME> <DX_NAME> dic </DX_NAME>
<GENERIC_NAME> xoterna_breezhaler </GENERIC_NAME> <GENERIC_NAME> indacaterol </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficult </DX_NAME> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> copd </DX_NAME>
<BRAND_NAME> firazyr </BRAND_NAME> <GENERIC_NAME> icatibant </GENERIC_NAME> <BRAND_NAME> firazyr </BRAND_NAME> <DX_NAME> hereditary_angioedema </DX_NAME> <DX_NAME> bradykinin_are_increased </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> diarrhoea </DX_NAME> <BRAND_NAME> firazyr </BRAND_NAME> <TREATMENT_NAME> firazyr_blocks </TREATMENT_NAME> <GENERIC_NAME> bradykinin </GENERIC_NAME>
<GENERIC_NAME> clofarabine </GENERIC_NAME> <GENERIC_NAME> clofarabine </GENERIC_NAME> <AGE> 21 </AGE> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> abnormal_growth </DX_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME>
<TREATMENT_NAME> enzyme_replacement_therapy </TREATMENT_NAME> <DX_NAME> type_1_gaucher_disease </DX_NAME> <DX_NAME> gaucher_disease </DX_NAME> <DX_NAME> genetic_disorder </DX_NAME> <GENERIC_NAME> glucocerebroside </GENERIC_NAME> <DX_NAME> gaucher_disease </DX_NAME> <GENERIC_NAME> velaglucerase_alfa </GENERIC_NAME> <DX_NAME> gaucher_disease </DX_NAME>
<BRAND_NAME> zykadia </BRAND_NAME> <BRAND_NAME> zykadia </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> ceritinib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> nsclc </DX_NAME> <BRAND_NAME> zykadia </BRAND_NAME> <DX_NAME> anaplastic_lymphoma_kinase </DX_NAME> <BRAND_NAME> zykadia </BRAND_NAME> <DX_NAME> alk_defects </DX_NAME> <DX_NAME> nsclc </DX_NAME> <BRAND_NAME> zykadia </BRAND_NAME>
<GENERIC_NAME> ribavirin </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <GENERIC_NAME> interferon_alfa </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> interferon_alfa2b </GENERIC_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> hcv </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> interferon_alfa2b </GENERIC_NAME> <DX_NAME> hepatitis_c </DX_NAME> <GENERIC_NAME> interferon </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> pegylated </GENERIC_NAME> <GENERIC_NAME> interferon </GENERIC_NAME> <GENERIC_NAME> alfa2b </GENERIC_NAME>
<BRAND_NAME> twynsta </BRAND_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessel_wall </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <BRAND_NAME> twynsta </BRAND_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME>
<GENERIC_NAME> enerzair_breezhaler </GENERIC_NAME> <GENERIC_NAME> indacaterol </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> mometasone_furoate_indacaterol </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <GENERIC_NAME> mometasone </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <GENERIC_NAME> steroids </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_problems </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> attacks_of_asthma </DX_NAME> <DX_NAME> enerzair_breezhaler </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> tight </DX_NAME> <DX_NAME> bronchoconstriction </DX_NAME> <DX_NAME> inflamed </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> wheezing </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_tightness </DX_NAME> <DX_NAME> cough </DX_NAME> <BRAND_NAME> enerzair </BRAND_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME>
<BRAND_NAME> lartruvo </BRAND_NAME> <GENERIC_NAME> olaratumab </GENERIC_NAME> <GENERIC_NAME> olaratumab </GENERIC_NAME> <GENERIC_NAME> olaratumab </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> lartruvo </BRAND_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> soft_tissue </SYSTEM_ORGAN_SITE> <DX_NAME> soft_tissue_sarcoma </DX_NAME> <TIME_TO_MEDICATION_NAME> previously </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> soft_tissue </SYSTEM_ORGAN_SITE> <DX_NAME> soft_tissue_sarcoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> soft_tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> fat </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cartilage </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE>
<SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> oral_cavity </SYSTEM_ORGAN_SITE> <DX_NAME> oral_cavity_cancers </DX_NAME> <GENERIC_NAME> tilmanocept </GENERIC_NAME> <GENERIC_NAME> radioactive_medicine </GENERIC_NAME> <GENERIC_NAME> sodium_pertechnetate </GENERIC_NAME> <GENERIC_NAME> tilmanocept </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body_areas </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sentinel_lymph_nodes </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<TREATMENT_NAME> antibiotic_medicine </TREATMENT_NAME> <GENERIC_NAME> tobramycin </GENERIC_NAME> <TREATMENT_NAME> antibiotic_medicines </TREATMENT_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_infections </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> pseudomonas_aeruginosa </DX_NAME> <DX_NAME> pseudomonas_aeruginosa </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infection </DX_NAME>
<NAME> zarzio </NAME> <TEST_NAME> white_blood_cell_growth_factor </TEST_NAME> <TEST_NAME> granulocyte_colony_stimulating_factor </TEST_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> neutropenia </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplant </PROCEDURE_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> bone_marrow </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> neutropenia </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> infections </DX_NAME>
<BRAND_NAME> vimpat </BRAND_NAME> <BRAND_NAME> vimpat </BRAND_NAME> <GENERIC_NAME> lacosamide </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <BRAND_NAME> vimpat </BRAND_NAME> <BRAND_NAME> vimpat </BRAND_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partialonset_seizure </DX_NAME> <DX_NAME> generalisation </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <BRAND_NAME> vimpat </BRAND_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME>
<GENERIC_NAME> glucagon </GENERIC_NAME> <DX_NAME> hypoglycaemia </DX_NAME> <DX_NAME> low_blood_sugar </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> hypoglycaemia </DX_NAME>
<GENERIC_NAME> tremfya </GENERIC_NAME> <GENERIC_NAME> guselkumab </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <DX_NAME> psoriasis </DX_NAME> <GENERIC_NAME> tremfya </GENERIC_NAME> <DX_NAME> “plaque_psoriasis” </DX_NAME> <DX_NAME> inflammatory_condition </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nails </SYSTEM_ORGAN_SITE> <DX_NAME> improve_the_condition </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> appearance_of_nails </SYSTEM_ORGAN_SITE> <DX_NAME> scaling </DX_NAME> <DX_NAME> shedding </DX_NAME> <DX_NAME> flaking </DX_NAME> <DX_NAME> itching </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> burning </DX_NAME>
<GENERIC_NAME> simbrinza </GENERIC_NAME> <GENERIC_NAME> brinzolamide </GENERIC_NAME> <GENERIC_NAME> brimonidine_tartrate </GENERIC_NAME> <GENERIC_NAME> brinzolamide </GENERIC_NAME> <GENERIC_NAME> carbonic_anhydrase_inhibitors </GENERIC_NAME> <GENERIC_NAME> brimonidine_tartrate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <GENERIC_NAME> simbrinza </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <AGE> 18 </AGE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> glaucoma </DX_NAME> <DX_NAME> ocular_hypertension </DX_NAME> <DX_NAME> high_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> pantoprazole </GENERIC_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> reflux_symptoms </DX_NAME> <DX_NAME> heartburn </DX_NAME> <DX_NAME> acid_regurgitation </DX_NAME> <DX_NAME> reflux </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> inflamed </DX_NAME> <DX_NAME> painful </DX_NAME> <DX_NAME> painful_burning_sensation </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <DX_NAME> heartburn </DX_NAME> <DX_NAME> sour_taste </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> acid_regurgitation </DX_NAME> <DX_NAME> acid_reflux </DX_NAME> <DX_NAME> heartburn </DX_NAME> <DX_NAME> feel_worse </DX_NAME>
<GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> generalised_anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> peripheral_neuropathic_pain </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> pain_sensations </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> cramping </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> tingling </DX_NAME> <DX_NAME> numbness </DX_NAME> <DX_NAME> pins_and_needles </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> mood_changes </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_seizures </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_treatment </TREATMENT_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> worry </DX_NAME> <DX_NAME> difficult_to_control </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> restlessness </DX_NAME> <DX_NAME> feeling_keyed_up </DX_NAME> <DX_NAME> fatigued </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> difficulty_concentrating </DX_NAME> <DX_NAME> mind_going_blank </DX_NAME> <DX_NAME> feeling_irritable </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_tension </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME>
<GENERIC_NAME> tolucombi </GENERIC_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <TREATMENT_NAME> thiazide_diuretics </TREATMENT_NAME> <TEST_NAME> urine_output </TEST_NAME> <DX_NAME> blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME> <GENERIC_NAME> tolucombi </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> essential_hypertension </DX_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> tolucombi </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <GENERIC_NAME> tolucombi </GENERIC_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME>
<GENERIC_NAME> “rituximab” </GENERIC_NAME> <GENERIC_NAME> rituximab </GENERIC_NAME> <DX_NAME> die </DX_NAME> <GENERIC_NAME> rituzena </GENERIC_NAME> <GENERIC_NAME> rituzena </GENERIC_NAME> <GENERIC_NAME> rituzena </GENERIC_NAME> <DX_NAME> nonhodgkin’s_lymphoma </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <GENERIC_NAME> rituzena </GENERIC_NAME> <TREATMENT_NAME> “chemotherapy” </TREATMENT_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> cll </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cll </DX_NAME> <DX_NAME> blymphocytes </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <DX_NAME> cll </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> wegener’s_granulomatosis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TREATMENT_NAME> corticosteroids </TREATMENT_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> naloxegol </GENERIC_NAME> <DX_NAME> constipation </DX_NAME> <DX_NAME> pain </DX_NAME> <TREATMENT_NAME> pain_medicines </TREATMENT_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <GENERIC_NAME> opioids </GENERIC_NAME> <GENERIC_NAME> morphine </GENERIC_NAME> <GENERIC_NAME> oxycodone </GENERIC_NAME> <GENERIC_NAME> fentanyl </GENERIC_NAME> <GENERIC_NAME> tramadol </GENERIC_NAME> <GENERIC_NAME> codeine </GENERIC_NAME> <GENERIC_NAME> laxatives </GENERIC_NAME> <TREATMENT_NAME> laxatives </TREATMENT_NAME> <DX_NAME> constipation </DX_NAME> <DX_NAME> Constipation </DX_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> stomach_pain </DX_NAME> <DX_NAME> rectal_straining </DX_NAME> <DX_NAME> hard_to_move_the_stool </DX_NAME> <SYSTEM_ORGAN_SITE> rectum </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> anus </SYSTEM_ORGAN_SITE> <DX_NAME> hard_stools </DX_NAME> <DX_NAME> stools </DX_NAME> <DX_NAME> incomplete_emptying </DX_NAME> <SYSTEM_ORGAN_SITE> rectum </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> bowel_movement </DX_NAME> <DX_NAME> stool </DX_NAME> <SYSTEM_ORGAN_SITE> rectum </SYSTEM_ORGAN_SITE> <GENERIC_NAME> opioids </GENERIC_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <DX_NAME> constipation </DX_NAME> <GENERIC_NAME> laxative </GENERIC_NAME> <DX_NAME> constipation </DX_NAME> <DX_NAME> Moventig </DX_NAME> <TREATMENT_NAME> clinical_trials </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> bowel_movements </DX_NAME> <DX_NAME> constipation </DX_NAME> <GENERIC_NAME> opioids </GENERIC_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME>
<BRAND_NAME> zeffix </BRAND_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <BRAND_NAME> zeffix </BRAND_NAME> <DX_NAME> hepatitis_b_infection </DX_NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <TREATMENT_NAME> nucleoside_analogue_reverse_transcriptase_inhibitors </TREATMENT_NAME> <DX_NAME> hepatitis_b_is_a_virus </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_damage </DX_NAME> <BRAND_NAME> zeffix </BRAND_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <BRAND_NAME> zeffix </BRAND_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_damage </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_function </DX_NAME> <BRAND_NAME> zeffix </BRAND_NAME> <TEST_NAME> blood_tests </TEST_NAME>
<BRAND_NAME> givlaari </BRAND_NAME> <BRAND_NAME> givlaari </BRAND_NAME> <BRAND_NAME> givlaari </BRAND_NAME> <BRAND_NAME> givlaari </BRAND_NAME> <DX_NAME> hepatic_porphyria </DX_NAME> <AGE> 12 </AGE> <DX_NAME> hepatic_porphyria </DX_NAME> <DX_NAME> hepatic_porphyria </DX_NAME> <DX_NAME> defect </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> aminolevulinic_acid </GENERIC_NAME> <GENERIC_NAME> ala </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> attacks_of_pain </DX_NAME> <DX_NAME> nausea </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_weakness </DX_NAME> <DX_NAME> changes_in_mental_functioning </DX_NAME> <DX_NAME> hepatic_porphyria </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> longerterm_complications </DX_NAME> <DX_NAME> hepatic_porphyria </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <BRAND_NAME> givlaari </BRAND_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE>
<DX_NAME> cancer </DX_NAME> <GENERIC_NAME> ‘cytarabine’ </GENERIC_NAME> <BRAND_NAME> vyxeos </BRAND_NAME> <BRAND_NAME> vyxeos </BRAND_NAME> <GENERIC_NAME> liposomal </GENERIC_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> myeloid_leukaemia </DX_NAME>
<GENERIC_NAME> gimeracil </GENERIC_NAME> <GENERIC_NAME> oteracil </GENERIC_NAME> <GENERIC_NAME> fluoropyrimidine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME>
<TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <GENERIC_NAME> raltegravir </GENERIC_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <TREATMENT_NAME> nucleoside_analogue_reverse_transcriptase_inhibitors </TREATMENT_NAME> <TREATMENT_NAME> hiv_integrase_strand_transfer_inhibitors </TREATMENT_NAME> <TREATMENT_NAME> dutrebis </TREATMENT_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> immune_deficiency_syndrome </DX_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> dic </DX_NAME>
<BRAND_NAME> multaq </BRAND_NAME> <GENERIC_NAME> dronedarone </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_beat </DX_NAME> <BRAND_NAME> multaq </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_rhythm </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_beats </DX_NAME> <DX_NAME> atrial_fibrillation </DX_NAME> <PROCEDURE_NAME> cardioversion </PROCEDURE_NAME> <DX_NAME> irregular_heart_rhythm </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <BRAND_NAME> multaq </BRAND_NAME> <BRAND_NAME> multaq </BRAND_NAME>
<GENERIC_NAME> rasilamlo </GENERIC_NAME> <GENERIC_NAME> rasilamlo </GENERIC_NAME> <GENERIC_NAME> aliskiren </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <GENERIC_NAME> aliskiren </GENERIC_NAME> <TREATMENT_NAME> renin_inhibitor </TREATMENT_NAME> <GENERIC_NAME> angiotensin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> calcium_channel_blockers </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> damage_the_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> disorders </DX_NAME> <GENERIC_NAME> rasilamlo </GENERIC_NAME> <GENERIC_NAME> rasilamlo </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> aliskiren </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <DX_NAME> dic </DX_NAME>
<GENERIC_NAME> trastuzumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <TEST_NAME> monoclonal_antibodies </TEST_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_and_gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> tumour </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <TREATMENT_NAME> aromatase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> aromatase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> hormone_receptorpositive </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <DX_NAME> high_levels_of_her2 </DX_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME>
<GENERIC_NAME> cladribine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> flare-ups_of_symptoms </DX_NAME>
<GENERIC_NAME> caffeine_citrate </GENERIC_NAME> <DX_NAME> apnoea </DX_NAME> <DX_NAME> premature_newborns </DX_NAME> <DX_NAME> short_periods </DX_NAME> <DX_NAME> premature_babies_stop_breathing </DX_NAME> <DX_NAME> baby’s_breathing </DX_NAME> <DX_NAME> fully_developed </DX_NAME> <DX_NAME> interrupted_breathing </DX_NAME> <DX_NAME> premature_newborns </DX_NAME>
<GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> hospira </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <AGE> 18 </AGE> <GENERIC_NAME> pegylated_liposomal_doxorubicin </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <GENERIC_NAME> melphalan </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <TIME_TO_TREATMENT_NAME> previously </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> thalidomide </GENERIC_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME> <TREATMENT_NAME> induction_treatment </TREATMENT_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <DX_NAME> mantle_cell_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <GENERIC_NAME> rituximab </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <TREATMENT_NAME> blood_stem_cell_transplantation </TREATMENT_NAME>
<GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <DX_NAME> postmenopausal </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <TREATMENT_NAME> steroids </TREATMENT_NAME> <DX_NAME> paget’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> thinning </DX_NAME> <DX_NAME> weakening </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> break_more_easily </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <TREATMENT_NAME> steroids </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> breaking_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> decreased_circulating_levels </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <TIME_TO_DX_NAME> recently </TIME_TO_DX_NAME> <DX_NAME> broken </DX_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> trauma </DX_NAME> <DX_NAME> fall </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_breaks </DX_NAME> <DX_NAME> paget’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> paget’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> weaker_than_normal </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> deformed </DX_NAME> <DX_NAME> painful </DX_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE>
<BRAND_NAME> ivabradine </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> heart_medicine </TREATMENT_NAME> <DX_NAME> angina_pectoris </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_rate </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> heart_medicines </TREATMENT_NAME> <GENERIC_NAME> betablocker </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_rate </DX_NAME> <GENERIC_NAME> betablocker </GENERIC_NAME> <TREATMENT_NAME> betablocker_therapy </TREATMENT_NAME> <TREATMENT_NAME> beta_blockers </TREATMENT_NAME> <GENERIC_NAME> beta_blockers </GENERIC_NAME> <DX_NAME> angina_pectoris </DX_NAME> <DX_NAME> stable_angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> angina </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> discomfort </DX_NAME> <DX_NAME> angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <SYSTEM_ORGAN_SITE> ankle </SYSTEM_ORGAN_SITE> <DX_NAME> ankle_swelling </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart’s </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> angina_attack </DX_NAME> <DX_NAME> angina_attacks </DX_NAME> <DX_NAME> elevated_heart_rate_adversely_affects </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <BRAND_NAME> ivabradine </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> flixabi </GENERIC_NAME> <GENERIC_NAME> infliximab </GENERIC_NAME> <GENERIC_NAME> infliximab </GENERIC_NAME> <DX_NAME> inflammatory_diseases </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> bechterew’s_disease </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <GENERIC_NAME> flixabi </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <GENERIC_NAME> flixabi </GENERIC_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> bechterew’s_disease </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <GENERIC_NAME> flixabi </GENERIC_NAME> <DX_NAME> psoriasis_psoriasis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> plaque_psoriasis </DX_NAME> <TREATMENT_NAME> phototherapy </TREATMENT_NAME> <GENERIC_NAME> flixabi </GENERIC_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> ulcerative_colitis </DX_NAME> <GENERIC_NAME> flixabi </GENERIC_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> crohn’s_disease </DX_NAME> <GENERIC_NAME> flixabi </GENERIC_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> abnormal_openings </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME>
<BRAND_NAME> ivacaftor </BRAND_NAME> <BRAND_NAME> tezacaftor </BRAND_NAME> <GENERIC_NAME> elexacaftor </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cells_to_work_better </DX_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> cf </DX_NAME> <DX_NAME> cf </DX_NAME> <DX_NAME> inherited_condition </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> digestive_system </SYSTEM_ORGAN_SITE> <BRAND_NAME> ivacaftor </BRAND_NAME> <AGE> 12 </AGE> <DX_NAME> cf </DX_NAME> <DX_NAME> genetic_mutations </DX_NAME> <DX_NAME> f508del_mutations </DX_NAME> <DX_NAME> f508del_mutation </DX_NAME> <DX_NAME> function_mutation </DX_NAME> <DX_NAME> function_mutation_is_defined </DX_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <BRAND_NAME> tezacaftor </BRAND_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <NAME> kaftrio </NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <BRAND_NAME> tezacaftor </BRAND_NAME> <BRAND_NAME> ivacaftor </BRAND_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> follitropin_alfa </GENERIC_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <DX_NAME> pregnant </DX_NAME> <DX_NAME> vitro_fertilisation” </DX_NAME> <TEST_NAME> chorionic_gonadotropin” </TEST_NAME> <TEST_NAME> hcg </TEST_NAME>
<GENERIC_NAME> imatinib_teva </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> cml </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> myelodysplastic/myeloproliferative_diseases </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> hypereosinophilic_syndrome </DX_NAME> <DX_NAME> eosinophilic_leukaemia </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> gist </DX_NAME> <DX_NAME> gist </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowels </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> imatinib_teva </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME>
<GENERIC_NAME> oncaspar </GENERIC_NAME> <GENERIC_NAME> pegaspargase </GENERIC_NAME> <GENERIC_NAME> asparaginase </GENERIC_NAME> <GENERIC_NAME> asparagine </GENERIC_NAME> <GENERIC_NAME> asparagine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> white_blood_cell_cancer </DX_NAME> <TREATMENT_NAME> functional_blood_cells </TREATMENT_NAME>
<BRAND_NAME> SANCUSO </BRAND_NAME> <GENERIC_NAME> granisetron </GENERIC_NAME> <TREATMENT_NAME> antiemetics </TREATMENT_NAME> <BRAND_NAME> SANCUSO </BRAND_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> nausea </DX_NAME> <DX_NAME> feeling_sick </DX_NAME> <DX_NAME> vomiting </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> difficulty_swallowing </DX_NAME> <DX_NAME> soreness </DX_NAME> <DX_NAME> dryness </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> first_day </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> hepatitis </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_problems </DX_NAME> <TREATMENT_NAME> “haemodialysis” </TREATMENT_NAME> <TREATMENT_NAME> “haemodialysis” </TREATMENT_NAME> <TIME_TO_TREATMENT_NAME> in_the_future </TIME_TO_TREATMENT_NAME> <DX_NAME> fendrix </DX_NAME> <AGE> 15 </AGE> <DX_NAME> hepatitis_b </DX_NAME> <DX_NAME> hepatitis_b </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_swollen </DX_NAME> <TIME_TO_DX_NAME> 6_weeks_to_6_months </TIME_TO_DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> flu </DX_NAME> <DX_NAME> headache </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> feeling_very_tired </DX_NAME> <DX_NAME> dark_urine </DX_NAME> <DX_NAME> pale_stools </DX_NAME> <SYSTEM_ORGAN_SITE> faeces </SYSTEM_ORGAN_SITE> <DX_NAME> yellow_skin_or_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> jaundice </DX_NAME> <DX_NAME> hepatitis_b_do_not_look_or_feel_ill </DX_NAME> <DX_NAME> illness </DX_NAME> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_problems </DX_NAME> <DX_NAME> “cirrhosis” </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_cancer </DX_NAME> <TREATMENT_NAME> vaccines </TREATMENT_NAME> <TREATMENT_NAME> vaccinated </TREATMENT_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> infections </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME>
<GENERIC_NAME> galcanezumab </GENERIC_NAME> <DX_NAME> migraine </DX_NAME> <DX_NAME> migraine </DX_NAME> <DX_NAME> migraines </DX_NAME> <DX_NAME> frequency </DX_NAME> <DX_NAME> migraine_headache </DX_NAME> <DX_NAME> improve_your_quality_of_life </DX_NAME>
<BRAND_NAME> zepatier </BRAND_NAME> <BRAND_NAME> zepatier </BRAND_NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <GENERIC_NAME> grazoprevir </GENERIC_NAME> <BRAND_NAME> zepatier </BRAND_NAME> <BRAND_NAME> zepatier </BRAND_NAME> <DX_NAME> hepatitis_c_infection </DX_NAME> <AGE> 18 </AGE> <DX_NAME> hepatitis_c </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_c_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <BRAND_NAME> zepatier </BRAND_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <BRAND_NAME> zepatier </BRAND_NAME>
<GENERIC_NAME> opicapone </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> movement_problems </DX_NAME> <DX_NAME> parkinson's_disease </DX_NAME> <DX_NAME> progressive_disease </DX_NAME> <SYSTEM_ORGAN_SITE> nervous_system </SYSTEM_ORGAN_SITE> <DX_NAME> shaking </DX_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <GENERIC_NAME> dopa_decarboxylase_inhibitors </GENERIC_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> movement_problems </DX_NAME>
<GENERIC_NAME> elebrato_ellipta </GENERIC_NAME> <GENERIC_NAME> elebrato_ellipta </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> umeclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TREATMENT_NAME> steroids </TREATMENT_NAME> <GENERIC_NAME> umeclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <TREATMENT_NAME> bronchodilators </TREATMENT_NAME> <GENERIC_NAME> elebrato_ellipta </GENERIC_NAME> <GENERIC_NAME> elebrato_ellipta </GENERIC_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficult </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <SYSTEM_ORGAN_SITE> small_air_passages </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> copd </DX_NAME> <GENERIC_NAME> elebrato_ellipta </GENERIC_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> attack </DX_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME>
<TREATMENT_NAME> gene_therapy </TREATMENT_NAME> <BRAND_NAME> luxturna </BRAND_NAME> <DX_NAME> vision_loss </DX_NAME> <DX_NAME> retinal_dystrophy </DX_NAME> <DX_NAME> mutations_in_the_rpe65_gene </DX_NAME> <DX_NAME> loss_of_sight </DX_NAME> <DX_NAME> eventual_blindness </DX_NAME> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <DX_NAME> disease_in_humans </DX_NAME> <TEST_NAME> genetic_testing </TEST_NAME> <DX_NAME> vision_loss </DX_NAME> <DX_NAME> mutations_in_the_rpe65_gene </DX_NAME>
<GENERIC_NAME> procoralan </GENERIC_NAME> <BRAND_NAME> ivabradine </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> heart_medicine </TREATMENT_NAME> <DX_NAME> angina_pectoris </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_rate </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> heart_medicines </TREATMENT_NAME> <GENERIC_NAME> betablocker </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_rate </DX_NAME> <GENERIC_NAME> betablocker </GENERIC_NAME> <TREATMENT_NAME> betablocker_therapy </TREATMENT_NAME> <TREATMENT_NAME> beta_blockers </TREATMENT_NAME> <GENERIC_NAME> beta_blockers </GENERIC_NAME> <DX_NAME> angina_pectoris </DX_NAME> <DX_NAME> stable_angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> angina </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> discomfort </DX_NAME> <DX_NAME> angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <SYSTEM_ORGAN_SITE> ankle </SYSTEM_ORGAN_SITE> <DX_NAME> ankle_swelling </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart’s </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> angina_attack </DX_NAME> <DX_NAME> angina_attacks </DX_NAME> <DX_NAME> elevated_heart_rate_adversely_affects </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <BRAND_NAME> ivabradine </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE>
<NAME> lumark </NAME> <GENERIC_NAME> lutetium </GENERIC_NAME> <GENERIC_NAME> chloride </GENERIC_NAME> <TREATMENT_NAME> radiolabelling_medicines </TREATMENT_NAME> <TREATMENT_NAME> radiolabelled) </TREATMENT_NAME> <TREATMENT_NAME> radioactive </TREATMENT_NAME> <TREATMENT_NAME> lutetium </TREATMENT_NAME> <GENERIC_NAME> lutetium </GENERIC_NAME> <TREATMENT_NAME> radiolabel_medicines </TREATMENT_NAME> <GENERIC_NAME> radiolabel_medicines </GENERIC_NAME> <GENERIC_NAME> lutetium </GENERIC_NAME> <GENERIC_NAME> chloride </GENERIC_NAME> <GENERIC_NAME> lutetium </GENERIC_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<GENERIC_NAME> darunavir_mylan </GENERIC_NAME> <GENERIC_NAME> darunavir_mylan </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> antiretroviral_medicines </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME>
<TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> virus_infection </DX_NAME> <DX_NAME> pneumonia </DX_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME>
<GENERIC_NAME> imatinib_teva </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> cml </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> myelodysplastic/myeloproliferative_diseases </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> hypereosinophilic_syndrome </DX_NAME> <DX_NAME> eosinophilic_leukaemia </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> dermatofibrosarcoma_protuberans </DX_NAME> <DX_NAME> dfsp </DX_NAME> <DX_NAME> dfsp </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME>
<GENERIC_NAME> marixino </GENERIC_NAME> <GENERIC_NAME> memantine_hydrochloride </GENERIC_NAME> <DX_NAME> memory_loss </DX_NAME> <DX_NAME> alzheimer’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> marixino </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> alzheimer’s_disease </DX_NAME>
<GENERIC_NAME> parecoxib </GENERIC_NAME> <GENERIC_NAME> dynastat </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <GENERIC_NAME> cox2_inhibitors </GENERIC_NAME> <TREATMENT_NAME> cox2_inhibitors </TREATMENT_NAME> <GENERIC_NAME> cyclooxygenase2_inhibitors </GENERIC_NAME> <TREATMENT_NAME> cyclooxygenase2_inhibitors </TREATMENT_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> swelling </DX_NAME>
<GENERIC_NAME> stocrin </GENERIC_NAME> <GENERIC_NAME> efavirenz </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> nonnucleoside_reverse_transcriptase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> nonnucleoside_reverse_transcriptase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> stocrin </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> stocrin </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <DX_NAME> virus_in_the_blood </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME>
<BRAND_NAME> kisqali </BRAND_NAME> <BRAND_NAME> kisqali </BRAND_NAME> <GENERIC_NAME> ribociclib </GENERIC_NAME> <BRAND_NAME> kisqali </BRAND_NAME> <BRAND_NAME> kisqali </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> aromatase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> aromatase_inhibitor </GENERIC_NAME> <GENERIC_NAME> fulvestrant </GENERIC_NAME> <TREATMENT_NAME> hormonal_anticancer_therapies </TREATMENT_NAME> <DX_NAME> menopause </DX_NAME> <TREATMENT_NAME> luteinising_hormone_releasing_hormone </TREATMENT_NAME> <BRAND_NAME> kisqali </BRAND_NAME> <BRAND_NAME> kisqali </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> kisqali </BRAND_NAME>
<GENERIC_NAME> entecavir </GENERIC_NAME> <TREATMENT_NAME> antiviral_medicines </TREATMENT_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> entecavir </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <GENERIC_NAME> entecavir </GENERIC_NAME> <DX_NAME> hbv_infection </DX_NAME> <TIME_TO_DX_NAME> less_than_18_years </TIME_TO_DX_NAME> <TIME_TO_MEDICATION_NAME> less_than_18_years </TIME_TO_MEDICATION_NAME> <AGE> 18 </AGE> <GENERIC_NAME> entecavir </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <GENERIC_NAME> entecavir </GENERIC_NAME> <DX_NAME> virus_in_your_body </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> cinacalcet_accordpharma </GENERIC_NAME> <GENERIC_NAME> cinacalcet </GENERIC_NAME> <SYSTEM_ORGAN_SITE> parathyroid_glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> parathyroids </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> small_glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> thyroid_gland </SYSTEM_ORGAN_SITE> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <DX_NAME> high_levels_of_calcium </DX_NAME> <DX_NAME> hypercalcaemia </DX_NAME> <DX_NAME> parathyroid_cancer </DX_NAME> <DX_NAME> high_levels_of_calcium </DX_NAME> <DX_NAME> hypercalcaemia </DX_NAME> <DX_NAME> primary_hyperparathyroidism </DX_NAME> <PROCEDURE_NAME> removal_of_the_gland </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> gland </SYSTEM_ORGAN_SITE> <AGE> 18 </AGE> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> parathyroid_glands </SYSTEM_ORGAN_SITE> <DX_NAME> hyperparathyroidism </DX_NAME> <DX_NAME> hyperparathyroidism </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> hyperparathyroidism </DX_NAME> <DX_NAME> loss_of_calcium </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_pain </DX_NAME> <DX_NAME> fractures </DX_NAME> <DX_NAME> problems_with_blood_and_heart_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_stones </DX_NAME> <DX_NAME> mental_illness </DX_NAME> <DX_NAME> coma </DX_NAME>
<BRAND_NAME> brineura </BRAND_NAME> <GENERIC_NAME> cerliponase_alfa </GENERIC_NAME> <TREATMENT_NAME> enzyme_replacement_therapies </TREATMENT_NAME> <GENERIC_NAME> neuronal_ceroid_lipofuscinosis </GENERIC_NAME> <DX_NAME> neuronal_ceroid_lipofuscinosis_type_2 </DX_NAME> <DX_NAME> cln2)_disease </DX_NAME> <GENERIC_NAME> tripeptidyl_peptidase1 </GENERIC_NAME> <DX_NAME> tripeptidyl_peptidase1 </DX_NAME> <DX_NAME> tpp1)_deficiency </DX_NAME> <DX_NAME> cln2_disease </DX_NAME> <DX_NAME> cln2_disease </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> asparaginase </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> amino_acid </GENERIC_NAME> <GENERIC_NAME> asparagine </GENERIC_NAME> <GENERIC_NAME> asparagine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> blood_cancer </DX_NAME>
<BRAND_NAME> fuzeon </BRAND_NAME> <BRAND_NAME> fuzeon </BRAND_NAME> <BRAND_NAME> fuzeon </BRAND_NAME> <BRAND_NAME> fuzeon </BRAND_NAME> <GENERIC_NAME> enfuvirtide </GENERIC_NAME> <BRAND_NAME> fuzeon </BRAND_NAME> <BRAND_NAME> fuzeon </BRAND_NAME> <DX_NAME> human_immune_deficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <BRAND_NAME> fuzeon </BRAND_NAME> <DX_NAME> hiv_infection </DX_NAME> <BRAND_NAME> fuzeon </BRAND_NAME> <DX_NAME> hiv_infection </DX_NAME> <BRAND_NAME> fuzeon </BRAND_NAME> <BRAND_NAME> fuzeon </BRAND_NAME>
<GENERIC_NAME> teriparatide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> terrosa </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> thin </DX_NAME> <DX_NAME> fragile </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME>
<BRAND_NAME> eylea </BRAND_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> macular_degeneration </DX_NAME> <DX_NAME> impaired_vision </DX_NAME> <DX_NAME> macular_oedema </DX_NAME> <SYSTEM_ORGAN_SITE> retinal_vein </SYSTEM_ORGAN_SITE> <DX_NAME> retinal_vein_occlusion </DX_NAME> <DX_NAME> branch_rvo </DX_NAME> <DX_NAME> brvo </DX_NAME> <DX_NAME> central_rvo </DX_NAME> <DX_NAME> crvo </DX_NAME> <DX_NAME> impaired_vision </DX_NAME> <DX_NAME> diabetic_macular_oedema </DX_NAME> <DX_NAME> impaired_vision </DX_NAME> <DX_NAME> myopic_choroidal_neovascularisation </DX_NAME> <DX_NAME> myopic_cnv </DX_NAME> <GENERIC_NAME> aflibercept </GENERIC_NAME> <DX_NAME> placental_growth_factor </DX_NAME> <DX_NAME> abnormal_formation </DX_NAME> <DX_NAME> blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> leak_of_blood </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> damage_to_tissues </DX_NAME> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> crvo </DX_NAME> <DX_NAME> blockage </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <DX_NAME> leakage_of_fluid </DX_NAME> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <DX_NAME> fine_vision </DX_NAME> <DX_NAME> macular_oedema </DX_NAME> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <DX_NAME> macula_swells </DX_NAME> <DX_NAME> central_vision </DX_NAME> <DX_NAME> blurry </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <DX_NAME> leakage_of_fluid </DX_NAME> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <DX_NAME> macular_oedema </DX_NAME> <DX_NAME> diabetic_macular_oedema </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> leaking_of_fluid </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <DX_NAME> blurry </DX_NAME> <DX_NAME> eylea </DX_NAME> <BRAND_NAME> eylea </BRAND_NAME> <DX_NAME> abnormal_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> leak_fluid </DX_NAME> <DX_NAME> bleed </DX_NAME> <DX_NAME> eylea </DX_NAME> <BRAND_NAME> eylea </BRAND_NAME> <DX_NAME> vision_loss </DX_NAME> <DX_NAME> crvo </DX_NAME>
<DX_NAME> perianal_fistulas </DX_NAME> <DX_NAME> crohn´s_disease </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <DX_NAME> perianal_fistulas </DX_NAME> <DX_NAME> abnormal_channels </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> rectum </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> anus </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> anus </SYSTEM_ORGAN_SITE> <DX_NAME> openings </DX_NAME> <SYSTEM_ORGAN_SITE> anus </SYSTEM_ORGAN_SITE> <DX_NAME> perianal_fistulas </DX_NAME> <SYSTEM_ORGAN_SITE> perianal_fistulas </SYSTEM_ORGAN_SITE> <DX_NAME> openings </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> pus </DX_NAME> <DX_NAME> infected_liquid </DX_NAME> <DX_NAME> abscesses </DX_NAME> <DX_NAME> perianal_fistulas </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> irritation </DX_NAME> <DX_NAME> discharge </DX_NAME> <DX_NAME> pus </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> perianal_fistulas </DX_NAME> <SYSTEM_ORGAN_SITE> perianal_fistulas </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> fistulas_healing </DX_NAME> <DX_NAME> fistula </DX_NAME> <BRAND_NAME> alofisel </BRAND_NAME> <GENERIC_NAME> darvadstrocel </GENERIC_NAME> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> fat_tissue </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> allogenic_stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> repair_of_the_tissue </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> saxagliptin </GENERIC_NAME> <TREATMENT_NAME> dpp4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <TREATMENT_NAME> dipeptidyl_peptidase4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> biguanides </GENERIC_NAME> <TREATMENT_NAME> oral_antidiabetics </TREATMENT_NAME> <GENERIC_NAME> antidiabetics </GENERIC_NAME> <BRAND_NAME> komboglyze </BRAND_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> komboglyze </GENERIC_NAME> <GENERIC_NAME> saxagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TREATMENT_NAME> antidiabetic_medicines </TREATMENT_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME>
<DX_NAME> hepatitis_c_infection </DX_NAME> <DX_NAME> ‘hepatitis_c_virus’ </DX_NAME> <DX_NAME> hcv </DX_NAME> <GENERIC_NAME> olysio </GENERIC_NAME> <GENERIC_NAME> olysio </GENERIC_NAME> <DX_NAME> hepatitis_c_infection </DX_NAME> <BRAND_NAME> olysio </BRAND_NAME> <GENERIC_NAME> olysio </GENERIC_NAME> <DX_NAME> hepatitis_c_infection </DX_NAME> <DX_NAME> hepatitis_c_infection </DX_NAME> <DX_NAME> hcv </DX_NAME> <DX_NAME> hepatitis_c_infection </DX_NAME> <DX_NAME> clear_hcv </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> aripiprazole </GENERIC_NAME> <BRAND_NAME> mylan_pharma </BRAND_NAME> <GENERIC_NAME> aripiprazole </GENERIC_NAME> <AGE> 15 </AGE> <DX_NAME> disease_characterised </DX_NAME> <DX_NAME> mistaken_beliefs </DX_NAME> <DX_NAME> incoherent_speech_and_behaviour </DX_NAME> <DX_NAME> emotional_flatness </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <GENERIC_NAME> aripiprazole </GENERIC_NAME> <AGE> 13 </AGE> <DX_NAME> condition_with_symptoms </DX_NAME> <DX_NAME> feeling_"high" </DX_NAME> <DX_NAME> excessive_amounts_of_energy </DX_NAME> <DX_NAME> needing_much_less_sleep_than_usual </DX_NAME> <DX_NAME> racing_ideas </DX_NAME> <DX_NAME> irritability </DX_NAME> <GENERIC_NAME> aripiprazole </GENERIC_NAME>
<GENERIC_NAME> colistimethate_sodium </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> antibiotic </GENERIC_NAME> <GENERIC_NAME> polymyxin </GENERIC_NAME> <NAME> Colobreathe </NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_infections </DX_NAME> <DX_NAME> Pseudomonas_aeruginosa </DX_NAME> <AGE> 6 </AGE> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> Pseudomonas_aeruginosa </DX_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> bacterial_cell_membrane </DX_NAME> <SYSTEM_ORGAN_SITE> membrane </SYSTEM_ORGAN_SITE> <DX_NAME> lethal_effect </DX_NAME>
<DX_NAME> osteoporosis </DX_NAME> <DX_NAME> postmenopausal </DX_NAME> <DX_NAME> fracture </DX_NAME> <DX_NAME> postmenopausal </DX_NAME> <DX_NAME> fracture </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone_tissue </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> fragile </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hips </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_diseases </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> fracture </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> caelyx_pegylated_liposomal </GENERIC_NAME> <TREATMENT_NAME> pegylated_liposomal </TREATMENT_NAME> <TREATMENT_NAME> antitumour_agent </TREATMENT_NAME> <TREATMENT_NAME> caelyx_pegylated_liposomal </TREATMENT_NAME> <GENERIC_NAME> caelyx_pegylated_liposomal </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_problems </DX_NAME> <TREATMENT_NAME> caelyx_pegylated_liposomal </TREATMENT_NAME> <GENERIC_NAME> caelyx_pegylated_liposomal </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> ovary </SYSTEM_ORGAN_SITE> <GENERIC_NAME> caelyx_pegylated_liposomal </GENERIC_NAME> <TREATMENT_NAME> pegylated_liposomal </TREATMENT_NAME> <GENERIC_NAME> medicine </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> therapy </TREATMENT_NAME> <TREATMENT_NAME> caelyx_pegylated_liposomal </TREATMENT_NAME> <GENERIC_NAME> caelyx_pegylated_liposomal </GENERIC_NAME> <DX_NAME> sarcoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> kaposi’s_sarcoma </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> tumour </DX_NAME> <GENERIC_NAME> caelyx_pegylated_liposomal </GENERIC_NAME> <TREATMENT_NAME> caelyx_pegylated_liposomal_contains </TREATMENT_NAME> <GENERIC_NAME> doxorubicin_hydrochloride </GENERIC_NAME> <GENERIC_NAME> caelyx_pegylated_liposomal </GENERIC_NAME> <GENERIC_NAME> pegylated_liposomes </GENERIC_NAME>
<GENERIC_NAME> bevespi_aerosphere </GENERIC_NAME> <GENERIC_NAME> glycopyrronium </GENERIC_NAME> <GENERIC_NAME> formoterol_fumarate_dihydrate </GENERIC_NAME> <GENERIC_NAME> longacting_bronchodilators </GENERIC_NAME> <TREATMENT_NAME> longacting_bronchodilators </TREATMENT_NAME> <TREATMENT_NAME> bevespi_aerosphere </TREATMENT_NAME> <GENERIC_NAME> bevespi_aerosphere </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficult </DX_NAME> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> bevespi_aerosphere_delivers </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> copd </DX_NAME>
<GENERIC_NAME> Olanzapine </GENERIC_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <GENERIC_NAME> Olanzapine </GENERIC_NAME> <GENERIC_NAME> Olanzapine </GENERIC_NAME> <DX_NAME> Schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> manic_episodes </DX_NAME> <DX_NAME> condition_with_symptoms </DX_NAME> <DX_NAME> excitement </DX_NAME> <DX_NAME> euphoria </DX_NAME> <GENERIC_NAME> Olanzapine </GENERIC_NAME> <DX_NAME> recurrence </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> manic_episode </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME>
<DX_NAME> hiv </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <TREATMENT_NAME> cd4_cells </TREATMENT_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> ‘combination_therapy’ </TREATMENT_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> infected_blood </DX_NAME>
<TREATMENT_NAME> radiopharmaceutical_product </TREATMENT_NAME> <BRAND_NAME> neuraceq </BRAND_NAME> <GENERIC_NAME> florbetaben </GENERIC_NAME> <BRAND_NAME> neuraceq </BRAND_NAME> <DX_NAME> memory_problems </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <TEST_NAME> brain_scan </TEST_NAME> <TEST_NAME> pet_scan </TEST_NAME> <TEST_NAME> neuraceq_pet_scan </TEST_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <TEST_NAME> brain_function_tests </TEST_NAME> <DX_NAME> plaques </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <BRAND_NAME> neuraceq </BRAND_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<GENERIC_NAME> piperaquine_tetraphosphate </GENERIC_NAME> <GENERIC_NAME> artenimol </GENERIC_NAME> <DX_NAME> malaria </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> Malaria </DX_NAME> <DX_NAME> infection </DX_NAME>
<GENERIC_NAME> prasugrel </GENERIC_NAME> <GENERIC_NAME> prasugrel </GENERIC_NAME> <TREATMENT_NAME> antiplatelet_agents </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <DX_NAME> blood_clot </DX_NAME> <DX_NAME> thrombus </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> clots </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> myocardial_infarction </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> unstable_angina </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <GENERIC_NAME> prasugrel </GENERIC_NAME> <DX_NAME> blood_clot </DX_NAME> <GENERIC_NAME> prasugrel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> unstable_angina </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> narrowed_artery_supplying_blood </DX_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <GENERIC_NAME> prasugrel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> dying </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> aspirin </GENERIC_NAME> <TREATMENT_NAME> antiplatelet_agent </TREATMENT_NAME>
<DX_NAME> angiotensinii </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_function </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> impaired_kidney_function </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> darunavir_krka </GENERIC_NAME> <GENERIC_NAME> darunavir_krka </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> darunavir_krka </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <GENERIC_NAME> darunavir_krka </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> darunavir_krka </GENERIC_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicines </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicines </GENERIC_NAME> <GENERIC_NAME> darunavir_krka </GENERIC_NAME> <GENERIC_NAME> cobicistat </GENERIC_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME>
<GENERIC_NAME> roflumilast </GENERIC_NAME> <GENERIC_NAME> roflumilast </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd_symptoms </DX_NAME> <DX_NAME> bronchitis </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> disease </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> tightening </DX_NAME> <DX_NAME> obstruction </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <SYSTEM_ORGAN_SITE> walls </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> small_air_passages </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> wheezing </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_tightness </DX_NAME> <DX_NAME> difficulty_in_breathing </DX_NAME> <TREATMENT_NAME> bronchodilators </TREATMENT_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME>
<GENERIC_NAME> filgrastim </GENERIC_NAME> <TEST_NAME> white_blood_cell_growth_factor </TEST_NAME> <TEST_NAME> granulocyte_colony_stimulating_factor </TEST_NAME> <GENERIC_NAME> filgrastim </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TEST_NAME> bone_marrow </TEST_NAME> <DX_NAME> neutropenia </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> filgrastim </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> filgrastim </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplant </PROCEDURE_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> bone_marrow </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> neutropenia </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> infections </DX_NAME>
<SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> inflammation </DX_NAME> <AGE> 18 </AGE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> axial_spondyloarthritis </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> erelzi </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> painful </DX_NAME> <DX_NAME> swollen </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> feet </SYSTEM_ORGAN_SITE> <DX_NAME> erelzi </DX_NAME> <DX_NAME> structural_damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> idiopathic_arthritis </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> polyarthritis </DX_NAME> <TEST_NAME> rheumatoid_factor </TEST_NAME> <DX_NAME> rheumatoid_factor_positive </DX_NAME> <DX_NAME> extended_oligoarthritis </DX_NAME> <AGE> 2 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <AGE> 12 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> enthesitisrelated_arthritis </DX_NAME> <AGE> 12 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> psoriasis </DX_NAME> <AGE> 6 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> inadequate_response </DX_NAME> <TREATMENT_NAME> phototherapies </TREATMENT_NAME> <TREATMENT_NAME> systemic_therapies </TREATMENT_NAME>
<TEST_NAME> breath_test </TEST_NAME> <DX_NAME> helicobacter_pylori </DX_NAME> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <TEST_NAME> breath_test </TEST_NAME> <DX_NAME> pylori_infection </DX_NAME> <DX_NAME> h._pylori </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <GENERIC_NAME> pylobactell </GENERIC_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> truberzi </GENERIC_NAME> <NAME> truberzi </NAME> <GENERIC_NAME> eluxadoline </GENERIC_NAME> <DX_NAME> irritable_bowel_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> diarrhoea </DX_NAME> <DX_NAME> ibs </DX_NAME> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <DX_NAME> gut_disorder </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> stomach_ache </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> stomach_discomfort </DX_NAME> <DX_NAME> diarrhoea </DX_NAME> <DX_NAME> urgent_bowel_movements </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> truberzi_acts </DX_NAME> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowels </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> discomfort </DX_NAME>
<DX_NAME> premature_birth </DX_NAME> <DX_NAME> pregnant </DX_NAME> <TIME_TO_DX_NAME> week_24_to_week_33 </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> week_24_to_week_33 </TIME_TO_DX_NAME> <DX_NAME> pregnancy </DX_NAME> <DX_NAME> contractions </DX_NAME> <SYSTEM_ORGAN_SITE> uterus </SYSTEM_ORGAN_SITE> <DX_NAME> contractions </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> uterus </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> arsenic </GENERIC_NAME> <GENERIC_NAME> trioxide </GENERIC_NAME> <DX_NAME> promyelocytic_leukaemia </DX_NAME> <DX_NAME> apl </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> abnormal_white_blood_cells </DX_NAME> <DX_NAME> abnormal_bleeding </DX_NAME> <DX_NAME> bruising </DX_NAME>
<BRAND_NAME> arava </BRAND_NAME> <TREATMENT_NAME> antirheumatic_medicines </TREATMENT_NAME> <GENERIC_NAME> leflunomide </GENERIC_NAME> <BRAND_NAME> arava </BRAND_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> difficulty_moving </DX_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> loss_of_appetite </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> loss_of_energy </DX_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> lack_of_red_blood_cells </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> difficulty_moving </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> patches_of_red </DX_NAME> <DX_NAME> scaly_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_lesions </DX_NAME>
<GENERIC_NAME> cobicistat </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus1 </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> immune_deficiency_syndrome </DX_NAME> <AGE> 12 </AGE> <TEST_NAME> weighing </TEST_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <TREATMENT_NAME> protease_inhibitors </TREATMENT_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> atazanavir </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME>
<SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> strong_analgesic </TREATMENT_NAME> <DX_NAME> pain </DX_NAME> <TREATMENT_NAME> pain_reliever </TREATMENT_NAME> <GENERIC_NAME> fentanyl </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arm </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <GENERIC_NAME> fentanyl </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> feel_worse </DX_NAME>
<GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <DX_NAME> angiotensinii </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> irbesartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_function </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> impaired_kidney_function </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> blincyto </GENERIC_NAME> <GENERIC_NAME> blinatumomab </GENERIC_NAME> <TREATMENT_NAME> antineoplastic_agents </TREATMENT_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> abnormal_white_blood_cancer </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> relapsed/refractory_acute_lymphoblastic_leukaemia </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> residual_disease </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME>
<TEST_NAME> monoclonal_antibodies </TEST_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <TEST_NAME> fviii_blood_level </TEST_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> blood_to_clot </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> blood_clotting </DX_NAME>
<BRAND_NAME> cellcept </BRAND_NAME> <GENERIC_NAME> mycophenolate_mofetil </GENERIC_NAME> <BRAND_NAME> cellcept </BRAND_NAME> <GENERIC_NAME> croscarmellose_sodium </GENERIC_NAME> <GENERIC_NAME> polyvidone </GENERIC_NAME> <GENERIC_NAME> magnesium_stearate </GENERIC_NAME> <GENERIC_NAME> iron_oxide </GENERIC_NAME> <GENERIC_NAME> red_iron_oxide </GENERIC_NAME> <GENERIC_NAME> titanium_dioxide </GENERIC_NAME> <GENERIC_NAME> black_iron_oxide </GENERIC_NAME> <GENERIC_NAME> potassium_hydroxide </GENERIC_NAME> <URL> https://www.ema.europa.eu </URL> <BRAND_NAME> cellcept </BRAND_NAME> <BRAND_NAME> cellcept </BRAND_NAME> <ADDRESS> gmbh_emilbarellstrasse </ADDRESS> <ADDRESS> 1_79639 </ADDRESS> <ADDRESS> grenzachwyhlen_germany </ADDRESS> <NAME> roche_pharma </NAME> <ADDRESS> emilbarellstr </ADDRESS> <PHONE_OR_FAX> 1,_79639 </PHONE_OR_FAX> <ADDRESS> grenzach_wyhlen,_germany </ADDRESS> <ID> 525_82_11 </ID> <PHONE_OR_FAX> 370_5_2546799 </PHONE_OR_FAX> <NAME> republika_roche </NAME> <NAME> s._r. </NAME> <NAME> o._tel </NAME> <ID> 20382111 </ID> <ADDRESS> magyarország_roche </ADDRESS> <NAME> danmark_roche </NAME> <ADDRESS> malta </ADDRESS> <ADDRESS> ireland)_deutschland_roche_pharma </ADDRESS> <NAME> roche_nederland </NAME> <PHONE_OR_FAX> 438050 </PHONE_OR_FAX> <ADDRESS> eesti_roche_eesti </ADDRESS> <PHONE_OR_FAX> 372_6_177_380 </PHONE_OR_FAX> <ADDRESS> austria_gmbh_tel </ADDRESS> <ADDRESS> españa_roche_farma_s.a._tel </ADDRESS> <NAME> 34_91_324_81_00_polska_roche </NAME> <PHONE_OR_FAX> 425_70_00_112 </PHONE_OR_FAX> <NAME> hrvatska_roche </NAME> <NAME> românia_roche </NAME> <NAME> românia </NAME> <PHONE_OR_FAX> 206_47_01 </PHONE_OR_FAX> <NAME> ireland </NAME> <NAME> slovenija_roche </NAME> <PHONE_OR_FAX> 354_540_8000 </PHONE_OR_FAX> <NAME> roche_slovensko </NAME> <PHONE_OR_FAX> 421_2_52638201 </PHONE_OR_FAX> <NAME> italia_roche </NAME> <NAME> roche </NAME> <NAME> latvija_roche </NAME> <NAME> latvija_sia </NAME> <PHONE_OR_FAX> 371_6_7039831 </PHONE_OR_FAX> <ADDRESS> united_kingdom_roche </ADDRESS>
<GENERIC_NAME> orlistat </GENERIC_NAME> <DX_NAME> weight_loss </DX_NAME> <DX_NAME> overweight </DX_NAME> <TEST_NAME> body_mass_index </TEST_NAME> <TEST_NAME> bmi </TEST_NAME> <DX_NAME> healthy_weight </DX_NAME> <DX_NAME> overweight </DX_NAME> <TEST_NAME> height </TEST_NAME> <DX_NAME> overweight </DX_NAME> <TEST_NAME> height </TEST_NAME> <TEST_NAME> weigh </TEST_NAME> <TEST_NAME> weight </TEST_NAME> <TEST_NAME> height </TEST_NAME> <TEST_NAME> height </TEST_NAME> <TEST_NAME> weight </TEST_NAME> <TEST_NAME> height </TEST_NAME> <TEST_NAME> weight </TEST_NAME> <TEST_NAME> st </TEST_NAME> <TEST_NAME> st </TEST_NAME> <TEST_NAME> st </TEST_NAME> <TEST_NAME> st </TEST_NAME> <TEST_NAME> st </TEST_NAME> <DATE> 5'_8''_13 </DATE> <TEST_NAME> st </TEST_NAME> <DATE> 5'_10''_13 </DATE> <TEST_NAME> st </TEST_NAME> <TEST_NAME> st </TEST_NAME> <DATE> 6'_2''_15 </DATE> <DX_NAME> overweight </DX_NAME> <DX_NAME> overweight </DX_NAME> <DX_NAME> diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <DX_NAME> feel_unwell </DX_NAME> <SYSTEM_ORGAN_SITE> digestive_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> lose_more_weight </DX_NAME>
<GENERIC_NAME> letermovir </GENERIC_NAME> <TIME_TO_PROCEDURE_NAME> recently </TIME_TO_PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplant </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> immune_system_is_weak </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplant </PROCEDURE_NAME> <DX_NAME> ill </DX_NAME> <DX_NAME> cmv </DX_NAME>
<SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> urethra </SYSTEM_ORGAN_SITE> <DX_NAME> smooth_muscle </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <DX_NAME> urinary_symptoms </DX_NAME> <DX_NAME> enlargement </DX_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> prostatic </SYSTEM_ORGAN_SITE> <DX_NAME> prostatic_hyperplasia </DX_NAME> <DX_NAME> difficulty_in_starting_to_pass_water </DX_NAME> <DX_NAME> feeling_of_not_completely_emptying_the_bladder </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE>
<BRAND_NAME> busilvex </BRAND_NAME> <GENERIC_NAME> busulfan </GENERIC_NAME> <GENERIC_NAME> alkylating_agents </GENERIC_NAME> <BRAND_NAME> busilvex </BRAND_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> transplant </PROCEDURE_NAME> <BRAND_NAME> busilvex </BRAND_NAME> <TIME_TO_PROCEDURE_NAME> prior </TIME_TO_PROCEDURE_NAME> <PROCEDURE_NAME> transplantation </PROCEDURE_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <GENERIC_NAME> fludarabine </GENERIC_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <GENERIC_NAME> melphalan </GENERIC_NAME> <PROCEDURE_NAME> transplant </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_or_haematopoietic_progenitor_cell </PROCEDURE_NAME>
<NAME> intanza </NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> complications </DX_NAME> <PROCEDURE_NAME> injection </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> flu_infection </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TIME_TO_TREATMENT_NAME> 23_weeks </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> vaccination </TREATMENT_NAME>
<GENERIC_NAME> rapiscan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart_arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <GENERIC_NAME> rapiscan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TEST_NAME> heart_scan </TEST_NAME> <TEST_NAME> images </TEST_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TEST_NAME> scan </TEST_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hand </SYSTEM_ORGAN_SITE> <TEST_NAME> images </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart_muscles </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_flow </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TEST_NAME> catheterisation </TEST_NAME> <TEST_NAME> imaging </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TEST_NAME> angiography </TEST_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> cardiac_catheterisation </PROCEDURE_NAME> <PROCEDURE_NAME> catheter_is_inserted </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> femoral </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> radial_artery </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> narrowing </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> laventair_ellipta </GENERIC_NAME> <GENERIC_NAME> laventair_ellipta </GENERIC_NAME> <GENERIC_NAME> laventair_ellipta </GENERIC_NAME> <GENERIC_NAME> umeclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <GENERIC_NAME> laventair_ellipta </GENERIC_NAME> <GENERIC_NAME> laventair_ellipta </GENERIC_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> copd </DX_NAME> <GENERIC_NAME> laventair_ellipta </GENERIC_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> attack </DX_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME>
<GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> generalised_anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> peripheral_neuropathic_pain </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> pain_sensations </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> cramping </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> tingling </DX_NAME> <DX_NAME> numbness </DX_NAME> <DX_NAME> pins_and_needles </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> mood_changes </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_seizures </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin_sandoz </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> current </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_treatment </TREATMENT_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> worry </DX_NAME> <DX_NAME> difficult_to_control </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> restlessness </DX_NAME> <DX_NAME> feeling_keyed_up </DX_NAME> <DX_NAME> fatigued </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> difficulty_concentrating </DX_NAME> <DX_NAME> mind_going_blank </DX_NAME> <DX_NAME> feeling_irritable </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_tension </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME>
<BRAND_NAME> synagis </BRAND_NAME> <GENERIC_NAME> palivizumab </GENERIC_NAME> <DX_NAME> respiratory_syncytial_virus </DX_NAME> <DX_NAME> rsv </DX_NAME> <DX_NAME> illness </DX_NAME> <DX_NAME> respiratory_syncytial_virus </DX_NAME> <DX_NAME> rsv </DX_NAME> <DX_NAME> rsv_disease </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_problems </DX_NAME> <BRAND_NAME> synagis </BRAND_NAME> <DX_NAME> rsv_illness </DX_NAME>
<GENERIC_NAME> hydrocortisone </GENERIC_NAME> <GENERIC_NAME> hydrocortisone </GENERIC_NAME> <GENERIC_NAME> glucocorticoid </GENERIC_NAME> <DX_NAME> adrenal_insufficiency </DX_NAME> <DX_NAME> cortisol_deficiency </DX_NAME> <DX_NAME> adrenal_insufficiency </DX_NAME> <SYSTEM_ORGAN_SITE> adrenal_glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <TEST_NAME> hormone_cortisol </TEST_NAME> <DX_NAME> adrenal_insufficiency </DX_NAME> <TREATMENT_NAME> replacement_therapy </TREATMENT_NAME> <DX_NAME> adrenal_insufficiency </DX_NAME> <GENERIC_NAME> hydrocortisone </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TIME_TO_MEDICATION_NAME> throughout_the_day </TIME_TO_MEDICATION_NAME> <TEST_NAME> cortisol_levels </TEST_NAME> <TEST_NAME> cortisol_level </TEST_NAME> <TIME_TO_TEST_NAME> in </TIME_TO_TEST_NAME> <TIME_TO_TEST_NAME> late_evening </TIME_TO_TEST_NAME>
<GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> “insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <AGE> 6 </AGE> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <PROCEDURE_NAME> injection </PROCEDURE_NAME> <TEST_NAME> blood_sugar </TEST_NAME>
<GENERIC_NAME> sildenafil </GENERIC_NAME> <GENERIC_NAME> sildenafil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <GENERIC_NAME> sildenafil </GENERIC_NAME> <DX_NAME> erection </DX_NAME> <DX_NAME> sexually_stimulated </DX_NAME> <GENERIC_NAME> sildenafil </GENERIC_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <DX_NAME> cannot_get </DX_NAME> <DX_NAME> erect_penis_suitable_for_sexual_activity </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> brentuximab_vedotin </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <DX_NAME> hodgkin_lymphoma </DX_NAME> <DX_NAME> anaplastic_large_cell_lymphoma </DX_NAME> <DX_NAME> cutaneous_tcell_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> classical_hodgkin_lymphoma </DX_NAME> <DX_NAME> hodgkin_lymphoma </DX_NAME> <DX_NAME> classical_hodgkin_lymphoma </DX_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> vinblastine </GENERIC_NAME> <GENERIC_NAME> dacarbazine </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> hodgkin_lymphoma </DX_NAME> <DX_NAME> classical_hodgkin_lymphoma </DX_NAME> <PROCEDURE_NAME> autologous_stem_cell_transplant </PROCEDURE_NAME> <DX_NAME> classical_hodgkin_lymphoma </DX_NAME> <TREATMENT_NAME> infusion </TREATMENT_NAME> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> autologous_stem_cell_transplant </PROCEDURE_NAME> <PROCEDURE_NAME> autologous_stem_cell_transplant </PROCEDURE_NAME> <DX_NAME> anaplastic_large_cell_lymphoma </DX_NAME> <DX_NAME> nonhodgkin_lymphoma </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> anaplastic_large_cell_lymphoma </DX_NAME> <GENERIC_NAME> cyclophosphamide </GENERIC_NAME> <GENERIC_NAME> doxorubicin </GENERIC_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> anaplastic_large_cell_lymphoma </DX_NAME> <DX_NAME> cutaneous_tcell_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> cutaneous_tcell_lymphoma </DX_NAME> <DX_NAME> cutaneous_tcell_lymphoma </DX_NAME>
<GENERIC_NAME> fulvestrant </GENERIC_NAME> <GENERIC_NAME> fulvestrant </GENERIC_NAME> <GENERIC_NAME> estrogen_blockers </GENERIC_NAME> <GENERIC_NAME> estrogens </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> fulvestrant </GENERIC_NAME> <DX_NAME> postmenopausal </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> palbociclib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <TREATMENT_NAME> luteinizing_hormone_releasing_hormone </TREATMENT_NAME> <TREATMENT_NAME> lhrh)_agonist </TREATMENT_NAME> <GENERIC_NAME> fulvestrant </GENERIC_NAME> <GENERIC_NAME> palbociclib </GENERIC_NAME> <GENERIC_NAME> palbociclib </GENERIC_NAME> <GENERIC_NAME> palbociclib </GENERIC_NAME>
<BRAND_NAME> ixiaro </BRAND_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> encephalitis_virus </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <BRAND_NAME> ixiaro </BRAND_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> encephalitis_virus </DX_NAME> <ADDRESS> asia </ADDRESS> <DX_NAME> transmitted_to_humans </DX_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> disease </DX_NAME> <DX_NAME> flulike_illness </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> chills </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> headache </DX_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> vomiting </DX_NAME> <DX_NAME> confusion </DX_NAME> <DX_NAME> agitation </DX_NAME> <BRAND_NAME> ixiaro </BRAND_NAME> <NAME> je </NAME>
<DX_NAME> cancer </DX_NAME> <GENERIC_NAME> avapritinib </GENERIC_NAME> <DX_NAME> digestive_tract_cancer </DX_NAME> <DX_NAME> gastrointestinal_stromal_tumour </DX_NAME> <DX_NAME> gist </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> buprenorphine </GENERIC_NAME> <GENERIC_NAME> opioid_medicine </GENERIC_NAME> <TREATMENT_NAME> opioid_medicine </TREATMENT_NAME> <DX_NAME> opioid_dependence </DX_NAME>
<GENERIC_NAME> endolucinbeta </GENERIC_NAME> <GENERIC_NAME> endolucinbeta </GENERIC_NAME> <GENERIC_NAME> lutetium </GENERIC_NAME> <GENERIC_NAME> chloride </GENERIC_NAME> <TREATMENT_NAME> betaradiation </TREATMENT_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME> <GENERIC_NAME> endolucinbeta </GENERIC_NAME> <TREATMENT_NAME> carrier_medicine </TREATMENT_NAME> <TREATMENT_NAME> carrier_medicine </TREATMENT_NAME> <GENERIC_NAME> endolucinbeta </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> carrier_medicines </TREATMENT_NAME> <TREATMENT_NAME> lutetium </TREATMENT_NAME> <GENERIC_NAME> lutetium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> endolucinbeta </GENERIC_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME> <GENERIC_NAME> endolucinbeta </GENERIC_NAME>
<GENERIC_NAME> dexmedetomidine </GENERIC_NAME> <PROCEDURE_NAME> sedation </PROCEDURE_NAME> <DX_NAME> calm </DX_NAME> <DX_NAME> drowsiness </DX_NAME> <DX_NAME> sleep </DX_NAME> <PROCEDURE_NAME> sedation </PROCEDURE_NAME> <PROCEDURE_NAME> surgical_procedures </PROCEDURE_NAME>
<GENERIC_NAME> nicotinic_acid </GENERIC_NAME> <DX_NAME> flushing </DX_NAME> <DX_NAME> side_effect </DX_NAME> <GENERIC_NAME> nicotinic_acid </GENERIC_NAME> <TEST_NAME> cholesterol_level </TEST_NAME> <TEST_NAME> total_cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> apo_b </TEST_NAME> <TEST_NAME> ldl </TEST_NAME> <TEST_NAME> raise_levels </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <TEST_NAME> apo_ai </TEST_NAME> <TEST_NAME> hdl </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> total_cholesterol </TEST_NAME> <TEST_NAME> ldl </TEST_NAME> <TEST_NAME> hdl </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <DX_NAME> plaque </DX_NAME> <DX_NAME> plaque </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> hdl_cholesterol </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <TEST_NAME> triglycerides </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_problems </DX_NAME> <DX_NAME> cholesterol_problems </DX_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> simple_blood_test </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME> <DX_NAME> dyslipidaemia </DX_NAME> <TEST_NAME> cholesterol_levels </TEST_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TREATMENT_NAME> cholesterollowering_medicines </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> dic </DX_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TEST_NAME> mixed_dyslipidaemia </TEST_NAME> <DX_NAME> dyslipidaemia </DX_NAME> <DX_NAME> high_blood_levels_of_‘bad’_ldl_cholesterol_and_triglycerides </DX_NAME> <TEST_NAME> blood_levels </TEST_NAME> <TEST_NAME> ldl_cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME> <TEST_NAME> levels </TEST_NAME> <TEST_NAME> hdl_cholesterol </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME> <TEST_NAME> cholesterol </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME>
<BRAND_NAME> imvanex </BRAND_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> smallpox_infection </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> smallpox_virus </DX_NAME> <BRAND_NAME> imvanex </BRAND_NAME> <GENERIC_NAME> smallpox_virus </GENERIC_NAME> <DX_NAME> smallpox_virus </DX_NAME> <BRAND_NAME> variola </BRAND_NAME> <DX_NAME> smallpox </DX_NAME>
<GENERIC_NAME> catumaxomab </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <DX_NAME> malignant_ascites </DX_NAME> <DX_NAME> malignant_ascites </DX_NAME> <DX_NAME> accumulation_of_fluid </DX_NAME> <SYSTEM_ORGAN_SITE> abdominal_space </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> peritoneal_cavity </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME>
<SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> clot </DX_NAME> <DX_NAME> intravascular_thrombosis </DX_NAME> <BRAND_NAME> CEPROTIN </BRAND_NAME> <DX_NAME> thrombotic </DX_NAME> <DX_NAME> haemorrhagic_skin_lesions </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> purpura </DX_NAME> <DX_NAME> congenital_protein_C_deficiency </DX_NAME> <BRAND_NAME> CEPROTIN </BRAND_NAME> <TREATMENT_NAME> blood_thinner_medication </TREATMENT_NAME> <TREATMENT_NAME> anticoagulant_medication </TREATMENT_NAME> <BRAND_NAME> coumarin </BRAND_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_lesion </DX_NAME> <DX_NAME> necrosis </DX_NAME> <BRAND_NAME> CEPROTIN </BRAND_NAME> <DX_NAME> thrombosis </DX_NAME> <DX_NAME> congenital_protein_C_deficiency </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> invasive_therapy </TREATMENT_NAME> <BRAND_NAME> coumarin </BRAND_NAME> <TREATMENT_NAME> anticoagulant_medication </TREATMENT_NAME> <GENERIC_NAME> anticoagulant_medication </GENERIC_NAME> <TREATMENT_NAME> blood_thinner </TREATMENT_NAME> <GENERIC_NAME> blood_thinner </GENERIC_NAME> <TREATMENT_NAME> therapy </TREATMENT_NAME> <BRAND_NAME> coumarin </BRAND_NAME> <TREATMENT_NAME> coumarin_therapy </TREATMENT_NAME> <BRAND_NAME> coumarin </BRAND_NAME> <TREATMENT_NAME> coumarin_therapy </TREATMENT_NAME>
<GENERIC_NAME> enoxaparin_sodium </GENERIC_NAME> <GENERIC_NAME> heparin </GENERIC_NAME> <GENERIC_NAME> lmwh </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <DX_NAME> illness </DX_NAME> <DX_NAME> unstable_angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_problems </DX_NAME>
<GENERIC_NAME> lynparza </GENERIC_NAME> <GENERIC_NAME> lynparza </GENERIC_NAME> <GENERIC_NAME> olaparib </GENERIC_NAME> <GENERIC_NAME> olaparib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> parp_inhibitor </TREATMENT_NAME> <TREATMENT_NAME> adenosine_diphosphateribose </TREATMENT_NAME> <TREATMENT_NAME> polymerase_inhibitor </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> parp_inhibitors </TREATMENT_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> cancer </DX_NAME> <PROCEDURE_NAME> repair_dna </PROCEDURE_NAME> <GENERIC_NAME> lynparza </GENERIC_NAME> <GENERIC_NAME> lynparza </GENERIC_NAME> <DX_NAME> ovarian_cancer </DX_NAME> <DX_NAME> ovarian_cancer” </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> platinumbased_chemotherapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> telmisartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <TREATMENT_NAME> thiazide_diuretics </TREATMENT_NAME> <TEST_NAME> urine_output </TEST_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME>
<GENERIC_NAME> riprazo </GENERIC_NAME> <GENERIC_NAME> aliskiren </GENERIC_NAME> <GENERIC_NAME> aliskiren_belongs </GENERIC_NAME> <GENERIC_NAME> renin_inhibitors </GENERIC_NAME> <GENERIC_NAME> riprazo </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> renin_inhibitors </GENERIC_NAME> <GENERIC_NAME> angiotensin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> damage_the_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> disorders </DX_NAME>
<GENERIC_NAME> glustin </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <TREATMENT_NAME> antidiabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> antidiabetic_medicine </GENERIC_NAME> <GENERIC_NAME> noninsulin </GENERIC_NAME> <DX_NAME> noninsulin_dependent </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glustin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME>
<BRAND_NAME> rebif </BRAND_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> central_nervous_system </SYSTEM_ORGAN_SITE> <DX_NAME> multiple_sclerosis </DX_NAME> <BRAND_NAME> rebif </BRAND_NAME> <GENERIC_NAME> interferon_beta </GENERIC_NAME> <BRAND_NAME> rebif </BRAND_NAME> <DX_NAME> multiple_sclerosis </DX_NAME>
<GENERIC_NAME> competact </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <TREATMENT_NAME> antidiabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> antidiabetic_medicine </GENERIC_NAME> <DX_NAME> type_2 </DX_NAME> <GENERIC_NAME> noninsulin </GENERIC_NAME> <DX_NAME> noninsulin_dependent </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> overweight </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TREATMENT_NAME> hormone_that_controls_blood_sugar_levels </TREATMENT_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME>
<TREATMENT_NAME> antibiotic_medicine </TREATMENT_NAME> <GENERIC_NAME> tobramycin </GENERIC_NAME> <TREATMENT_NAME> antibiotic_medicines </TREATMENT_NAME> <DX_NAME> cystic_fibrosis </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_infections </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> pseudomonas_aeruginosa </DX_NAME> <DX_NAME> pseudomonas_aeruginosa </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> cystic_fibrosis </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infection </DX_NAME>
<DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> congenital_factor_viii_deficiency </DX_NAME> <DX_NAME> von_willebrand_factor </DX_NAME> <DX_NAME> von_willebrand's_disease </DX_NAME>
<GENERIC_NAME> flucelvax_tetra </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <GENERIC_NAME> vaccine_against_flu </GENERIC_NAME> <TREATMENT_NAME> flu_(influenza </TREATMENT_NAME> <GENERIC_NAME> influenza </GENERIC_NAME> <GENERIC_NAME> flucelvax_tetra </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <GENERIC_NAME> flucelvax_tetra </GENERIC_NAME> <DX_NAME> flu </DX_NAME> <AGE> 9 </AGE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza_virus </DX_NAME> <TIME_TO_DX_NAME> 2020/2021 </TIME_TO_DX_NAME> <DATE> 2020/2021 </DATE>
<GENERIC_NAME> sofosbuvir </GENERIC_NAME> <GENERIC_NAME> velpatasvir </GENERIC_NAME> <DX_NAME> viral_infection </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_C </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> Epclusa </GENERIC_NAME>
<GENERIC_NAME> mycamine </GENERIC_NAME> <GENERIC_NAME> micafungin </GENERIC_NAME> <GENERIC_NAME> mycamine </GENERIC_NAME> <TREATMENT_NAME> antifungal_medicine </TREATMENT_NAME> <GENERIC_NAME> antifungal_medicine </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> fungal_cells </TREATMENT_NAME> <DX_NAME> fungal_cells </DX_NAME> <GENERIC_NAME> mycamine </GENERIC_NAME> <DX_NAME> fungal_infections </DX_NAME> <DX_NAME> fungal </DX_NAME> <DX_NAME> yeast_cells </DX_NAME> <GENERIC_NAME> mycamine </GENERIC_NAME> <DX_NAME> systemic_infections </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> defects </DX_NAME> <GENERIC_NAME> mycamine </GENERIC_NAME> <TREATMENT_NAME> antifungal_treatments </TREATMENT_NAME> <DX_NAME> fungal_infection </DX_NAME> <DX_NAME> candidiasis </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> fungal_infection </DX_NAME> <SYSTEM_ORGAN_SITE> oesophagus </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <PROCEDURE_NAME> bonemarrow_transplant </PROCEDURE_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> levels_of_neutrophils </TEST_NAME> <TEST_NAME> white_blood_cell) </TEST_NAME> <TIME_TO_TEST_NAME> 10 </TIME_TO_TEST_NAME>
<BRAND_NAME> lorviqua </BRAND_NAME> <BRAND_NAME> lorviqua </BRAND_NAME> <GENERIC_NAME> lorlatinib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> nsclc </DX_NAME> <DX_NAME> anaplastic_lymphoma </DX_NAME> <BRAND_NAME> lorviqua </BRAND_NAME> <GENERIC_NAME> alectinib </GENERIC_NAME> <GENERIC_NAME> ceritinib </GENERIC_NAME> <TREATMENT_NAME> alk_inhibitors </TREATMENT_NAME> <TIME_TO_MEDICATION_NAME> previously </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> crizotinib </GENERIC_NAME> <TREATMENT_NAME> alk_inhibitor </TREATMENT_NAME> <BRAND_NAME> lorviqua </BRAND_NAME> <BRAND_NAME> lorviqua </BRAND_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> lorviqua </BRAND_NAME>
<GENERIC_NAME> bivalirudin </GENERIC_NAME> <TREATMENT_NAME> antithrombotic_medicine </TREATMENT_NAME> <TREATMENT_NAME> antithrombotics </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <DX_NAME> coronary_syndromes </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> angioplasty </PROCEDURE_NAME> <PROCEDURE_NAME> percutaneous_coronary_intervention_pci </PROCEDURE_NAME>
<NAME> votubia </NAME> <DX_NAME> votubia </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> everolimus </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> renal_angiomyolipomas </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> subependymal_giant_cell_astrocytomas </DX_NAME> <DX_NAME> genetic_disorder </DX_NAME> <DX_NAME> tuberous_sclerosis </DX_NAME> <DX_NAME> tsc </DX_NAME> <GENERIC_NAME> votubia </GENERIC_NAME> <DX_NAME> tsc </DX_NAME> <DX_NAME> angiomyolipoma </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME>
<GENERIC_NAME> ambrisentan </GENERIC_NAME> <GENERIC_NAME> ambrisentan </GENERIC_NAME> <TREATMENT_NAME> antihypertensives </TREATMENT_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> pulmonary_arterial_hypertension </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> pulmonary_arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> pah </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> tired </DX_NAME> <DX_NAME> dizzy </DX_NAME> <DX_NAME> short_of_breath </DX_NAME> <SYSTEM_ORGAN_SITE> pulmonary_arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <GENERIC_NAME> ambrisentan </GENERIC_NAME> <DX_NAME> pah </DX_NAME>
<NAME> sarclisa </NAME> <NAME> sarclisa </NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> isatuximab </GENERIC_NAME> <TEST_NAME> monoclonal_antibodies </TEST_NAME> <DX_NAME> myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> myeloma </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <NAME> sarclisa </NAME> <GENERIC_NAME> sarclisa </GENERIC_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <GENERIC_NAME> pomalidomide </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> sarclisa </GENERIC_NAME>
<GENERIC_NAME> dapagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <TREATMENT_NAME> oral_antidiabetics </TREATMENT_NAME> <GENERIC_NAME> antidiabetics </GENERIC_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes” </DX_NAME> <AGE> 18 </AGE> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> dapagliflozin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <TREATMENT_NAME> glp1_receptor_agonist </TREATMENT_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> dapagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> overdose </DX_NAME> <GENERIC_NAME> dapagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME>
<BRAND_NAME> dzuveo </BRAND_NAME> <GENERIC_NAME> sufentanil </GENERIC_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <GENERIC_NAME> sufentanil </GENERIC_NAME> <DX_NAME> pain </DX_NAME>
<TREATMENT_NAME> radiopharmaceutical_product </TREATMENT_NAME> <BRAND_NAME> axumin </BRAND_NAME> <GENERIC_NAME> fluciclovine </GENERIC_NAME> <TEST_NAME> pet_scan </TEST_NAME> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <TEST_NAME> tests </TEST_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <TEST_NAME> prostate_specific_antigen </TEST_NAME> <TEST_NAME> psa </TEST_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> axumin_pet_scan </TEST_NAME> <DX_NAME> cancer </DX_NAME> <TEST_NAME> scan </TEST_NAME> <BRAND_NAME> axumin </BRAND_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<PROCEDURE_NAME> injecting </PROCEDURE_NAME> <TEST_NAME> biopoin </TEST_NAME> <GENERIC_NAME> biopoin </GENERIC_NAME> <TEST_NAME> biopoin </TEST_NAME> <GENERIC_NAME> biopoin </GENERIC_NAME> <GENERIC_NAME> epoetin_theta </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TEST_NAME> biopoin </TEST_NAME> <TEST_NAME> biopoin </TEST_NAME> <GENERIC_NAME> biopoin </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> weakness </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> renal_failure </DX_NAME> <DX_NAME> nonmyeloid_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> umeclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> attack </DX_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME>
<SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> tumour </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <TEST_NAME> hormone_receptor </TEST_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <TREATMENT_NAME> aromatase_inhibitor </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <TIME_TO_TREATMENT_NAME> currently </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<GENERIC_NAME> epoetin_zeta </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> eerithroepoehtin </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <TREATMENT_NAME> haemodialysis </TREATMENT_NAME> <PROCEDURE_NAME> peritoneal_dialysis </PROCEDURE_NAME> <TREATMENT_NAME> dialysis </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <GENERIC_NAME> erythropoietin </GENERIC_NAME> <DX_NAME> red_cell_production </DX_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> solid_tumours </DX_NAME> <DX_NAME> malignant_lymphoma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> bone_marrow_cancer </DX_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> knee_replacement_operations </PROCEDURE_NAME> <TREATMENT_NAME> blood_transfusions </TREATMENT_NAME> <DX_NAME> anaemia </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> bone_marrow_disorder </DX_NAME> <DX_NAME> disruption </DX_NAME> <DX_NAME> myelodysplastic_syndromes </DX_NAME> <TREATMENT_NAME> blood_transfusion </TREATMENT_NAME>
<GENERIC_NAME> Opatanol </GENERIC_NAME> <DX_NAME> seasonal_allergic_conjunctivitis </DX_NAME> <DX_NAME> Allergic_conjunctivitis </DX_NAME> <DX_NAME> allergic_reactions </DX_NAME> <DX_NAME> itching </DX_NAME> <DX_NAME> redness </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <GENERIC_NAME> Opatanol </GENERIC_NAME> <DX_NAME> allergic_conditions </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> allergic_reaction </DX_NAME>
<URL> http://www.ema.europa.eu/docs/en </URL> <TIME_TO_MEDICATION_NAME> 2013/03/ </TIME_TO_MEDICATION_NAME> <DATE> 2013/03/wc500139752.doc_74 </DATE> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> soluble_human_insulin </GENERIC_NAME> <GENERIC_NAME> isophane_human_insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> zinc_chloride </GENERIC_NAME> <GENERIC_NAME> glycerol </GENERIC_NAME> <GENERIC_NAME> metacresol </GENERIC_NAME> <GENERIC_NAME> phenol </GENERIC_NAME> <GENERIC_NAME> disodium_phosphate_dihydrate </GENERIC_NAME> <GENERIC_NAME> sodium_hydroxide </GENERIC_NAME> <GENERIC_NAME> hydrochloric_acid </GENERIC_NAME> <GENERIC_NAME> protamine_sulfate </GENERIC_NAME>
<BRAND_NAME> lysodren </BRAND_NAME> <NAME> lysodren </NAME> <GENERIC_NAME> antitumoral_medicine </GENERIC_NAME> <TREATMENT_NAME> antitumoral_medicine </TREATMENT_NAME> <DX_NAME> non_operable </DX_NAME> <DX_NAME> malignant_tumours_of_the_adrenal_glands </DX_NAME> <SYSTEM_ORGAN_SITE> adrenal_glands </SYSTEM_ORGAN_SITE>
<DX_NAME> clot </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> hereditary_factor_viii_deficiency </DX_NAME>
<GENERIC_NAME> teduglutide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> gastrointestinal_tract </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <DX_NAME> short_bowel_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> short_bowel_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> disorder </DX_NAME> <DX_NAME> inability_to_absorb_food_nutrients_and_fluid </DX_NAME> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgical_removal </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> small_intestine </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> valdoxan </GENERIC_NAME> <GENERIC_NAME> agomelatine </GENERIC_NAME> <TREATMENT_NAME> antidepressants </TREATMENT_NAME> <BRAND_NAME> valdoxan </BRAND_NAME> <DX_NAME> depression </DX_NAME> <BRAND_NAME> valdoxan </BRAND_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> disturbance_of_mood </DX_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> deep_sadness </DX_NAME> <DX_NAME> feelings_of_worthlessness </DX_NAME> <DX_NAME> loss_of_interest_in_favourite_activities </DX_NAME> <DX_NAME> sleep_disturbances </DX_NAME> <DX_NAME> feeling_of_being_slowed_down </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> changes_in_weight </DX_NAME> <BRAND_NAME> valdoxan </BRAND_NAME> <DX_NAME> depression </DX_NAME>
<GENERIC_NAME> trastuzumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <TEST_NAME> monoclonal_antibodies </TEST_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> trazimera </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_and_gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> tumour </DX_NAME> <GENERIC_NAME> trazimera </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <TREATMENT_NAME> aromatase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> aromatase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> hormone_receptorpositive </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <DX_NAME> high_levels_of_her2 </DX_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> 5flououracil </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME>
<GENERIC_NAME> lacosamide </GENERIC_NAME> <GENERIC_NAME> lacosamide </GENERIC_NAME> <GENERIC_NAME> lacosamide </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <GENERIC_NAME> lacosamide </GENERIC_NAME> <GENERIC_NAME> lacosamide </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partialonset_seizure </DX_NAME> <DX_NAME> generalisation </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> lacosamide </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME>
<GENERIC_NAME> ospemifene </GENERIC_NAME> <GENERIC_NAME> ospemifene </GENERIC_NAME> <TREATMENT_NAME> selective_estrogen_receptor_modulators </TREATMENT_NAME> <NAME> senshio </NAME> <DX_NAME> postmenopausal_symptoms </DX_NAME> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> itching </DX_NAME> <DX_NAME> dryness </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> dyspareunia </DX_NAME> <TREATMENT_NAME> local_oestrogen_therapy </TREATMENT_NAME> <DX_NAME> vulvar_and_vaginal_atrophy </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vaginal_walls </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <DX_NAME> postmenopause </DX_NAME> <GENERIC_NAME> oestrogen </GENERIC_NAME> <DX_NAME> vulvar_and_vaginal_atrophy </DX_NAME>
<BRAND_NAME> gardasil </BRAND_NAME> <AGE> 9 </AGE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <AGE> 9 </AGE> <DX_NAME> human_papillomavirus </DX_NAME> <DX_NAME> hpv </DX_NAME> <DATE> 11,_16,_18,_31,_33,_45,_52 </DATE> <DX_NAME> precancerous_lesions </DX_NAME> <DX_NAME> cancers </DX_NAME> <SYSTEM_ORGAN_SITE> genitals </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cervix </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vulva </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> precancerous_lesions </DX_NAME> <DX_NAME> cancers </DX_NAME> <SYSTEM_ORGAN_SITE> anus </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> genital </SYSTEM_ORGAN_SITE> <DX_NAME> genital_warts </DX_NAME> <BRAND_NAME> gardasil </BRAND_NAME> <AGE> 9 </AGE> <AGE> 9 </AGE> <TIME_TO_MEDICATION_NAME> 9_to_26 </TIME_TO_MEDICATION_NAME> <AGE> 26 </AGE> <AGE> 9 </AGE> <AGE> 45 </AGE> <AGE> 9 </AGE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> hpv_related_diseases </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> disease </DX_NAME> <DX_NAME> hpv </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> infected </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> hpvrelated_diseases </DX_NAME> <TREATMENT_NAME> vaccinated </TREATMENT_NAME> <BRAND_NAME> gardasil </BRAND_NAME> <TREATMENT_NAME> full_vaccination </TREATMENT_NAME> <BRAND_NAME> gardasil </BRAND_NAME> <GENERIC_NAME> hpv_vaccine </GENERIC_NAME> <TREATMENT_NAME> hpv_vaccine </TREATMENT_NAME> <BRAND_NAME> gardasil </BRAND_NAME> <BRAND_NAME> gardasil </BRAND_NAME>
<DX_NAME> clots </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> bleeding_disorder </DX_NAME> <DX_NAME> factor_viii_deficiency </DX_NAME> <DX_NAME> factor_viii_is_missing </DX_NAME> <DX_NAME> factor_viii_level </DX_NAME> <DX_NAME> bleeding_tendency </DX_NAME>
<BRAND_NAME> foscan </BRAND_NAME> <GENERIC_NAME> temoporfin </GENERIC_NAME> <BRAND_NAME> foscan </BRAND_NAME> <GENERIC_NAME> porphyrin_photosensitising_medicine </GENERIC_NAME> <DX_NAME> sensitivity_to_light </DX_NAME> <TREATMENT_NAME> photodynamic_therapy </TREATMENT_NAME> <BRAND_NAME> foscan </BRAND_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> neck_cancer </DX_NAME>
<GENERIC_NAME> yescarta </GENERIC_NAME> <TREATMENT_NAME> modified_cell_therapy” </TREATMENT_NAME> <GENERIC_NAME> yescarta </GENERIC_NAME> <TREATMENT_NAME> modified_white_blood_cells </TREATMENT_NAME> <TREATMENT_NAME> infusion </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <DX_NAME> bcell_lymphoma </DX_NAME> <DX_NAME> dlbcl </DX_NAME> <DX_NAME> bcell_lymphoma </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> fluenz_tetra </GENERIC_NAME> <NAME> fluenz_tetra </NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> flu) </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza_virus </DX_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME>
<GENERIC_NAME> paglitaz </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <TREATMENT_NAME> antidiabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> antidiabetic_medicine </GENERIC_NAME> <DX_NAME> type_2 </DX_NAME> <GENERIC_NAME> noninsulin </GENERIC_NAME> <DX_NAME> noninsulin_dependent </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> paglitaz </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> 3_to_6_months </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> paglitaz </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME>
<TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> imipenem </GENERIC_NAME> <GENERIC_NAME> cilastatin </GENERIC_NAME> <GENERIC_NAME> relebactam </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <AGE> 18 </AGE>
<NAME> libtayo </NAME> <GENERIC_NAME> cemiplimab </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> cutaneous_squamous_cell_carcinoma </DX_NAME> <DX_NAME> cancer </DX_NAME>
<BRAND_NAME> avanafil </BRAND_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_(pde5)_inhibitors </TREATMENT_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <DX_NAME> cannot_get </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <DX_NAME> sexual_activity </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <DX_NAME> erectile_dysfunction </DX_NAME>
<GENERIC_NAME> lamivudine </GENERIC_NAME> <BRAND_NAME> teva </BRAND_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <DX_NAME> hepatitis_b_infection </DX_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <TREATMENT_NAME> antiviral_medicine </TREATMENT_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <TREATMENT_NAME> nucleoside_analogue_reverse_transcriptase_inhibitors </TREATMENT_NAME> <DX_NAME> hepatitis_b_is_a_virus </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_damage </DX_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <GENERIC_NAME> hepatitis_b_virus </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_damage </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_function </DX_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <TEST_NAME> blood_tests </TEST_NAME>
<TREATMENT_NAME> twinrix_paediatric </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> hepatitis_a_and_hepatitis </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> infectious_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_a_virus </DX_NAME> <DX_NAME> hepatitis_a_virus </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <TIME_TO_DX_NAME> 3_to_6_weeks </TIME_TO_DX_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> feeling_sick </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> aches </DX_NAME> <DX_NAME> pains </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> jaundice </DX_NAME> <DX_NAME> jaundice </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> swollen </DX_NAME> <DX_NAME> inflamed </DX_NAME> <DX_NAME> vaginal_secretions </DX_NAME> <DX_NAME> infected </DX_NAME> <TREATMENT_NAME> vaccination </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME>
<GENERIC_NAME> erenumab </GENERIC_NAME> <DX_NAME> migraine </DX_NAME> <DX_NAME> migraine </DX_NAME> <DX_NAME> migraine </DX_NAME>
<GENERIC_NAME> cystadrops </GENERIC_NAME> <GENERIC_NAME> cystadrops </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <GENERIC_NAME> cysteamine </GENERIC_NAME> <GENERIC_NAME> mercaptamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cornea </SYSTEM_ORGAN_SITE> <DX_NAME> cystinosis </DX_NAME> <DX_NAME> cystinosis_cystinosis </DX_NAME> <DX_NAME> hereditary_disease </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> amino_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> accumulation_of_crystals </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> increased_sensitivity_to_light </DX_NAME> <DX_NAME> photophobia </DX_NAME> <DX_NAME> corneal_deterioration </DX_NAME> <DX_NAME> keratopathy </DX_NAME> <DX_NAME> loss_of_vision </DX_NAME>
<GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> generalised_anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> peripheral_neuropathic_pain </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> shingles </DX_NAME> <DX_NAME> pain_sensations </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> cramping </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> tingling </DX_NAME> <DX_NAME> numbness </DX_NAME> <DX_NAME> pins_and_needles </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> mood_changes </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_seizures </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_treatment </TREATMENT_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> worry </DX_NAME> <DX_NAME> difficult_to_control </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> restlessness </DX_NAME> <DX_NAME> feeling_keyed_up </DX_NAME> <DX_NAME> fatigued </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> difficulty_concentrating </DX_NAME> <DX_NAME> mind_going_blank </DX_NAME> <DX_NAME> feeling_irritable </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_tension </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME>
<GENERIC_NAME> nevirapine </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> nevirapine </GENERIC_NAME> <GENERIC_NAME> nevirapine </GENERIC_NAME> <TREATMENT_NAME> nonnucleoside_reverse_transcriptase_inhibitors </TREATMENT_NAME> <TREATMENT_NAME> reverse_transcriptase </TREATMENT_NAME> <GENERIC_NAME> nevirapine </GENERIC_NAME> <TREATMENT_NAME> reverse_transcriptase </TREATMENT_NAME> <GENERIC_NAME> nevirapine </GENERIC_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> nevirapine </GENERIC_NAME> <GENERIC_NAME> nevirapine </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> nevirapine </GENERIC_NAME>
<GENERIC_NAME> midazolam </GENERIC_NAME> <GENERIC_NAME> midazolam </GENERIC_NAME> <GENERIC_NAME> benzodiazepines </GENERIC_NAME> <DX_NAME> convulsive </DX_NAME> <DX_NAME> seizure </DX_NAME> <TREATMENT_NAME> resuscitation </TREATMENT_NAME> <DX_NAME> epilepsy </DX_NAME>
<GENERIC_NAME> glyxambi </GENERIC_NAME> <GENERIC_NAME> antidiabetic_medicine </GENERIC_NAME> <GENERIC_NAME> empagliflozin </GENERIC_NAME> <GENERIC_NAME> linagliptin </GENERIC_NAME> <GENERIC_NAME> empagliflozin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_glucose_levels </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> linagliptin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glyxambi </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> sulphonylurea </DX_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <GENERIC_NAME> empagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> sulphonylurea </DX_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <GENERIC_NAME> linagliptin </GENERIC_NAME> <GENERIC_NAME> glyxambi </GENERIC_NAME> <GENERIC_NAME> empagliflozin </GENERIC_NAME> <GENERIC_NAME> linagliptin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> poor_circulation </DX_NAME> <SYSTEM_ORGAN_SITE> limbs </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> peginterferon_beta1a </GENERIC_NAME> <GENERIC_NAME> peginterferon_beta1a </GENERIC_NAME> <GENERIC_NAME> interferon </GENERIC_NAME> <GENERIC_NAME> interferons </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <AGE> 18 </AGE> <SYSTEM_ORGAN_SITE> central_nervous_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cns </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> relapsingremitting </DX_NAME> <DX_NAME> periods </DX_NAME> <DX_NAME> flareups_of_symptoms </DX_NAME> <DX_NAME> relapses </DX_NAME> <DX_NAME> feeling_offbalance_or_light_headed </DX_NAME> <DX_NAME> walking_problems </DX_NAME> <DX_NAME> stiffness </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_spasms </DX_NAME> <DX_NAME> tiredness </DX_NAME> <DX_NAME> numbness </DX_NAME> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arms </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> bladder_and_bowel_problems </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> sexual_problems </DX_NAME> <DX_NAME> vision_difficulty_thinking_and_concentrating </DX_NAME> <DX_NAME> depression </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> aclasta </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <DX_NAME> postmenopausal </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <TREATMENT_NAME> corticosteroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> paget’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> thinning </DX_NAME> <DX_NAME> weakening </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> break_more_easily </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <TREATMENT_NAME> steroids </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> breaking_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> decreased_circulating_levels </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> trauma </DX_NAME> <DX_NAME> fall </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_breaks </DX_NAME> <DX_NAME> paget’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> paget’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> weaker_than_normal </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> deformed </DX_NAME> <DX_NAME> painful </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> xyrem </GENERIC_NAME> <GENERIC_NAME> sodium_oxybate </GENERIC_NAME> <GENERIC_NAME> xyrem </GENERIC_NAME> <BRAND_NAME> xyrem </BRAND_NAME> <DX_NAME> narcolepsy </DX_NAME> <DX_NAME> cataplexy </DX_NAME> <DX_NAME> narcolepsy </DX_NAME> <DX_NAME> sleep_disorder </DX_NAME> <DX_NAME> attacks_of_sleep </DX_NAME> <DX_NAME> cataplexy </DX_NAME> <DX_NAME> sleep_paralysis </DX_NAME> <DX_NAME> hallucinations </DX_NAME> <DX_NAME> poor_sleep </DX_NAME> <DX_NAME> cataplexy </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_weakness </DX_NAME> <DX_NAME> paralysis </DX_NAME> <DX_NAME> losing_consciousness </DX_NAME> <DX_NAME> emotional_reaction </DX_NAME> <DX_NAME> anger </DX_NAME> <DX_NAME> fear </DX_NAME> <DX_NAME> joy </DX_NAME> <NAME> joy </NAME> <DX_NAME> laughter </DX_NAME>
<BRAND_NAME> simponi </BRAND_NAME> <GENERIC_NAME> golimumab </GENERIC_NAME> <BRAND_NAME> simponi </BRAND_NAME> <DX_NAME> polyarticular_juvenile_idiopathic_arthritis </DX_NAME> <BRAND_NAME> simponi </BRAND_NAME> <DX_NAME> necrosis_factor_alpha’ </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> polyarticular_juvenile_idiopathic_arthritis </DX_NAME> <DX_NAME> polyarticular_juvenile_idiopathic_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> joint_pain </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> polyarticular_juvenile_idiopathic_arthritis </DX_NAME> <BRAND_NAME> simponi </BRAND_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME>
<GENERIC_NAME> zonisamide </GENERIC_NAME> <GENERIC_NAME> zonisamide </GENERIC_NAME> <GENERIC_NAME> zonisamide </GENERIC_NAME> <DX_NAME> seizures </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> partial_seizure </DX_NAME> <DX_NAME> seizure </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> zonisamide </GENERIC_NAME> <DX_NAME> seizures </DX_NAME> <DX_NAME> seizures </DX_NAME>
<GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> ‘azacitidine’ </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <PROCEDURE_NAME> stem_cell_transplantation </PROCEDURE_NAME> <DX_NAME> higherrisk_myelodysplastic_syndromes </DX_NAME> <DX_NAME> mds </DX_NAME> <DX_NAME> myelomonocytic_leukaemia </DX_NAME> <DX_NAME> cmml </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> aml </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> azacitidine </GENERIC_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME> <TEST_NAME> ribonucleic_acid </TEST_NAME> <TEST_NAME> rna) </TEST_NAME> <TEST_NAME> deoxyribonucleic_acid </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> myelodysplastic_disorders </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> azacitidine </GENERIC_NAME>
<GENERIC_NAME> “rituximab” </GENERIC_NAME> <GENERIC_NAME> rituximab </GENERIC_NAME> <BRAND_NAME> Rixathon </BRAND_NAME> <BRAND_NAME> Rixathon </BRAND_NAME> <DX_NAME> Non-Hodgkin’s_Lymphoma </DX_NAME> <SYSTEM_ORGAN_SITE> lymph_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <BRAND_NAME> Rixathon </BRAND_NAME> <TREATMENT_NAME> “chemotherapy” </TREATMENT_NAME> <BRAND_NAME> Rixathon </BRAND_NAME> <NAME> Rixathon </NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> CLL </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <DX_NAME> CLL </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <DX_NAME> CLL </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> Rheumatoid_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> Rheumatoid_arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> side_effects </DX_NAME> <BRAND_NAME> Rixathon </BRAND_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <TEST_NAME> blood_test </TEST_NAME> <TEST_NAME> rheumatoid_factor </TEST_NAME> <TEST_NAME> anti-_Cyclic_Citrullinated_Peptide </TEST_NAME> <TEST_NAME> anti-CCP </TEST_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> Granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> Wegener’s_granulomatosis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> Granulomatosis </DX_NAME> <DX_NAME> polyangiitis </DX_NAME> <DX_NAME> microscopic_polyangiitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> Pemphigus_vulgaris </DX_NAME> <DX_NAME> pemphigus_vulgaris </DX_NAME> <DX_NAME> Pemphigus_vulgaris </DX_NAME> <DX_NAME> autoimmune_condition </DX_NAME> <DX_NAME> painful_blisters </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lining_of_the_mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> genitals </SYSTEM_ORGAN_SITE>
<BRAND_NAME> mirvaso </BRAND_NAME> <GENERIC_NAME> brimonidine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE> <DX_NAME> redness </DX_NAME> <DX_NAME> rosacea </DX_NAME> <DX_NAME> redness </DX_NAME> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE> <DX_NAME> rosacea </DX_NAME> <DX_NAME> high_levels_of_blood_flow </DX_NAME> <SYSTEM_ORGAN_SITE> facial_skin </SYSTEM_ORGAN_SITE> <DX_NAME> enlargement </DX_NAME> <DX_NAME> dilation </DX_NAME> <SYSTEM_ORGAN_SITE> small_blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <BRAND_NAME> mirvaso </BRAND_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> blood_flow </DX_NAME> <DX_NAME> redness </DX_NAME>
<GENERIC_NAME> ‘decitabine’ </GENERIC_NAME> <GENERIC_NAME> dacogen </GENERIC_NAME> <GENERIC_NAME> dacogen </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <GENERIC_NAME> dacogen </GENERIC_NAME> <DX_NAME> aml </DX_NAME>
<BRAND_NAME> Zynquista </BRAND_NAME> <GENERIC_NAME> sotagliflozin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> Sotagliflozin </GENERIC_NAME> <DX_NAME> passed_out_in_urine </DX_NAME> <DX_NAME> diabetes </DX_NAME> <BRAND_NAME> Zynquista </BRAND_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TEST_NAME> body_mass_index </TEST_NAME> <TEST_NAME> BMI </TEST_NAME> <TEST_NAME> BMI </TEST_NAME> <TEST_NAME> weight </TEST_NAME> <TEST_NAME> height </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME>
<GENERIC_NAME> paliperidone </GENERIC_NAME> <TREATMENT_NAME> antipsychotic_medicines </TREATMENT_NAME> <TREATMENT_NAME> maintenance_treatment </TREATMENT_NAME> <DX_NAME> schizophrenia </DX_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME> <GENERIC_NAME> risperidone </GENERIC_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME> <GENERIC_NAME> risperidone </GENERIC_NAME> <TIME_TO_MEDICATION_NAME> in_the_past </TIME_TO_MEDICATION_NAME> <TIME_TO_MEDICATION_NAME> in_the_past </TIME_TO_MEDICATION_NAME> <TIME_TO_MEDICATION_NAME> prior </TIME_TO_MEDICATION_NAME> <TIME_TO_MEDICATION_NAME> prior </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> paliperidone </GENERIC_NAME> <GENERIC_NAME> risperidone </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> hallucinations </DX_NAME> <DX_NAME> delusions </DX_NAME> <DX_NAME> lack_of_behaviours </DX_NAME> <DX_NAME> feelings_that_are_normally_present </DX_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> trouble_speaking_in_a_clear_and_logical_way </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> tense </DX_NAME>
<TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <TREATMENT_NAME> integrase_strand_transfer_inhibitor </TREATMENT_NAME> <GENERIC_NAME> emtricitabine </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> nucleoside_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> tenofovir_alafenamide </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> nucleotide_reverse_transcriptase_inhibitor </TREATMENT_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME>
<GENERIC_NAME> verteporfin </GENERIC_NAME> <TREATMENT_NAME> photodynamic_therapy </TREATMENT_NAME> <GENERIC_NAME> visudyne </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> macular_degeneration </DX_NAME> <DX_NAME> pathological_myopia </DX_NAME> <DX_NAME> vision_loss </DX_NAME> <DX_NAME> vision_loss </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lightsensitive_membrane </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> choroidal_neovascularisation </DX_NAME> <DX_NAME> macular_degeneration </DX_NAME> <DX_NAME> choroidal_neovascularisation </DX_NAME> <DX_NAME> pathological_myopia </DX_NAME>
<BRAND_NAME> tecfidera </BRAND_NAME> <BRAND_NAME> tecfidera </BRAND_NAME> <GENERIC_NAME> dimethyl_fumarate </GENERIC_NAME> <BRAND_NAME> tecfidera </BRAND_NAME> <BRAND_NAME> tecfidera </BRAND_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> central_nervous_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cns </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <DX_NAME> relapsingremitting </DX_NAME> <DX_NAME> relapses </DX_NAME> <SYSTEM_ORGAN_SITE> nervous_system </SYSTEM_ORGAN_SITE> <DX_NAME> nervous_system_symptoms </DX_NAME> <DX_NAME> walking_difficulties </DX_NAME> <DX_NAME> feeling_off_balance </DX_NAME> <DX_NAME> visual_difficulties </DX_NAME> <DX_NAME> blurred </DX_NAME> <DX_NAME> double_vision </DX_NAME> <BRAND_NAME> tecfidera </BRAND_NAME> <BRAND_NAME> tecfidera </BRAND_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> generalised_anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_seizures </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_treatment </TREATMENT_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> worry </DX_NAME> <DX_NAME> difficult_to_control </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> restlessness </DX_NAME> <DX_NAME> feeling_keyed_up </DX_NAME> <DX_NAME> fatigued </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> difficulty_concentrating </DX_NAME> <DX_NAME> mind_going_blank </DX_NAME> <DX_NAME> feeling_irritable </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_tension </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME>
<GENERIC_NAME> ibandronic_acid_teva </GENERIC_NAME> <GENERIC_NAME> ibandronic_acid </GENERIC_NAME> <GENERIC_NAME> ibandronic_acid_teva </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <DX_NAME> lost_from_your_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME>
<BRAND_NAME> toviaz </BRAND_NAME> <GENERIC_NAME> fesoterodine_fumarate </GENERIC_NAME> <TREATMENT_NAME> antimuscarinic_treatment </TREATMENT_NAME> <DX_NAME> overactive_bladder </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <BRAND_NAME> toviaz </BRAND_NAME> <DX_NAME> overactive_bladder </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> able_to_control </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> urgency_incontinence </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> urgency </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> urinary_frequency </DX_NAME>
<DX_NAME> gastroenteropancreatic_neuroendocrine_tumours </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> death </DX_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<GENERIC_NAME> brexpiprazole </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> hearing </DX_NAME> <DX_NAME> incoherent_speech_and_behaviour </DX_NAME> <DX_NAME> emotional_flatness </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> relapse </DX_NAME>
<GENERIC_NAME> ixekizumab </GENERIC_NAME> <DX_NAME> inflammatory_diseases </DX_NAME> <DX_NAME> plaque_psoriasis </DX_NAME> <DX_NAME> plaque_psoriasis </DX_NAME> <AGE> 6 </AGE> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> spondyloarthritis </DX_NAME> <DX_NAME> axial_spondyloarthritis </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> plaque_psoriasis </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_condition </DX_NAME> <DX_NAME> “plaque_psoriasis” </DX_NAME> <AGE> 6 </AGE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> scaling </DX_NAME> <DX_NAME> itching </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> “psoriatic_arthritis” </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <GENERIC_NAME> taltz </GENERIC_NAME> <GENERIC_NAME> taltz </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> taltz </GENERIC_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> spinal_joints </SYSTEM_ORGAN_SITE> <DX_NAME> axial_spondyloarthritis </DX_NAME> <TEST_NAME> xrays </TEST_NAME> <DX_NAME> axial_spondyloarthritis” </DX_NAME> <TEST_NAME> xrays </TEST_NAME> <DX_NAME> axial_spondyloarthritis” </DX_NAME> <DX_NAME> axial_spondyloarthritis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> improve_your_physical_function </DX_NAME>
<SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <GENERIC_NAME> pegaptanib </GENERIC_NAME> <DX_NAME> abnormal_formation </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> macular_degeneration </DX_NAME> <DX_NAME> vision_loss </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> part_of_the_retina </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> abnormal_blood_vessels_grow </DX_NAME> <SYSTEM_ORGAN_SITE> retina </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> bleed </DX_NAME> <DX_NAME> leak_fluid </DX_NAME> <SYSTEM_ORGAN_SITE> macula </SYSTEM_ORGAN_SITE> <DX_NAME> macula_to_bulge </DX_NAME> <DX_NAME> vision_loss </DX_NAME> <DX_NAME> abnormal_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> bleeding </DX_NAME> <DX_NAME> leakage </DX_NAME> <DX_NAME> abnormal_blood_vessels_growth </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE>
<DX_NAME> hiv </DX_NAME> <DX_NAME> immunodeficiency_virus’ </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> nonnucleoside_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <TREATMENT_NAME> lamivudine_a_nucleoside_analogue_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <TREATMENT_NAME> tenofovir_disoproxil_a_nucleoside_analogue_reverse_transcriptase_inhibitor </TREATMENT_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> immune_deficiency_syndrome’ </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> hiv </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> early_death </DX_NAME> <DX_NAME> catching_infections </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> immune_system_is_weak </DX_NAME>
<GENERIC_NAME> orgalutran </GENERIC_NAME> <GENERIC_NAME> ganirelix </GENERIC_NAME> <TREATMENT_NAME> gnrh_regulates </TREATMENT_NAME> <DX_NAME> follicles_in_the_ovaries </DX_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <DX_NAME> follicles </DX_NAME> <PROCEDURE_NAME> release_the_mature_egg_cells </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> follicles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> vitro_fertilisation </TREATMENT_NAME> <TREATMENT_NAME> ivf </TREATMENT_NAME> <DX_NAME> pregnant </DX_NAME> <PROCEDURE_NAME> release_of_egg_cells </PROCEDURE_NAME> <TREATMENT_NAME> recombinant_follicle_stimulating_hormone </TREATMENT_NAME> <GENERIC_NAME> corifollitropin_alfa </GENERIC_NAME> <TREATMENT_NAME> follicle_stimulant </TREATMENT_NAME>
<GENERIC_NAME> genvoya </GENERIC_NAME> <GENERIC_NAME> genvoya </GENERIC_NAME> <GENERIC_NAME> genvoya </GENERIC_NAME> <GENERIC_NAME> elvitegravir </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> integrase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> cobicistat </GENERIC_NAME> <TREATMENT_NAME> booster </TREATMENT_NAME> <GENERIC_NAME> elvitegravir_emtricitabine </GENERIC_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> nucleoside_reverse_transcriptase_inhibitor </GENERIC_NAME> <TREATMENT_NAME> nucleoside_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> tenofovir_alafenamide </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> nucleotide_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> genvoya </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME>
<GENERIC_NAME> fluad_tetra </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> flu_(influenza </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza_virus </DX_NAME> <DX_NAME> flu </DX_NAME> <GENERIC_NAME> fluad_tetra </GENERIC_NAME> <DX_NAME> flu </DX_NAME> <AGE> 65 </AGE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza_virus </DX_NAME>
<GENERIC_NAME> ropeginterferon_alfa2b </GENERIC_NAME> <GENERIC_NAME> interferons </GENERIC_NAME> <GENERIC_NAME> interferons </GENERIC_NAME> <GENERIC_NAME> polycythaemia_vera </GENERIC_NAME> <DX_NAME> polycythaemia_vera </DX_NAME> <GENERIC_NAME> polycythaemia_vera </GENERIC_NAME> <DX_NAME> polycythaemia_vera </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> clot </DX_NAME>
<TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> hepatitis_a_and_hepatitis </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis_a_virus </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> swollen </DX_NAME> <DX_NAME> inflamed </DX_NAME> <DX_NAME> infected_person </DX_NAME> <TIME_TO_DX_NAME> 3_to_6_weeks </TIME_TO_DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> feel_sick </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> aches </DX_NAME> <DX_NAME> pains </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> dark_urine </DX_NAME> <DX_NAME> pale_faeces </DX_NAME> <DX_NAME> yellowish_skin_or_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> jaundice </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> swollen </DX_NAME> <DX_NAME> inflamed </DX_NAME> <DX_NAME> virus </DX_NAME> <DX_NAME> infected_person </DX_NAME> <DX_NAME> vaginal_secretions </DX_NAME> <TIME_TO_DX_NAME> 6_weeks_to </TIME_TO_DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> infected_look_or_feel_ill </DX_NAME> <DX_NAME> feel_sick </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> aches </DX_NAME> <DX_NAME> pains </DX_NAME> <DX_NAME> very_ill </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> dark_urine </DX_NAME> <DX_NAME> pale_faeces </DX_NAME> <DX_NAME> yellowish_skin_or_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> jaundice </DX_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_problems </DX_NAME> <DX_NAME> scarring </DX_NAME> <DX_NAME> cirrhosis </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_cancer </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> hepatitis_a_or_b_infections </DX_NAME> <TREATMENT_NAME> vaccines </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <BRAND_NAME> ambirix </BRAND_NAME> <DX_NAME> hepatitis_a_or_b_virus </DX_NAME> <BRAND_NAME> ambirix </BRAND_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> hepatitis_a_or_b_viruses </DX_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> infections </DX_NAME> <DX_NAME> hepatitis_a_or_b_virus </DX_NAME>
<BRAND_NAME> myalepta </BRAND_NAME> <GENERIC_NAME> metreleptin </GENERIC_NAME> <GENERIC_NAME> metreleptin </GENERIC_NAME> <BRAND_NAME> myalepta </BRAND_NAME> <BRAND_NAME> myalepta </BRAND_NAME> <DX_NAME> lipodystrophy </DX_NAME> <DX_NAME> generalised_lipodystrophy </DX_NAME> <DX_NAME> partial_lipodystrophy </DX_NAME> <DX_NAME> congenital_or_familial_lipodystrophy </DX_NAME> <DX_NAME> partial_lipodystrophy </DX_NAME> <DX_NAME> viral_illness </DX_NAME> <DX_NAME> lipodystrophy </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> metreleptin </GENERIC_NAME> <GENERIC_NAME> leptin </GENERIC_NAME>
<BRAND_NAME> Zubsolv </BRAND_NAME> <GENERIC_NAME> buprenorphine </GENERIC_NAME> <GENERIC_NAME> naloxone </GENERIC_NAME> <BRAND_NAME> Zubsolv </BRAND_NAME> <TREATMENT_NAME> opioid </TREATMENT_NAME> <GENERIC_NAME> opioid </GENERIC_NAME> <TREATMENT_NAME> narcotic </TREATMENT_NAME> <GENERIC_NAME> narcotic </GENERIC_NAME> <GENERIC_NAME> morphine </GENERIC_NAME> <BRAND_NAME> Zubsolv </BRAND_NAME> <AGE> 15 </AGE> <BRAND_NAME> Zubsolv </BRAND_NAME> <GENERIC_NAME> buprenorphine </GENERIC_NAME> <GENERIC_NAME> naloxone </GENERIC_NAME>
<SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lymph_nodes </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <BRAND_NAME> imlygic </BRAND_NAME> <GENERIC_NAME> talimogene_laherparepvec </GENERIC_NAME> <DX_NAME> herpes_simplex_virus </DX_NAME> <DX_NAME> cold_sore_virus </DX_NAME> <DX_NAME> infected_tumour_cells </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> Pemetrexed </GENERIC_NAME> <NAME> Lilly </NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> Pemetrexed </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <DX_NAME> malignant_pleural_mesothelioma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> Pemetrexed </GENERIC_NAME> <NAME> Lilly </NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> Pemetrexed </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> Pemetrexed </GENERIC_NAME> <NAME> Lilly </NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<GENERIC_NAME> etanercept </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> inflammation </DX_NAME> <AGE> 18 </AGE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> autoimmune_disorder </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammatory_arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> axial_spondyloarthritis </DX_NAME> <DX_NAME> inflammatory_arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> sacroiliac_joints </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> scaly_patches </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <DX_NAME> painful </DX_NAME> <DX_NAME> swollen </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> feet </SYSTEM_ORGAN_SITE> <DX_NAME> structural_damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> idiopathic_arthritis </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> polyarthritis </DX_NAME> <TEST_NAME> rheumatoid_factor </TEST_NAME> <DX_NAME> rheumatoid_factor_positive </DX_NAME> <DX_NAME> extended_oligoarthritis </DX_NAME> <AGE> 2 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <AGE> 12 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> arthritis </DX_NAME> <AGE> 12 </AGE> <TEST_NAME> weighing </TEST_NAME> <DX_NAME> psoriasis </DX_NAME> <AGE> 6 </AGE> <TEST_NAME> weighing </TEST_NAME> <TREATMENT_NAME> phototherapies </TREATMENT_NAME> <TREATMENT_NAME> systemic_therapies </TREATMENT_NAME>
<NAME> namuscla </NAME> <GENERIC_NAME> mexiletine </GENERIC_NAME> <GENERIC_NAME> namuscla </GENERIC_NAME> <DX_NAME> myotonia </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> myotonic_disorders </DX_NAME> <DX_NAME> genetic_defects </DX_NAME> <DX_NAME> affect_muscle_function </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> pregabalin </GENERIC_NAME> <BRAND_NAME> mylan_pharma </BRAND_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> generalised_anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_seizures </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_treatment </TREATMENT_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <GENERIC_NAME> pregabalin </GENERIC_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> worry </DX_NAME> <DX_NAME> difficult_to_control </DX_NAME> <DX_NAME> gad </DX_NAME> <DX_NAME> restlessness </DX_NAME> <DX_NAME> feeling_keyed_up </DX_NAME> <DX_NAME> fatigued </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> difficulty_concentrating </DX_NAME> <DX_NAME> mind_going_blank </DX_NAME> <DX_NAME> feeling_irritable </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_tension </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME>
<GENERIC_NAME> elotuzumab </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <GENERIC_NAME> elotuzumab </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <GENERIC_NAME> elotuzumab </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <DX_NAME> myeloma </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> pomalidomide </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> temozolomide </GENERIC_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_tumour </DX_NAME> <DX_NAME> glioblastoma_multiforme </DX_NAME> <GENERIC_NAME> temozolomide </GENERIC_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_tumour </DX_NAME> <DX_NAME> glioblastoma_multiforme </DX_NAME> <DX_NAME> anaplastic </DX_NAME> <DX_NAME> astrocytoma </DX_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> glucocorticoids </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> allergy </DX_NAME> <DX_NAME> rhinitis </DX_NAME> <DX_NAME> allergy </DX_NAME> <BRAND_NAME> avamys </BRAND_NAME> <DX_NAME> allergic_rhinitis </DX_NAME> <DX_NAME> stuffy </DX_NAME> <DX_NAME> runny </DX_NAME> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <DX_NAME> sneezing </DX_NAME> <DX_NAME> watery </DX_NAME> <DX_NAME> itchy </DX_NAME> <DX_NAME> red_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> allergy_symptoms </DX_NAME> <DX_NAME> allergy </DX_NAME> <DX_NAME> hayfever </DX_NAME>
<GENERIC_NAME> edarbi </GENERIC_NAME> <GENERIC_NAME> azilsartan_medoxomil </GENERIC_NAME> <BRAND_NAME> aiiras </BRAND_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <TEST_NAME> edarbi_blocks </TEST_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <TIME_TO_DX_NAME> over_18 </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> over_18 </TIME_TO_DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME>
<DX_NAME> cancer </DX_NAME> <AGE> 12 </AGE> <DX_NAME> tumour </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> ‘nonsmall_cell_lung_cancer’ </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> nsclc </DX_NAME> <DX_NAME> change_in_the_ros1_gene </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> ntrk_inhibitors </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nsclc </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> ros1_inhibitors </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME>
<GENERIC_NAME> fremanezumab </GENERIC_NAME> <DX_NAME> migraine </DX_NAME> <GENERIC_NAME> fremanezumab </GENERIC_NAME> <DX_NAME> migraine_attacks </DX_NAME> <DX_NAME> migraine </DX_NAME> <DX_NAME> migraine </DX_NAME> <DX_NAME> migraine_attacks </DX_NAME> <DX_NAME> headache </DX_NAME> <DX_NAME> disability </DX_NAME> <DX_NAME> migraine </DX_NAME> <DX_NAME> migraine_attacks </DX_NAME>
<GENERIC_NAME> peginterferon_alfa2a </GENERIC_NAME> <TREATMENT_NAME> longacting_interferon </TREATMENT_NAME> <GENERIC_NAME> interferon </GENERIC_NAME> <GENERIC_NAME> interferon </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> diseases </DX_NAME> <DX_NAME> hepatitis_b </DX_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis_c </DX_NAME> <AGE> 5 </AGE> <DX_NAME> hepatitis_b </DX_NAME> <DX_NAME> c_are_viral_infections </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> hepatitis_c </DX_NAME> <GENERIC_NAME> pegasys </GENERIC_NAME>
<GENERIC_NAME> conestat_alfa </GENERIC_NAME> <GENERIC_NAME> conestat_alfa </GENERIC_NAME> <GENERIC_NAME> recombinant </GENERIC_NAME> <DX_NAME> blood_disorder </DX_NAME> <DX_NAME> hereditary_angioedema </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> abdomen </SYSTEM_ORGAN_SITE> <DX_NAME> difficulty_breathing </DX_NAME> <DX_NAME> attack </DX_NAME>
<GENERIC_NAME> ellipta </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> ellipta </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <DATE> 92/22 </DATE> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> copd </DX_NAME> <GENERIC_NAME> ellipta </GENERIC_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> attack </DX_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TREATMENT_NAME> steroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <SYSTEM_ORGAN_SITE> small_air_passages </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_problems </DX_NAME> <TREATMENT_NAME> corticosteroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> copd </DX_NAME> <GENERIC_NAME> long_acting_bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> small_air_passages </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> asthma </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> tight </DX_NAME> <DX_NAME> bronchoconstriction </DX_NAME> <DX_NAME> swollen </DX_NAME> <DX_NAME> irritated </DX_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> wheezing </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_tightness </DX_NAME> <DX_NAME> cough </DX_NAME> <GENERIC_NAME> ellipta </GENERIC_NAME> <DX_NAME> flareups </DX_NAME> <BRAND_NAME> flareups </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> inflamed </DX_NAME> <DX_NAME> thickened </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> cough </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_discomfort </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> flareups </DX_NAME> <DX_NAME> copd_symptoms </DX_NAME>
<GENERIC_NAME> rolapitant </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> sick </DX_NAME> <DX_NAME> nauseous </DX_NAME> <DX_NAME> sick </DX_NAME> <DX_NAME> vomiting </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> cancer_treatment_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> vomiting </DX_NAME> <DX_NAME> sick </DX_NAME> <DX_NAME> sick </DX_NAME> <GENERIC_NAME> rolapitant </GENERIC_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> vomiting </DX_NAME>
<GENERIC_NAME> brigatinib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> kinase_inhibitor </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> anaplastic_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME>
<BRAND_NAME> prandin </BRAND_NAME> <TREATMENT_NAME> oral_antidiabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> antidiabetic_medicine </GENERIC_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TEST_NAME> glucose </TEST_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <BRAND_NAME> prandin </BRAND_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> weight_reduction </TREATMENT_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <BRAND_NAME> prandin </BRAND_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <BRAND_NAME> prandin </BRAND_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<BRAND_NAME> Xermelo </BRAND_NAME> <GENERIC_NAME> telotristat_ethyl </GENERIC_NAME> <BRAND_NAME> Xermelo </BRAND_NAME> <DX_NAME> tumour </DX_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <DX_NAME> diarrhoea </DX_NAME> <TREATMENT_NAME> injections </TREATMENT_NAME> <GENERIC_NAME> ‘somatostatin </GENERIC_NAME> <GENERIC_NAME> lanreotide </GENERIC_NAME> <GENERIC_NAME> octreotide </GENERIC_NAME> <TREATMENT_NAME> injections </TREATMENT_NAME> <BRAND_NAME> Xermelo </BRAND_NAME> <BRAND_NAME> Xermelo </BRAND_NAME> <DX_NAME> diarrhoea </DX_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <DX_NAME> tumour </DX_NAME> <DX_NAME> diarrhoea </DX_NAME>
<BRAND_NAME> picato </BRAND_NAME> <GENERIC_NAME> ingenol_mebutate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> actinic_keratosis </DX_NAME> <DX_NAME> solar_keratosis </DX_NAME> <DX_NAME> actinic_keratoses </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <NAME> sunshine </NAME> <BRAND_NAME> picato </BRAND_NAME> <DX_NAME> actinic_keratosis </DX_NAME> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> scalp </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> macimorelin </GENERIC_NAME> <GENERIC_NAME> macimorelin </GENERIC_NAME> <TREATMENT_NAME> natural_hormone </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> pituitary_gland </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> release_growth_hormone </PROCEDURE_NAME> <GENERIC_NAME> macimorelin </GENERIC_NAME> <TREATMENT_NAME> growth_hormone </TREATMENT_NAME> <TREATMENT_NAME> growth_hormone </TREATMENT_NAME> <DX_NAME> growth_hormone_deficiency </DX_NAME> <TREATMENT_NAME> growth_hormone </TREATMENT_NAME>
<PROCEDURE_NAME> surgical_operations </PROCEDURE_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> oozing </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <GENERIC_NAME> raplixa </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> stiripentol </GENERIC_NAME> <TREATMENT_NAME> antiepileptics </TREATMENT_NAME> <GENERIC_NAME> clobazam </GENERIC_NAME> <GENERIC_NAME> valproate </GENERIC_NAME> <TREATMENT_NAME> antiepileptic_medicines </TREATMENT_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> myoclonic_epilepsy </DX_NAME> <DX_NAME> infancy </DX_NAME> <DX_NAME> dravet’s_syndrome </DX_NAME> <DX_NAME> child’s_epilepsy </DX_NAME> <GENERIC_NAME> clobazam </GENERIC_NAME> <GENERIC_NAME> valproate </GENERIC_NAME>
<BRAND_NAME> alimta </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> alimta </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <DX_NAME> malignant_pleural_mesothelioma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <BRAND_NAME> alimta </BRAND_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <BRAND_NAME> alimta </BRAND_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <BRAND_NAME> alimta </BRAND_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> febrile_neutropenia </DX_NAME> <DX_NAME> low_white_blood_cell_count </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> fever </DX_NAME> <TREATMENT_NAME> cytotoxic_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME>
<GENERIC_NAME> rapilysin </GENERIC_NAME> <GENERIC_NAME> reteplase </GENERIC_NAME> <GENERIC_NAME> recombinant_plasminogen_activator </GENERIC_NAME> <GENERIC_NAME> thrombolytic_medicine </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombolysis </DX_NAME> <GENERIC_NAME> rapilysin </GENERIC_NAME> <DX_NAME> myocardial_infarction </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> blood_clot </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME>
<BRAND_NAME> mmrvaxpro </BRAND_NAME> <DX_NAME> measles </DX_NAME> <DX_NAME> mumps </DX_NAME> <DX_NAME> rubella_viruses </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> measles </DX_NAME> <DX_NAME> mumps </DX_NAME> <DX_NAME> rubella_viruses </DX_NAME> <DX_NAME> infections </DX_NAME> <BRAND_NAME> mmrvaxpro </BRAND_NAME> <DX_NAME> measles </DX_NAME> <DX_NAME> mumps </DX_NAME> <DX_NAME> rubella </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TIME_TO_TREATMENT_NAME> 12_months </TIME_TO_TREATMENT_NAME> <BRAND_NAME> mmrvaxpro </BRAND_NAME> <BRAND_NAME> mmrvaxpro </BRAND_NAME> <DX_NAME> measles </DX_NAME> <TREATMENT_NAME> postexposure_vaccination </TREATMENT_NAME> <AGE> 9 </AGE> <DX_NAME> pregnant </DX_NAME> <DX_NAME> mumps </DX_NAME> <TEST_NAME> rubella </TEST_NAME> <DX_NAME> rubella </DX_NAME> <DX_NAME> measles </DX_NAME> <DX_NAME> mumps </DX_NAME> <DX_NAME> rubella </DX_NAME> <DX_NAME> healthy </DX_NAME>
<GENERIC_NAME> mozobil </GENERIC_NAME> <GENERIC_NAME> plerixafor </GENERIC_NAME> <TREATMENT_NAME> blood_stem_cells </TREATMENT_NAME> <TREATMENT_NAME> protein_“ties”_blood_stem_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <GENERIC_NAME> plerixafor </GENERIC_NAME> <PROCEDURE_NAME> release_of_stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> apheresis </PROCEDURE_NAME> <PROCEDURE_NAME> transplant </PROCEDURE_NAME> <GENERIC_NAME> mozobil </GENERIC_NAME> <TREATMENT_NAME> blood_stem_cells </TREATMENT_NAME> <TREATMENT_NAME> reintroduction </TREATMENT_NAME> <PROCEDURE_NAME> transplantation </PROCEDURE_NAME> <DX_NAME> lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <AGE> 18 </AGE> <DX_NAME> lymphoma </DX_NAME>
<BRAND_NAME> triumeq </BRAND_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> abacavir </GENERIC_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <GENERIC_NAME> dolutegravir </GENERIC_NAME> <GENERIC_NAME> abacavir </GENERIC_NAME> <GENERIC_NAME> lamivudine </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <DX_NAME> hiv_infection </DX_NAME> <TREATMENT_NAME> nucleoside_analogue_reverse_transcriptase_inhibitors </TREATMENT_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> integrase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> integrase_inhibitors </GENERIC_NAME> <BRAND_NAME> triumeq </BRAND_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <AGE> 12 </AGE> <TEST_NAME> weigh </TEST_NAME> <TEST_NAME> hlab </TEST_NAME> <BRAND_NAME> triumeq </BRAND_NAME> <TEST_NAME> hlab </TEST_NAME> <DX_NAME> hypersensitivity </DX_NAME> <BRAND_NAME> triumeq </BRAND_NAME> <DX_NAME> ‘hypersensitivity </DX_NAME> <BRAND_NAME> triumeq </BRAND_NAME> <DX_NAME> hiv_infection </DX_NAME> <TREATMENT_NAME> cd4_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> triumeq </BRAND_NAME>
<GENERIC_NAME> sonidegib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> basal_cell_carcinoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME> <DX_NAME> basal_cell_carcinoma </DX_NAME>
<DX_NAME> optruma </DX_NAME> <GENERIC_NAME> raloxifene_hydrochloride </GENERIC_NAME> <DX_NAME> optruma </DX_NAME> <BRAND_NAME> optruma </BRAND_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> postmenopausal </DX_NAME> <DX_NAME> optruma </DX_NAME> <DX_NAME> vertebral_fractures </DX_NAME> <DX_NAME> postmenopausal_osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> hip_fractures </DX_NAME> <TREATMENT_NAME> nonhormonal_medicines </TREATMENT_NAME> <TREATMENT_NAME> selective_oestrogen_receptor_modulators </TREATMENT_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> optruma </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> thin </DX_NAME> <DX_NAME> fragile </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hips </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE> <DX_NAME> back_pain </DX_NAME> <DX_NAME> loss_of_height </DX_NAME>
<GENERIC_NAME> retinoids </GENERIC_NAME> <BRAND_NAME> panretin </BRAND_NAME> <DX_NAME> sarcoma </DX_NAME> <DX_NAME> lesions </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> hiv_treatment </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> lesion </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> swollen </DX_NAME> <BRAND_NAME> panretin </BRAND_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> nitisinone </GENERIC_NAME> <GENERIC_NAME> nitisinone </GENERIC_NAME> <DX_NAME> hereditary_tyrosinemia </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> nitisinone </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> tyrosine </GENERIC_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME> <GENERIC_NAME> amino_acid </GENERIC_NAME>
<GENERIC_NAME> rotigotine </GENERIC_NAME> <GENERIC_NAME> ‘dopamine </GENERIC_NAME> <GENERIC_NAME> dopamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> restless_legs_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> rls </DX_NAME> <DX_NAME> discomfort </DX_NAME> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arms </SYSTEM_ORGAN_SITE> <DX_NAME> urges_to_move_around </DX_NAME> <DX_NAME> sleep_disturbance </DX_NAME> <DX_NAME> feeling_tired </DX_NAME> <DX_NAME> sleepy </DX_NAME>
<GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <TREATMENT_NAME> dpp4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <TREATMENT_NAME> dipeptidyl_peptidase4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> sulphonylureas </GENERIC_NAME> <DX_NAME> sulphonylureas </DX_NAME> <GENERIC_NAME> glitazones </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> glucose </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> amputation </DX_NAME> <PROCEDURE_NAME> amputation </PROCEDURE_NAME>
<GENERIC_NAME> duloxetine </GENERIC_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <GENERIC_NAME> noradrenaline </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nervous_system </SYSTEM_ORGAN_SITE> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> feeling_of_anxiety </DX_NAME> <DX_NAME> nervousness </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> stabbing </DX_NAME> <DX_NAME> stinging </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> electric_shock </DX_NAME> <DX_NAME> loss_of_feeling </DX_NAME> <SYSTEM_ORGAN_SITE> affected_area </SYSTEM_ORGAN_SITE> <DX_NAME> cold </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety </DX_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <DX_NAME> feeling_better </DX_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME>
<GENERIC_NAME> zinplava </GENERIC_NAME> <GENERIC_NAME> bezlotoxumab </GENERIC_NAME> <GENERIC_NAME> zinplava </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <DX_NAME> clostridium_difficile_infection </DX_NAME> <DX_NAME> cdi </DX_NAME> <AGE> 18 </AGE> <DX_NAME> cdi </DX_NAME> <GENERIC_NAME> zinplava </GENERIC_NAME> <DX_NAME> cdi </DX_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> cdi </DX_NAME> <DX_NAME> cdi </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> stomach_pain </DX_NAME> <DX_NAME> diarrhoea </DX_NAME> <DX_NAME> zinplava </DX_NAME> <GENERIC_NAME> zinplava </GENERIC_NAME> <DX_NAME> cdi </DX_NAME> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE>
<BRAND_NAME> janumet </BRAND_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> sulphonylureas </GENERIC_NAME> <DX_NAME> sulphonylureas </DX_NAME> <GENERIC_NAME> glitazones </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> glucose </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> amputation </DX_NAME> <PROCEDURE_NAME> amputation </PROCEDURE_NAME>
<NAME> foclivia </NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> influenza </DX_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> flu) </TREATMENT_NAME> <TREATMENT_NAME> pandemic_flu </TREATMENT_NAME> <DX_NAME> pandemic_flu </DX_NAME> <DX_NAME> influenza </DX_NAME> <TREATMENT_NAME> pandemic_flu </TREATMENT_NAME> <DX_NAME> pandemic_flu </DX_NAME> <AGE> 18 </AGE> <AGE> 60 </AGE> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> flu </DX_NAME> <TREATMENT_NAME> vaccines </TREATMENT_NAME>
<GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> pharma </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> nerve_cells_die </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> acetylcholinesterase </GENERIC_NAME> <GENERIC_NAME> butyrylcholinesterase </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> alzheimer’s_disease </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_disorder </DX_NAME> <DX_NAME> memory </DX_NAME> <DX_NAME> intellectual_ability_and_behaviour </DX_NAME> <GENERIC_NAME> oral_solution </GENERIC_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME>
<GENERIC_NAME> epoetin_beta </GENERIC_NAME> <GENERIC_NAME> epoetin_beta </GENERIC_NAME> <GENERIC_NAME> lyophilisate </GENERIC_NAME> <GENERIC_NAME> urea </GENERIC_NAME> <GENERIC_NAME> sodium_chloride </GENERIC_NAME> <GENERIC_NAME> polysorbate_20 </GENERIC_NAME> <GENERIC_NAME> sodium_dihydrogen_phosphate </GENERIC_NAME> <GENERIC_NAME> disodium_hydrogen_phosphate </GENERIC_NAME> <GENERIC_NAME> calcium_chloride </GENERIC_NAME> <GENERIC_NAME> glycine </GENERIC_NAME> <GENERIC_NAME> lleucine </GENERIC_NAME> <GENERIC_NAME> lisoleucine </GENERIC_NAME> <GENERIC_NAME> l_threonine </GENERIC_NAME> <GENERIC_NAME> lglutamic_acid </GENERIC_NAME> <GENERIC_NAME> lphenylalanine </GENERIC_NAME> <GENERIC_NAME> benzyl_alcohol </GENERIC_NAME> <GENERIC_NAME> benzalkonium_chloride </GENERIC_NAME> <GENERIC_NAME> preservatives </GENERIC_NAME> <URL> https://www.ema.europa.eu </URL> <GENERIC_NAME> epoetin_beta </GENERIC_NAME> <ADDRESS> emilbarellstrasse </ADDRESS> <ADDRESS> 79639_grenzachwyhlen_germany </ADDRESS> <NAME> roche_pharma </NAME> <ADDRESS> emilbarellstrasse </ADDRESS> <ADDRESS> d79639_grenzachwyhlen_germany </ADDRESS> <ID> 525_82_11 </ID> <PHONE_OR_FAX> 370_5_2546799 </PHONE_OR_FAX> <URL> luxembourg/luxemburg_(voir/siehe_belgique/belgien </URL> <NAME> republika_roche </NAME> <NAME> s._r. </NAME> <NAME> o._tel </NAME> <ID> 20382111 </ID> <ADDRESS> magyarország_roche </ADDRESS> <NAME> danmark_roche </NAME> <ADDRESS> malta </ADDRESS> <ADDRESS> ireland)_deutschland_roche_pharma </ADDRESS> <NAME> roche </NAME> <PHONE_OR_FAX> 438050 </PHONE_OR_FAX> <ADDRESS> eesti_roche_eesti </ADDRESS> <PHONE_OR_FAX> 372_6_177_380 </PHONE_OR_FAX> <NAME> roche_austria </NAME> <NAME> roche_farma </NAME> <ID> 425_70 </ID> <NAME> hrvatska_roche </NAME> <NAME> românia_roche </NAME> <NAME> românia </NAME> <PHONE_OR_FAX> 206_47_01 </PHONE_OR_FAX> <NAME> ireland </NAME> <NAME> slovenija_roche </NAME> <PHONE_OR_FAX> 354_540_8000 </PHONE_OR_FAX> <NAME> roche_slovensko </NAME> <PHONE_OR_FAX> 421_2_52638201 </PHONE_OR_FAX> <NAME> italia_roche </NAME> <NAME> roche </NAME> <NAME> latvija_roche </NAME> <NAME> latvija_sia </NAME> <PHONE_OR_FAX> 371_6_7039831 </PHONE_OR_FAX> <ADDRESS> united_kingdom_roche </ADDRESS>
<BRAND_NAME> keytruda </BRAND_NAME> <GENERIC_NAME> pembrolizumab </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <BRAND_NAME> keytruda </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> keytruda </BRAND_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_cancer </DX_NAME> <DX_NAME> melanoma </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <DX_NAME> classical_hodgkin_lymphoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> bladder_cancer </DX_NAME> <DX_NAME> urothelial_carcinoma </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> neck_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> head </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> neck </SYSTEM_ORGAN_SITE> <DX_NAME> neck_squamous_cell_carcinoma </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cancer </DX_NAME> <DX_NAME> renal_cell_carcinoma </DX_NAME> <BRAND_NAME> keytruda </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <BRAND_NAME> keytruda </BRAND_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <DX_NAME> melanoma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> adjuvant_therapy </TREATMENT_NAME> <BRAND_NAME> keytruda </BRAND_NAME>
<GENERIC_NAME> ribavirin </GENERIC_NAME> <BRAND_NAME> teva_pharma </BRAND_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <GENERIC_NAME> interferon_alfa2b </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <BRAND_NAME> teva_pharma </BRAND_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <BRAND_NAME> teva_pharma </BRAND_NAME> <GENERIC_NAME> interferon_alfa2b </GENERIC_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> hcv </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> interferon_alfa2b </GENERIC_NAME> <DX_NAME> hepatitis_c </DX_NAME> <TREATMENT_NAME> alpha_interferon </TREATMENT_NAME> <GENERIC_NAME> alpha_interferon </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> pegylated </GENERIC_NAME> <GENERIC_NAME> interferon </GENERIC_NAME> <GENERIC_NAME> alfa2b </GENERIC_NAME>
<GENERIC_NAME> nitisinone </GENERIC_NAME> <DX_NAME> hereditary_tyrosinemia </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> tyrosine </GENERIC_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME> <GENERIC_NAME> amino_acid </GENERIC_NAME>
<BRAND_NAME> xeloda </BRAND_NAME> <TREATMENT_NAME> cytostatic_medicines </TREATMENT_NAME> <BRAND_NAME> xeloda </BRAND_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <TREATMENT_NAME> cytostatic_medicine </TREATMENT_NAME> <BRAND_NAME> xeloda </BRAND_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> rectal </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gastric </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> cancers </DX_NAME> <BRAND_NAME> xeloda </BRAND_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <DX_NAME> colon_cancer </DX_NAME> <PROCEDURE_NAME> removal_of_the_tumour </PROCEDURE_NAME> <DX_NAME> tumour </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <BRAND_NAME> xeloda </BRAND_NAME>
<GENERIC_NAME> linaclotide </GENERIC_NAME> <DX_NAME> irritable_bowel_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> constipation </DX_NAME> <DX_NAME> ibs </DX_NAME> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <DX_NAME> gut_disorder </DX_NAME> <DX_NAME> ibs </DX_NAME> <DX_NAME> constipation </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> stomach_or_abdominal_pain </DX_NAME> <DX_NAME> feeling_bloated </DX_NAME> <DX_NAME> hard,_small_or_pelletlike_stools </DX_NAME> <SYSTEM_ORGAN_SITE> faeces </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> bloated </DX_NAME> <DX_NAME> restore_the_normal_functioning_of_your_bowels </DX_NAME> <SYSTEM_ORGAN_SITE> bowels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> bowel_movements </DX_NAME>
<GENERIC_NAME> dulaglutide </GENERIC_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> diabetes_medicine </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> insulin </GENERIC_NAME>
<TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> diphtheria </DX_NAME> <TREATMENT_NAME> tetanus </TREATMENT_NAME> <DX_NAME> pertussis </DX_NAME> <DX_NAME> hepatitis_b </DX_NAME> <DX_NAME> poliomyelitis </DX_NAME> <DX_NAME> serious_diseases </DX_NAME> <TREATMENT_NAME> haemophilus_influenzae_type </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> diphtheria </DX_NAME> <DX_NAME> bacterial_infection </DX_NAME> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> jaw </SYSTEM_ORGAN_SITE> <DX_NAME> deep_wound </DX_NAME> <DX_NAME> spasms </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> inability_to_breathe </DX_NAME> <DX_NAME> suffocation </DX_NAME> <DX_NAME> pertussis </DX_NAME> <DX_NAME> whooping_cough </DX_NAME> <DX_NAME> infectious_illness </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> problems_with_breathing </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> cough </DX_NAME> <DX_NAME> whooping_cough </DX_NAME> <SYSTEM_ORGAN_SITE> ear </SYSTEM_ORGAN_SITE> <DX_NAME> ear_infections </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_infections </DX_NAME> <DX_NAME> bronchitis </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_infections </DX_NAME> <DX_NAME> pneumonia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_damage </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> swollen </DX_NAME> <DX_NAME> inflamed </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TIME_TO_DX_NAME> eventually </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> eventually </TIME_TO_DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_problems </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_cancer </DX_NAME> <DX_NAME> poliomyelitis </DX_NAME> <DX_NAME> polio </DX_NAME> <DX_NAME> viruses </DX_NAME> <DX_NAME> affect </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> paralysis </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_weakness </DX_NAME> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> paralysis </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> control_breathing </DX_NAME> <DX_NAME> swallowing_can_be_fatal </DX_NAME> <TREATMENT_NAME> haemophilus_influenzae </TREATMENT_NAME> <DX_NAME> haemophilus_influenzae_type_b_infections </DX_NAME> <GENERIC_NAME> hib </GENERIC_NAME> <DX_NAME> hib_infections </DX_NAME> <DX_NAME> bacterial_infections </DX_NAME> <DX_NAME> meningitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_damage </DX_NAME> <DX_NAME> deafness </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_blindness </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <DX_NAME> difficulties_in_swallowing </DX_NAME> <DX_NAME> breathing </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> bacteria </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> live_bacteria </DX_NAME> <DX_NAME> infectious_diseases </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME>
<BRAND_NAME> stivarga </BRAND_NAME> <GENERIC_NAME> regorafenib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> stivarga </BRAND_NAME> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <DX_NAME> rectal_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> fluoropyrimidinebased_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> antivegf_therapy </TREATMENT_NAME> <TREATMENT_NAME> antiegfr_therapy </TREATMENT_NAME> <DX_NAME> gist </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> anticancer_medicines </TREATMENT_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <GENERIC_NAME> sunitinib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_cancer </DX_NAME> <TREATMENT_NAME> anticancer_medicine </TREATMENT_NAME> <GENERIC_NAME> anticancer_medicine </GENERIC_NAME> <GENERIC_NAME> sorafenib </GENERIC_NAME> <BRAND_NAME> stivarga </BRAND_NAME>
<GENERIC_NAME> aclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bronchioles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> effects_of_the_disease </DX_NAME> <DX_NAME> copd_symptoms </DX_NAME>
<GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <GENERIC_NAME> pegfilgrastim </GENERIC_NAME> <GENERIC_NAME> polyethylene_glycol </GENERIC_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> febrile_neutropenia </DX_NAME> <TREATMENT_NAME> cytotoxic_chemotherapy </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> infection </DX_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> infection </DX_NAME>
<SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung_tissue </SYSTEM_ORGAN_SITE> <TEST_NAME> neutrophil_elastase </TEST_NAME> <TEST_NAME> neutrophil_elastase </TEST_NAME> <DX_NAME> damage </DX_NAME> <DX_NAME> deficiency </DX_NAME> <DX_NAME> alpha1proteinase_inhibitor_deficiency </DX_NAME> <DX_NAME> inherited_condition </DX_NAME> <DX_NAME> alpha1_antitrypsin_deficiency </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_condition </DX_NAME> <DX_NAME> emphysema </DX_NAME> <DX_NAME> emphysema </DX_NAME> <TEST_NAME> neutrophil_elastase </TEST_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> alpha1proteinase_inhibitor </TREATMENT_NAME> <DX_NAME> emphysema </DX_NAME>
<GENERIC_NAME> nivolumab </GENERIC_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> nivolumab </GENERIC_NAME> <GENERIC_NAME> nivolumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <GENERIC_NAME> nivolumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer_cells </DX_NAME>
<GENERIC_NAME> dapagliflozin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <AGE> 18 </AGE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_1_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> Edistride </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> overweight </DX_NAME> <DX_NAME> obese </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <GENERIC_NAME> Edistride </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> diabetes_medicines </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> Edistride </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> Edistride </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> Type_2_diabetes </DX_NAME> <GENERIC_NAME> Edistride </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> Edistride </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> insulin_aspart </GENERIC_NAME> <GENERIC_NAME> insulin_aspart </GENERIC_NAME> <GENERIC_NAME> insulin_aspart </GENERIC_NAME> <GENERIC_NAME> phenol </GENERIC_NAME> <GENERIC_NAME> metacresol </GENERIC_NAME> <GENERIC_NAME> glycerol </GENERIC_NAME> <GENERIC_NAME> zinc_acetate </GENERIC_NAME> <GENERIC_NAME> disodium_phosphate_dihydrate </GENERIC_NAME> <GENERIC_NAME> arginine_hydrochloride </GENERIC_NAME> <GENERIC_NAME> nicotinamide </GENERIC_NAME> <GENERIC_NAME> vitamin_b3 </GENERIC_NAME> <GENERIC_NAME> hydrochloric_acid </GENERIC_NAME> <GENERIC_NAME> sodium_hydroxide </GENERIC_NAME> <URL> http://www.ema.europa.eu/docs/en </URL> <URL> 2013/03/wc500139752.doc_http://www.ema.europa.eu/docs/en </URL> <DATE> 2013/03/wc500139752.doc_59 </DATE>
<BRAND_NAME> ibrance </BRAND_NAME> <GENERIC_NAME> palbociclib </GENERIC_NAME> <GENERIC_NAME> palbociclib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> tumour </DX_NAME> <GENERIC_NAME> aromatase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> aromatase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> fulvestrant </GENERIC_NAME> <TREATMENT_NAME> hormonal_anticancer_therapies </TREATMENT_NAME>
<BRAND_NAME> vantavo </BRAND_NAME> <BRAND_NAME> vantavo </BRAND_NAME> <GENERIC_NAME> alendronic_acid </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <GENERIC_NAME> colecalciferol </GENERIC_NAME> <GENERIC_NAME> vitamin_d3 </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <DX_NAME> loss_of_bone </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> hip_fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> vitamin_d </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> vitamin_d_deficiency </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_weakness </DX_NAME> <DX_NAME> falls </DX_NAME> <DX_NAME> fractures </DX_NAME> <GENERIC_NAME> vantavo </GENERIC_NAME> <GENERIC_NAME> vantavo </GENERIC_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> vitamin_d_insufficiency </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> hip_fractures </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> thinning </DX_NAME> <DX_NAME> weakening </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skeleton </SYSTEM_ORGAN_SITE> <DX_NAME> skeleton_healthy </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> hurt </DX_NAME> <DX_NAME> breaks </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> height_loss </DX_NAME> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> injury </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrist </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> stooped_posture </DX_NAME> <DX_NAME> loss_of_mobility </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> exercise_programme </TREATMENT_NAME> <TREATMENT_NAME> balanced_diet </TREATMENT_NAME> <TREATMENT_NAME> dietary_supplements </TREATMENT_NAME>
<GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_complications </DX_NAME> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_metastases </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> primary_site </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <DX_NAME> tumour </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> hypercalcaemia </DX_NAME>
<GENERIC_NAME> alendronic_acid </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <GENERIC_NAME> colecalciferol </GENERIC_NAME> <GENERIC_NAME> vitamin_d3 </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <GENERIC_NAME> alendronate </GENERIC_NAME> <DX_NAME> loss_of_bone </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> hip_fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> vitamin_d </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> vitamin_d_deficiency </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_weakness </DX_NAME> <DX_NAME> falls </DX_NAME> <DX_NAME> fractures </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> vitamin_d_insufficiency </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> hip_fractures </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> thinning </DX_NAME> <DX_NAME> weakening </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skeleton </SYSTEM_ORGAN_SITE> <DX_NAME> skeleton_healthy </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> menopause </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> hurt </DX_NAME> <DX_NAME> breaks </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> height_loss </DX_NAME> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> injury </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrist </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> stooped_posture </DX_NAME> <DX_NAME> loss_of_mobility </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> broken_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> exercise_programme </TREATMENT_NAME> <TREATMENT_NAME> balanced_diet </TREATMENT_NAME> <TREATMENT_NAME> dietary_supplements </TREATMENT_NAME>
<GENERIC_NAME> dibotermin_alfa </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> back_spine </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <PROCEDURE_NAME> repair_fractures_of_the_shin_bone </PROCEDURE_NAME> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> shin_bone </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> lower_back_spine_fusion_surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> back_spine </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> disc </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> lower_back_spine_fusion_surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> back_spine </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_graft </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_graft </PROCEDURE_NAME> <PROCEDURE_NAME> lower_back_fusion_surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> back </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> shin_bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> shin_bone </SYSTEM_ORGAN_SITE> <DX_NAME> fracture </DX_NAME> <PROCEDURE_NAME> surgeries </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> shin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> fractures </DX_NAME>
<GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> antihistamine </GENERIC_NAME> <TREATMENT_NAME> antiallergy_medicine </TREATMENT_NAME> <DX_NAME> drowsy </DX_NAME> <DX_NAME> allergic_reaction </DX_NAME> <DX_NAME> allergic_rhinitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> nasal_passages </SYSTEM_ORGAN_SITE> <DX_NAME> allergy </DX_NAME> <DX_NAME> hay_fever </DX_NAME> <DX_NAME> allergy </DX_NAME> <AGE> 12 </AGE> <DX_NAME> sneezing </DX_NAME> <DX_NAME> runny </DX_NAME> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> palate </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <DX_NAME> red </DX_NAME> <DX_NAME> watery_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> urticaria </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_condition </DX_NAME> <DX_NAME> allergy </DX_NAME> <DX_NAME> itching </DX_NAME> <DX_NAME> hives </DX_NAME>
<GENERIC_NAME> netarsudil </GENERIC_NAME> <GENERIC_NAME> netarsudil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> eye_condition </DX_NAME> <DX_NAME> glaucoma </DX_NAME> <DX_NAME> raised_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> damage </DX_NAME> <DX_NAME> sight </DX_NAME>
<GENERIC_NAME> cresemba </GENERIC_NAME> <GENERIC_NAME> cresemba </GENERIC_NAME> <TREATMENT_NAME> antifungal_medicine </TREATMENT_NAME> <GENERIC_NAME> isavuconazole </GENERIC_NAME> <GENERIC_NAME> cresemba </GENERIC_NAME> <GENERIC_NAME> isavuconazole </GENERIC_NAME> <DX_NAME> fungus </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> cresemba </GENERIC_NAME> <GENERIC_NAME> cresemba </GENERIC_NAME> <DX_NAME> fungal_infections </DX_NAME> <DX_NAME> aspergillosis </DX_NAME> <DX_NAME> fungus </DX_NAME> <DX_NAME> mucormycosis </DX_NAME> <DX_NAME> fungus </DX_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME>
<GENERIC_NAME> noxafil </GENERIC_NAME> <GENERIC_NAME> posaconazole </GENERIC_NAME> <DX_NAME> fungal_infections </DX_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> noxafil </GENERIC_NAME> <DX_NAME> fungal_infections </DX_NAME> <TREATMENT_NAME> antifungal_medicines </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> antifungal_medicines </TREATMENT_NAME> <GENERIC_NAME> antifungal_medicines </GENERIC_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> fusarium </GENERIC_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> “mycetoma” </DX_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> fungus </DX_NAME> <GENERIC_NAME> amphotericin_b </GENERIC_NAME> <GENERIC_NAME> itraconazole </GENERIC_NAME> <GENERIC_NAME> fluconazole </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> throat_area </SYSTEM_ORGAN_SITE> <DX_NAME> fungal_infections </DX_NAME> <DX_NAME> fungal_infection </DX_NAME> <DX_NAME> weak_immune_system </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> “acute_myelogenous_leukemia” </DX_NAME> <DX_NAME> aml </DX_NAME> <DX_NAME> “myelodysplastic_syndromes” </DX_NAME> <DX_NAME> mds </DX_NAME> <TREATMENT_NAME> “highdose_immunosuppressive_therapy” </TREATMENT_NAME> <TREATMENT_NAME> “hematopoietic_stem_cell_transplant” </TREATMENT_NAME> <TREATMENT_NAME> hsct </TREATMENT_NAME>
<GENERIC_NAME> cystadane </GENERIC_NAME> <GENERIC_NAME> betaine_anhydrous </GENERIC_NAME> <DX_NAME> homocystinuria </DX_NAME> <DX_NAME> homocystinuria </DX_NAME> <GENERIC_NAME> cysteine </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <SYSTEM_ORGAN_SITE> veins </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> weakness </DX_NAME> <GENERIC_NAME> cystadane </GENERIC_NAME> <GENERIC_NAME> vitamin_b6 </GENERIC_NAME> <GENERIC_NAME> vitamin_b12 </GENERIC_NAME> <TEST_NAME> homocysteine_levels </TEST_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<DX_NAME> vi_disease </DX_NAME> <DX_NAME> mucopolysaccharidosis </DX_NAME> <DX_NAME> vi_disease </DX_NAME> <GENERIC_NAME> nacetylgalactosamine_4sulfatase </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> recombinant_enzyme </GENERIC_NAME> <GENERIC_NAME> galsulfase </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> macitentan </GENERIC_NAME> <DX_NAME> pulmonary_arterial_hypertension </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> pulmonary_arteries </SYSTEM_ORGAN_SITE> <DX_NAME> pah </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> tired </DX_NAME> <DX_NAME> dizzy </DX_NAME> <DX_NAME> short_of_breath </DX_NAME> <SYSTEM_ORGAN_SITE> pulmonary_arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE>
<BRAND_NAME> vosevi </BRAND_NAME> <GENERIC_NAME> sofosbuvir </GENERIC_NAME> <GENERIC_NAME> velpatasvir </GENERIC_NAME> <GENERIC_NAME> voxilaprevir </GENERIC_NAME> <DX_NAME> viral_infection </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_c. </DX_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> intrarosa </GENERIC_NAME> <GENERIC_NAME> prasterone </GENERIC_NAME> <GENERIC_NAME> intrarosa </GENERIC_NAME> <GENERIC_NAME> intrarosa </GENERIC_NAME> <DX_NAME> intrarosa </DX_NAME> <DX_NAME> postmenopausal </DX_NAME> <DX_NAME> vulvar_and_vaginal_atrophy </DX_NAME> <DX_NAME> menopausal_symptoms </DX_NAME> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> dryness </DX_NAME> <DX_NAME> irritation </DX_NAME> <DX_NAME> drop_in_the_levels_of_oestrogen_in_your_body </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <DX_NAME> vulvar_and_vaginal_atrophy </DX_NAME> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> discomfort </DX_NAME> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE>
<TREATMENT_NAME> thrombopoietin_receptor_agonists </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> clot </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> bleeding </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> tooth </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> tooth_extractions </PROCEDURE_NAME> <TEST_NAME> endoscopy </TEST_NAME> <TEST_NAME> platelets </TEST_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME>
<GENERIC_NAME> memantine_hydrochloride </GENERIC_NAME> <GENERIC_NAME> memantine </GENERIC_NAME> <DX_NAME> memory_loss </DX_NAME> <DX_NAME> alzheimer’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> alzheimer’s_disease </DX_NAME>
<GENERIC_NAME> Alpivab </GENERIC_NAME> <GENERIC_NAME> peramivir </GENERIC_NAME> <GENERIC_NAME> neuraminidase_inhibitors </GENERIC_NAME> <TREATMENT_NAME> neuraminidase_inhibitors </TREATMENT_NAME> <DX_NAME> influenza_virus </DX_NAME> <GENERIC_NAME> Alpivab </GENERIC_NAME> <DX_NAME> influenza </DX_NAME> <TREATMENT_NAME> hospitalisation </TREATMENT_NAME>
<GENERIC_NAME> evolocumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> high_cholesterol_level </DX_NAME> <TEST_NAME> cholesterol_level </TEST_NAME> <DX_NAME> hypercholesterolaemia </DX_NAME> <DX_NAME> heterozygous_familial </DX_NAME> <DX_NAME> nonfamilial]_or_mixed_dyslipidaemia </DX_NAME> <GENERIC_NAME> statins </GENERIC_NAME> <TIME_TO_TEST_NAME> 12 </TIME_TO_TEST_NAME> <TIME_TO_DX_NAME> 12 </TIME_TO_DX_NAME> <DX_NAME> high_cholesterol_level </DX_NAME> <TEST_NAME> cholesterol_level </TEST_NAME> <DX_NAME> homozygous_familial_hypercholesterolaemia </DX_NAME> <DX_NAME> high_cholesterol_level </DX_NAME> <TEST_NAME> cholesterol_level </TEST_NAME> <DX_NAME> cardiovascular_disease </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessel </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessel_problems </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> restore_blood_flow </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> fatty_deposits </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cardiovascular </SYSTEM_ORGAN_SITE> <DX_NAME> cardiovascular_disease </DX_NAME>
<BRAND_NAME> benlysta </BRAND_NAME> <BRAND_NAME> benlysta </BRAND_NAME> <TREATMENT_NAME> subcutaneous_injection </TREATMENT_NAME> <DX_NAME> lupus </DX_NAME> <DX_NAME> systemic_lupus_erythematosus </DX_NAME> <DX_NAME> sle </DX_NAME> <AGE> 18 </AGE> <DX_NAME> lupus </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <DX_NAME> attacks </DX_NAME> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> organ_damage </DX_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <GENERIC_NAME> benlysta </GENERIC_NAME> <TREATMENT_NAME> benlysta_contains_belimumab </TREATMENT_NAME> <GENERIC_NAME> belimumab </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <DX_NAME> lupus </DX_NAME> <BRAND_NAME> benlysta </BRAND_NAME> <DX_NAME> lupus </DX_NAME>
<GENERIC_NAME> burosumab </GENERIC_NAME> <DX_NAME> hypophosphataemia </DX_NAME> <DX_NAME> hypophosphataemia </DX_NAME> <DX_NAME> hypophosphataemia </DX_NAME> <DX_NAME> genetic_disease </DX_NAME> <TEST_NAME> hormone_called_fibroblast_growth_factor </TEST_NAME> <TEST_NAME> fgf23 </TEST_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <TEST_NAME> phosphate_levels </TEST_NAME>
<GENERIC_NAME> novorapid </GENERIC_NAME> <GENERIC_NAME> modern_insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> rapidacting_effect </DX_NAME> <GENERIC_NAME> insulin_products </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> novorapid </GENERIC_NAME> <DX_NAME> high_blood_sugar_level </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TREATMENT_NAME> novorapid </TREATMENT_NAME> <GENERIC_NAME> novorapid </GENERIC_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> novorapid </GENERIC_NAME> <TREATMENT_NAME> novorapid </TREATMENT_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> novorapid </GENERIC_NAME> <GENERIC_NAME> longacting_insulin </GENERIC_NAME> <TREATMENT_NAME> continuous_infusion </TREATMENT_NAME>
<GENERIC_NAME> ritonavir </GENERIC_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <TREATMENT_NAME> protease_inhibitor </TREATMENT_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <TREATMENT_NAME> antihiv_medicines </TREATMENT_NAME> <TREATMENT_NAME> antiretrovirals </TREATMENT_NAME> <GENERIC_NAME> antiretrovirals </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> ritonavir </GENERIC_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME>
<DX_NAME> acromegaly </DX_NAME> <DX_NAME> hormonal_disorder </DX_NAME> <DX_NAME> overgrowth_of_bone </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> soft_tissue </SYSTEM_ORGAN_SITE> <DX_NAME> soft_tissue_swelling </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <DX_NAME> disorders </DX_NAME>
<GENERIC_NAME> trastuzumab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <TEST_NAME> monoclonal_antibodies </TEST_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <GENERIC_NAME> trastuzumab </GENERIC_NAME> <BRAND_NAME> kanjinti </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> gastric_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> tumour </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> docetaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <TREATMENT_NAME> aromatase_inhibitors </TREATMENT_NAME> <GENERIC_NAME> aromatase_inhibitors </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> gastric_cancer </DX_NAME> <DX_NAME> high_levels_of_her2 </DX_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <GENERIC_NAME> 5fluorouracil </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME>
<BRAND_NAME> neofordex </BRAND_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <TREATMENT_NAME> hormone_called_a_glucocorticoid </TREATMENT_NAME> <GENERIC_NAME> glucocorticoid </GENERIC_NAME> <GENERIC_NAME> corticoid </GENERIC_NAME> <TREATMENT_NAME> corticoid_or_corticosteroid </TREATMENT_NAME> <GENERIC_NAME> corticosteroid </GENERIC_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> glucocorticoids </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> multiple_myeloma </DX_NAME>
<GENERIC_NAME> tadalafil </GENERIC_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <DX_NAME> cannot_get </DX_NAME> <DX_NAME> erect_penis_suitable_for_sexual_activity </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <GENERIC_NAME> tadalafil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <GENERIC_NAME> tadalafil </GENERIC_NAME> <GENERIC_NAME> tadalafil </GENERIC_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_inhibitors </TREATMENT_NAME> <GENERIC_NAME> tadalafil </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <DX_NAME> erectile_function </DX_NAME> <GENERIC_NAME> tadalafil </GENERIC_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <GENERIC_NAME> tadalafil </GENERIC_NAME> <DX_NAME> erectile_dysfunction </DX_NAME>
<BRAND_NAME> vyndaqel </BRAND_NAME> <BRAND_NAME> vyndaqel </BRAND_NAME> <DX_NAME> amyloidosis </DX_NAME> <DX_NAME> amyloid </DX_NAME> <DX_NAME> amyloid </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> polyneuropathy </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> amyloid </DX_NAME> <DX_NAME> ttr </DX_NAME> <DX_NAME> breaking_up </DX_NAME> <DX_NAME> amyloid </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> polyneuropathy </DX_NAME>
<GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <DX_NAME> type_2_diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sulphonylureas </GENERIC_NAME> <GENERIC_NAME> glitazones </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> glucose </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <PROCEDURE_NAME> amputation </PROCEDURE_NAME> <DX_NAME> amputation </DX_NAME>
<GENERIC_NAME> tygacil </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> antibiotic </GENERIC_NAME> <GENERIC_NAME> glycylcycline </GENERIC_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> tygacil </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> soft_tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> diabetic_foot_infections </DX_NAME> <SYSTEM_ORGAN_SITE> foot </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> abdomen </SYSTEM_ORGAN_SITE> <GENERIC_NAME> antibiotics </GENERIC_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME>
<DX_NAME> isturisa </DX_NAME> <GENERIC_NAME> osilodrostat </GENERIC_NAME> <DX_NAME> isturisa </DX_NAME> <DX_NAME> cushing’s_syndrome </DX_NAME> <DX_NAME> weight_gain </DX_NAME> <SYSTEM_ORGAN_SITE> waist </SYSTEM_ORGAN_SITE> <DX_NAME> moonshaped_face </DX_NAME> <SYSTEM_ORGAN_SITE> face </SYSTEM_ORGAN_SITE> <DX_NAME> bruising </DX_NAME> <DX_NAME> irregular_periods </DX_NAME> <DX_NAME> excessive_body_and_facial_hair </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> facial_hair </SYSTEM_ORGAN_SITE> <DX_NAME> feeling_weak </DX_NAME> <DX_NAME> tired </DX_NAME> <DX_NAME> unwell </DX_NAME> <SYSTEM_ORGAN_SITE> adrenal_glands </SYSTEM_ORGAN_SITE> <DX_NAME> cushing’s_syndrome </DX_NAME>
<GENERIC_NAME> dapagliflozin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <AGE> 18 </AGE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_1_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <BRAND_NAME> forxiga </BRAND_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> overweight </DX_NAME> <DX_NAME> obese </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <DX_NAME> forxiga </DX_NAME> <GENERIC_NAME> forxiga </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> diabetes_medicines </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> forxiga </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> forxiga </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <BRAND_NAME> forxiga </BRAND_NAME> <DX_NAME> diabetes </DX_NAME> <BRAND_NAME> forxiga </BRAND_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME>
<BRAND_NAME> novomix </BRAND_NAME> <GENERIC_NAME> modern_insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_products </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <BRAND_NAME> novomix </BRAND_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <BRAND_NAME> novomix </BRAND_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> type_2_diabetes_mellitus </DX_NAME> <BRAND_NAME> novomix </BRAND_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> antidiabetic_products </TREATMENT_NAME>
<DX_NAME> clots </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> inborn_factor_viii_deficiency </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME>
<DX_NAME> kanuma </DX_NAME> <GENERIC_NAME> sebelipase_alfa </GENERIC_NAME> <GENERIC_NAME> sebelipase_alfa </GENERIC_NAME> <DX_NAME> lysosomal_acid_lipase_deficiency </DX_NAME> <DX_NAME> lal_deficiency </DX_NAME> <DX_NAME> lal_deficiency </DX_NAME> <DX_NAME> genetic_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_damage </DX_NAME> <DX_NAME> high_blood_cholesterol </DX_NAME> <TREATMENT_NAME> enzyme_replacement_therapy </TREATMENT_NAME> <DX_NAME> lal_deficiency </DX_NAME> <DX_NAME> medical_complications </DX_NAME> <DX_NAME> impaired_growth </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_damage </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_complications </DX_NAME> <TEST_NAME> blood_levels </TEST_NAME> <TEST_NAME> ldl </TEST_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TEST_NAME> triglycerides </TEST_NAME>
<GENERIC_NAME> ivabradine_jensonr </GENERIC_NAME> <BRAND_NAME> ivabradine </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> heart_medicine </TREATMENT_NAME> <DX_NAME> angina_pectoris </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_rate </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> heart_medicines </TREATMENT_NAME> <GENERIC_NAME> betablockers </GENERIC_NAME> <GENERIC_NAME> betablocker </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_rate </DX_NAME> <GENERIC_NAME> betablocker </GENERIC_NAME> <TREATMENT_NAME> betablocker_therapy </TREATMENT_NAME> <GENERIC_NAME> betablockers </GENERIC_NAME> <DX_NAME> angina_pectoris </DX_NAME> <DX_NAME> stable_angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> angina </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> discomfort </DX_NAME> <DX_NAME> angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> angina </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <SYSTEM_ORGAN_SITE> ankle </SYSTEM_ORGAN_SITE> <DX_NAME> ankle_swelling </DX_NAME> <BRAND_NAME> ivabradine </BRAND_NAME> <BRAND_NAME> ivabradine </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart’s </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> angina_attack </DX_NAME> <BRAND_NAME> ivabradine </BRAND_NAME> <DX_NAME> angina_attacks </DX_NAME> <DX_NAME> dic </DX_NAME> <DX_NAME> elevated_heart_rate_adversely_affects </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <GENERIC_NAME> ivabradine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> infliximab </GENERIC_NAME> <GENERIC_NAME> infliximab </GENERIC_NAME> <DX_NAME> inflammatory_diseases </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> bechterew’s_disease </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> bechterew’s_disease </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> psoriasis_psoriasis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> plaque_psoriasis </DX_NAME> <TREATMENT_NAME> phototherapy </TREATMENT_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> abnormal_openings </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME>
<GENERIC_NAME> levetiracetam </GENERIC_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <GENERIC_NAME> sodium_acetate_trihydrate </GENERIC_NAME> <GENERIC_NAME> glacial_acetic_acid </GENERIC_NAME> <GENERIC_NAME> sodium_chloride </GENERIC_NAME> <GENERIC_NAME> levetiracetam </GENERIC_NAME> <GENERIC_NAME> levetiracetam_hospira_concentrate </GENERIC_NAME> <GENERIC_NAME> sterile_concentrate </GENERIC_NAME> <GENERIC_NAME> levetiracetam_hospira_concentrate </GENERIC_NAME> <ADDRESS> europe_ma_eeig_boulevard_de_la_plaine </ADDRESS> <ADDRESS> bruxelles_belgium_manufacturers_pfizer_service </ADDRESS> <NAME> bvba_hoge_wei </NAME> <ADDRESS> 1930_zaventem_belgium_hospira </ADDRESS> <GENERIC_NAME> zaventem_belgium_hospira </GENERIC_NAME> <ADDRESS> uk_limited_horizon_honey_lane_hurley_maidenhead_sl6_6rj_united_kingdom </ADDRESS> <BRAND_NAME> belgique </BRAND_NAME> <BRAND_NAME> lietuva </BRAND_NAME> <ADDRESS> luxembourg_sarl_filialas_lietuvoje_tel </ADDRESS> <PHONE_OR_FAX> 370_52_51_4000 </PHONE_OR_FAX> <PHONE_OR_FAX> 359_2_970_4333 </PHONE_OR_FAX> <ADDRESS> luxembourg/luxemburg_pfizer_sa/nv </ADDRESS> <NAME> tel </NAME> <ID> 420283004111 </ID> <ADDRESS> magyarország_pfizer_kft </ADDRESS> <ID> 356_21 </ID> <ADDRESS> deutschland_pfizer_pharma </ADDRESS> <ID> 8535555 </ID> <ADDRESS> luxembourg_sarl_eesti_filiaal_tel </ADDRESS> <NAME> austria_ges </NAME> <NAME> m.b </NAME> <PHONE_OR_FAX> 385_1_3908 </PHONE_OR_FAX> <ADDRESS> românia_pfizer_românia </ADDRESS> <ADDRESS> ireland_pfizer_healthcare_ireland </ADDRESS> <PHONE_OR_FAX> 616161 </PHONE_OR_FAX> <NAME> slovenija </NAME> <NAME> podružnica_za </NAME> <NAME> dejavnosti,_ljubljana_tel </NAME> <PHONE_OR_FAX> 354_540_8000 </PHONE_OR_FAX> <ADDRESS> +421–2–3355 </ADDRESS> <ADDRESS> 5500_italia_pfizer_s.r.l._tel </ADDRESS> <DATE> 06_33_18_21 </DATE> <ID> 24656165 </ID> <ADDRESS> sverige_pfizer </ADDRESS> <PHONE_OR_FAX> 8_550_520_00_latvija </PHONE_OR_FAX> <ADDRESS> luxembourg_sarl_filiāle_latvijā_tel </ADDRESS> <PHONE_OR_FAX> 371_670_35_775_united </PHONE_OR_FAX> <ADDRESS> kingdom_hospira_uk </ADDRESS> <PHONE_OR_FAX> 44_(0)_1628_515500 </PHONE_OR_FAX>
<BRAND_NAME> nimvastid </BRAND_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> nerve_cells_die </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> rivastigmine </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <GENERIC_NAME> acetylcholinesterase </GENERIC_NAME> <GENERIC_NAME> butyrylcholinesterase </GENERIC_NAME> <GENERIC_NAME> acetylcholine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> alzheimer’s_disease </DX_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <BRAND_NAME> nimvastid </BRAND_NAME> <DX_NAME> alzheimer’s_dementia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_disorder </DX_NAME> <DX_NAME> memory </DX_NAME> <DX_NAME> intellectual_ability_and_behaviour </DX_NAME> <GENERIC_NAME> oral_solution </GENERIC_NAME> <DX_NAME> dementia </DX_NAME> <DX_NAME> parkinson’s_disease </DX_NAME>
<BRAND_NAME> abilify </BRAND_NAME> <GENERIC_NAME> aripiprazole </GENERIC_NAME> <AGE> 15 </AGE> <DX_NAME> disease_characterised </DX_NAME> <DX_NAME> mistaken_beliefs </DX_NAME> <DX_NAME> incoherent_speech_and_behaviour </DX_NAME> <DX_NAME> emotional_flatness </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> guilty </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <BRAND_NAME> abilify </BRAND_NAME> <AGE> 13 </AGE> <DX_NAME> condition_with_symptoms </DX_NAME> <DX_NAME> feeling_"high" </DX_NAME> <DX_NAME> excessive_amounts_of_energy </DX_NAME> <DX_NAME> needing_much_less_sleep_than_usual </DX_NAME> <DX_NAME> racing_ideas </DX_NAME> <DX_NAME> irritability </DX_NAME> <BRAND_NAME> abilify </BRAND_NAME>
<BRAND_NAME> lonquex </BRAND_NAME> <BRAND_NAME> lonquex </BRAND_NAME> <GENERIC_NAME> lipegfilgrastim </GENERIC_NAME> <GENERIC_NAME> lipegfilgrastim </GENERIC_NAME> <BRAND_NAME> lonquex </BRAND_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> febrile_neutropenia </DX_NAME> <DX_NAME> low_white_blood_cell_count </DX_NAME> <TEST_NAME> white_blood_cell_count </TEST_NAME> <DX_NAME> fever </DX_NAME> <TREATMENT_NAME> cytotoxic_chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infection </DX_NAME>
<GENERIC_NAME> afamelanotide </GENERIC_NAME> <GENERIC_NAME> afamelanotide </GENERIC_NAME> <GENERIC_NAME> afamelanotide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> afamelanotide </GENERIC_NAME> <DX_NAME> erythropoietic_protoporphyria </DX_NAME> <DX_NAME> epp_is_a_condition </DX_NAME> <DX_NAME> sensitivity_to_sunlight </DX_NAME> <DX_NAME> toxic_effects </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> burning </DX_NAME> <BRAND_NAME> eumelanin </BRAND_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_photosensitivity </DX_NAME> <DX_NAME> sensitive_to_sunlight </DX_NAME>
<GENERIC_NAME> colesevelam </GENERIC_NAME> <GENERIC_NAME> hydrochloride </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> faeces </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> intestines </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hypercholesterolaemia </DX_NAME> <TEST_NAME> cholesterol </TEST_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <TREATMENT_NAME> cholesterollowering_medicines </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> statin </TREATMENT_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME> <GENERIC_NAME> ezetimibe </GENERIC_NAME> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <GENERIC_NAME> statin </GENERIC_NAME> <TREATMENT_NAME> statin </TREATMENT_NAME>
<GENERIC_NAME> Telmisartan </GENERIC_NAME> <BRAND_NAME> Actavis </BRAND_NAME> <GENERIC_NAME> telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessels_to_narrow </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> blood_pressure </DX_NAME> <GENERIC_NAME> Telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_pressure </TEST_NAME> <GENERIC_NAME> Telmisartan_Actavis </GENERIC_NAME> <DX_NAME> hypertension </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> High_blood_pressure </DX_NAME> <DX_NAME> damage_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attacks </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_or_kidney_failure </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> strokes </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> damage </DX_NAME> <GENERIC_NAME> Telmisartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> reduced_or_blocked_blood_supply </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> naldemedine </GENERIC_NAME> <DX_NAME> constipation </DX_NAME> <DX_NAME> pain </DX_NAME> <TREATMENT_NAME> pain_medicines </TREATMENT_NAME> <TREATMENT_NAME> opioids </TREATMENT_NAME> <GENERIC_NAME> opioids </GENERIC_NAME> <GENERIC_NAME> morphine </GENERIC_NAME> <GENERIC_NAME> oxycodone </GENERIC_NAME> <GENERIC_NAME> fentanyl </GENERIC_NAME> <GENERIC_NAME> tramadol </GENERIC_NAME> <GENERIC_NAME> codeine </GENERIC_NAME> <GENERIC_NAME> hydromorphone </GENERIC_NAME> <GENERIC_NAME> methadone </GENERIC_NAME> <GENERIC_NAME> opioid </GENERIC_NAME> <TREATMENT_NAME> opioid_pain_medicine </TREATMENT_NAME> <DX_NAME> pain </DX_NAME> <GENERIC_NAME> pain_medicine </GENERIC_NAME> <DX_NAME> pass_stools </DX_NAME> <DX_NAME> hard_stools </DX_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <DX_NAME> stomach_ache </DX_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> rectum </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> passing_stools </DX_NAME> <TREATMENT_NAME> opioid_medicine </TREATMENT_NAME> <GENERIC_NAME> opioid_medicine </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> noncancer_pain </DX_NAME> <GENERIC_NAME> laxative </GENERIC_NAME>
<BRAND_NAME> zalasta </BRAND_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME> <DX_NAME> schizophrenia </DX_NAME> <DX_NAME> disease_with_symptoms </DX_NAME> <DX_NAME> depressed </DX_NAME> <DX_NAME> anxious </DX_NAME> <DX_NAME> tense </DX_NAME> <DX_NAME> manic_episodes </DX_NAME> <DX_NAME> excitement </DX_NAME> <DX_NAME> euphoria </DX_NAME> <DX_NAME> recurrence </DX_NAME> <DX_NAME> bipolar_disorder </DX_NAME> <DX_NAME> manic_episode </DX_NAME> <GENERIC_NAME> olanzapine </GENERIC_NAME>
<GENERIC_NAME> portrazza </GENERIC_NAME> <GENERIC_NAME> necitumumab </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> squamous_nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <GENERIC_NAME> gemcitabine </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME>
<GENERIC_NAME> desloratadine </GENERIC_NAME> <GENERIC_NAME> antihistamine </GENERIC_NAME> <TREATMENT_NAME> antiallergy_medicine </TREATMENT_NAME> <DX_NAME> drowsy </DX_NAME> <DX_NAME> allergic_reaction </DX_NAME> <DX_NAME> allergic_rhinitis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> nasal_passages </SYSTEM_ORGAN_SITE> <DX_NAME> allergy </DX_NAME> <DX_NAME> hay_fever </DX_NAME> <DX_NAME> allergy </DX_NAME> <AGE> 12 </AGE> <DX_NAME> sneezing </DX_NAME> <DX_NAME> runny </DX_NAME> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <SYSTEM_ORGAN_SITE> palate </SYSTEM_ORGAN_SITE> <DX_NAME> itchy </DX_NAME> <DX_NAME> red </DX_NAME> <DX_NAME> watery_eyes </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <DX_NAME> urticaria </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_condition </DX_NAME> <DX_NAME> allergy </DX_NAME> <DX_NAME> itching </DX_NAME> <DX_NAME> hives </DX_NAME>
<GENERIC_NAME> temozolomide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> glioblastoma_multiforme </DX_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <DX_NAME> malignant_glioma </DX_NAME> <DX_NAME> glioblastoma_multiforme </DX_NAME> <DX_NAME> anaplastic_astrocytoma </DX_NAME>
<TREATMENT_NAME> oral_antidiabetic_medicine </TREATMENT_NAME> <GENERIC_NAME> repaglinide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TEST_NAME> glucose </TEST_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> exercise </TREATMENT_NAME> <TREATMENT_NAME> weight_reduction </TREATMENT_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<GENERIC_NAME> Stribild </GENERIC_NAME> <GENERIC_NAME> elvitegravir </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> integrase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> integrase_inhibitor </GENERIC_NAME> <GENERIC_NAME> cobicistat </GENERIC_NAME> <GENERIC_NAME> elvitegravir </GENERIC_NAME> <GENERIC_NAME> emtricitabine </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> nucleoside_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> nucleoside_reverse_transcriptase_inhibitor </GENERIC_NAME> <GENERIC_NAME> NRTI </GENERIC_NAME> <GENERIC_NAME> tenofovir_disoproxil </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> nucleotide_reverse_transcriptase_inhibitor </TREATMENT_NAME> <TREATMENT_NAME> NtRTI </TREATMENT_NAME> <GENERIC_NAME> Stribild </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> HIV </DX_NAME> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> Stribild </GENERIC_NAME> <DX_NAME> HIV </DX_NAME> <DX_NAME> infected_adolescents </DX_NAME> <TEST_NAME> weigh </TEST_NAME> <DX_NAME> HIV </DX_NAME> <TREATMENT_NAME> HIV_medicines </TREATMENT_NAME> <DX_NAME> side_effects </DX_NAME> <GENERIC_NAME> Stribild </GENERIC_NAME> <DX_NAME> HIV </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> HIV_infection </DX_NAME>
<BRAND_NAME> fycompa </BRAND_NAME> <GENERIC_NAME> perampanel </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> seizures </DX_NAME> <BRAND_NAME> fycompa </BRAND_NAME> <DX_NAME> fycompa </DX_NAME> <TREATMENT_NAME> antiepileptic_drugs </TREATMENT_NAME> <DX_NAME> epilepsy </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> partial_seizures </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> affect </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> seizures” </DX_NAME> <DX_NAME> convulsions </DX_NAME> <DX_NAME> staring_spells </DX_NAME>
<BRAND_NAME> akynzeo </BRAND_NAME> <BRAND_NAME> akynzeo </BRAND_NAME> <GENERIC_NAME> netupitant_palonosetron </GENERIC_NAME> <BRAND_NAME> akynzeo </BRAND_NAME> <BRAND_NAME> akynzeo </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> sick </DX_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> sick </DX_NAME> <DX_NAME> vomiting </DX_NAME> <DX_NAME> cancer </DX_NAME> <TREATMENT_NAME> ‘chemotherapy’ </TREATMENT_NAME> <BRAND_NAME> akynzeo </BRAND_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <DX_NAME> vomiting </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> nk1_receptor_antagonist </TREATMENT_NAME> <GENERIC_NAME> palonosetron </GENERIC_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <DX_NAME> vomiting </DX_NAME>
<GENERIC_NAME> velmanase_alfa </GENERIC_NAME> <TREATMENT_NAME> enzyme_replacement_therapies </TREATMENT_NAME> <DX_NAME> alphamannosidosis_disease </DX_NAME> <DX_NAME> nonneurological_symptoms </DX_NAME> <DX_NAME> alphamannosidosis_disease </DX_NAME> <DX_NAME> genetic_disorder </DX_NAME> <DX_NAME> lack_of_an_enzyme_named_alphamannosidase </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> facial_features </DX_NAME> <DX_NAME> mental_retardation </DX_NAME> <DX_NAME> difficulty_in_controlling_movements </DX_NAME> <DX_NAME> difficulties_in_hearing_and_speaking </DX_NAME> <DX_NAME> frequent_infections </DX_NAME> <DX_NAME> skeletal_problems </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_pain </DX_NAME> <DX_NAME> weakness </DX_NAME> <DX_NAME> alphamannosidosis_disease </DX_NAME>
<BRAND_NAME> eliquis </BRAND_NAME> <GENERIC_NAME> apixaban </GENERIC_NAME> <GENERIC_NAME> anticoagulants </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <BRAND_NAME> eliquis </BRAND_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> deep_vein </SYSTEM_ORGAN_SITE> <DX_NAME> deep_vein_thrombosis </DX_NAME> <DX_NAME> dvt </DX_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> knee_replacement_operations </PROCEDURE_NAME> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> leg </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> veins </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> blood_clot </DX_NAME> <SYSTEM_ORGAN_SITE> leg </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathlessness </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> pulmonary_embolism </DX_NAME> <DX_NAME> blood_clot </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> irregular_heart_beat </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> atrial_fibrillation </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <DX_NAME> systemic_embolism </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> veins </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> deep_vein </SYSTEM_ORGAN_SITE> <DX_NAME> deep_vein_thrombosis </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> pulmonary_embolism </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE>
<BRAND_NAME> Incruse_Ellipta </BRAND_NAME> <BRAND_NAME> Incruse_Ellipta </BRAND_NAME> <GENERIC_NAME> umeclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <GENERIC_NAME> Incruse_Ellipta </GENERIC_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> COPD </DX_NAME> <DX_NAME> COPD </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> Difficulties_in_breathing </DX_NAME> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> tightening </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> COPD </DX_NAME> <BRAND_NAME> Incruse_Ellipta </BRAND_NAME> <DX_NAME> attack </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> attack </DX_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME>
<GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> protaphane </GENERIC_NAME> <GENERIC_NAME> isophane </GENERIC_NAME> <GENERIC_NAME> nph)_human_insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> zinc_chloride </GENERIC_NAME> <GENERIC_NAME> glycerol </GENERIC_NAME> <GENERIC_NAME> metacresol </GENERIC_NAME> <GENERIC_NAME> phenol </GENERIC_NAME> <GENERIC_NAME> disodium_phosphate_dihydrate </GENERIC_NAME> <GENERIC_NAME> sodium_hydroxide </GENERIC_NAME> <GENERIC_NAME> hydrochloric_acid </GENERIC_NAME> <GENERIC_NAME> protamine_sulfate </GENERIC_NAME>
<GENERIC_NAME> ventavis </GENERIC_NAME> <GENERIC_NAME> iloprost </GENERIC_NAME> <GENERIC_NAME> prostacyclin </GENERIC_NAME> <DX_NAME> narrowing_of_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vessels </SYSTEM_ORGAN_SITE> <DX_NAME> pulmonary_hypertension </DX_NAME> <DX_NAME> pulmonary_hypertension </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> blood_pressure_is_too_high_in_the_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> strain </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE>
<BRAND_NAME> vaxchora </BRAND_NAME> <NAME> vaxchora </NAME> <TREATMENT_NAME> oral_vaccine </TREATMENT_NAME> <GENERIC_NAME> oral_vaccine </GENERIC_NAME> <DX_NAME> immunological_defence </DX_NAME> <SYSTEM_ORGAN_SITE> gut </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <AGE> 6 </AGE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TIME_TO_TREATMENT_NAME> 10_days </TIME_TO_TREATMENT_NAME> <BRAND_NAME> vaxchora </BRAND_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> diarrhoea </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME>
<GENERIC_NAME> nulojix </GENERIC_NAME> <GENERIC_NAME> belatacept </GENERIC_NAME> <TREATMENT_NAME> immunosuppressants </TREATMENT_NAME> <GENERIC_NAME> nulojix </GENERIC_NAME> <PROCEDURE_NAME> transplanted </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> immunosuppressive_medicines </TREATMENT_NAME> <GENERIC_NAME> mycophenolic_acid </GENERIC_NAME> <TREATMENT_NAME> mycophenolic_acid </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TREATMENT_NAME> corticosteroids </TREATMENT_NAME> <TREATMENT_NAME> interleukin(il)2_receptor_antagonist </TREATMENT_NAME> <TIME_TO_PROCEDURE_NAME> first_week_after </TIME_TO_PROCEDURE_NAME> <TIME_TO_TREATMENT_NAME> first_week_after </TIME_TO_TREATMENT_NAME> <PROCEDURE_NAME> transplantation </PROCEDURE_NAME>
<GENERIC_NAME> aliskiren </GENERIC_NAME> <GENERIC_NAME> aliskiren_belongs </GENERIC_NAME> <GENERIC_NAME> renin_inhibitors </GENERIC_NAME> <GENERIC_NAME> renin_inhibitors </GENERIC_NAME> <GENERIC_NAME> angiotensin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> damage_the_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> disorders </DX_NAME>
<GENERIC_NAME> infanrix_hexa </GENERIC_NAME> <DX_NAME> diphtheria </DX_NAME> <DX_NAME> bacterial_infection </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> swollen </DX_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> suffocation </DX_NAME> <DX_NAME> bacteria </DX_NAME> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> nerve_damage </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_problems </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> bacteria </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> scratches </DX_NAME> <DX_NAME> wounds </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> wounds </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> burns </DX_NAME> <DX_NAME> fractures </DX_NAME> <DX_NAME> deep_wounds </DX_NAME> <DX_NAME> wounds </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_stiffness </DX_NAME> <DX_NAME> painful_muscle_spasms </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> death </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_spasms </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_fractures </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> whooping_cough </DX_NAME> <DX_NAME> pertussis </DX_NAME> <DX_NAME> infectious_illness </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> problems_with_breathing </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> cough </DX_NAME> <DX_NAME> whooping_cough </DX_NAME> <SYSTEM_ORGAN_SITE> ear </SYSTEM_ORGAN_SITE> <DX_NAME> ear_infections </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_infections </DX_NAME> <DX_NAME> bronchitis </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_infections </DX_NAME> <DX_NAME> pneumonia </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_damage </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_swollen </DX_NAME> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> infected_people </DX_NAME> <DX_NAME> polio </DX_NAME> <DX_NAME> viral_infection </DX_NAME> <DX_NAME> polio </DX_NAME> <DX_NAME> illness </DX_NAME> <DX_NAME> permanent_damage </DX_NAME> <DX_NAME> death </DX_NAME> <DX_NAME> polio </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> unable_to_move </DX_NAME> <DX_NAME> paralysis </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing </DX_NAME> <SYSTEM_ORGAN_SITE> arms </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> haemophilus_influenzae_type_b_(hib </TREATMENT_NAME> <GENERIC_NAME> hib </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_swelling </DX_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> mental_slowness </DX_NAME> <DX_NAME> retardation </DX_NAME> <DX_NAME> cerebral_palsy </DX_NAME> <DX_NAME> deafness </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_34_blindness </DX_NAME> <DX_NAME> swelling </DX_NAME> <SYSTEM_ORGAN_SITE> throat </SYSTEM_ORGAN_SITE> <DX_NAME> death </DX_NAME> <DX_NAME> bacteria </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> tissues </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <GENERIC_NAME> infanrix_hexa </GENERIC_NAME> <GENERIC_NAME> infanrix_hexa </GENERIC_NAME> <TREATMENT_NAME> vaccines </TREATMENT_NAME> <TREATMENT_NAME> infanrix_hexa </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME>
<GENERIC_NAME> ifirmacombi </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <DX_NAME> angiotensinii </DX_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <TREATMENT_NAME> diuretics </TREATMENT_NAME> <DX_NAME> increased_urine_output </DX_NAME> <GENERIC_NAME> ifirmacombi </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> irbesartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> blood_pressure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME>
<GENERIC_NAME> efficib </GENERIC_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <TREATMENT_NAME> dpp4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dpp4_inhibitors </GENERIC_NAME> <TREATMENT_NAME> dipeptidyl_peptidase4_inhibitors </TREATMENT_NAME> <GENERIC_NAME> dipeptidyl_peptidase4_inhibitors </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> sulphonylureas </GENERIC_NAME> <DX_NAME> sulphonylureas </DX_NAME> <GENERIC_NAME> glitazones </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> glucose </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> amputation </DX_NAME> <PROCEDURE_NAME> amputation </PROCEDURE_NAME>
<BRAND_NAME> Icandra </BRAND_NAME> <GENERIC_NAME> vildagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <NAME> Icandra </NAME> <BRAND_NAME> Icandra </BRAND_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> insulin-dependent_diabetes_mellitus </DX_NAME> <DX_NAME> Type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> Insulin </GENERIC_NAME> <GENERIC_NAME> Glucagon </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <BRAND_NAME> Icandra </BRAND_NAME> <GENERIC_NAME> vildagliptin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> vildagliptin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> glucagon </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> complications </DX_NAME> <DX_NAME> diabetes </DX_NAME>
<BRAND_NAME> vibativ </BRAND_NAME> <GENERIC_NAME> telavancin </GENERIC_NAME> <TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> glycopeptide </GENERIC_NAME> <BRAND_NAME> vibativ </BRAND_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> artificial_ventilation </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> staphylococcus_aureus </DX_NAME> <DX_NAME> mrsa </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infections </DX_NAME> <GENERIC_NAME> telavancin </GENERIC_NAME> <BRAND_NAME> vibativ </BRAND_NAME> <GENERIC_NAME> antibiotics </GENERIC_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infection </DX_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME> <GENERIC_NAME> antibiotics </GENERIC_NAME> <BRAND_NAME> vibativ </BRAND_NAME>
<GENERIC_NAME> ciclosporin </GENERIC_NAME> <GENERIC_NAME> ciclosporin </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> verkazia </DX_NAME> <TIME_TO_DX_NAME> 4_to_18 </TIME_TO_DX_NAME> <DX_NAME> vernal_keratoconjunctivitis </DX_NAME> <DX_NAME> allergic_condition </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> membrane </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> human_insulin </GENERIC_NAME> <GENERIC_NAME> zinc_chloride </GENERIC_NAME> <GENERIC_NAME> glycerol </GENERIC_NAME> <GENERIC_NAME> metacresol </GENERIC_NAME> <GENERIC_NAME> sodium_hydroxide </GENERIC_NAME> <GENERIC_NAME> hydrochloric_acid </GENERIC_NAME>
<GENERIC_NAME> pixantrone </GENERIC_NAME> <GENERIC_NAME> pixantrone_dimaleate </GENERIC_NAME> <GENERIC_NAME> pixantrone </GENERIC_NAME> <GENERIC_NAME> lactose_monohydrate </GENERIC_NAME> <GENERIC_NAME> sodium_hydroxide </GENERIC_NAME> <GENERIC_NAME> hydrochloric_acid </GENERIC_NAME> <GENERIC_NAME> sodium_chloride </GENERIC_NAME> <BRAND_NAME> Pixuvri </BRAND_NAME> <GENERIC_NAME> concentrate </GENERIC_NAME> <GENERIC_NAME> pixantrone </GENERIC_NAME> <ID> 92284 </ID> <ADDRESS> Laboratoires_Servier_Industrie </ADDRESS> <ADDRESS> 905_Route_de_Saran_45520 </ADDRESS> <ADDRESS> Gidy_France </ADDRESS> <BRAND_NAME> Belgique </BRAND_NAME> <ADDRESS> Belgien_S.A. </ADDRESS> <ADDRESS> Luxemburg_S.A. </ADDRESS> <NAME> Tel </NAME> <ADDRESS> Magyarország_Servier_Hungaria_Kft </ADDRESS> <ADDRESS> Malta_V.J._Salomone_Pharma_Ltd_Tel </ADDRESS> <PHONE_OR_FAX> 356_21_22_01_74_Deutschland </PHONE_OR_FAX> <ADDRESS> Deutschland_GmbH_Tel </ADDRESS> <TEST_NAME> GmbH </TEST_NAME> <NAME> Farma </NAME> <TEST_NAME> B.V. </TEST_NAME> <ID> 5246700 </ID> <ADDRESS> Eesti_Servier_Laboratories </ADDRESS> <TEST_NAME> Tlf </TEST_NAME> <ADDRESS> Austria_GmbH_Tel </ADDRESS> <TEST_NAME> GmbH </TEST_NAME> <NAME> Servier_Pharma </NAME> <NAME> d._o._o._Tel </NAME> <ADDRESS> România_Servier_Pharma_SRL_Tel </ADDRESS> <PHONE_OR_FAX> 528_52_80_Ireland </PHONE_OR_FAX> <ADDRESS> Ireland </ADDRESS> <PHONE_OR_FAX> 1_663_8110 </PHONE_OR_FAX> <NAME> Slovenija_Servier_Pharma_d. </NAME> <PHONE_OR_FAX> 354_540_8000 </PHONE_OR_FAX> <NAME> Slovensko_spol </NAME> <NAME> Tel </NAME> <PHONE_OR_FAX> 421_2_5920 </PHONE_OR_FAX> <NAME> Italia_Servier </NAME> <NAME> Italia </NAME> <ADDRESS> S.p.A._Tel </ADDRESS> <ID> 669081 </ID> <NAME> Suomi/Finland_Servier </NAME> <ADDRESS> Finland_Oy_P._/Tel </ADDRESS> <TEST_NAME> CA_Papaellinas </TEST_NAME> <TEST_NAME> Sverige_AB </TEST_NAME> <NAME> Latvija_SIA </NAME> <ADDRESS> Latvia_Tel </ADDRESS> <ADDRESS> 371_67502039 </ADDRESS> <ADDRESS> United_Kingdom_Servier_Laboratories_Ltd_Tel </ADDRESS> <PHONE_OR_FAX> 44_(0)1753_666409 </PHONE_OR_FAX>
<GENERIC_NAME> giapreza </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> emtriva </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <BRAND_NAME> emtriva </BRAND_NAME> <BRAND_NAME> emtriva </BRAND_NAME> <DX_NAME> difficulty_in_swallowing </DX_NAME> <GENERIC_NAME> emtriva </GENERIC_NAME> <GENERIC_NAME> emtriva </GENERIC_NAME> <GENERIC_NAME> emtricitabine </GENERIC_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> emtricitabine </GENERIC_NAME> <TREATMENT_NAME> nucleoside_reverse_transcriptase_inhibitor </TREATMENT_NAME> <DX_NAME> hiv_virus </DX_NAME> <GENERIC_NAME> emtriva </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> emtriva </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> antiretroviral_therapy </TREATMENT_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> emtriva </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME>
<URL> http://www.ema.europa.eu/docs/en </URL> <DATE> 2013 </DATE> <GENERIC_NAME> eptotermin_alfa </GENERIC_NAME> <GENERIC_NAME> opgenra </GENERIC_NAME> <GENERIC_NAME> eptotermin_alfa </GENERIC_NAME> <GENERIC_NAME> eptotermin_alfa </GENERIC_NAME> <GENERIC_NAME> eptotermin_alfa </GENERIC_NAME> <ADDRESS> international_science_centre </ADDRESS> <ADDRESS> park_castletroy_limerick </ADDRESS> <ADDRESS> ireland_tel </ADDRESS> <ID> 35361585100 </ID> <ID> 35361585151 </ID> <EMAIL> medicalinfo@olympusbiotech.com </EMAIL> <ADDRESS> biotech_international_limited_raheen </ADDRESS> <ADDRESS> business_park_limerick </ADDRESS> <ADDRESS> ireland_olympus_biotech_international_limited_block_2,_international_science_centre </ADDRESS> <NAME> park_castletroy,_limerick_ireland </NAME>
<GENERIC_NAME> besilesomab </GENERIC_NAME> <GENERIC_NAME> radioactive_solution </GENERIC_NAME> <GENERIC_NAME> besilesomab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> vein </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> diabetic_foot_infection </DX_NAME> <SYSTEM_ORGAN_SITE> foot </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<BRAND_NAME> zytiga </BRAND_NAME> <GENERIC_NAME> abiraterone_acetate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <BRAND_NAME> zytiga </BRAND_NAME> <GENERIC_NAME> testosterone </GENERIC_NAME> <SYSTEM_ORGAN_SITE> prostate </SYSTEM_ORGAN_SITE> <DX_NAME> prostate_cancer </DX_NAME> <BRAND_NAME> zytiga </BRAND_NAME> <TREATMENT_NAME> hormone_therapy </TREATMENT_NAME> <TREATMENT_NAME> lowers_testosterone </TREATMENT_NAME> <TREATMENT_NAME> androgen_deprivation_therapy </TREATMENT_NAME> <GENERIC_NAME> prednisone </GENERIC_NAME> <GENERIC_NAME> prednisolone </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> fluid_retention </DX_NAME>
<BRAND_NAME> otezla </BRAND_NAME> <BRAND_NAME> otezla </BRAND_NAME> <TREATMENT_NAME> phosphodiesterase_4_inhibitors </TREATMENT_NAME> <DX_NAME> inflammation </DX_NAME> <BRAND_NAME> otezla </BRAND_NAME> <BRAND_NAME> otezla </BRAND_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <TREATMENT_NAME> ‘diseasemodifying_antirheumatic </TREATMENT_NAME> <TREATMENT_NAME> dmards </TREATMENT_NAME> <DX_NAME> plaque_psoriasis </DX_NAME> <TREATMENT_NAME> phototherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> ultraviolet_light_systemic_therapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> ‘ciclosporin’ </GENERIC_NAME> <GENERIC_NAME> ‘methotrexate’ </GENERIC_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> mouth_ulcers </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> plaque_psoriasis </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> red </DX_NAME> <DX_NAME> scaly </DX_NAME> <DX_NAME> itchy </DX_NAME> <DX_NAME> painful_patches </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> scalp </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nails </SYSTEM_ORGAN_SITE> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> mouth_ulcers </DX_NAME> <BRAND_NAME> otezla </BRAND_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <TIME_TO_MEDICATION_NAME> currently </TIME_TO_MEDICATION_NAME> <BRAND_NAME> otezla </BRAND_NAME> <DX_NAME> inflammation </DX_NAME> <BRAND_NAME> otezla </BRAND_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> behçet’s_disease </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <BRAND_NAME> otezla </BRAND_NAME> <DX_NAME> swollen </DX_NAME> <DX_NAME> painful </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <BRAND_NAME> otezla </BRAND_NAME> <DX_NAME> psoriatic_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> plaques </DX_NAME> <BRAND_NAME> otezla </BRAND_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> ulcers </DX_NAME> <DX_NAME> pain </DX_NAME> <BRAND_NAME> otezla </BRAND_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME>
<GENERIC_NAME> duloxetine </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <GENERIC_NAME> noradrenaline </GENERIC_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> generalised </DX_NAME> <DX_NAME> anxiety_disorder </DX_NAME> <DX_NAME> feeling_of_anxiety </DX_NAME> <DX_NAME> nervousness </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> stabbing </DX_NAME> <DX_NAME> stinging </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> electric_shock </DX_NAME> <DX_NAME> loss_of_feeling </DX_NAME> <SYSTEM_ORGAN_SITE> affected_area </SYSTEM_ORGAN_SITE> <DX_NAME> cold </DX_NAME> <DX_NAME> pain </DX_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety </DX_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <TIME_TO_MEDICATION_NAME> two_weeks </TIME_TO_MEDICATION_NAME> <TIME_TO_DX_NAME> two_weeks </TIME_TO_DX_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> feeling_better </DX_NAME> <DX_NAME> depression </DX_NAME> <DX_NAME> anxiety </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <TIME_TO_DX_NAME> some_weeks </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> some_weeks </TIME_TO_DX_NAME>
<BRAND_NAME> elmiron </BRAND_NAME> <GENERIC_NAME> pentosan_polysulfate_sodium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <BRAND_NAME> elmiron </BRAND_NAME> <SYSTEM_ORGAN_SITE> bladder </SYSTEM_ORGAN_SITE> <DX_NAME> bladder_pain_syndrome </DX_NAME> <DX_NAME> bleeds </DX_NAME> <DX_NAME> lesions </DX_NAME> <SYSTEM_ORGAN_SITE> bladder_wall </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME> <DX_NAME> urge_to_urinate </DX_NAME>
<GENERIC_NAME> follitropin_alfa </GENERIC_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> ovary </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> ovary </SYSTEM_ORGAN_SITE> <DX_NAME> pregnant </DX_NAME> <TEST_NAME> chorionic_gonadotropin” </TEST_NAME> <TEST_NAME> hcg </TEST_NAME>
<BRAND_NAME> victoza </BRAND_NAME> <GENERIC_NAME> liraglutide </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <SYSTEM_ORGAN_SITE> stomach </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <BRAND_NAME> victoza </BRAND_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> diabetes_medicine </TREATMENT_NAME> <BRAND_NAME> victoza </BRAND_NAME> <DX_NAME> diabetes </DX_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <TREATMENT_NAME> oral_antidiabetics </TREATMENT_NAME> <GENERIC_NAME> antidiabetics </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <GENERIC_NAME> sulfonylurea </GENERIC_NAME> <TREATMENT_NAME> sodiumglucose_cotransporter_2_inhibitor </TREATMENT_NAME> <GENERIC_NAME> sodiumglucose_cotransporter_2_inhibitor </GENERIC_NAME> <GENERIC_NAME> sglt2i </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME>
<GENERIC_NAME> pemetrexed </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <DX_NAME> malignant_pleural_mesothelioma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <TIME_TO_TREATMENT_NAME> prior </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> pemetrexed </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME>
<GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <GENERIC_NAME> teva_pharma </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <DX_NAME> postmenopausal </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <TREATMENT_NAME> corticosteroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <DX_NAME> paget’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> thinning </DX_NAME> <DX_NAME> weakening </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> menopause </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> break_more_easily </DX_NAME> <DX_NAME> osteoporosis </DX_NAME> <TREATMENT_NAME> steroids </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <DX_NAME> breaking_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> osteoporosis </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME> <DX_NAME> decreased_circulating_levels </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_loss </DX_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <DX_NAME> trauma </DX_NAME> <DX_NAME> fall </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_breaks </DX_NAME> <DX_NAME> paget’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> paget’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> weaker_than_normal </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> deformed </DX_NAME> <DX_NAME> painful </DX_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> rapamune </GENERIC_NAME> <GENERIC_NAME> sirolimus </GENERIC_NAME> <TREATMENT_NAME> immunosuppressants </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> kidney_transplant </PROCEDURE_NAME> <GENERIC_NAME> rapamune </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> immunosuppressant_medicines </TREATMENT_NAME> <TREATMENT_NAME> corticosteroids </TREATMENT_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TIME_TO_TREATMENT_NAME> first_2_to_3 </TIME_TO_TREATMENT_NAME> <TIME_TO_MEDICATION_NAME> first_2_to_3 </TIME_TO_MEDICATION_NAME> <GENERIC_NAME> ciclosporin </GENERIC_NAME> <GENERIC_NAME> rapamune </GENERIC_NAME> <DX_NAME> lymphangioleiomyomatosis </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> declining_lung_function </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <DX_NAME> shortness_of_breath </DX_NAME>
<BRAND_NAME> vizimpro </BRAND_NAME> <GENERIC_NAME> dacomitinib </GENERIC_NAME> <TREATMENT_NAME> protein_tyrosine_kinase_inhibitors </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> vizimpro </BRAND_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> ‘nonsmall_cell_lung_cancer’ </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> vizimpro </BRAND_NAME> <BRAND_NAME> vizimpro </BRAND_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> norelgestromin </GENERIC_NAME> <GENERIC_NAME> oestrogen </GENERIC_NAME> <GENERIC_NAME> ethinyl_estradiol </GENERIC_NAME> <NAME> evra </NAME> <TREATMENT_NAME> ‘combined_hormonal </TREATMENT_NAME> <DX_NAME> pregnancy </DX_NAME>
<TEST_NAME> white_blood_cell_growth_factor </TEST_NAME> <TEST_NAME> granulocyte_colonystimulating_factor </TEST_NAME> <TEST_NAME> bone_marrow </TEST_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> neutropenia </DX_NAME> <DX_NAME> infection </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplant </PROCEDURE_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> highdose_chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> stem_cells </PROCEDURE_NAME> <PROCEDURE_NAME> bone_marrow </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME> <DX_NAME> neutropenia </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> infections </DX_NAME>
<GENERIC_NAME> temybric_ellipta </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> umeclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> fluticasone_furoate </GENERIC_NAME> <GENERIC_NAME> corticosteroids </GENERIC_NAME> <TREATMENT_NAME> steroids </TREATMENT_NAME> <GENERIC_NAME> umeclidinium_bromide </GENERIC_NAME> <GENERIC_NAME> vilanterol </GENERIC_NAME> <GENERIC_NAME> bronchodilators </GENERIC_NAME> <TREATMENT_NAME> bronchodilators </TREATMENT_NAME> <GENERIC_NAME> temybric_ellipta </GENERIC_NAME> <GENERIC_NAME> temybric_ellipta </GENERIC_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficult </DX_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> irritation </DX_NAME> <SYSTEM_ORGAN_SITE> small_air_passages </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> breathing_difficulties </DX_NAME> <DX_NAME> copd </DX_NAME> <GENERIC_NAME> temybric_ellipta </GENERIC_NAME> <DX_NAME> breathing_problems </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> attack_of_breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> attack </DX_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME>
<GENERIC_NAME> perflutren </GENERIC_NAME> <GENERIC_NAME> 1,2dipalmitoylsnglycero3phosphatidylcholine </GENERIC_NAME> <GENERIC_NAME> 1,2_dipalmitoylsnglycero3phosphatidic_acid </GENERIC_NAME> <GENERIC_NAME> monosodium_salt </GENERIC_NAME> <GENERIC_NAME> dppa </GENERIC_NAME> <GENERIC_NAME> methoxypolyethylene_glycol_5000_carbamoyl </GENERIC_NAME> <GENERIC_NAME> 2dipalmitoylsnglycero3phosphatidylethanolamine </GENERIC_NAME> <GENERIC_NAME> monosodium_salt </GENERIC_NAME> <GENERIC_NAME> mpeg5000_dppe </GENERIC_NAME> <GENERIC_NAME> sodium_dihydrogen_phosphate_monohydrate </GENERIC_NAME> <GENERIC_NAME> disodium_hydrogen_phosphate_heptahydrate </GENERIC_NAME> <GENERIC_NAME> sodium_chloride </GENERIC_NAME> <GENERIC_NAME> propylene_glycol </GENERIC_NAME> <GENERIC_NAME> glycerol </GENERIC_NAME> <ADDRESS> park_shannon,_co._clare </ADDRESS> <ADDRESS> fw97_ireland_tel </ADDRESS> <PHONE_OR_FAX> 353_1_223_3542 </PHONE_OR_FAX> <ADDRESS> 2324_tafarnaubach </ADDRESS> <ADDRESS> est._tredegar,_wales </ADDRESS> <ADDRESS> 3aa </ADDRESS> <ADDRESS> united_kingdom </ADDRESS> <ADDRESS> 7,_city_north_business_campus_stamullen </ADDRESS> <ADDRESS> co._meath </ADDRESS> <ADDRESS> ireland </ADDRESS>
<GENERIC_NAME> leflunomide </GENERIC_NAME> <TREATMENT_NAME> antirheumatic_medicines </TREATMENT_NAME> <GENERIC_NAME> leflunomide </GENERIC_NAME> <GENERIC_NAME> leflunomide </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> difficulty_moving </DX_NAME> <DX_NAME> pain </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> loss_of_appetite </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> loss_of_energy </DX_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> lack_of_red_blood_cells </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> swelling </DX_NAME> <DX_NAME> difficulty_moving </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> patches_of_red </DX_NAME> <DX_NAME> scaly_skin </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> skin_lesions </DX_NAME>
<GENERIC_NAME> budesonide </GENERIC_NAME> <GENERIC_NAME> formoterol_fumarate_dihydrate </GENERIC_NAME> <GENERIC_NAME> budesonide </GENERIC_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <GENERIC_NAME> formoterol_fumarate_dihydrate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <AGE> 13 </AGE> <AGE> 17 </AGE> <DX_NAME> asthma </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <TREATMENT_NAME> asthma_inhalers </TREATMENT_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME> <BRAND_NAME> vylaer_spiromax </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> cough </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_discomfort </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> copd </DX_NAME>
<TREATMENT_NAME> angiotensin_receptor_neprilysin_inhibitor </TREATMENT_NAME> <GENERIC_NAME> sacubitril </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> weak </DX_NAME> <DX_NAME> cannot_pump_enough_blood </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> fatigue </DX_NAME> <DX_NAME> tiredness </DX_NAME> <SYSTEM_ORGAN_SITE> ankle </SYSTEM_ORGAN_SITE> <DX_NAME> ankle_swelling </DX_NAME>
<TEST_NAME> ammonia_plasma_levels </TEST_NAME> <TEST_NAME> ammonia_level </TEST_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> coma </DX_NAME> <DX_NAME> hyperammonaemia </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_enzyme_n_acetylglutamate_synthase </DX_NAME> <GENERIC_NAME> acetylglutamate_synthase </GENERIC_NAME> <DX_NAME> rare_disorder </DX_NAME> <DX_NAME> disorder </DX_NAME>
<BRAND_NAME> xarelto </BRAND_NAME> <DX_NAME> coronary_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> unstable_angina </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <TEST_NAME> cardiac_blood_tests </TEST_NAME> <BRAND_NAME> xarelto </BRAND_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> dying </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <BRAND_NAME> xarelto </BRAND_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> ticlopidine </GENERIC_NAME> <DX_NAME> blood_clot </DX_NAME> <SYSTEM_ORGAN_SITE> coronary_artery </SYSTEM_ORGAN_SITE> <DX_NAME> coronary_artery_disease </DX_NAME> <DX_NAME> peripheral_artery_disease </DX_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <BRAND_NAME> xarelto </BRAND_NAME> <DX_NAME> blot_clots </DX_NAME> <BRAND_NAME> xarelto </BRAND_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <BRAND_NAME> xarelto </BRAND_NAME> <GENERIC_NAME> rivaroxaban </GENERIC_NAME> <TEST_NAME> blood_clotting_factor </TEST_NAME> <TEST_NAME> factor_xa </TEST_NAME> <DX_NAME> clots </DX_NAME>
<GENERIC_NAME> liprolog </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> liprolog </GENERIC_NAME> <GENERIC_NAME> normal_human_insulin </GENERIC_NAME> <GENERIC_NAME> insulin_molecule </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> liprolog </GENERIC_NAME> <GENERIC_NAME> liprolog </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME>
<TREATMENT_NAME> nucleoside_reverse_transcriptase_inhibitors </TREATMENT_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <DX_NAME> hiv </DX_NAME> <TREATMENT_NAME> antiretroviral_therapy </TREATMENT_NAME> <DX_NAME> infecting </DX_NAME> <DX_NAME> infections </DX_NAME> <DX_NAME> weakened_immunity </DX_NAME> <DX_NAME> infections </DX_NAME> <TREATMENT_NAME> preventive_treatment </TREATMENT_NAME>
<TREATMENT_NAME> antibiotic </TREATMENT_NAME> <GENERIC_NAME> fidaxomicin </GENERIC_NAME> <GENERIC_NAME> dificlir_filmcoated </GENERIC_NAME> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> lining_of_the_colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> large_intestine </SYSTEM_ORGAN_SITE> <DX_NAME> bacteria </DX_NAME> <DX_NAME> clostridioides_difficile </DX_NAME> <DX_NAME> illness </DX_NAME> <DX_NAME> painful </DX_NAME> <DX_NAME> diarrhoea </DX_NAME> <DX_NAME> bacteria </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> diarrhoea </DX_NAME>
<GENERIC_NAME> granpidam </GENERIC_NAME> <GENERIC_NAME> sildenafil </GENERIC_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_(pde5)_inhibitors </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> pulmonary_arterial_hypertension </DX_NAME>
<GENERIC_NAME> empagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> poor_circulation </DX_NAME> <SYSTEM_ORGAN_SITE> limbs </SYSTEM_ORGAN_SITE> <GENERIC_NAME> empagliflozin </GENERIC_NAME> <GENERIC_NAME> sodium_glucose_cotransporter2 </GENERIC_NAME> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <GENERIC_NAME> metformin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <AGE> 18 </AGE> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> empagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> overdose </DX_NAME> <GENERIC_NAME> empagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME>
<GENERIC_NAME> semaglutide </GENERIC_NAME> <AGE> 18 </AGE> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> diabetes_medicine </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TEST_NAME> blood_sugar </TEST_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_problems </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> eye_disorders </DX_NAME> <DX_NAME> poor_circulation </DX_NAME> <SYSTEM_ORGAN_SITE> limbs </SYSTEM_ORGAN_SITE> <TEST_NAME> blood_sugar_levels </TEST_NAME>
<GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessel_wall </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> valsartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> amlodipine </GENERIC_NAME> <GENERIC_NAME> valsartan </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME>
<BRAND_NAME> evoltra </BRAND_NAME> <GENERIC_NAME> clofarabine </GENERIC_NAME> <GENERIC_NAME> clofarabine </GENERIC_NAME> <BRAND_NAME> evoltra </BRAND_NAME> <AGE> 21 </AGE> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> abnormal_growth </DX_NAME> <TREATMENT_NAME> white_blood_cells </TREATMENT_NAME>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <BRAND_NAME> teva_pharma_b </BRAND_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> aggregation_inhibitors </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> “atherosclerosis” </DX_NAME> <DX_NAME> blood_clot </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> hardening </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <TIME_TO_DX_NAME> recently </TIME_TO_DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> arterial_disease” </DX_NAME> <DX_NAME> diseases_of_the_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_pain </DX_NAME> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_k_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <BRAND_NAME> teva_pharma </BRAND_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> dic </DX_NAME>
<GENERIC_NAME> brivaracetam </GENERIC_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> epilepsy </DX_NAME> <DX_NAME> partial_seizures </DX_NAME> <DX_NAME> generalisation </DX_NAME> <DX_NAME> partial_seizures </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> partial_seizures </DX_NAME> <SYSTEM_ORGAN_SITE> sides </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> seizures </DX_NAME> <BRAND_NAME> briviact </BRAND_NAME> <DX_NAME> epilepsy </DX_NAME>
<DX_NAME> obesity </DX_NAME> <SYSTEM_ORGAN_SITE> digestive_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> digestive_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> obesity </DX_NAME>
<NAME> alkindi </NAME> <GENERIC_NAME> hydrocortisone </GENERIC_NAME> <GENERIC_NAME> hydrocortisone </GENERIC_NAME> <GENERIC_NAME> hydrocortisone </GENERIC_NAME> <TEST_NAME> hormone_cortisol </TEST_NAME> <SYSTEM_ORGAN_SITE> adrenal_glands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <NAME> alkindi </NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> adrenal_gland </SYSTEM_ORGAN_SITE> <DX_NAME> adrenal_insufficiency </DX_NAME> <DX_NAME> congenital_adrenal_hyperplasia </DX_NAME>
<BRAND_NAME> remicade </BRAND_NAME> <GENERIC_NAME> infliximab </GENERIC_NAME> <GENERIC_NAME> infliximab </GENERIC_NAME> <TEST_NAME> monoclonal_antibody </TEST_NAME> <BRAND_NAME> remicade </BRAND_NAME> <DX_NAME> inflammatory_diseases </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> bechterew’s_disease </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <BRAND_NAME> remicade </BRAND_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <BRAND_NAME> remicade </BRAND_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <BRAND_NAME> remicade </BRAND_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <BRAND_NAME> remicade </BRAND_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> bechterew’s_disease </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> spine </SYSTEM_ORGAN_SITE> <DX_NAME> ankylosing_spondylitis </DX_NAME> <BRAND_NAME> remicade </BRAND_NAME> <DX_NAME> psoriasis_psoriasis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> plaque_psoriasis </DX_NAME> <TREATMENT_NAME> phototherapy </TREATMENT_NAME> <BRAND_NAME> remicade </BRAND_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> ulcerative_colitis </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> ulcerative_colitis </DX_NAME> <BRAND_NAME> remicade </BRAND_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> inflammatory_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <DX_NAME> crohn’s_disease </DX_NAME> <BRAND_NAME> remicade </BRAND_NAME> <DX_NAME> crohn’s_disease </DX_NAME> <DX_NAME> abnormal_openings </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME>
<GENERIC_NAME> saxagliptin </GENERIC_NAME> <GENERIC_NAME> dapagliflozin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> oral_diabetes_medicines </TREATMENT_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <AGE> 18 </AGE> <DX_NAME> diabetes </DX_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME>
<BRAND_NAME> kuvan </BRAND_NAME> <GENERIC_NAME> sapropterin </GENERIC_NAME> <GENERIC_NAME> tetrahydrobiopterin </GENERIC_NAME> <GENERIC_NAME> amino_acid </GENERIC_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME> <GENERIC_NAME> amino_acid </GENERIC_NAME> <GENERIC_NAME> tyrosine </GENERIC_NAME> <BRAND_NAME> kuvan </BRAND_NAME> <DX_NAME> hyperphenylalaninaemia </DX_NAME> <DX_NAME> hpa </DX_NAME> <DX_NAME> phenylketonuria </DX_NAME> <TEST_NAME> hpa </TEST_NAME> <TEST_NAME> pku </TEST_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME> <BRAND_NAME> kuvan </BRAND_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME> <DX_NAME> inherited_disease </DX_NAME> <DX_NAME> bh4_deficiency </DX_NAME> <BRAND_NAME> kuvan </BRAND_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME> <GENERIC_NAME> phenylalanine </GENERIC_NAME>
<GENERIC_NAME> bromfenac </GENERIC_NAME> <GENERIC_NAME> nonsteroidal_anti_inflammatory_drugs </GENERIC_NAME> <TREATMENT_NAME> nonsteroidal_anti_inflammatory_drugs </TREATMENT_NAME> <GENERIC_NAME> nsaids </GENERIC_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> eye_inflammation </DX_NAME> <DX_NAME> cataract </DX_NAME> <PROCEDURE_NAME> cataract_surgery </PROCEDURE_NAME>
<GENERIC_NAME> alfa_pegol </GENERIC_NAME> <TREATMENT_NAME> longacting_recombinant_coagulation_factor_viii_product </TREATMENT_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> inborn_factor_viii_deficiency </DX_NAME> <DX_NAME> haemophilia </DX_NAME> <DX_NAME> factor_viii_is_missing </DX_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> bevacizumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> bevacizumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lymph_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <GENERIC_NAME> bevacizumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bowel </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> colon </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> rectum </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> fluoropyrimidine </GENERIC_NAME> <TREATMENT_NAME> fluoropyrimidine_medicine </TREATMENT_NAME> <BRAND_NAME> zirabev </BRAND_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> capecitabine </GENERIC_NAME> <BRAND_NAME> zirabev </BRAND_NAME> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <BRAND_NAME> zirabev </BRAND_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> platinum </GENERIC_NAME> <BRAND_NAME> zirabev </BRAND_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cancer </DX_NAME> <GENERIC_NAME> interferon </GENERIC_NAME> <NAME> zirabev </NAME> <BRAND_NAME> zirabev </BRAND_NAME> <SYSTEM_ORGAN_SITE> fallopian_tube </SYSTEM_ORGAN_SITE> <DX_NAME> peritoneal_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> fallopian_tube </SYSTEM_ORGAN_SITE> <DX_NAME> peritoneal_cancer </DX_NAME> <GENERIC_NAME> carboplatin </GENERIC_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> fallopian_tube </SYSTEM_ORGAN_SITE> <DX_NAME> peritoneal_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <BRAND_NAME> zirabev </BRAND_NAME> <GENERIC_NAME> carboplatin </GENERIC_NAME> <GENERIC_NAME> gemcitabine </GENERIC_NAME> <GENERIC_NAME> carboplatin </GENERIC_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> fallopian_tube </SYSTEM_ORGAN_SITE> <DX_NAME> peritoneal_cancer </DX_NAME> <TREATMENT_NAME> chemotherapy_regimen </TREATMENT_NAME> <TREATMENT_NAME> platinum_agent </TREATMENT_NAME> <BRAND_NAME> zirabev </BRAND_NAME> <GENERIC_NAME> topotecan </GENERIC_NAME> <GENERIC_NAME> pegylated_liposomal_doxorubicin </GENERIC_NAME> <BRAND_NAME> zirabev </BRAND_NAME> <DX_NAME> cervical_cancer </DX_NAME> <BRAND_NAME> zirabev </BRAND_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> cisplatin </GENERIC_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> topotecan </GENERIC_NAME> <GENERIC_NAME> platinum </GENERIC_NAME> <TREATMENT_NAME> platinum_therapy </TREATMENT_NAME>
<TREATMENT_NAME> contraceptive_pill </TREATMENT_NAME> <DX_NAME> pregnancy </DX_NAME> <GENERIC_NAME> nomegestrol_acetate </GENERIC_NAME> <GENERIC_NAME> progestogen </GENERIC_NAME> <GENERIC_NAME> estradiol </GENERIC_NAME> <GENERIC_NAME> oestrogen </GENERIC_NAME> <GENERIC_NAME> placebo </GENERIC_NAME> <TREATMENT_NAME> contraceptive_pills </TREATMENT_NAME> <GENERIC_NAME> contraceptive_pills </GENERIC_NAME> <GENERIC_NAME> estradiol </GENERIC_NAME> <GENERIC_NAME> oestrogen </GENERIC_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <GENERIC_NAME> nomegestrol_acetate </GENERIC_NAME> <GENERIC_NAME> progestogen </GENERIC_NAME> <TREATMENT_NAME> hormone_progesterone </TREATMENT_NAME> <GENERIC_NAME> progesterone </GENERIC_NAME> <GENERIC_NAME> progesterone </GENERIC_NAME> <SYSTEM_ORGAN_SITE> ovaries </SYSTEM_ORGAN_SITE> <DX_NAME> menstrual_cycle </DX_NAME>
<GENERIC_NAME> ibandronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> ‘bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME> <DX_NAME> tumour </DX_NAME> <DX_NAME> lost_from_your_bones </DX_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <DX_NAME> weaker </DX_NAME>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <TEST_NAME> platelets </TEST_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> irregular_heartbeat </DX_NAME> <GENERIC_NAME> vitamin_k_antagonists </GENERIC_NAME> <DX_NAME> clots </DX_NAME> <DX_NAME> clots </DX_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <BRAND_NAME> zentiva </BRAND_NAME> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> bleeding </DX_NAME>
<BRAND_NAME> zinbryta </BRAND_NAME> <BRAND_NAME> zinbryta </BRAND_NAME> <BRAND_NAME> zinbryta </BRAND_NAME> <GENERIC_NAME> daclizumab_beta </GENERIC_NAME> <TREATMENT_NAME> monoclonal_antibody </TREATMENT_NAME> <BRAND_NAME> zinbryta </BRAND_NAME> <BRAND_NAME> zinbryta </BRAND_NAME> <DX_NAME> zinbryta </DX_NAME> <DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> central_nervous_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <DX_NAME> loss_of_myelin </DX_NAME> <DX_NAME> demyelination </DX_NAME> <DX_NAME> attacks </DX_NAME> <DX_NAME> relapses </DX_NAME> <SYSTEM_ORGAN_SITE> nerves </SYSTEM_ORGAN_SITE> <DX_NAME> difficulty_with_walking </DX_NAME> <DX_NAME> vision_and_balance </DX_NAME> <DX_NAME> disappear </DX_NAME> <DX_NAME> relapse </DX_NAME> <DX_NAME> dic </DX_NAME> <BRAND_NAME> zinbryta </BRAND_NAME> <BRAND_NAME> zinbryta </BRAND_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <DX_NAME> zinbryta </DX_NAME> <BRAND_NAME> zinbryta </BRAND_NAME> <DX_NAME> zinbryta </DX_NAME> <BRAND_NAME> zinbryta </BRAND_NAME>
<TIME_TO_DX_NAME> age_of </TIME_TO_DX_NAME> <AGE> 9 </AGE> <DX_NAME> infection </DX_NAME> <DX_NAME> human_papillomaviruses </DX_NAME> <DX_NAME> hpv </DX_NAME> <SYSTEM_ORGAN_SITE> cervical </SYSTEM_ORGAN_SITE> <DX_NAME> cervical_cancer </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> cervix </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> uterus </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> anal </SYSTEM_ORGAN_SITE> <DX_NAME> anal_cancer </DX_NAME> <DX_NAME> precancerous </DX_NAME> <SYSTEM_ORGAN_SITE> cervical </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vulvar </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vaginal </SYSTEM_ORGAN_SITE> <DX_NAME> vaginal_and_anal_lesions </DX_NAME> <SYSTEM_ORGAN_SITE> anal </SYSTEM_ORGAN_SITE> <DX_NAME> changes_in_genital_or_anal_cells </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> human_papillomavirus </DX_NAME> <DX_NAME> hpv </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DATE> 16 </DATE> <AGE> 18 </AGE> <DX_NAME> cervical_cancers </DX_NAME> <DX_NAME> anal_cancers </DX_NAME> <DX_NAME> lesions </DX_NAME> <SYSTEM_ORGAN_SITE> vulva </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> vagina </SYSTEM_ORGAN_SITE> <DX_NAME> lesions </DX_NAME> <SYSTEM_ORGAN_SITE> anus </SYSTEM_ORGAN_SITE> <DX_NAME> anogenital_cancers </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> hpv_related_diseases </DX_NAME> <DX_NAME> hpv </DX_NAME> <TIME_TO_DX_NAME> at_the </TIME_TO_DX_NAME> <TIME_TO_TREATMENT_NAME> at_the </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> vaccination </TREATMENT_NAME>
<GENERIC_NAME> fentanyl </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> breakthrough_pain </DX_NAME> <DX_NAME> pain </DX_NAME> <GENERIC_NAME> morphine </GENERIC_NAME> <GENERIC_NAME> fentanyl </GENERIC_NAME> <GENERIC_NAME> oxycodone </GENERIC_NAME> <GENERIC_NAME> hydromorphone </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <TREATMENT_NAME> opioid_medicines </TREATMENT_NAME> <GENERIC_NAME> opioid_medicines </GENERIC_NAME> <DX_NAME> cancer_pain </DX_NAME> <TREATMENT_NAME> nasal_spray </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <GENERIC_NAME> fentanyl </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nose </SYSTEM_ORGAN_SITE> <DX_NAME> pain </DX_NAME>
<GENERIC_NAME> memantine_hydrochloride </GENERIC_NAME> <DX_NAME> memory_loss </DX_NAME> <DX_NAME> alzheimer’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> alzheimer’s_disease </DX_NAME>
<GENERIC_NAME> rezolsta </GENERIC_NAME> <GENERIC_NAME> rezolsta </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> cobicistat </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> cobicistat </GENERIC_NAME> <GENERIC_NAME> darunavir </GENERIC_NAME> <GENERIC_NAME> rezolsta </GENERIC_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> rezolsta </GENERIC_NAME> <DX_NAME> hiv_infection </DX_NAME> <GENERIC_NAME> rezolsta </GENERIC_NAME> <TEST_NAME> weigh </TEST_NAME> <DX_NAME> infected </DX_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> rezolsta </GENERIC_NAME> <GENERIC_NAME> rezolsta </GENERIC_NAME> <TREATMENT_NAME> hiv_medicines </TREATMENT_NAME>
<PROCEDURE_NAME> injection </PROCEDURE_NAME> <BRAND_NAME> Enbrel </BRAND_NAME> <BRAND_NAME> Enbrel </BRAND_NAME> <BRAND_NAME> Enbrel </BRAND_NAME> <DX_NAME> inflammation </DX_NAME> <BRAND_NAME> Enbrel </BRAND_NAME> <DX_NAME> inflammation </DX_NAME> <AGE> 18 </AGE> <BRAND_NAME> Enbrel </BRAND_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <DX_NAME> axial_spondyloarthritis </DX_NAME> <DX_NAME> ankylosing_spondylitis </DX_NAME> <DX_NAME> psoriasis </DX_NAME> <DX_NAME> rheumatoid_arthritis </DX_NAME> <BRAND_NAME> Enbrel </BRAND_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <BRAND_NAME> Enbrel </BRAND_NAME> <DX_NAME> damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <DX_NAME> rheumatoid_arthritis </DX_NAME> <DX_NAME> psoriatic_arthritis </DX_NAME> <SYSTEM_ORGAN_SITE> joint </SYSTEM_ORGAN_SITE> <BRAND_NAME> Enbrel </BRAND_NAME> <DX_NAME> painful </DX_NAME> <DX_NAME> swollen </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hands </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> wrists </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> feet </SYSTEM_ORGAN_SITE> <BRAND_NAME> Enbrel </BRAND_NAME> <DX_NAME> structural_damage </DX_NAME> <SYSTEM_ORGAN_SITE> joints </SYSTEM_ORGAN_SITE> <BRAND_NAME> Enbrel </BRAND_NAME> <DX_NAME> idiopathic_arthritis </DX_NAME> <GENERIC_NAME> methotrexate </GENERIC_NAME> <DX_NAME> Polyarthritis </DX_NAME> <DX_NAME> rheumatoid_factor_positive </DX_NAME> <DX_NAME> extended_oligoarthritis </DX_NAME> <AGE> 2 </AGE> <DX_NAME> Psoriatic_arthritis </DX_NAME> <AGE> 12 </AGE> <DX_NAME> enthesitis-related_arthritis </DX_NAME> <AGE> 12 </AGE> <DX_NAME> psoriasis </DX_NAME> <AGE> 6 </AGE> <DX_NAME> inadequate_response </DX_NAME> <TREATMENT_NAME> phototherapies </TREATMENT_NAME> <TREATMENT_NAME> systemic_therapies </TREATMENT_NAME>
<GENERIC_NAME> reblozyl </GENERIC_NAME> <GENERIC_NAME> luspatercept </GENERIC_NAME> <DX_NAME> myelodysplastic_syndromes </DX_NAME> <DX_NAME> myelodysplastic_syndromes </DX_NAME> <DX_NAME> mds </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> bone_marrow_disorders </DX_NAME> <TEST_NAME> bone_marrow_disorders </TEST_NAME> <TEST_NAME> red_blood_cells </TEST_NAME> <DX_NAME> red_blood_cells_become_abnormal </DX_NAME> <TEST_NAME> red_blood_cell_count </TEST_NAME> <DX_NAME> red_blood_cell_count </DX_NAME> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> red_blood_cell_transfusions </TREATMENT_NAME> <GENERIC_NAME> reblozyl </GENERIC_NAME> <DX_NAME> anaemia </DX_NAME> <DX_NAME> mds </DX_NAME> <TREATMENT_NAME> red_blood_cell_transfusions </TREATMENT_NAME> <TREATMENT_NAME> erythropoietin_therapies </TREATMENT_NAME> <DX_NAME> passed_down_through_genes </DX_NAME> <TEST_NAME> red_blood_cell_count </TEST_NAME> <DX_NAME> red_blood_cell_count </DX_NAME> <DX_NAME> anaemia </DX_NAME> <TREATMENT_NAME> red_blood_cell_transfusions </TREATMENT_NAME> <GENERIC_NAME> reblozyl </GENERIC_NAME> <TREATMENT_NAME> red_blood_cell_transfusions </TREATMENT_NAME> <GENERIC_NAME> reblozyl </GENERIC_NAME> <GENERIC_NAME> reblozyl </GENERIC_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <TREATMENT_NAME> red_blood_cells </TREATMENT_NAME> <GENERIC_NAME> reblozyl </GENERIC_NAME> <TREATMENT_NAME> red_blood_cell_transfusions </TREATMENT_NAME> <TREATMENT_NAME> regular_blood_transfusions </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<NAME> esmya </NAME> <GENERIC_NAME> ulipristal_acetate </GENERIC_NAME> <DX_NAME> uterine_fibroids </DX_NAME> <DX_NAME> myomas </DX_NAME> <DX_NAME> noncancerous_tumours </DX_NAME> <SYSTEM_ORGAN_SITE> uterus </SYSTEM_ORGAN_SITE> <NAME> esmya </NAME> <AGE> 18 </AGE> <DX_NAME> menopause </DX_NAME> <DX_NAME> uterine_fibroids </DX_NAME> <DX_NAME> heavy_menstrual_bleeding </DX_NAME> <DX_NAME> pelvic_pain </DX_NAME> <DX_NAME> discomfort </DX_NAME> <SYSTEM_ORGAN_SITE> belly </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> operation </PROCEDURE_NAME> <DX_NAME> fibroids </DX_NAME> <DX_NAME> fibroids </DX_NAME> <DX_NAME> bleeding </DX_NAME> <DX_NAME> red_blood_cell_count </DX_NAME>
<GENERIC_NAME> mogamulizumab </GENERIC_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> mycosis_fungoides </DX_NAME> <DX_NAME> sézary_syndrome </DX_NAME> <DX_NAME> cancers </DX_NAME> <DX_NAME> cutaneous_tcell_lymphomas </DX_NAME> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> ratiopharm </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <DX_NAME> blood_clotting </DX_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME> <DX_NAME> disturbed_blood_flow </DX_NAME> <SYSTEM_ORGAN_SITE> arms </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <DX_NAME> vascular_occlusions </DX_NAME> <DX_NAME> type_of_chest_pain </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> ‘myocardial_infarction’ </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <PROCEDURE_NAME> stent_in_the_blocked </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> artery </SYSTEM_ORGAN_SITE> <GENERIC_NAME> acetylsalicylic_acid </GENERIC_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> blood_clotting </DX_NAME>
<GENERIC_NAME> SUSTIVA </GENERIC_NAME> <GENERIC_NAME> efavirenz </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <TREATMENT_NAME> non-nucleoside_reverse_transcriptase_inhibitors </TREATMENT_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> HIV </DX_NAME> <DX_NAME> infection </DX_NAME> <TEST_NAME> weighing </TEST_NAME> <GENERIC_NAME> SUSTIVA </GENERIC_NAME> <DX_NAME> HIV_infection </DX_NAME> <GENERIC_NAME> SUSTIVA </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicines </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicines </GENERIC_NAME> <DX_NAME> virus_in_the_blood </DX_NAME> <DX_NAME> illnesses </DX_NAME> <DX_NAME> HIV_infection </DX_NAME>
<GENERIC_NAME> ketoconazole </GENERIC_NAME> <GENERIC_NAME> ketoconazole </GENERIC_NAME> <DX_NAME> cushing’s_syndrome </DX_NAME> <AGE> 12 </AGE> <DX_NAME> cushing’s_syndrome </DX_NAME> <SYSTEM_ORGAN_SITE> adrenal_glands </SYSTEM_ORGAN_SITE> <GENERIC_NAME> ketoconazole </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> cushing’s_syndrome </DX_NAME>
<GENERIC_NAME> vokanamet </GENERIC_NAME> <GENERIC_NAME> canagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <TREATMENT_NAME> dpp4_inhibitor </TREATMENT_NAME> <GENERIC_NAME> sitagliptin </GENERIC_NAME> <GENERIC_NAME> saxagliptin </GENERIC_NAME> <GENERIC_NAME> linagliptin </GENERIC_NAME> <GENERIC_NAME> sulphonylurea </GENERIC_NAME> <GENERIC_NAME> glimepiride </GENERIC_NAME> <GENERIC_NAME> glipizide </GENERIC_NAME> <GENERIC_NAME> pioglitazone </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> vokanamet </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <TREATMENT_NAME> diabetes_medicines </TREATMENT_NAME> <GENERIC_NAME> canagliflozin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> vokanamet </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_disease </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_disease </DX_NAME> <DX_NAME> blindness </DX_NAME> <DX_NAME> amputation </DX_NAME> <PROCEDURE_NAME> amputation </PROCEDURE_NAME>
<TREATMENT_NAME> radiopharmaceutical_product </TREATMENT_NAME> <BRAND_NAME> amyvid </BRAND_NAME> <GENERIC_NAME> florbetapir </GENERIC_NAME> <BRAND_NAME> amyvid </BRAND_NAME> <DX_NAME> memory_problems </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <TEST_NAME> brain_scan </TEST_NAME> <TEST_NAME> pet_scan </TEST_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <TEST_NAME> brain_function_tests </TEST_NAME> <DX_NAME> memory_problems </DX_NAME> <TEST_NAME> amyvid_pet_scan </TEST_NAME> <DX_NAME> plaques </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> plaques </DX_NAME> <DX_NAME> alzheimer’s_disease </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> dementias </DX_NAME> <BRAND_NAME> amyvid </BRAND_NAME> <TREATMENT_NAME> radiation </TREATMENT_NAME>
<TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> hepatitis_a_and_hepatitis </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> infectious_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_a_virus </DX_NAME> <DX_NAME> hepatitis_a_virus </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <TIME_TO_DX_NAME> 3_to_6_weeks </TIME_TO_DX_NAME> <DX_NAME> nausea </DX_NAME> <DX_NAME> feeling_sick </DX_NAME> <DX_NAME> fever </DX_NAME> <DX_NAME> aches </DX_NAME> <DX_NAME> pains </DX_NAME> <SYSTEM_ORGAN_SITE> eyes </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> jaundice </DX_NAME> <DX_NAME> jaundice </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis </DX_NAME> <DX_NAME> hepatitis_b_virus </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> swollen </DX_NAME> <DX_NAME> inflamed </DX_NAME> <DX_NAME> vaginal_secretions </DX_NAME> <DX_NAME> infected </DX_NAME> <TREATMENT_NAME> vaccination </TREATMENT_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME>
<GENERIC_NAME> miglustat </GENERIC_NAME> <DX_NAME> yargesa </DX_NAME> <DX_NAME> type_1_gaucher_disease </DX_NAME> <DX_NAME> gaucher_disease </DX_NAME> <GENERIC_NAME> glucosylceramide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spleen </SYSTEM_ORGAN_SITE> <DX_NAME> changes_in_the_blood_and_bone_disease </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> type_1_gaucher_disease </DX_NAME> <TREATMENT_NAME> enzyme_replacement_therapy </TREATMENT_NAME> <DX_NAME> yargesa </DX_NAME> <TREATMENT_NAME> enzyme_replacement_therapy </TREATMENT_NAME> <DX_NAME> yargesa </DX_NAME> <DX_NAME> neurological_symptoms </DX_NAME> <DX_NAME> niemannpick_type_c_disease </DX_NAME> <DX_NAME> niemannpick_type_c_disease </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> slow_eye_movements </DX_NAME> <SYSTEM_ORGAN_SITE> eye </SYSTEM_ORGAN_SITE> <DX_NAME> balance </DX_NAME> <DX_NAME> swallowing </DX_NAME> <DX_NAME> memory </DX_NAME> <DX_NAME> seizures </DX_NAME> <GENERIC_NAME> ‘glucosylceramide </GENERIC_NAME>
<BRAND_NAME> inlyta </BRAND_NAME> <GENERIC_NAME> axitinib </GENERIC_NAME> <GENERIC_NAME> axitinib </GENERIC_NAME> <DX_NAME> tumour </DX_NAME> <DX_NAME> cancer </DX_NAME> <BRAND_NAME> inlyta </BRAND_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_cancer </DX_NAME> <DX_NAME> renal_cell_carcinoma </DX_NAME> <GENERIC_NAME> sunitinib </GENERIC_NAME>
<BRAND_NAME> pradaxa </BRAND_NAME> <GENERIC_NAME> dabigatran_etexilate </GENERIC_NAME> <GENERIC_NAME> anticoagulants </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> blood_clot </DX_NAME> <BRAND_NAME> pradaxa </BRAND_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> veins </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> knee </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> hip </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> hip_replacement_surgery </PROCEDURE_NAME>
<GENERIC_NAME> orphacol </GENERIC_NAME> <GENERIC_NAME> cholic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> defects </DX_NAME> <DX_NAME> bile_acid_production </DX_NAME> <DX_NAME> defect_in_bile_acid_production </DX_NAME>
<GENERIC_NAME> zoledronic_acid_actavis </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_complications </DX_NAME> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_metastases </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> primary_site </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <DX_NAME> tumour </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> hypercalcaemia </DX_NAME>
<GENERIC_NAME> thalidomide </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> myeloma’ </DX_NAME> <GENERIC_NAME> ‘bortezomib’ </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <GENERIC_NAME> chemotherapy_medicine </GENERIC_NAME> <GENERIC_NAME> ‘dexamethasone’ </GENERIC_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> ‘dexamethasone’ </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <GENERIC_NAME> lenalidomide </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <DX_NAME> myeloma </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> myeloma </DX_NAME> <DX_NAME> myeloma </DX_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> imnovid </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> imnovid </GENERIC_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <TIME_TO_DX_NAME> 11_months </TIME_TO_DX_NAME> <GENERIC_NAME> bortezomib </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> imnovid </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <GENERIC_NAME> imnovid </GENERIC_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME> <DX_NAME> myeloma </DX_NAME> <GENERIC_NAME> dexamethasone </GENERIC_NAME>
<GENERIC_NAME> omnitrope </GENERIC_NAME> <GENERIC_NAME> recombinant_human </GENERIC_NAME> <GENERIC_NAME> somatropin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bones </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> fat </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscle_tissues </SYSTEM_ORGAN_SITE> <DX_NAME> turner_syndrome </DX_NAME> <DX_NAME> turner_syndrome </DX_NAME> <DX_NAME> genetic_disorder </DX_NAME> <DX_NAME> renal_(kidney)_insufficiency </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> lose_their_ability_to_function_normally </DX_NAME> <DX_NAME> affect_growth </DX_NAME> <DX_NAME> praderwilli_syndrome </DX_NAME> <DX_NAME> chromosomal_disorder </DX_NAME> <TREATMENT_NAME> growth_hormone </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <DX_NAME> muscle_mass </DX_NAME> <DX_NAME> growth_hormone_deficiency </DX_NAME> <GENERIC_NAME> omnitrope </GENERIC_NAME> <DX_NAME> growth_hormone_deficiency </DX_NAME> <TEST_NAME> growth_hormone_status </TEST_NAME> <DX_NAME> growth_hormone_deficiency </DX_NAME> <GENERIC_NAME> omnitrope </GENERIC_NAME> <TREATMENT_NAME> growth_hormone_treatment </TREATMENT_NAME>
<GENERIC_NAME> edoxaban </GENERIC_NAME> <GENERIC_NAME> anticoagulants </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> blood_clotting </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> irregular_heart_rhythm </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> nonvalvular_atrial_fibrillation </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> veins </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> deep_vein </SYSTEM_ORGAN_SITE> <DX_NAME> deep_vein_thrombosis </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> pulmonary_embolism </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> legs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> descovy </GENERIC_NAME> <GENERIC_NAME> emtricitabine </GENERIC_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <TREATMENT_NAME> nucleoside_reverse_transcriptase_inhibitor </TREATMENT_NAME> <GENERIC_NAME> tenofovir_alafenamide </GENERIC_NAME> <TREATMENT_NAME> antiretroviral_medicine </TREATMENT_NAME> <GENERIC_NAME> antiretroviral_medicine </GENERIC_NAME> <TREATMENT_NAME> nucleotide_reverse_transcriptase_inhibitor </TREATMENT_NAME> <TREATMENT_NAME> descovy_blocks </TREATMENT_NAME> <GENERIC_NAME> descovy </GENERIC_NAME> <DX_NAME> hiv </DX_NAME> <GENERIC_NAME> descovy </GENERIC_NAME> <DX_NAME> human_immunodeficiency_virus </DX_NAME> <DX_NAME> infection </DX_NAME> <TEST_NAME> weigh </TEST_NAME>
<GENERIC_NAME> duloxetine </GENERIC_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <GENERIC_NAME> noradrenaline </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nervous_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> mouth </SYSTEM_ORGAN_SITE> <DX_NAME> stress_urinary_incontinence </DX_NAME> <DX_NAME> stress_urinary_incontinence </DX_NAME> <DX_NAME> accidental_loss </DX_NAME> <DX_NAME> leakage_of_urine </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> sneezing </DX_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> training_program </TREATMENT_NAME> <TREATMENT_NAME> pelvic_floor_muscle_training </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> muscle </SYSTEM_ORGAN_SITE>
<BRAND_NAME> xadago </BRAND_NAME> <GENERIC_NAME> safinamide </GENERIC_NAME> <GENERIC_NAME> dopamine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> parkinson’s_disease </DX_NAME> <BRAND_NAME> xadago </BRAND_NAME> <DX_NAME> parkinson’s_disease </DX_NAME> <DX_NAME> difficulties_moving </DX_NAME> <BRAND_NAME> xadago </BRAND_NAME> <GENERIC_NAME> levodopa </GENERIC_NAME> <DX_NAME> parkinson’s_disease </DX_NAME>
<BRAND_NAME> HyQvia </BRAND_NAME> <BRAND_NAME> HyQvia </BRAND_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> recombinant_human_hyaluronidase </GENERIC_NAME> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <DX_NAME> infections </DX_NAME> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <BRAND_NAME> HyQvia </BRAND_NAME> <DX_NAME> frequent_infections </DX_NAME> <BRAND_NAME> HyQvia </BRAND_NAME> <TEST_NAME> immunoglobulin_levels </TEST_NAME> <TEST_NAME> blood_to_normal_levels </TEST_NAME> <TREATMENT_NAME> replacement_therapy </TREATMENT_NAME> <BRAND_NAME> HyQvia </BRAND_NAME> <TREATMENT_NAME> replacement_therapy </TREATMENT_NAME> <DX_NAME> inborn_inability </DX_NAME> <DX_NAME> reduced_ability_to_produce_antibodies </DX_NAME> <DX_NAME> primary_immunodeficiencies </DX_NAME> <DX_NAME> blood_cancer </DX_NAME> <DX_NAME> lymphocytic_leukaemia </DX_NAME> <DX_NAME> lack_of_antibody_production </DX_NAME> <DX_NAME> recurrent_infections </DX_NAME> <TREATMENT_NAME> antibiotics </TREATMENT_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> multiple_myeloma </DX_NAME> <DX_NAME> lack_of_antibody_production </DX_NAME> <DX_NAME> recurrent_infections </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <DX_NAME> bacteria </DX_NAME> <GENERIC_NAME> pneumococci </GENERIC_NAME> <TIME_TO_PROCEDURE_NAME> prior </TIME_TO_PROCEDURE_NAME> <TIME_TO_PROCEDURE_NAME> prior </TIME_TO_PROCEDURE_NAME> <PROCEDURE_NAME> transplantation </PROCEDURE_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_cells </PROCEDURE_NAME>
<GENERIC_NAME> aliskiren </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> hypertension </DX_NAME> <GENERIC_NAME> aliskiren </GENERIC_NAME> <TREATMENT_NAME> renin_inhibitor </TREATMENT_NAME> <GENERIC_NAME> angiotensin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <GENERIC_NAME> thiazide </GENERIC_NAME> <TREATMENT_NAME> diuretics </TREATMENT_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> damage_the_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> kidneys </SYSTEM_ORGAN_SITE> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_failure </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <SYSTEM_ORGAN_SITE> kidney </SYSTEM_ORGAN_SITE> <DX_NAME> kidney_failure </DX_NAME> <TEST_NAME> blood_pressure </TEST_NAME> <DX_NAME> disorders </DX_NAME> <DX_NAME> high_blood_pressure </DX_NAME> <GENERIC_NAME> aliskiren </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME> <GENERIC_NAME> aliskiren </GENERIC_NAME> <GENERIC_NAME> hydrochlorothiazide </GENERIC_NAME>
<BRAND_NAME> rotarix </BRAND_NAME> <DX_NAME> gastroenteritis </DX_NAME> <DX_NAME> diarrhoea </DX_NAME> <DX_NAME> vomiting </DX_NAME> <DX_NAME> rotavirus_infection </DX_NAME> <BRAND_NAME> rotarix </BRAND_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> diarrhoea </DX_NAME> <DX_NAME> contact_with_stools </DX_NAME> <DX_NAME> infected_person </DX_NAME> <DX_NAME> ill </DX_NAME> <DX_NAME> vomiting </DX_NAME> <DX_NAME> diarrhoea </DX_NAME> <DX_NAME> lifethreatening_loss </DX_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <TREATMENT_NAME> vaccines </TREATMENT_NAME> <BRAND_NAME> rotarix </BRAND_NAME> <DX_NAME> infections </DX_NAME>
<GENERIC_NAME> xagrid </GENERIC_NAME> <GENERIC_NAME> anagrelide </GENERIC_NAME> <GENERIC_NAME> xagrid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TEST_NAME> bone_marrow </TEST_NAME> <DX_NAME> thrombocythaemia </DX_NAME> <DX_NAME> thrombocythaemia </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TEST_NAME> platelets </TEST_NAME> <DX_NAME> blood_circulation_and_clotting </DX_NAME>
<GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> tumour </DX_NAME> <DX_NAME> side_effects </DX_NAME> <DX_NAME> side_effects </DX_NAME> <BRAND_NAME> pazenir </BRAND_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> breast </SYSTEM_ORGAN_SITE> <DX_NAME> breast_cancer </DX_NAME> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <DX_NAME> pancreatic_cancer </DX_NAME> <GENERIC_NAME> gemcitabine </GENERIC_NAME> <DX_NAME> metastatic_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <DX_NAME> pancreatic_cancer </DX_NAME> <DX_NAME> pancreatic_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> paclitaxel </GENERIC_NAME> <GENERIC_NAME> gemcitabine </GENERIC_NAME> <GENERIC_NAME> gemcitabine </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <GENERIC_NAME> carboplatin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_cancer </DX_NAME> <DX_NAME> “nonsmall_cell_lung_cancer” </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> nonsmall_cell_lung_cancer </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> surgery </PROCEDURE_NAME> <TREATMENT_NAME> radiotherapy </TREATMENT_NAME>
<GENERIC_NAME> Imatinib_Actavis </GENERIC_NAME> <GENERIC_NAME> imatinib </GENERIC_NAME> <DX_NAME> cancer </DX_NAME> <GENERIC_NAME> Imatinib_Actavis </GENERIC_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> CML </DX_NAME> <DX_NAME> Leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> myeloid_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> Imatinib_Actavis </GENERIC_NAME> <GENERIC_NAME> Imatinib_Actavis </GENERIC_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> Ph-positive_ALL </DX_NAME> <DX_NAME> Leukaemia </DX_NAME> <DX_NAME> cancer </DX_NAME> <DX_NAME> infection </DX_NAME> <DX_NAME> lymphoblastic_leukaemia </DX_NAME> <DX_NAME> leukaemia </DX_NAME> <GENERIC_NAME> Imatinib_Actavis </GENERIC_NAME> <GENERIC_NAME> Imatinib_Actavis </GENERIC_NAME> <DX_NAME> Myelodysplastic/myeloproliferative_diseases </DX_NAME> <DX_NAME> MDS/MPD </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> Hypereosinophilic_syndrome </DX_NAME> <DX_NAME> HES </DX_NAME> <DX_NAME> eosinophilic_leukaemia </DX_NAME> <DX_NAME> blood_diseases </DX_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> Dermatofibrosarcoma_protuberans </DX_NAME> <DX_NAME> DFSP </DX_NAME> <DX_NAME> DFSP </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <GENERIC_NAME> Imatinib_Actavis </GENERIC_NAME> <GENERIC_NAME> Imatinib </GENERIC_NAME>
<GENERIC_NAME> anagrelide </GENERIC_NAME> <GENERIC_NAME> anagrelide </GENERIC_NAME> <GENERIC_NAME> anagrelide </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TEST_NAME> bone_marrow </TEST_NAME> <DX_NAME> thrombocythaemia </DX_NAME> <DX_NAME> thrombocythaemia </DX_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <TEST_NAME> platelets </TEST_NAME> <DX_NAME> blood_circulation_and_clotting </DX_NAME>
<GENERIC_NAME> iron </GENERIC_NAME> <GENERIC_NAME> ferric_maltol </GENERIC_NAME> <GENERIC_NAME> sodium_laurilsulfate </GENERIC_NAME> <GENERIC_NAME> magnesium_stearate </GENERIC_NAME> <GENERIC_NAME> colloidal_anhydrous_silica_crospovidone </GENERIC_NAME> <GENERIC_NAME> titanium_dioxide </GENERIC_NAME> <GENERIC_NAME> vivaldistraat </GENERIC_NAME> <ADDRESS> netherlands_manufacturer_piramal_healthcare_uk_limited_whalton_road_morpeth_northumberland_ne61_3ya,_uk_patheon_france </ADDRESS> <ADDRESS> 24_40_boulevard_de_champaret_38300 </ADDRESS> <ADDRESS> bourgoinjallieu_france </ADDRESS> <NAME> lu </NAME> <URL> \bg\cz\dk\fi\hr\hu\is\no\pl\_ro\se\si\sk_norgine </URL> <DATE> 16_39_27 </DATE> <EMAIL> medinfo.benelux@norgine.com </EMAIL> <ID> 4315037244 </ID> <EMAIL> office@aoporphan.com </EMAIL> <ID> 641984970 </ID> <EMAIL> info@norgine.de </EMAIL> <ID> 826666 </ID> <EMAIL> medinfo@norgine.com </EMAIL> <EMAIL> iberiamedinfo@norgine.com </EMAIL> <ID> 141399400 </ID> <EMAIL> infomedicale.norginefrance@norgine.com </EMAIL> <NAME> italia_s.r.l. </NAME> <ID> 977211 </ID> <EMAIL> medinfoitaly@norgine.com </EMAIL> <EMAIL> medinfo.benelux@norgine.com </EMAIL> <ID> 218952735 </ID> <EMAIL> iberiamedinfo@norgine.com </EMAIL> <ID> 826600 </ID> <EMAIL> gmedicalaffairs@norgine.com </EMAIL>
<GENERIC_NAME> insulin_human </GENERIC_NAME> <GENERIC_NAME> insulin_human </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_human </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_human </GENERIC_NAME> <DX_NAME> high_blood_sugar </DX_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <DX_NAME> diabetes_mellitus </DX_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_human </GENERIC_NAME> <DX_NAME> hyperglycaemic_coma </DX_NAME> <DX_NAME> coma </DX_NAME> <DX_NAME> blood_sugar </DX_NAME> <DX_NAME> ketoacidosis </DX_NAME> <DX_NAME> buildup_of_acid </DX_NAME> <PROCEDURE_NAME> surgery </PROCEDURE_NAME>
<GENERIC_NAME> defibrotide </GENERIC_NAME>
<DX_NAME> hepatitis_c_infection </DX_NAME> <DX_NAME> hepatitis_c_infection </DX_NAME> <GENERIC_NAME> peginterferon_alfa </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <GENERIC_NAME> telaprevir </GENERIC_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <GENERIC_NAME> peginterferon_alfa </GENERIC_NAME> <GENERIC_NAME> ribavirin </GENERIC_NAME> <DX_NAME> hepatitis_c_infection </DX_NAME> <DX_NAME> hepatitis_c_infection </DX_NAME> <TIME_TO_TREATMENT_NAME> previously </TIME_TO_TREATMENT_NAME> <TREATMENT_NAME> interferonbased_regimen </TREATMENT_NAME>
<GENERIC_NAME> filgrastim </GENERIC_NAME> <GENERIC_NAME> filgrastim </GENERIC_NAME> <GENERIC_NAME> filgrastim </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <DX_NAME> infection </DX_NAME> <GENERIC_NAME> accofil </GENERIC_NAME> <TREATMENT_NAME> chemotherapy </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplantation </PROCEDURE_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> neutropenia </DX_NAME> <TEST_NAME> white_blood_cells </TEST_NAME> <DX_NAME> hiv_infection </DX_NAME> <TREATMENT_NAME> hiv_infection_peripheral_blood_stem_cell_mobilisation </TREATMENT_NAME> <TREATMENT_NAME> stimulate_stem_cells </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> bone_marrow </SYSTEM_ORGAN_SITE> <PROCEDURE_NAME> bone_marrow_transplantation </PROCEDURE_NAME>
<GENERIC_NAME> budesonide </GENERIC_NAME> <GENERIC_NAME> formoterol_fumarate_dihydrate </GENERIC_NAME> <GENERIC_NAME> budesonide </GENERIC_NAME> <DX_NAME> swelling </DX_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <GENERIC_NAME> formoterol_fumarate_dihydrate </GENERIC_NAME> <SYSTEM_ORGAN_SITE> muscles </SYSTEM_ORGAN_SITE> <AGE> 13 </AGE> <AGE> 17 </AGE> <DX_NAME> asthma </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> asthma </DX_NAME> <BRAND_NAME> spiromax </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <TREATMENT_NAME> asthma_inhalers </TREATMENT_NAME> <GENERIC_NAME> salbutamol </GENERIC_NAME> <BRAND_NAME> duoresp_spiromax </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <DX_NAME> asthma </DX_NAME> <GENERIC_NAME> duoresp_spiromax </GENERIC_NAME> <DX_NAME> asthma </DX_NAME> <BRAND_NAME> duoresp_spiromax </BRAND_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> breathlessness </DX_NAME> <DX_NAME> wheezing </DX_NAME> <GENERIC_NAME> duoresp_spiromax </GENERIC_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> asthma </DX_NAME> <DX_NAME> obstructive_pulmonary_disease </DX_NAME> <DX_NAME> copd </DX_NAME> <DX_NAME> copd </DX_NAME> <SYSTEM_ORGAN_SITE> lung </SYSTEM_ORGAN_SITE> <DX_NAME> lung_disease </DX_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> shortness_of_breath </DX_NAME> <DX_NAME> cough </DX_NAME> <SYSTEM_ORGAN_SITE> chest </SYSTEM_ORGAN_SITE> <DX_NAME> chest_discomfort </DX_NAME> <DX_NAME> coughing </DX_NAME> <DX_NAME> copd </DX_NAME>
<GENERIC_NAME> bosentan </GENERIC_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> blood_vessels_to_narrow </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <DX_NAME> pulmonary_arterial_hypertension </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> narrowing_of_the_blood_vessels </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> high_blood_pressure </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> pulmonary_arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <TREATMENT_NAME> oxygen </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> pulmonary_arteries </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> pah </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> limitation_of_physical_activity </DX_NAME> <DX_NAME> pah </DX_NAME> <DX_NAME> scleroderma </DX_NAME> <DX_NAME> systemic_sclerosis </DX_NAME> <DX_NAME> abnormal_growth </DX_NAME> <SYSTEM_ORGAN_SITE> connective_tissue </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> skin </SYSTEM_ORGAN_SITE> <DX_NAME> congenital_(inborn </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_defects </DX_NAME> <DX_NAME> shunts </DX_NAME> <DX_NAME> abnormal_passageways </DX_NAME> <DX_NAME> abnormal_flow_of_blood </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> lungs </SYSTEM_ORGAN_SITE> <DX_NAME> ulcers </DX_NAME> <DX_NAME> sores </DX_NAME> <SYSTEM_ORGAN_SITE> fingers </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> toes </SYSTEM_ORGAN_SITE> <DX_NAME> scleroderma </DX_NAME> <SYSTEM_ORGAN_SITE> finger </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> toe </SYSTEM_ORGAN_SITE> <DX_NAME> toe_ulcers </DX_NAME>
<SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> liver_disease </DX_NAME> <DX_NAME> low_platelet_count </DX_NAME> <DX_NAME> thrombocytopenia </DX_NAME> <DX_NAME> bleeding </DX_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <TREATMENT_NAME> platelets </TREATMENT_NAME> <TREATMENT_NAME> blood_cells </TREATMENT_NAME> <DX_NAME> clot </DX_NAME> <DX_NAME> bleeding </DX_NAME>
<GENERIC_NAME> ariclaim </GENERIC_NAME> <GENERIC_NAME> duloxetine </GENERIC_NAME> <GENERIC_NAME> ariclaim </GENERIC_NAME> <BRAND_NAME> serotonin </BRAND_NAME> <GENERIC_NAME> noradrenaline </GENERIC_NAME> <SYSTEM_ORGAN_SITE> nervous_system </SYSTEM_ORGAN_SITE> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <DX_NAME> burning </DX_NAME> <DX_NAME> stabbing </DX_NAME> <DX_NAME> stinging </DX_NAME> <DX_NAME> shooting </DX_NAME> <DX_NAME> aching </DX_NAME> <DX_NAME> electric_shock </DX_NAME> <DX_NAME> loss_of_feeling </DX_NAME> <SYSTEM_ORGAN_SITE> affected_area </SYSTEM_ORGAN_SITE> <DX_NAME> cold </DX_NAME> <DX_NAME> pain </DX_NAME> <DX_NAME> diabetic </DX_NAME> <DX_NAME> neuropathic_pain </DX_NAME> <TIME_TO_DX_NAME> some_weeks </TIME_TO_DX_NAME> <TIME_TO_DX_NAME> some_weeks </TIME_TO_DX_NAME>
<GENERIC_NAME> clopidogrel </GENERIC_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <TEST_NAME> platelets </TEST_NAME> <TREATMENT_NAME> antiplatelet_medicinal_products </TREATMENT_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombosis </DX_NAME> <DX_NAME> blood_clots </DX_NAME> <DX_NAME> thrombi </DX_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherothrombosis </DX_NAME> <DX_NAME> atherothrombotic_events </DX_NAME> <DX_NAME> stroke </DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> death </DX_NAME> <GENERIC_NAME> clopidogrel </GENERIC_NAME> <DX_NAME> blood_clots </DX_NAME> <SYSTEM_ORGAN_SITE> arteries </SYSTEM_ORGAN_SITE> <DX_NAME> atherosclerosis </DX_NAME> <TIME_TO_DX_NAME> previously </TIME_TO_DX_NAME> <SYSTEM_ORGAN_SITE> heart </SYSTEM_ORGAN_SITE> <DX_NAME> heart_attack </DX_NAME> <DX_NAME> stroke </DX_NAME> <DX_NAME> peripheral_arterial_disease </DX_NAME>
<GENERIC_NAME> somatropin_biopartners </GENERIC_NAME> <GENERIC_NAME> somatropin </GENERIC_NAME> <DX_NAME> lack_(deficiency </DX_NAME> <DX_NAME> growth_hormone_deficiency </DX_NAME>
<GENERIC_NAME> vizarsin </GENERIC_NAME> <GENERIC_NAME> sildenafil </GENERIC_NAME> <TREATMENT_NAME> phosphodiesterase_type_5_(pde5)_inhibitors </TREATMENT_NAME> <SYSTEM_ORGAN_SITE> blood_vessels </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE> <GENERIC_NAME> vizarsin </GENERIC_NAME> <DX_NAME> erection </DX_NAME> <DX_NAME> sexually_stimulated </DX_NAME> <GENERIC_NAME> vizarsin </GENERIC_NAME> <DX_NAME> erectile_dysfunction </DX_NAME> <DX_NAME> cannot_get </DX_NAME> <DX_NAME> erect_penis_suitable_for_sexual_activity </DX_NAME> <SYSTEM_ORGAN_SITE> penis </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> starlix </GENERIC_NAME> <BRAND_NAME> starlix </BRAND_NAME> <GENERIC_NAME> nateglinide </GENERIC_NAME> <TREATMENT_NAME> oral_antidiabetics </TREATMENT_NAME> <GENERIC_NAME> antidiabetics </GENERIC_NAME> <GENERIC_NAME> starlix </GENERIC_NAME> <DX_NAME> type_2_diabetes </DX_NAME> <GENERIC_NAME> starlix </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <GENERIC_NAME> metformin </GENERIC_NAME> <BRAND_NAME> starlix </BRAND_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <DX_NAME> type_2_diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> starlix </GENERIC_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> starlix </GENERIC_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE>
<GENERIC_NAME> insulin_lispro_sanofi </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <GENERIC_NAME> normal_human_insulin </GENERIC_NAME> <GENERIC_NAME> insulin_molecule </GENERIC_NAME> <DX_NAME> diabetes </DX_NAME> <SYSTEM_ORGAN_SITE> pancreas </SYSTEM_ORGAN_SITE> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_lispro_sanofi </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_lispro_sanofi </GENERIC_NAME> <GENERIC_NAME> insulin_lispro_sanofi </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin </GENERIC_NAME> <GENERIC_NAME> insulin_lispro_sanofi </GENERIC_NAME>
<GENERIC_NAME> daklinza </GENERIC_NAME> <GENERIC_NAME> daclatasvir </GENERIC_NAME> <DX_NAME> hepatitis_c </DX_NAME> <DX_NAME> infectious_disease </DX_NAME> <SYSTEM_ORGAN_SITE> liver </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_c_virus </DX_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <DX_NAME> hepatitis_c_virus </DX_NAME> <SYSTEM_ORGAN_SITE> body </SYSTEM_ORGAN_SITE> <DX_NAME> hepatitis_c_infection </DX_NAME> <GENERIC_NAME> daklinza </GENERIC_NAME>
<DX_NAME> multiple_sclerosis </DX_NAME> <DX_NAME> active_disease </DX_NAME> <DX_NAME> active_disease </DX_NAME> <DX_NAME> relapses </DX_NAME> <TEST_NAME> mri </TEST_NAME> <TEST_NAME> magnetic_resonance_imaging </TEST_NAME> <DX_NAME> inflammation </DX_NAME> <SYSTEM_ORGAN_SITE> central_nervous_system </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> cns </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> immune_system </SYSTEM_ORGAN_SITE> <TEST_NAME> white_blood_cells </TEST_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> spinal_cord </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> nerve </SYSTEM_ORGAN_SITE> <DX_NAME> nerve_damage </DX_NAME> <DX_NAME> disability </DX_NAME> <SYSTEM_ORGAN_SITE> brain </SYSTEM_ORGAN_SITE> <DX_NAME> brain_lesions </DX_NAME> <DX_NAME> relapses </DX_NAME>
<TREATMENT_NAME> influenza_virus </TREATMENT_NAME> <DATE> 2004 </DATE> <GENERIC_NAME> haemagglutinin </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <GENERIC_NAME> squalene </GENERIC_NAME> <GENERIC_NAME> dlαtocopherol </GENERIC_NAME> <GENERIC_NAME> polysorbate </GENERIC_NAME> <GENERIC_NAME> adjuvants </GENERIC_NAME> <TREATMENT_NAME> vaccine </TREATMENT_NAME> <GENERIC_NAME> polysorbate_80 </GENERIC_NAME> <GENERIC_NAME> octoxynol </GENERIC_NAME> <GENERIC_NAME> thiomersal </GENERIC_NAME> <GENERIC_NAME> sodium_chloride </GENERIC_NAME> <GENERIC_NAME> disodium_hydrogen_phosphate </GENERIC_NAME> <GENERIC_NAME> potassium_dihydrogen_phosphate </GENERIC_NAME> <GENERIC_NAME> potassium_chloride </GENERIC_NAME> <GENERIC_NAME> magnesium_chloride </GENERIC_NAME>
<BRAND_NAME> zometa </BRAND_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <GENERIC_NAME> zoledronic_acid </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_complications </DX_NAME> <DX_NAME> fractures </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> bone_metastases </DX_NAME> <DX_NAME> cancer </DX_NAME> <SYSTEM_ORGAN_SITE> primary_site </SYSTEM_ORGAN_SITE> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <DX_NAME> tumour </DX_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <GENERIC_NAME> calcium </GENERIC_NAME> <SYSTEM_ORGAN_SITE> bone </SYSTEM_ORGAN_SITE> <DX_NAME> hypercalcaemia </DX_NAME>
